{ "instance": { "rdy-20220331.htm": { "axisCustom": 41, "axisStandard": 45, "contextCount": 1277, "dts": { "calculationLink": { "local": [ "rdy-20220331_cal.xml" ] }, "definitionLink": { "local": [ "rdy-20220331_def.xml" ] }, "inline": { "local": [ "rdy-20220331.htm" ] }, "labelLink": { "local": [ "rdy-20220331_lab.xml" ] }, "presentationLink": { "local": [ "rdy-20220331_pre.xml" ] }, "schema": { "local": [ "rdy-20220331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" ] } }, "elementCount": 1654, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 5, "total": 5 }, "keyCustom": 302, "keyStandard": 453, "memberCustom": 341, "memberStandard": 65, "nsprefix": "rdy", "nsuri": "http://www.drreddys.com/20220331", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "1001 - Document - Cover Page", "role": "http://www.drreddys.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1010 - Disclosure - Significant accounting policies", "role": "http://www.drreddys.com/role/SignificantAccountingPolicies", "shortName": "Significant accounting policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R100": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfDetailInformationAboutOfInventoriesRecognizedInConsolidatedIncomeStatementTextBlock", "ifrs-full:DisclosureOfInventoriesExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1100 - Disclosure - Inventories (Details 1)", "role": "http://www.drreddys.com/role/InventoriesDetails1", "shortName": "Inventories (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfDetailInformationAboutOfInventoriesRecognizedInConsolidatedIncomeStatementTextBlock", "ifrs-full:DisclosureOfInventoriesExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R101": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:OtherCurrentAssets", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1101 - Disclosure - Other assets (Details)", "role": "http://www.drreddys.com/role/OtherAssetsDetails", "shortName": "Other assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfDetailedInformationAboutOtherAssetsTableTextBlock", "ifrs-full:DisclosureOfOtherAssetsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_AssetTypeMemberRDYAssetTypeAxis", "decimals": "-6", "lang": null, "name": "ifrs-full:CurrentReceivablesFromTaxesOtherThanIncomeTax", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R102": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2021", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:PropertyPlantAndEquipment", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1102 - Disclosure - Property, plant and equipment (Details)", "role": "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails", "shortName": "Property, plant and equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "lang": null, "name": "rdy:ImpairmentOfCapitalWorkInProgress", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R103": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:SummaryOfDetailedInformationAboutRightofuseAssetsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2021", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:RightofuseAssets", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1103 - Disclosure - Property, plant and equipment (Details 1)", "role": "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails1", "shortName": "Property, plant and equipment (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "rdy:SummaryOfDetailedInformationAboutRightofuseAssetsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2020", "decimals": "-6", "lang": null, "name": "ifrs-full:RightofuseAssets", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R104": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:SummaryOfDetailedInformationAboutAmountsRecognizedInIncomeStatementForRightofuseAssetsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:DepreciationRightofuseAssets", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1104 - Disclosure - Property, plant and equipment (Details 2)", "role": "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails2", "shortName": "Property, plant and equipment (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:SummaryOfDetailedInformationAboutAmountsRecognizedInIncomeStatementForRightofuseAssetsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "lang": null, "name": "ifrs-full:InterestExpenseOnLeaseLiabilities", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R105": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1105 - Disclosure - Property, plant and equipment (Details Textual)", "role": "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetailsTextual", "shortName": "Property, plant and equipment (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R106": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfReconciliationOfChangesInGoodwillTableTextBlock", "ifrs-full:DisclosureOfGoodwillExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "rdy:GoodwillGrossBalance", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1106 - Disclosure - Goodwill (Details)", "role": "http://www.drreddys.com/role/GoodwillDetails", "shortName": "Goodwill (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfReconciliationOfChangesInGoodwillTableTextBlock", "ifrs-full:DisclosureOfGoodwillExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "rdy:GoodwillGrossBalance", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R107": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:Goodwill", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1107 - Disclosure - Goodwill (Details 1)", "role": "http://www.drreddys.com/role/GoodwillDetails1", "shortName": "Goodwill (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "td", "tr", "table", "rdy:DisclosureOfInformationForCashGeneratingUnitsTableTextBlock", "ifrs-full:DisclosureOfGoodwillExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMemberifrsfullIndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis", "decimals": "-6", "lang": null, "name": "ifrs-full:Goodwill", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R108": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfReconciliationOfChangesInGoodwillTableTextBlock", "ifrs-full:DisclosureOfGoodwillExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "rdy:ImpairmentLossRecordedInGoodwillTillDate", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1108 - Disclosure - Goodwill (Details Textual)", "role": "http://www.drreddys.com/role/GoodwillDetailsTextual", "shortName": "Goodwill (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "ifrs-full:DisclosureOfGoodwillExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_GlobalGenericsComplexInjectablesMemberifrsfullIndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis", "decimals": "-6", "lang": null, "name": "rdy:ImpairmentLossRecordedInGoodwillTillDate", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R109": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2021", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1109 - Disclosure - Other intangible assets (Details)", "role": "http://www.drreddys.com/role/OtherIntangibleAssetsDetails", "shortName": "Other intangible assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatoryTextBlock", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2020_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis", "decimals": "-6", "lang": null, "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfFairValueMeasurementExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1011 - Disclosure - Determination of fair values", "role": "http://www.drreddys.com/role/DeterminationOfFairValues", "shortName": "Determination of fair values", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfFairValueMeasurementExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R110": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2021", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1110 - Disclosure - Other intangible assets (Details 1)", "role": "http://www.drreddys.com/role/OtherIntangibleAssetsDetails1", "shortName": "Other intangible assets (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfDetailedInformationAboutIntangibleAssetsUnderDevelopmentTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2020_IntangibleAssetsUnderDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis", "decimals": "-6", "lang": null, "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R111": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DescriptionOfSignificantSeparatelyAcquiredIntangibleAssetsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_WockhardtLimitedMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DescriptionAndCarryingAmountOfIntangibleAssetsMaterialToEntity", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1111 - Disclosure - Other intangible assets (Details 2)", "role": "http://www.drreddys.com/role/OtherIntangibleAssetsDetails2", "shortName": "Other intangible assets (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DescriptionOfSignificantSeparatelyAcquiredIntangibleAssetsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_WockhardtLimitedMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DescriptionAndCarryingAmountOfIntangibleAssetsMaterialToEntity", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R112": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2020To03_31_2021", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:ImpairmentLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1112 - Disclosure - Other intangible assets (Details Textual)", "role": "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual", "shortName": "Other intangible assets (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2020To03_31_2021", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:ImpairmentLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R113": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:InvestmentAccountedForUsingEquityMethod", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1113 - Disclosure - Investment in equity accounted investees (Details)", "role": "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails", "shortName": "Investment in equity accounted investees (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R114": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:CurrentAssets", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1114 - Disclosure - Investment in equity accounted investees (Details 1)", "role": "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails1", "shortName": "Investment in equity accounted investees (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfDetailedInformationAboutJointVentureTableTextBlock", "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_KunshanRotamReddyPharmaceuticalsCoLimitedMemberifrsfullJointVenturesAxis", "decimals": "-6", "lang": null, "name": "ifrs-full:CurrentAssets", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R115": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:InvestmentAccountedForUsingEquityMethod", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1115 - Disclosure - Investment in equity accounted investees (Details 2)", "role": "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails2", "shortName": "Investment in equity accounted investees (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfDetailedInformationAboutJointVentureTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_DresEnergyPrivateLimitedMemberifrsfullJointVenturesAxis", "decimals": "-6", "lang": null, "name": "ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R116": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": null, "name": "ifrs-full:DividendsReceivedFromInvestmentsAccountedForUsingEquityMethodClassifiedAsInvestingActivities", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "true" }, "groupType": "disclosure", "isDefault": "false", "longName": "1116 - Disclosure - Investment in equity accounted investees (Details Textual)", "role": "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetailsTextual", "shortName": "Investment in equity accounted investees (Details Textual)", "subGroupType": "details", "uniqueAnchor": null }, "R117": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:TradeAndOtherPayablesTableTextBlock", "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1117 - Disclosure - Trade and other payables (Details)", "role": "http://www.drreddys.com/role/TradeAndOtherPayablesDetails", "shortName": "Trade and other payables (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:TradeAndOtherPayablesTableTextBlock", "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R118": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:ShorttermBorrowings", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1118 - Disclosure - Loans and borrowings (Details)", "role": "http://www.drreddys.com/role/LoansAndBorrowingsDetails", "shortName": "Loans and borrowings (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfShortTermBorrowingsTableTextBlock", "ifrs-full:DisclosureOfBorrowingsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_PreshipmentCreditMemberifrsfullBorrowingsByNameAxis", "decimals": "-6", "lang": null, "name": "ifrs-full:ShorttermBorrowings", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R119": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfInterestRateProfileOfShortTermBorrowingsTableTextBlock", "ifrs-full:DisclosureOfBorrowingsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_PackingCreditBorrowingsInrMemberifrsfullBorrowingsByNameAxis", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:BorrowingsOriginalCurrency", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1119 - Disclosure - Loans and borrowings (Details 1)", "role": "http://www.drreddys.com/role/LoansAndBorrowingsDetails1", "shortName": "Loans and borrowings (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfInterestRateProfileOfShortTermBorrowingsTableTextBlock", "ifrs-full:DisclosureOfBorrowingsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_PackingCreditBorrowingsInrMemberifrsfullBorrowingsByNameAxis", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:BorrowingsOriginalCurrency", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1012 - Disclosure - Segment reporting", "role": "http://www.drreddys.com/role/SegmentReporting", "shortName": "Segment reporting", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R120": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:CurrentPortionOfLongtermBorrowings", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1120 - Disclosure - Loans and borrowings (Details 2)", "role": "http://www.drreddys.com/role/LoansAndBorrowingsDetails2", "shortName": "Loans and borrowings (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfLongTermBorrowingsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_ObligationsUnderLeasesMemberifrsfullCategoriesOfRelatedPartiesAxis", "decimals": "-6", "lang": null, "name": "ifrs-full:CurrentLeaseLiabilities", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R121": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfInterestRateProfileOfLongtermBorrowingsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_INRsrtCurrencyAxis_NonConvertibleDebenturesMemberifrsfullBorrowingsByNameAxis", "decimals": "4", "first": true, "lang": null, "name": "ifrs-full:BorrowingsInterestRate", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1121 - Disclosure - Loans and borrowings (Details 3)", "role": "http://www.drreddys.com/role/LoansAndBorrowingsDetails3", "shortName": "Loans and borrowings (Details 3)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfInterestRateProfileOfLongtermBorrowingsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_INRsrtCurrencyAxis_NonConvertibleDebenturesMemberifrsfullBorrowingsByNameAxis", "decimals": "4", "first": true, "lang": null, "name": "ifrs-full:BorrowingsInterestRate", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R122": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "rdy:DisclosureOfContractualMaturitiesOfLongTermBorrowingsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "rdy:NonCurrentPortionOfNonCurrentDebenturesUndiscounted", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1122 - Disclosure - Loans and borrowings (Details 4)", "role": "http://www.drreddys.com/role/LoansAndBorrowingsDetails4", "shortName": "Loans and borrowings (Details 4)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "rdy:DisclosureOfContractualMaturitiesOfLongTermBorrowingsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "rdy:NonCurrentPortionOfNonCurrentDebenturesUndiscounted", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R123": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2021", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:LiabilitiesArisingFromFinancingActivities", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1123 - Disclosure - Loans and borrowings (Details 5)", "role": "http://www.drreddys.com/role/LoansAndBorrowingsDetails5", "shortName": "Loans and borrowings (Details 5)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2020", "decimals": "-6", "lang": null, "name": "ifrs-full:LiabilitiesArisingFromFinancingActivities", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R124": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2021", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:UndrawnBorrowingFacilities", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1124 - Disclosure - Loans and borrowings (Details Textual)", "role": "http://www.drreddys.com/role/LoansAndBorrowingsDetailsTextual", "shortName": "Loans and borrowings (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2021_AurigenePharmaceuticalServicesLimitedMemberifrsfullSignificantInvestmentsInSubsidiariesAxis_NonConvertibleDebenturesMemberifrsfullBorrowingsByNameAxis", "decimals": "-6", "lang": null, "name": "ifrs-full:NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R125": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "rdy:DisclosureOfProvisionTableTextBlock", "ifrs-full:DisclosureOfOtherProvisionsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2021", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:OtherProvisions", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1125 - Disclosure - Provisions (Details)", "role": "http://www.drreddys.com/role/ProvisionsDetails", "shortName": "Provisions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "rdy:DisclosureOfProvisionTableTextBlock", "ifrs-full:DisclosureOfOtherProvisionsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "lang": null, "name": "rdy:DueToCreditorsForExpenses", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R126": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:DisclosureOfProvisionTableTextBlock", "ifrs-full:DisclosureOfOtherProvisionsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:OtherProvisions", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1126 - Disclosure - Provisions (Details Textual)", "role": "http://www.drreddys.com/role/ProvisionsDetailsTextual", "shortName": "Provisions (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfOtherProvisionsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_OtherEnvironmentRelatedProvisionMemberifrsfullClassesOfProvisionsAxis", "decimals": "-6", "lang": null, "name": "rdy:InitialLiabilityAssumed", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R127": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:ScheduleOfOtherLiabilitiesTableTextBlock", "ifrs-full:DisclosureOfOtherLiabilitiesExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1127 - Disclosure - Other liabilities (Details)", "role": "http://www.drreddys.com/role/OtherLiabilitiesDetails", "shortName": "Other liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:ScheduleOfOtherLiabilitiesTableTextBlock", "ifrs-full:DisclosureOfOtherLiabilitiesExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R128": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2021", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:IssuedCapital", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1128 - Disclosure - Share Capital (Details)", "role": "http://www.drreddys.com/role/ShareCapitalDetails", "shortName": "Share Capital (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfClassesOfShareCapitalTableTextBlock", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2021_OrdinarySharesMemberifrsfullComponentsOfEquityAxis", "decimals": "0", "lang": null, "name": "ifrs-full:NumberOfSharesAuthorised", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R129": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:DisclosureOfDetailedInformationAboutDividendsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:DividendsRecognisedAsDistributionsToOwnersPerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_INR_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1129 - Disclosure - Share Capital (Details 1)", "role": "http://www.drreddys.com/role/ShareCapitalDetails1", "shortName": "Share Capital (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:DisclosureOfDetailedInformationAboutDividendsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:DividendsRecognisedAsDistributionsToOwnersPerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_INR_per_Share", "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfBusinessCombinationsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1013 - Disclosure - Business Combinations", "role": "http://www.drreddys.com/role/BusinessCombinations", "shortName": "Business Combinations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfBusinessCombinationsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R130": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P05_19_2022To05_19_2022", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwnersPerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_INR_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1130 - Disclosure - Share Capital (Details Textual)", "role": "http://www.drreddys.com/role/ShareCapitalDetailsTextual", "shortName": "Share Capital (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P05_19_2022To05_19_2022", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwnersPerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_INR_per_Share", "xsiNil": "false" } }, "R131": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:BasicEarningsPerShareTableTextBlock", "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:NumberOfSharesOutstanding", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1131 - Disclosure - Earnings per share (Details)", "role": "http://www.drreddys.com/role/EarningsPerShareDetails", "shortName": "Earnings per share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:BasicEarningsPerShareTableTextBlock", "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2021", "decimals": "0", "lang": null, "name": "ifrs-full:NumberOfSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R132": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:BasicEarningsPerShareTableTextBlock", "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:WeightedAverageShares", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1132 - Disclosure - Earnings per share (Details 1)", "role": "http://www.drreddys.com/role/EarningsPerShareDetails1", "shortName": "Earnings per share (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DilutedEarningsPerShareTableTextBlock", "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2020To03_31_2021", "decimals": "0", "lang": null, "name": "ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R133": { "firstAnchor": { "ancestors": [ "div", "div", "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1133 - Disclosure - Earnings per share (Details Textual)", "role": "http://www.drreddys.com/role/EarningsPerShareDetailsTextual", "shortName": "Earnings per share (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R134": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:ScheduleOfRevenueTableTextBlock", "ifrs-full:DisclosureOfRevenueExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:RevenueFromSaleOfGoods", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1134 - Disclosure - Revenue from contracts with customers and trade receivables (Details)", "role": "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails", "shortName": "Revenue from contracts with customers and trade receivables (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:ScheduleOfRevenueTableTextBlock", "ifrs-full:DisclosureOfRevenueExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:RevenueFromSaleOfGoods", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R135": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1135 - Disclosure - Revenue from contracts with customers and trade receivables (Details 1)", "role": "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails1", "shortName": "Revenue from contracts with customers and trade receivables (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfRevenueBySegmentsTableTextBlock", "ifrs-full:DisclosureOfRevenueExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_OthersSegmentsMemberifrsfullSegmentsAxis", "decimals": "-6", "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R136": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1136 - Disclosure - Revenue from contracts with customers and trade receivables (Details 2)", "role": "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails2", "shortName": "Revenue from contracts with customers and trade receivables (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:DisclosureAndDetailsAboutRevenueWithInGlobalGenericSegmentsTableTextBlock", "ifrs-full:DisclosureOfRevenueExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_GlobalGenericsMemberifrsfullSegmentsAxis_NervousSystemMemberifrsfullProductsAndServicesAxis", "decimals": "-6", "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R137": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1137 - Disclosure - Revenue from contracts with customers and trade receivables (Details 3)", "role": "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails3", "shortName": "Revenue from contracts with customers and trade receivables (Details 3)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureAndDetailsAboutRevenueFromTherapeuticsAreasTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_AntiinfectiveMemberifrsfullProductsAndServicesAxis_PharmaceuticalServicesAndActiveIngredientMemberifrsfullSegmentsAxis", "decimals": "-6", "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R138": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1138 - Disclosure - Revenue from contracts with customers and trade receivables (Details 4)", "role": "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails4", "shortName": "Revenue from contracts with customers and trade receivables (Details 4)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:DisaggregationOfRevenueByGeographicalAreasTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_IndiaCountryMemberifrsfullGeographicalAreasAxis", "decimals": "-6", "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R139": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:DisclosureOfReconciliationOfDeferredRevenueTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2021", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:DeferredIncomeOtherThanContractLiabilities", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1139 - Disclosure - Revenue from contracts with customers and trade receivables (Details 5)", "role": "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails5", "shortName": "Revenue from contracts with customers and trade receivables (Details 5)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:DisclosureOfReconciliationOfDeferredRevenueTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2020", "decimals": "-6", "lang": null, "name": "ifrs-full:DeferredIncomeOtherThanContractLiabilities", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1014 - Disclosure - Cash and cash equivalents", "role": "http://www.drreddys.com/role/CashAndCashEquivalents", "shortName": "Cash and cash equivalents", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R140": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "rdy:DisclosureOfProvisionTableTextBlock", "ifrs-full:DisclosureOfOtherProvisionsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2021", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:OtherProvisions", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1140 - Disclosure - Revenue from contracts with customers and trade receivables (Details 6)", "role": "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails6", "shortName": "Revenue from contracts with customers and trade receivables (Details 6)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfAccrualForTheCompanysNorthAmericaOperationTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2019_ChargebacksMemberRDYProvisionAxis", "decimals": "-6", "lang": null, "name": "ifrs-full:OtherProvisions", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R141": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfProvisionTableTextBlock", "ifrs-full:DisclosureOfOtherProvisionsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:AdditionalProvisionsOtherProvisions", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1141 - Disclosure - Revenue from contracts with customers and trade receivables (Details 7)", "role": "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails7", "shortName": "Revenue from contracts with customers and trade receivables (Details 7)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "rdy:ScheduleOfMovementOfRefundLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2020_RefundLiabilityMemberRDYProvisionAxis", "decimals": "-6", "lang": null, "name": "ifrs-full:RefundsProvision", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R142": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:DisclosureOfContractLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:Advances", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1142 - Disclosure - Revenue from contracts with customers and trade receivables (Details 8)", "role": "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails8", "shortName": "Revenue from contracts with customers and trade receivables (Details 8)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:DisclosureOfContractLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:Advances", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R143": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:ContractAssets", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1143 - Disclosure - Revenue from contracts with customers and trade receivables (Details Textual)", "role": "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetailsTextual", "shortName": "Revenue from contracts with customers and trade receivables (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:ContractAssets", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R144": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:OtherOperatingIncomeExpenseTableTextBlock", "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:GainsLossesOnDisposalsOfNoncurrentAssets", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1144 - Disclosure - Other income, net (Details)", "role": "http://www.drreddys.com/role/OtherIncomeNetDetails", "shortName": "Other income, net (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:OtherOperatingIncomeExpenseTableTextBlock", "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:GainsLossesOnDisposalsOfNoncurrentAssets", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R145": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:ScheduleOfFinanceExpenseIncomeTableTextBlock", "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:MiscellaneousOtherOperatingIncome", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1145 - Disclosure - Other income, net (Details Textual)", "role": "http://www.drreddys.com/role/OtherIncomeNetDetailsTextual", "shortName": "Other income, net (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:OtherOperatingIncomeExpenseTableTextBlock", "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "lang": null, "name": "rdy:UpFrontPaymentReceived", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R146": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:ScheduleOfFinanceExpenseIncomeTableTextBlock", "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:InvestmentIncome", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1146 - Disclosure - Finance income, net (Details)", "role": "http://www.drreddys.com/role/FinanceIncomeNetDetails", "shortName": "Finance income, net (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:ScheduleOfFinanceExpenseIncomeTableTextBlock", "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:InvestmentIncome", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R147": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "rdy:DisclosureOfIncomeTaxTableTextBlock", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:CurrentTaxExpenseIncome", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1147 - Disclosure - Income taxes (Details)", "role": "http://www.drreddys.com/role/IncomeTaxesDetails", "shortName": "Income taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "rdy:DisclosureOfIncomeTaxTableTextBlock", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:CurrentTaxExpenseIncome", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R148": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:CurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityTableTextBlock", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:IncomeTaxRelatingToAvailableforsaleFinancialAssetsOfOtherComprehensiveIncome", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1148 - Disclosure - Income taxes (Details 1)", "role": "http://www.drreddys.com/role/IncomeTaxesDetails1", "shortName": "Income taxes (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:CurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityTableTextBlock", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:IncomeTaxRelatingToAvailableforsaleFinancialAssetsOfOtherComprehensiveIncome", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R149": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:ProfitLossBeforeTax", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1149 - Disclosure - Income taxes (Details 2)", "role": "http://www.drreddys.com/role/IncomeTaxesDetails2", "shortName": "Income taxes (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:ReconciliationBetweenEnactedAndEffectiveTaxRatesTableTextBlock", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2020To03_31_2021", "decimals": "4", "lang": null, "name": "ifrs-full:ApplicableTaxRate", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1015 - Disclosure - Other investments", "role": "http://www.drreddys.com/role/OtherInvestments", "shortName": "Other investments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R150": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfUnrecognisedDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1150 - Disclosure - Income taxes (Details 3)", "role": "http://www.drreddys.com/role/IncomeTaxesDetails3", "shortName": "Income taxes (Details 3)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfUnrecognisedDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R151": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:DisclosureOfTaxEffectsOfSignificantTemporaryDifferencesThatResultedInDeferredTaxTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:DeferredTaxLiabilityAsset", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1151 - Disclosure - Income taxes (Details 4)", "role": "http://www.drreddys.com/role/IncomeTaxesDetails4", "shortName": "Income taxes (Details 4)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:DisclosureOfTaxEffectsOfSignificantTemporaryDifferencesThatResultedInDeferredTaxTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:DeferredTaxLiabilityAsset", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R152": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:DisclosureOfMovementInDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2021", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:NetDeferredTaxAssets", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1152 - Disclosure - Income taxes (Details 5)", "role": "http://www.drreddys.com/role/IncomeTaxesDetails5", "shortName": "Income taxes (Details 5)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:DisclosureOfMovementInDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2020", "decimals": "-6", "lang": null, "name": "ifrs-full:NetDeferredTaxAssets", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R153": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "rdy:DeferredIncomeTaxesNotRecognizedOnUndistributedEarningsOfSubsidiaries", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1153 - Disclosure - Income taxes (Details Textual)", "role": "http://www.drreddys.com/role/IncomeTaxesDetailsTextual", "shortName": "Income taxes (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "rdy:DeferredIncomeTaxesNotRecognizedOnUndistributedEarningsOfSubsidiaries", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R154": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:SupplementalInformationAboutExpenseByNatureTextBlock", "ifrs-full:DisclosureOfExpensesByNatureExplanatory", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:EmployeeBenefitsExpense", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1154 - Disclosure - Nature of Expense (Details)", "role": "http://www.drreddys.com/role/NatureOfExpenseDetails", "shortName": "Nature of Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:SupplementalInformationAboutExpenseByNatureTextBlock", "ifrs-full:DisclosureOfExpensesByNatureExplanatory", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "lang": null, "name": "ifrs-full:DepreciationExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R155": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:CostRecognizedInIncomeStatementTextBlock", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_ParentCompanyGratuityPlanMemberifrsfullDefinedBenefitPlansAxis", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1155 - Disclosure - Employee benefits (Details)", "role": "http://www.drreddys.com/role/EmployeeBenefitsDetails", "shortName": "Employee benefits (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:CostRecognizedInIncomeStatementTextBlock", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_ParentCompanyGratuityPlanMemberifrsfullDefinedBenefitPlansAxis", "decimals": "-6", "lang": null, "name": "ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R156": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_ParentCompanyGratuityPlanMemberifrsfullDefinedBenefitPlansAxis", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:DefinedBenefitObligationAtPresentValue", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1156 - Disclosure - Employee benefits (Details 1)", "role": "http://www.drreddys.com/role/EmployeeBenefitsDetails1", "shortName": "Employee benefits (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_ParentCompanyGratuityPlanMemberifrsfullDefinedBenefitPlansAxis", "decimals": "-6", "lang": null, "name": "ifrs-full:PlanAssetsAtFairValue", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R157": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2021_ParentCompanyGratuityPlanMemberifrsfullDefinedBenefitPlansAxis", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:DefinedBenefitObligationAtPresentValue", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1157 - Disclosure - Employee benefits (Details 2)", "role": "http://www.drreddys.com/role/EmployeeBenefitsDetails2", "shortName": "Employee benefits (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureofChangesInPresentValueOfDefinedBenefitObligationsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_ParentCompanyGratuityPlanMemberifrsfullDefinedBenefitPlansAxis", "decimals": "-6", "lang": null, "name": "rdy:InterestExpenseIncomeDefinedBenefitObligation", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R158": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfFairValueOfPlanAssetsExplanatory", "ix:continuation", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2021_GratuityBenefitsOfParentMemberifrsfullNetDefinedBenefitLiabilityAssetAxis", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:PlanAssetsAtFairValue", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1158 - Disclosure - Employee benefits (Details 3)", "role": "http://www.drreddys.com/role/EmployeeBenefitsDetails3", "shortName": "Employee benefits (Details 3)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfFairValueOfPlanAssetsExplanatory", "ix:continuation", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2020_GratuityBenefitsOfParentMemberifrsfullNetDefinedBenefitLiabilityAssetAxis", "decimals": "-6", "lang": null, "name": "ifrs-full:PlanAssetsAtFairValue", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R159": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory", "ix:continuation", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_ParentCompanyGratuityPlanMemberifrsfullDefinedBenefitPlansAxis", "decimals": "-6", "first": true, "lang": null, "name": "rdy:DefinedBenefitObligationAtPresentValueWithoutEffectOfSalaryGrowth", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1159 - Disclosure - Employee benefits (Details 4)", "role": "http://www.drreddys.com/role/EmployeeBenefitsDetails4", "shortName": "Employee benefits (Details 4)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory", "ix:continuation", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_ParentCompanyGratuityPlanMemberifrsfullDefinedBenefitPlansAxis", "decimals": "-6", "first": true, "lang": null, "name": "rdy:DefinedBenefitObligationAtPresentValueWithoutEffectOfSalaryGrowth", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1016 - Disclosure - Trade and other receivables", "role": "http://www.drreddys.com/role/TradeAndOtherReceivables", "shortName": "Trade and other receivables", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R160": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfAssumptionsUsedToDetermineBenefitObligationsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_EmployeeBenefitObligationsMemberifrsfullActuarialAssumptionsAxis_ParentCompanyGratuityPlanMemberifrsfullDefinedBenefitPlansAxis", "decimals": "4", "first": true, "lang": null, "name": "ifrs-full:ActuarialAssumptionOfDiscountRates", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1160 - Disclosure - Employee benefits (Details 5)", "role": "http://www.drreddys.com/role/EmployeeBenefitsDetails5", "shortName": "Employee benefits (Details 5)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfAssumptionsUsedToDetermineBenefitObligationsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_EmployeeBenefitObligationsMemberifrsfullActuarialAssumptionsAxis_ParentCompanyGratuityPlanMemberifrsfullDefinedBenefitPlansAxis", "decimals": "4", "first": true, "lang": null, "name": "ifrs-full:ActuarialAssumptionOfDiscountRates", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R161": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfDisaggregationOfPlanAssetsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_FundsManagedByInsurersMemberRDYAssetCategoryAxis_ParentCompanyGratuityPlanMemberifrsfullNetDefinedBenefitLiabilityAssetAxis", "decimals": "2", "first": true, "lang": null, "name": "rdy:PercentageOfWeightedAverageAssetAllocation", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1161 - Disclosure - Employee benefits (Details 7)", "role": "http://www.drreddys.com/role/EmployeeBenefitsDetails7", "shortName": "Employee benefits (Details 7)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfDisaggregationOfPlanAssetsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_FundsManagedByInsurersMemberRDYAssetCategoryAxis_ParentCompanyGratuityPlanMemberifrsfullNetDefinedBenefitLiabilityAssetAxis", "decimals": "2", "first": true, "lang": null, "name": "rdy:PercentageOfWeightedAverageAssetAllocation", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R162": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfExpectedFutureCashFlowsInRespectOfPostemploymentBenefitsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_ParentCompanyGratuityPlanMemberifrsfullNetDefinedBenefitLiabilityAssetAxis", "decimals": "-6", "first": true, "lang": null, "name": "rdy:ExpectedContribution", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1162 - Disclosure - Employee benefits (Details 8)", "role": "http://www.drreddys.com/role/EmployeeBenefitsDetails8", "shortName": "Employee benefits (Details 8)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfExpectedFutureCashFlowsInRespectOfPostemploymentBenefitsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_ParentCompanyGratuityPlanMemberifrsfullNetDefinedBenefitLiabilityAssetAxis", "decimals": "-6", "first": true, "lang": null, "name": "rdy:ExpectedContribution", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R163": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:CostRecognizedInIncomeStatementTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_IndustriasQuimicasFalconDeMexicoPensionPlanMemberifrsfullDefinedBenefitPlansAxis", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1163 - Disclosure - Employee benefits (Details 9)", "role": "http://www.drreddys.com/role/EmployeeBenefitsDetails9", "shortName": "Employee benefits (Details 9)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:CostRecognizedInIncomeStatementTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_IndustriasQuimicasFalconDeMexicoPensionPlanMemberifrsfullDefinedBenefitPlansAxis", "decimals": "-6", "lang": null, "name": "ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R164": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_IndustriasQuimicasFalconDeMexicoPensionPlanMemberifrsfullDefinedBenefitPlansAxis", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:DefinedBenefitObligationAtPresentValue", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1164 - Disclosure - Employee benefits (Details 10)", "role": "http://www.drreddys.com/role/EmployeeBenefitsDetails10", "shortName": "Employee benefits (Details 10)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_IndustriasQuimicasFalconDeMexicoPensionPlanMemberifrsfullDefinedBenefitPlansAxis", "decimals": "-6", "lang": null, "name": "ifrs-full:SurplusDeficitInPlan", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R165": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2021_IndustriasQuimicasFalconDeMexicoPensionPlanMemberifrsfullDefinedBenefitPlansAxis", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:DefinedBenefitObligationAtPresentValue", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1165 - Disclosure - Employee benefits (Details 11)", "role": "http://www.drreddys.com/role/EmployeeBenefitsDetails11", "shortName": "Employee benefits (Details 11)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureofChangesInPresentValueOfDefinedBenefitObligationsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_IndustriasQuimicasFalconDeMexicoPensionPlanMemberifrsfullDefinedBenefitPlansAxis", "decimals": "-6", "lang": null, "name": "rdy:InterestExpenseIncomeDefinedBenefitObligation", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R166": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2021_IndustriasQuimicasFalconDeMexicoPensionPlanMemberifrsfullDefinedBenefitPlansAxis", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:PlanAssetsAtFairValue", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1166 - Disclosure - Employee benefits (Details 12)", "role": "http://www.drreddys.com/role/EmployeeBenefitsDetails12", "shortName": "Employee benefits (Details 12)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfFairValueOfPlanAssetsExplanatory", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_IndustriasQuimicasFalconDeMexicoPensionPlanMemberifrsfullDefinedBenefitPlansAxis", "decimals": "-6", "lang": null, "name": "ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R167": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_IndustriasQuimicasFalconDeMexicoPensionPlanMemberifrsfullDefinedBenefitPlansAxis", "decimals": "-6", "first": true, "lang": null, "name": "rdy:DefinedBenefitObligationAtPresentValueWithoutEffectOfSalaryGrowth", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1167 - Disclosure - Employee benefits (Details 13)", "role": "http://www.drreddys.com/role/EmployeeBenefitsDetails13", "shortName": "Employee benefits (Details 13)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_IndustriasQuimicasFalconDeMexicoPensionPlanMemberifrsfullDefinedBenefitPlansAxis", "decimals": "-6", "first": true, "lang": null, "name": "rdy:DefinedBenefitObligationAtPresentValueWithoutEffectOfSalaryGrowth", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R168": { "firstAnchor": { "ancestors": [ "div", "div", "div", "td", "tr", "table", "ix:continuation", "rdy:DisclosureOfAssumptionsUsedToDetermineBenefitObligationsTableTextBlock", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_EmployeeBenefitObligationsMemberifrsfullActuarialAssumptionsAxis_IndustriasQuimicasFalconDeMexicoPensionPlanMemberifrsfullDefinedBenefitPlansAxis", "decimals": "4", "first": true, "lang": null, "name": "ifrs-full:ActuarialAssumptionOfDiscountRates", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1168 - Disclosure - Employee benefits (Details 14)", "role": "http://www.drreddys.com/role/EmployeeBenefitsDetails14", "shortName": "Employee benefits (Details 14)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "td", "tr", "table", "ix:continuation", "rdy:DisclosureOfAssumptionsUsedToDetermineBenefitObligationsTableTextBlock", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_EmployeeBenefitObligationsMemberifrsfullActuarialAssumptionsAxis_IndustriasQuimicasFalconDeMexicoPensionPlanMemberifrsfullDefinedBenefitPlansAxis", "decimals": "4", "first": true, "lang": null, "name": "ifrs-full:ActuarialAssumptionOfDiscountRates", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R169": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfDisaggregationOfPlanAssetsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_FundsManagedByInsurersMemberRDYAssetCategoryAxis_IndustriasQuimicasFalconDeMexicoPensionPlanMemberifrsfullDefinedBenefitPlansAxis", "decimals": "2", "first": true, "lang": null, "name": "rdy:PercentageOfWeightedAverageAssetAllocation", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1169 - Disclosure - Employee benefits (Details 16)", "role": "http://www.drreddys.com/role/EmployeeBenefitsDetails16", "shortName": "Employee benefits (Details 16)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfDisaggregationOfPlanAssetsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_FundsManagedByInsurersMemberRDYAssetCategoryAxis_IndustriasQuimicasFalconDeMexicoPensionPlanMemberifrsfullDefinedBenefitPlansAxis", "decimals": "2", "first": true, "lang": null, "name": "rdy:PercentageOfWeightedAverageAssetAllocation", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfInventoriesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1017 - Disclosure - Inventories", "role": "http://www.drreddys.com/role/Inventories", "shortName": "Inventories", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfInventoriesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R170": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfExpectedFutureCashFlowsInRespectOfPostemploymentBenefitsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_IndustriasQuimicaFalconDeMexicoMemberifrsfullDefinedBenefitPlansAxis_YearZeroMemberRDYTimeTakensAxis", "decimals": "-6", "first": true, "lang": null, "name": "rdy:ExpectedContribution", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1170 - Disclosure - Employee benefits (Details 17)", "role": "http://www.drreddys.com/role/EmployeeBenefitsDetails17", "shortName": "Employee benefits (Details 17)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfExpectedFutureCashFlowsInRespectOfPostemploymentBenefitsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_IndustriasQuimicaFalconDeMexicoMemberifrsfullDefinedBenefitPlansAxis_YearZeroMemberRDYTimeTakensAxis", "decimals": "-6", "first": true, "lang": null, "name": "rdy:ExpectedContribution", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R171": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:SupplementalInformationAboutExpenseByNatureTextBlock", "ifrs-full:DisclosureOfExpensesByNatureExplanatory", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:EmployeeBenefitsExpense", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1171 - Disclosure - Employee benefits (Details Textual)", "role": "http://www.drreddys.com/role/EmployeeBenefitsDetailsTextual", "shortName": "Employee benefits (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ifrs-full:DisclosureOfFairValueOfPlanAssetsExplanatory", "ix:continuation", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2021_GratuityBenefitsOfParentMemberifrsfullNetDefinedBenefitLiabilityAssetAxis", "decimals": "-6", "lang": null, "name": "ifrs-full:LiabilitiesIncurred", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R172": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfNumberOfOptionsReservedTableTextBlock", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_Drl2002PlanMemberRDYDrlAxis", "decimals": "0", "first": true, "lang": null, "name": "rdy:OptionsReservedUnderStockPlan", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1172 - Disclosure - Employee stock incentive plans (Details)", "role": "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails", "shortName": "Employee stock incentive plans (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfNumberOfOptionsReservedTableTextBlock", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_Drl2002PlanMemberRDYDrlAxis", "decimals": "0", "first": true, "lang": null, "name": "rdy:OptionsReservedUnderStockPlan", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R173": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2021_CategoryBParValueOptionsMemberifrsfullClassesOfOrdinarySharesAxis_Drl2002PlanMemberRDYDrl2002PlanAxis_ExercisepricesRs5MemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:NumberOfOutstandingShareOptions", "reportCount": 1, "unitRef": "Unit_Number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1173 - Disclosure - Employee stock incentive plans (Details 1)", "role": "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails1", "shortName": "Employee stock incentive plans (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2020_CategoryBParValueOptionsMemberifrsfullClassesOfOrdinarySharesAxis_Drl2002PlanMemberRDYDrl2002PlanAxis_ExercisepricesRs5MemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis", "decimals": "0", "lang": null, "name": "ifrs-full:NumberOfOutstandingShareOptions", "reportCount": 1, "unique": true, "unitRef": "Unit_Number", "xsiNil": "false" } }, "R174": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2021_CategoryMemberifrsfullClassesOfOrdinarySharesAxis_DrlTwoThousandSevenPlanMemberRDYDrl2007PlanAxis", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:NumberOfOutstandingShareOptions", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1174 - Disclosure - Employee stock incentive plans (Details 2)", "role": "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails2", "shortName": "Employee stock incentive plans (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2020_CategoryMemberifrsfullClassesOfOrdinarySharesAxis_DrlTwoThousandSevenPlanMemberRDYDrl2007PlanAxis", "decimals": "0", "lang": null, "name": "ifrs-full:NumberOfOutstandingShareOptions", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R175": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureAndDetailsAbout2018PlanTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_DRL2018PlanMemberRDYPlanAxis", "decimals": "0", "first": true, "lang": null, "name": "rdy:OptionsReservedAgainstEquityShares", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1175 - Disclosure - Employee stock incentive plans (Details 3)", "role": "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails3", "shortName": "Employee stock incentive plans (Details 3)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureAndDetailsAbout2018PlanTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_DRL2018PlanMemberRDYPlanAxis", "decimals": "0", "first": true, "lang": null, "name": "rdy:OptionsReservedAgainstEquityShares", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R176": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfNumberOfShareOptionsWeightedAverageExercisePriceRangeOfExercisePricesAndWeightedAverageRemainingContractualLifeTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2021_DrlTwoThousandEighteenPlanMemberRDYDrl2018PlanNameAxis", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:NumberOfOutstandingShareOptions", "reportCount": 1, "unitRef": "Unit_Number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1176 - Disclosure - Employee stock incentive plans (Details 4)", "role": "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails4", "shortName": "Employee stock incentive plans (Details 4)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfNumberOfShareOptionsWeightedAverageExercisePriceRangeOfExercisePricesAndWeightedAverageRemainingContractualLifeTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2020_DrlTwoThousandEighteenPlanMemberRDYDrl2018PlanNameAxis", "decimals": "0", "lang": null, "name": "ifrs-full:NumberOfOutstandingShareOptions", "reportCount": 1, "unique": true, "unitRef": "Unit_Number", "xsiNil": "false" } }, "R177": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:ScheduleOfWeightedAverageInputsOfFairValueOfOptionsGrantedTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P01_17_2022To01_17_2022", "decimals": "4", "first": true, "lang": null, "name": "ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1177 - Disclosure - Employee stock incentive plans (Details 5)", "role": "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails5", "shortName": "Employee stock incentive plans (Details 5)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:ScheduleOfWeightedAverageInputsOfFairValueOfOptionsGrantedTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P01_17_2022To01_17_2022", "decimals": "4", "first": true, "lang": null, "name": "ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R178": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:DisclosureOfDetailedInformationAboutShareBasedPaymentExpenseTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1178 - Disclosure - Employee stock incentive plans (Details 6)", "role": "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails6", "shortName": "Employee stock incentive plans (Details 6)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:DisclosureOfDetailedInformationAboutShareBasedPaymentExpenseTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R179": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_DrlTwoThousandEighteenPlanMemberRDYDrl2018PlanNameAxis", "decimals": "0", "first": true, "lang": null, "name": "rdy:EmployeeStockOptionTreasurySharesPurchased", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1179 - Disclosure - Employee stock incentive plans (Details Textual)", "role": "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetailsTextual", "shortName": "Employee stock incentive plans (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_DrlTwoThousandEighteenPlanMemberRDYDrl2018PlanNameAxis", "decimals": "0", "first": true, "lang": null, "name": "rdy:EmployeeStockOptionTreasurySharesPurchased", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfOtherAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1018 - Disclosure - Other assets", "role": "http://www.drreddys.com/role/OtherAssets", "shortName": "Other assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfOtherAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R180": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "rdy:CateringExpensesPaid", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1180 - Disclosure - Related parties (Details)", "role": "http://www.drreddys.com/role/RelatedPartiesDetails", "shortName": "Related parties (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "rdy:CateringExpensesPaid", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R181": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:ScheduleOfOutstandingBalancesForRelatedPartyTransactionsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_KeyManagementPersonnelOfEntityOrParentMemberifrsfullCategoriesOfRelatedPartiesAxis", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:AmountsReceivableRelatedPartyTransactions", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1181 - Disclosure - Related parties (Details 1)", "role": "http://www.drreddys.com/role/RelatedPartiesDetails1", "shortName": "Related parties (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:ScheduleOfOutstandingBalancesForRelatedPartyTransactionsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_KeyManagementPersonnelOfEntityOrParentMemberifrsfullCategoriesOfRelatedPartiesAxis", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:AmountsReceivableRelatedPartyTransactions", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R182": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:KeyManagementPersonnelCompensation", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1182 - Disclosure - Related parties (Details 2)", "role": "http://www.drreddys.com/role/RelatedPartiesDetails2", "shortName": "Related parties (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfCompensationPaidOrPayableToKeyManagementPersonnelTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_KeyManagementPersonnelMemberifrsfullCategoriesOfRelatedPartiesAxis", "decimals": "-6", "lang": null, "name": "ifrs-full:KeyManagementPersonnelCompensation", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R183": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:CashAndCashEquivalents", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1183 - Disclosure - Financial instruments (Details)", "role": "http://www.drreddys.com/role/FinancialInstrumentsDetails", "shortName": "Financial instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:CarryingValueAndFairValueOfFinancialInstrumentsTableTextBlock", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_TotalCarryingValueMemberRDYValueTypeOfFinancialInstrumentAxis", "decimals": "-6", "lang": null, "name": "ifrs-full:CashAndCashEquivalents", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R184": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfDetailedInformationAboutFairValueMeasurementOfAssetsAndLiabilitiesTableTextBlock", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_RecurringFairValueMeasurementMemberifrsfullMeasurementAxis", "decimals": "-6", "first": true, "lang": null, "name": "rdy:DerivativeFinanicialAssetsAndLiabilties", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1184 - Disclosure - Financial instruments (Details 1)", "role": "http://www.drreddys.com/role/FinancialInstrumentsDetails1", "shortName": "Financial instruments (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfDetailedInformationAboutFairValueMeasurementOfAssetsAndLiabilitiesTableTextBlock", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_RecurringFairValueMeasurementMemberifrsfullMeasurementAxis", "decimals": "-6", "first": true, "lang": null, "name": "rdy:DerivativeFinanicialAssetsAndLiabilties", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R185": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1185 - Disclosure - Financial instruments (Details 2)", "role": "http://www.drreddys.com/role/FinancialInstrumentsDetails2", "shortName": "Financial instruments (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfDetailedInformationAboutOfGainlossRecognizedInRespectOfDerivativeContractsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_DerivativesMemberifrsfullClassesOfAssetsAxis", "decimals": "-6", "lang": null, "name": "rdy:NetGainsLossesOnForeignExchangeDerivativeAndInterestRateSwapsContracts", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R186": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:DisclosureOfNotionalAmountOfOutstandingForeignExchangeDerivativeContractsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_ContractOneMemberifrsfullHedgingInstrumentsAxis_ForwardContractAudInrSellsMemberifrsfullClassesOfFinancialAssetsAxis_HedgesOfRecognisedAssetsAndLiabilitiesMemberifrsfullTypesOfHedgesAxis", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:NotionalAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_AUD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1186 - Disclosure - Financial instruments (Details 3)", "role": "http://www.drreddys.com/role/FinancialInstrumentsDetails3", "shortName": "Financial instruments (Details 3)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:DisclosureOfNotionalAmountOfOutstandingForeignExchangeDerivativeContractsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_ContractOneMemberifrsfullHedgingInstrumentsAxis_ForwardContractAudInrSellsMemberifrsfullClassesOfFinancialAssetsAxis_HedgesOfRecognisedAssetsAndLiabilitiesMemberifrsfullTypesOfHedgesAxis", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:NotionalAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_AUD", "xsiNil": "false" } }, "R187": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:DisclosureOfDetailedInformationAboutHighlyProbableForecastTransactionsHedgedItemsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_UsDollarsMemberRDYTypeOfCurrencyAxis", "decimals": "-6", "first": true, "lang": null, "name": "rdy:PeriodsWhenCashFlowsExpectedToOccur", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1187 - Disclosure - Financial instruments (Details 4)", "role": "http://www.drreddys.com/role/FinancialInstrumentsDetails4", "shortName": "Financial instruments (Details 4)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:DisclosureOfDetailedInformationAboutHighlyProbableForecastTransactionsHedgedItemsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_UsDollarsMemberRDYTypeOfCurrencyAxis", "decimals": "-6", "first": true, "lang": null, "name": "rdy:PeriodsWhenCashFlowsExpectedToOccur", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R188": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:CarryingValueAndFairValueOfFinancialInstrumentsTableTextBlock", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:OtherNonfinancialAssets", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1188 - Disclosure - Financial instruments (Details Textual)", "role": "http://www.drreddys.com/role/FinancialInstrumentsDetailsTextual", "shortName": "Financial instruments (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:CarryingValueAndFairValueOfFinancialInstrumentsTableTextBlock", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:OtherNonfinancialAssets", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R189": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:CashAndCashEquivalents", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1189 - Disclosure - Financial risk management (Details)", "role": "http://www.drreddys.com/role/FinancialRiskManagementDetails", "shortName": "Financial risk management (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfForeignCurrencyRiskFromNonderivativeFinancialInstrumentsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_ForeignCurrencyRiskFromNonderivativeFinancialInstrumentsMemberifrsfullClassesOfFinancialInstrumentsAxis", "decimals": "-6", "lang": null, "name": "ifrs-full:CashAndCashEquivalents", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1019 - Disclosure - Property, plant and equipment", "role": "http://www.drreddys.com/role/PropertyPlantAndEquipment", "shortName": "Property, plant and equipment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R190": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:AnalysisOfAgeOfTradeAndOtherReceivablesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:TradeAndOtherReceivables", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1190 - Disclosure - Financial risk management (Details 1)", "role": "http://www.drreddys.com/role/FinancialRiskManagementDetails1", "shortName": "Financial risk management (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:AnalysisOfAgeOfTradeAndOtherReceivablesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_FinancialAssetsPastDueButNotImpairedMemberifrsfullImpairmentOfFinancialAssetsAxis", "decimals": "-6", "lang": null, "name": "ifrs-full:TradeAndOtherReceivables", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R191": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:MaturityAnalysisForFinancialLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:TradeAndOtherPayables", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1191 - Disclosure - Financial risk management (Details 2)", "role": "http://www.drreddys.com/role/FinancialRiskManagementDetails2", "shortName": "Financial risk management (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:MaturityAnalysisForFinancialLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:TradeAndOtherPayables", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R192": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:UndrawnBorrowingFacilities", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1192 - Disclosure - Financial risk management (Details Textual)", "role": "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual", "shortName": "Financial risk management (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "lang": null, "name": "rdy:WorkingCapital", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R193": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2009To03_31_2011", "decimals": "-6", "first": true, "lang": null, "name": "rdy:DemandMadeByCommercialTaxesDepartmentToCompanyExcludingPenaltyAndInterest", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1193 - Disclosure - Contingencies (Details)", "role": "http://www.drreddys.com/role/ContingenciesDetails", "shortName": "Contingencies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2009To03_31_2011", "decimals": "-6", "first": true, "lang": null, "name": "rdy:DemandMadeByCommercialTaxesDepartmentToCompanyExcludingPenaltyAndInterest", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R194": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:DisclosureOfProvisionTableTextBlock", "ifrs-full:DisclosureOfOtherProvisionsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:OtherProvisions", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1194 - Disclosure - Contingencies (Details Textual)", "role": "http://www.drreddys.com/role/ContingenciesDetailsTextual", "shortName": "Contingencies (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "lang": null, "name": "rdy:DemandMadeByIndianSalesTaxAuthoritiesToCompany", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R195": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:DisclosureOfDetailedInformationOfPartialConsiderationUnderCollaborationLicenseAndOptionAgreementTextBlock", "rdy:CollaborationLicenseAndOptionAgreementTextBlock", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn01_18_2015_CurisIncMemberRDYNamePartyInvolvedInTransactionAxis", "decimals": "-5", "first": true, "lang": null, "name": "ifrs-full:NumberOfSharesIssued", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1195 - Disclosure - Collaboration, License and Option Agreement with Curis, Inc (Details)", "role": "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetails", "shortName": "Collaboration, License and Option Agreement with Curis, Inc (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:DisclosureOfDetailedInformationOfPartialConsiderationUnderCollaborationLicenseAndOptionAgreementTextBlock", "rdy:CollaborationLicenseAndOptionAgreementTextBlock", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn09_07_2016_CurisIncMemberRDYNamePartyInvolvedInTransactionAxis", "decimals": "-6", "lang": null, "name": "rdy:FairValueOfInstrumentsOrInterests", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R196": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "ifrs-full:DisclosureOfFairValueOfEachInvestmentInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeExplanatory", "rdy:CollaborationLicenseAndOptionAgreementTextBlock", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_CurisIncMemberRDYNamePartyInvolvedInTransactionAxis", "decimals": "-6", "first": true, "lang": null, "name": "rdy:AmortisedCostOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1196 - Disclosure - Collaboration, License and Option Agreement with Curis, Inc (Details 1)", "role": "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetails1", "shortName": "Collaboration, License and Option Agreement with Curis, Inc (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "ifrs-full:DisclosureOfFairValueOfEachInvestmentInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeExplanatory", "rdy:CollaborationLicenseAndOptionAgreementTextBlock", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_CurisIncMemberRDYNamePartyInvolvedInTransactionAxis", "decimals": "-6", "first": true, "lang": null, "name": "rdy:AmortisedCostOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R197": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfDetailedInformationOfPartialConsiderationUnderCollaborationLicenseAndOptionAgreementTextBlock", "rdy:CollaborationLicenseAndOptionAgreementTextBlock", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn09_07_2016_CurisIncMemberRDYNamePartyInvolvedInTransactionAxis", "decimals": "-5", "first": true, "lang": null, "name": "rdy:MilestoneAndOtherPaymentsToBeReceived", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1197 - Disclosure - Collaboration, License and Option Agreement with Curis, Inc (Details Textual)", "role": "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetailsTextual", "shortName": "Collaboration, License and Option Agreement with Curis, Inc (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfDetailedInformationOfPartialConsiderationUnderCollaborationLicenseAndOptionAgreementTextBlock", "rdy:CollaborationLicenseAndOptionAgreementTextBlock", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn09_07_2016_CurisIncMemberRDYNamePartyInvolvedInTransactionAxis", "decimals": "-5", "first": true, "lang": null, "name": "rdy:MilestoneAndOtherPaymentsToBeReceived", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R198": { "firstAnchor": { "ancestors": [ "div", "div", "ifrs-full:RightsPreferencesAndRestrictionsAttachingToClassOfShareCapital", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:ParValuePerShare", "reportCount": 1, "unitRef": "Unit_INR_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1198 - Disclosure - Merger of Dr. Reddy's Holdings Limited into Dr. Reddy's Laboratories Limited (Details Textual)", "role": "http://www.drreddys.com/role/MergerOfDrReddySHoldingsLimitedIntoDrReddySLaboratoriesLimitedDetailsTextual", "shortName": "Merger of Dr. Reddy's Holdings Limited into Dr. Reddy's Laboratories Limited (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "rdy:DisclosureOfMergerOfDrReddysHoldingsLimitedInToDrReddysLaboratoriesLimitedExplanatoryTextBlock", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_08_2022To04_08_2022_EventsAfterReportingPeriodMemberifrsfullNonadjustingEventsAfterReportingPeriodAxis", "decimals": "INF", "lang": null, "name": "rdy:NumberOfEquitySharesHeldCancelledAsPerSchemeOfAmalgamationAndArrangement", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R199": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:ScheduleOfWeightedAverageInputsOfFairValueOfOptionsGrantedTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P01_17_2022To01_17_2022", "decimals": "2", "first": true, "lang": null, "name": "ifrs-full:ExercisePriceShareOptionsGranted2019", "reportCount": 1, "unitRef": "Unit_INR_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1199 - Disclosure - Subsequent events (Details Textual)", "role": "http://www.drreddys.com/role/SubsequentEventsDetailsTextual", "shortName": "Subsequent events (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn06_23_2022_NonadjustongEventsAfterReportingPeriodMemberifrsfullNonadjustingEventsAfterReportingPeriodAxis", "decimals": "0", "lang": null, "name": "ifrs-full:NumberOfSharesIssued", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:CashAndCashEquivalents", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002 - Statement - CONSOLIDATED STATEMENTS OF FINANCIAL POSITION", "role": "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition", "shortName": "CONSOLIDATED STATEMENTS OF FINANCIAL POSITION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "lang": null, "name": "ifrs-full:TradeAndOtherCurrentReceivables", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfGoodwillExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1020 - Disclosure - Goodwill", "role": "http://www.drreddys.com/role/Goodwill", "shortName": "Goodwill", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfGoodwillExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R200": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "ifrs-full:DisclosureOfInterestsInOtherEntitiesExplanatory", "rdy:DisclosureOfSignificantInvestmentsInSubsidiariesAssociatesAndJointVenturesExplanatoryTextBlock", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_AurigeneDiscoveryTechnologiesMalaysiaSdnBhdMemberifrsfullSignificantInvestmentsInSubsidiariesAxis", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1200 - Disclosure - Organizational structure (Details)", "role": "http://www.drreddys.com/role/OrganizationalStructureDetails", "shortName": "Organizational structure (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ifrs-full:DisclosureOfInterestsInOtherEntitiesExplanatory", "rdy:DisclosureOfSignificantInvestmentsInSubsidiariesAssociatesAndJointVenturesExplanatoryTextBlock", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_AurigeneDiscoveryTechnologiesMalaysiaSdnBhdMemberifrsfullSignificantInvestmentsInSubsidiariesAxis", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R201": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_KunshanRotamReddyPharmaceuticalsCoLimitedMemberifrsfullSignificantInvestmentsInSubsidiariesAxis", "decimals": "4", "first": true, "lang": null, "name": "ifrs-full:ProportionOfOwnershipInterestInSubsidiary", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1201 - Disclosure - Organizational structure (Details Textual)", "role": "http://www.drreddys.com/role/OrganizationalStructureDetailsTextual", "shortName": "Organizational structure (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_KunshanRotamReddyPharmaceuticalsCoLimitedMemberifrsfullSignificantInvestmentsInSubsidiariesAxis", "decimals": "4", "first": true, "lang": null, "name": "ifrs-full:ProportionOfOwnershipInterestInSubsidiary", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1021 - Disclosure - Other intangible assets", "role": "http://www.drreddys.com/role/OtherIntangibleAssets", "shortName": "Other intangible assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1022 - Disclosure - Investment in equity accounted investees", "role": "http://www.drreddys.com/role/InvestmentInEquityAccountedInvestees", "shortName": "Investment in equity accounted investees", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1023 - Disclosure - Trade and other payables", "role": "http://www.drreddys.com/role/TradeAndOtherPayables", "shortName": "Trade and other payables", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfBorrowingsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1024 - Disclosure - Loans and borrowings", "role": "http://www.drreddys.com/role/LoansAndBorrowings", "shortName": "Loans and borrowings", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfBorrowingsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfOtherProvisionsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1025 - Disclosure - Provisions", "role": "http://www.drreddys.com/role/Provisions", "shortName": "Provisions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfOtherProvisionsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfOtherLiabilitiesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1026 - Disclosure - Other liabilities", "role": "http://www.drreddys.com/role/OtherLiabilities", "shortName": "Other liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfOtherLiabilitiesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1027 - Disclosure - Share Capital", "role": "http://www.drreddys.com/role/ShareCapital", "shortName": "Share Capital", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1028 - Disclosure - Earnings per share", "role": "http://www.drreddys.com/role/EarningsPerShare", "shortName": "Earnings per share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfRevenueExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1029 - Disclosure - Revenue from contracts with customers and trade receivables", "role": "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivables", "shortName": "Revenue from contracts with customers and trade receivables", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfRevenueExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003 - Statement - CONSOLIDATED INCOME STATEMENTS", "role": "http://www.drreddys.com/role/ConsolidatedIncomeStatements", "shortName": "CONSOLIDATED INCOME STATEMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "lang": null, "name": "ifrs-full:CostOfSales", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1030 - Disclosure - Other income, net", "role": "http://www.drreddys.com/role/OtherIncomeNet", "shortName": "Other income, net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1031 - Disclosure - Finance income, net", "role": "http://www.drreddys.com/role/FinanceIncomeNet", "shortName": "Finance income, net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1032 - Disclosure - Income taxes", "role": "http://www.drreddys.com/role/IncomeTaxes", "shortName": "Income taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfExpensesByNatureExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1033 - Disclosure - Nature of Expense", "role": "http://www.drreddys.com/role/NatureOfExpense", "shortName": "Nature of Expense", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfExpensesByNatureExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1034 - Disclosure - Employee benefits", "role": "http://www.drreddys.com/role/EmployeeBenefits", "shortName": "Employee benefits", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1035 - Disclosure - Employee stock incentive plans", "role": "http://www.drreddys.com/role/EmployeeStockIncentivePlans", "shortName": "Employee stock incentive plans", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1036 - Disclosure - Related parties", "role": "http://www.drreddys.com/role/RelatedParties", "shortName": "Related parties", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1037 - Disclosure - Financial instruments", "role": "http://www.drreddys.com/role/FinancialInstruments", "shortName": "Financial instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1038 - Disclosure - Financial risk management", "role": "http://www.drreddys.com/role/FinancialRiskManagement", "shortName": "Financial risk management", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfContingentLiabilitiesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1039 - Disclosure - Contingencies", "role": "http://www.drreddys.com/role/Contingencies", "shortName": "Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfContingentLiabilitiesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:ProfitLoss", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "role": "http://www.drreddys.com/role/ConsolidatedStatementsOfComprehensiveIncome", "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "lang": null, "name": "ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:CollaborationLicenseAndOptionAgreementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1040 - Disclosure - Collaboration, License and Option Agreement with Curis, Inc", "role": "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisInc", "shortName": "Collaboration, License and Option Agreement with Curis, Inc", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:CollaborationLicenseAndOptionAgreementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfMergerOfDrReddysHoldingsLimitedInToDrReddysLaboratoriesLimitedExplanatoryTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1041 - Disclosure - Merger of Dr. Reddy's Holdings Limited into Dr. Reddy's Laboratories Limited", "role": "http://www.drreddys.com/role/MergerOfDrReddySHoldingsLimitedIntoDrReddySLaboratoriesLimited", "shortName": "Merger of Dr. Reddy's Holdings Limited into Dr. Reddy's Laboratories Limited", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfMergerOfDrReddysHoldingsLimitedInToDrReddysLaboratoriesLimitedExplanatoryTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfImpactOfCovid19AndMilitaryConflictBetweenRussiaAndUkraineExplanatoryTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1042 - Disclosure - Impact of COVID-19 and military conflict between Russia and Ukraine", "role": "http://www.drreddys.com/role/ImpactOfCovid19AndMilitaryConflictBetweenRussiaAndUkraine", "shortName": "Impact of COVID-19 and military conflict between Russia and Ukraine", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfImpactOfCovid19AndMilitaryConflictBetweenRussiaAndUkraineExplanatoryTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfupdateOnCyberIncidentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1043 - Disclosure - Update on Cyber Incident", "role": "http://www.drreddys.com/role/UpdateOnCyberIncident", "shortName": "Update on Cyber Incident", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfupdateOnCyberIncidentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfTheCodeOnSocialSecurity2020TextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1044 - Disclosure - The Code on Social Security, 2020", "role": "http://www.drreddys.com/role/TheCodeOnSocialSecurity2020", "shortName": "The Code on Social Security, 2020", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfTheCodeOnSocialSecurity2020TextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfRegulatoryInspectionOfFacilitiesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1045 - Disclosure - Regulatory Inspection of facilities", "role": "http://www.drreddys.com/role/RegulatoryInspectionOfFacilities", "shortName": "Regulatory Inspection of facilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfRegulatoryInspectionOfFacilitiesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1046 - Disclosure - Subsequent events", "role": "http://www.drreddys.com/role/SubsequentEvents", "shortName": "Subsequent events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfSignificantInvestmentsInSubsidiariesAssociatesAndJointVenturesExplanatoryTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1047 - Disclosure - Organizational structure", "role": "http://www.drreddys.com/role/OrganizationalStructure", "shortName": "Organizational structure", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfSignificantInvestmentsInSubsidiariesAssociatesAndJointVenturesExplanatoryTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:StatementOfIFRSCompliance", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1048 - Disclosure - Basis of preparation of financial statements (Policies)", "role": "http://www.drreddys.com/role/BasisOfPreparationOfFinancialStatementsPolicies", "shortName": "Basis of preparation of financial statements (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:StatementOfIFRSCompliance", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DescriptionOfAccountingPolicyForInitialApplicationOfStandardsOrInterpretationsExplanatoryPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1049 - Disclosure - Significant accounting policies (Policies)", "role": "http://www.drreddys.com/role/SignificantAccountingPoliciesPolicies", "shortName": "Significant accounting policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DescriptionOfAccountingPolicyForInitialApplicationOfStandardsOrInterpretationsExplanatoryPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2019", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:Equity", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY", "role": "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity", "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2019_IssuedCapitalMemberifrsfullComponentsOfEquityAxis", "decimals": "-6", "lang": null, "name": "ifrs-full:Equity", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfUsefulLivesOrDepreciationRatesPropertyPlantAndEquipmentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1050 - Disclosure - Significant accounting policies (Tables)", "role": "http://www.drreddys.com/role/SignificantAccountingPoliciesTables", "shortName": "Significant accounting policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfUsefulLivesOrDepreciationRatesPropertyPlantAndEquipmentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfOperatingSegmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1051 - Disclosure - Segment reporting (Tables)", "role": "http://www.drreddys.com/role/SegmentReportingTables", "shortName": "Segment reporting (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfOperatingSegmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1052 - Disclosure - Business Combinations (Tables)", "role": "http://www.drreddys.com/role/BusinessCombinationsTables", "shortName": "Business Combinations (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:CashAndCashEquivalentsTableTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1053 - Disclosure - Cash and cash equivalents (Tables)", "role": "http://www.drreddys.com/role/CashAndCashEquivalentsTables", "shortName": "Cash and cash equivalents (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:CashAndCashEquivalentsTableTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "div", "div", "ifrs-full:DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1054 - Disclosure - Other investments (Tables)", "role": "http://www.drreddys.com/role/OtherInvestmentsTables", "shortName": "Other investments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ifrs-full:DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:TradeAndOtherReceivablesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1055 - Disclosure - Trade and other receivables (Tables)", "role": "http://www.drreddys.com/role/TradeAndOtherReceivablesTables", "shortName": "Trade and other receivables (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:TradeAndOtherReceivablesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfInventoriesExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfDetailedInformationAboutInventoriesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1056 - Disclosure - Inventories (Tables)", "role": "http://www.drreddys.com/role/InventoriesTables", "shortName": "Inventories (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfInventoriesExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfDetailedInformationAboutInventoriesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfOtherAssetsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfDetailedInformationAboutOtherAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1057 - Disclosure - Other assets (Tables)", "role": "http://www.drreddys.com/role/OtherAssetsTables", "shortName": "Other assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfOtherAssetsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfDetailedInformationAboutOtherAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatoryTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1058 - Disclosure - Property, plant and equipment (Tables)", "role": "http://www.drreddys.com/role/PropertyPlantAndEquipmentTables", "shortName": "Property, plant and equipment (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatoryTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfGoodwillExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfReconciliationOfChangesInGoodwillTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1059 - Disclosure - Goodwill (Tables)", "role": "http://www.drreddys.com/role/GoodwillTables", "shortName": "Goodwill (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfGoodwillExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfReconciliationOfChangesInGoodwillTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "rdy:IncomeTaxRelatingToInvestmentsInEquityInstrumentsAndFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIncludedInOtherComprehensiveIncome", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Parenthetical)", "role": "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquityParenthetical", "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "rdy:IncomeTaxRelatingToInvestmentsInEquityInstrumentsAndFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIncludedInOtherComprehensiveIncome", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatoryTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1060 - Disclosure - Other intangible assets (Tables)", "role": "http://www.drreddys.com/role/OtherIntangibleAssetsTables", "shortName": "Other intangible assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatoryTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfEquitySharesHeldInEquityAccountedInvesteesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1061 - Disclosure - Investment in equity accounted investees (Tables)", "role": "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesTables", "shortName": "Investment in equity accounted investees (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfEquitySharesHeldInEquityAccountedInvesteesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:TradeAndOtherPayablesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1062 - Disclosure - Trade and other payables (Tables)", "role": "http://www.drreddys.com/role/TradeAndOtherPayablesTables", "shortName": "Trade and other payables (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:TradeAndOtherPayablesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfBorrowingsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfShortTermBorrowingsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1063 - Disclosure - Loans and borrowings (Tables)", "role": "http://www.drreddys.com/role/LoansAndBorrowingsTables", "shortName": "Loans and borrowings (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfBorrowingsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfShortTermBorrowingsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfOtherProvisionsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfProvisionTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1064 - Disclosure - Provisions (Tables)", "role": "http://www.drreddys.com/role/ProvisionsTables", "shortName": "Provisions (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfOtherProvisionsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfProvisionTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfOtherLiabilitiesExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:ScheduleOfOtherLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1065 - Disclosure - Other liabilities (Tables)", "role": "http://www.drreddys.com/role/OtherLiabilitiesTables", "shortName": "Other liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfOtherLiabilitiesExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:ScheduleOfOtherLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfClassesOfShareCapitalTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1066 - Disclosure - Share Capital (Tables)", "role": "http://www.drreddys.com/role/ShareCapitalTables", "shortName": "Share Capital (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfClassesOfShareCapitalTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:BasicEarningsPerShareTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1067 - Disclosure - Earnings per share (Tables)", "role": "http://www.drreddys.com/role/EarningsPerShareTables", "shortName": "Earnings per share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:BasicEarningsPerShareTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfRevenueExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:ScheduleOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1068 - Disclosure - Revenue from contracts with customers and trade receivables (Tables)", "role": "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesTables", "shortName": "Revenue from contracts with customers and trade receivables (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfRevenueExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:ScheduleOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:OtherOperatingIncomeExpenseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1069 - Disclosure - Other income, net (Tables)", "role": "http://www.drreddys.com/role/OtherIncomeNetTables", "shortName": "Other income, net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:OtherOperatingIncomeExpenseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:ProfitLoss", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "role": "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "lang": null, "name": "ifrs-full:AdjustmentsForIncomeTaxExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:ScheduleOfFinanceExpenseIncomeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1070 - Disclosure - Finance income, net (Tables)", "role": "http://www.drreddys.com/role/FinanceIncomeNetTables", "shortName": "Finance income, net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:ScheduleOfFinanceExpenseIncomeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfIncomeTaxTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1071 - Disclosure - Income taxes (Tables)", "role": "http://www.drreddys.com/role/IncomeTaxesTables", "shortName": "Income taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfIncomeTaxTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfExpensesByNatureExplanatory", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:SupplementalInformationAboutExpenseByNatureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1072 - Disclosure - Nature of Expense (Tables)", "role": "http://www.drreddys.com/role/NatureOfExpenseTables", "shortName": "Nature of Expense (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfExpensesByNatureExplanatory", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:SupplementalInformationAboutExpenseByNatureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_ParentCompanyGratuityPlanMemberifrsfullDefinedBenefitPlansAxis", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:CostRecognizedInIncomeStatementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1073 - Disclosure - Employee benefits (Tables)", "role": "http://www.drreddys.com/role/EmployeeBenefitsTables", "shortName": "Employee benefits (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_ParentCompanyGratuityPlanMemberifrsfullDefinedBenefitPlansAxis", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:CostRecognizedInIncomeStatementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:ScheduleOfWeightedAverageInputsOfFairValueOfOptionsGrantedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1074 - Disclosure - Employee stock incentive plans (Tables)", "role": "http://www.drreddys.com/role/EmployeeStockIncentivePlansTables", "shortName": "Employee stock incentive plans (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:ScheduleOfWeightedAverageInputsOfFairValueOfOptionsGrantedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1075 - Disclosure - Related parties (Tables)", "role": "http://www.drreddys.com/role/RelatedPartiesTables", "shortName": "Related parties (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:CarryingValueAndFairValueOfFinancialInstrumentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1076 - Disclosure - Financial instruments (Tables)", "role": "http://www.drreddys.com/role/FinancialInstrumentsTables", "shortName": "Financial instruments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:CarryingValueAndFairValueOfFinancialInstrumentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfForeignCurrencyRiskFromNonderivativeFinancialInstrumentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1077 - Disclosure - Financial risk management (Tables)", "role": "http://www.drreddys.com/role/FinancialRiskManagementTables", "shortName": "Financial risk management (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfForeignCurrencyRiskFromNonderivativeFinancialInstrumentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfShowCauseNoticesIssuedByCommercialTaxesDepartmentRegardingVatInputCreditTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1078 - Disclosure - Contingencies (Tables)", "role": "http://www.drreddys.com/role/ContingenciesTables", "shortName": "Contingencies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfShowCauseNoticesIssuedByCommercialTaxesDepartmentRegardingVatInputCreditTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "rdy:CollaborationLicenseAndOptionAgreementTextBlock", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfDetailedInformationOfPartialConsiderationUnderCollaborationLicenseAndOptionAgreementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1079 - Disclosure - Collaboration, License and Option Agreement with Curis, Inc (Tables)", "role": "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncTables", "shortName": "Collaboration, License and Option Agreement with Curis, Inc (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "rdy:CollaborationLicenseAndOptionAgreementTextBlock", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfDetailedInformationOfPartialConsiderationUnderCollaborationLicenseAndOptionAgreementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfNatureOfBusinessExplanatoryTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1008 - Disclosure - Reporting entity", "role": "http://www.drreddys.com/role/ReportingEntity", "shortName": "Reporting entity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "rdy:DisclosureOfNatureOfBusinessExplanatoryTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "rdy:DisclosureOfSignificantInvestmentsInSubsidiariesAssociatesAndJointVenturesExplanatoryTextBlock", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfInterestsInOtherEntitiesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1080 - Disclosure - Organizational structure (Tables)", "role": "http://www.drreddys.com/role/OrganizationalStructureTables", "shortName": "Organizational structure (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "rdy:DisclosureOfSignificantInvestmentsInSubsidiariesAssociatesAndJointVenturesExplanatoryTextBlock", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfInterestsInOtherEntitiesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "div", "div", "rdy:DescriptionOfConvenienceTranslationIntoUsDollarsTextBlockTextBlock", "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "2", "first": true, "lang": null, "name": "rdy:ConvenienceTranslationRate", "reportCount": 1, "unique": true, "unitRef": "Unit_INRPerUSD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1081 - Disclosure - Basis of preparation of financial statements (Details Textual)", "role": "http://www.drreddys.com/role/BasisOfPreparationOfFinancialStatementsDetailsTextual", "shortName": "Basis of preparation of financial statements (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "rdy:DescriptionOfConvenienceTranslationIntoUsDollarsTextBlockTextBlock", "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "2", "first": true, "lang": null, "name": "rdy:ConvenienceTranslationRate", "reportCount": 1, "unique": true, "unitRef": "Unit_INRPerUSD", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:DisclosureOfUsefulLivesOrDepreciationRatesPropertyPlantAndEquipmentTableTextBlock", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_BottomOfRangeMemberifrsfullRangeAxis_FactoryAndAdministrativeBuildingsMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1082 - Disclosure - Significant accounting policies (Details 1)", "role": "http://www.drreddys.com/role/SignificantAccountingPoliciesDetails1", "shortName": "Significant accounting policies (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:DisclosureOfUsefulLivesOrDepreciationRatesPropertyPlantAndEquipmentTableTextBlock", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_BottomOfRangeMemberifrsfullRangeAxis_FactoryAndAdministrativeBuildingsMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:DisclosureOfUsefulLivesOrAmortisationRatesIntangibleAssetsOtherThanGoodwillTableTextBlock", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_BottomOfRangeMemberifrsfullRangeAxis_RecipesFormulaeModelsDesignsAndPrototypesMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1083 - Disclosure - Significant accounting policies (Details 2)", "role": "http://www.drreddys.com/role/SignificantAccountingPoliciesDetails2", "shortName": "Significant accounting policies (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:DisclosureOfUsefulLivesOrAmortisationRatesIntangibleAssetsOtherThanGoodwillTableTextBlock", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_BottomOfRangeMemberifrsfullRangeAxis_RecipesFormulaeModelsDesignsAndPrototypesMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1084 - Disclosure - Segment reporting (Details)", "role": "http://www.drreddys.com/role/SegmentReportingDetails", "shortName": "Segment reporting (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "ix:continuation", "rdy:DisclosureOfOperatingSegmentsTableTextBlock", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_GlobalGenericsMemberifrsfullSegmentsAxis", "decimals": "-6", "lang": null, "name": "ifrs-full:GrossProfit", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R85": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1085 - Disclosure - Segment reporting (Details 2)", "role": "http://www.drreddys.com/role/SegmentReportingDetails2", "shortName": "Segment reporting (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "rdy:DisclosureAndDetailsAboutRevenueWithInGlobalGenericSegmentsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_GlobalGenericMemberifrsfullSegmentsAxis", "decimals": "-6", "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R86": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1086 - Disclosure - Segment reporting (Details 3)", "role": "http://www.drreddys.com/role/SegmentReportingDetails3", "shortName": "Segment reporting (Details 3)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureAndDetailsAboutRevenueFromTherapeuticsAreasTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_AntiInfectiveOneMemberifrsfullProductsAndServicesAxis_PharmaceuticalServicesAndActiveIngredientMemberifrsfullSegmentsAxis", "decimals": "-6", "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R87": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "rdy:DisaggregationOfRevenueByGeographicalAreasTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "rdy:Revenues", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1087 - Disclosure - Segment reporting (Details 4)", "role": "http://www.drreddys.com/role/SegmentReportingDetails4", "shortName": "Segment reporting (Details 4)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "rdy:DisaggregationOfRevenueByGeographicalAreasTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "rdy:Revenues", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R88": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:DisclosureOfAnalysisOfCompanysNoncurrentAssetsOtherThanFinancialInstrumentsAndDeferredTaxAssetsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1088 - Disclosure - Segment reporting (Details 5)", "role": "http://www.drreddys.com/role/SegmentReportingDetails5", "shortName": "Segment reporting (Details 5)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:DisclosureOfAnalysisOfCompanysNoncurrentAssetsOtherThanFinancialInstrumentsAndDeferredTaxAssetsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R89": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:DisclosureOfDistributionOfCompanysPropertyPlantAndEquipmentAcquiredByCountryTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "rdy:PropertyPlantAndEquipmentsIncludingCapitalWorkInProgressAndIntangibleAssetsAcquiredOtherThanGoodwillArisingOnBusinessCombination", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1089 - Disclosure - Segment reporting (Details 6)", "role": "http://www.drreddys.com/role/SegmentReportingDetails6", "shortName": "Segment reporting (Details 6)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:DisclosureOfDistributionOfCompanysPropertyPlantAndEquipmentAcquiredByCountryTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "rdy:PropertyPlantAndEquipmentsIncludingCapitalWorkInProgressAndIntangibleAssetsAcquiredOtherThanGoodwillArisingOnBusinessCombination", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1009 - Disclosure - Basis of preparation of financial statements", "role": "http://www.drreddys.com/role/BasisOfPreparationOfFinancialStatements", "shortName": "Basis of preparation of financial statements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R90": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:DisclosureOfAnalysisOfDepreciationAndAmortizationIncludedInCostOfRevenuesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_CostOfRevenuesMemberRDYTypeOfExpensesByNatureAxis", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:DepreciationAndAmortisationExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1090 - Disclosure - Segment reporting (Details 7)", "role": "http://www.drreddys.com/role/SegmentReportingDetails7", "shortName": "Segment reporting (Details 7)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "rdy:DisclosureOfAnalysisOfDepreciationAndAmortizationIncludedInCostOfRevenuesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022_CostOfRevenuesMemberRDYTypeOfExpensesByNatureAxis", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:DepreciationAndAmortisationExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R91": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1091 - Disclosure - Segment reporting (Details Textual)", "role": "http://www.drreddys.com/role/SegmentReportingDetailsTextual", "shortName": "Segment reporting (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "lang": null, "name": "rdy:IntersegmentRevenuesFromPsaiToGlobalGeneric", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R92": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn02_12_2020", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1092 - Disclosure - Business Combinations (Details Textual)", "role": "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual", "shortName": "Business Combinations (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "lang": null, "name": "ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R93": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:CashTransferred", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1093 - Disclosure - Business Combinations (Details)", "role": "http://www.drreddys.com/role/BusinessCombinationsDetails", "shortName": "Business Combinations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory", "ix:continuation", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2020To03_31_2021_WockhardtLimitedMemberifrsfullBusinessCombinationsAxis", "decimals": "-6", "lang": null, "name": "rdy:PaymentThroughEscrowAccount", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R94": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:CashAndCashEquivalentsTableTableTextBlock", "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:CashOnHand", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1094 - Disclosure - Cash and cash equivalents (Details)", "role": "http://www.drreddys.com/role/CashAndCashEquivalentsDetails", "shortName": "Cash and cash equivalents (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:CashAndCashEquivalentsTableTableTextBlock", "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:CashOnHand", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R95": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:CurrentInvestments", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1095 - Disclosure - Other investments (Details)", "role": "http://www.drreddys.com/role/OtherInvestmentsDetails", "shortName": "Other investments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ifrs-full:DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_AtCostMemberifrsfullMeasurementAxis", "decimals": "-6", "lang": null, "name": "ifrs-full:CurrentInvestments", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R96": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:TradeAndOtherReceivablesTableTextBlock", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "rdy:CurrentTradeAndOtherReceivableGross", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1096 - Disclosure - Trade and other receivables (Details)", "role": "http://www.drreddys.com/role/TradeAndOtherReceivablesDetails", "shortName": "Trade and other receivables (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:TradeAndOtherReceivablesTableTextBlock", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "rdy:CurrentTradeAndOtherReceivableGross", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R97": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:TradeAndOtherReceivablesTableTextBlock", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2021", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets", "reportCount": 1, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1097 - Disclosure - Trade and other receivables (Details 1)", "role": "http://www.drreddys.com/role/TradeAndOtherReceivablesDetails1", "shortName": "Trade and other receivables (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:AllowanceForCreditLossesTableTextBlock", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-6", "lang": null, "name": "rdy:AdditionalAllowanceRecognisedInProfitOrLossProvisionMadeDuringTheYearNetOfReversals", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R98": { "firstAnchor": { "ancestors": [ "div", "div", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_FactoringOfReceivablesMemberifrsfullContinuingInvolvementInDerecognisedFinancialAssetsByTypeOfTransferAxis", "decimals": "-6", "first": true, "lang": null, "name": "rdy:TradeReceivablesDerecognisedPursuantToSaleToTheBank", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1098 - Disclosure - Trade and other receivables (Details Textual)", "role": "http://www.drreddys.com/role/TradeAndOtherReceivablesDetailsTextual", "shortName": "Trade and other receivables (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022_FactoringOfReceivablesMemberifrsfullContinuingInvolvementInDerecognisedFinancialAssetsByTypeOfTransferAxis", "decimals": "-6", "first": true, "lang": null, "name": "rdy:TradeReceivablesDerecognisedPursuantToSaleToTheBank", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } }, "R99": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfDetailedInformationAboutInventoriesTextBlock", "ifrs-full:DisclosureOfInventoriesExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:RawMaterials", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1099 - Disclosure - Inventories (Details)", "role": "http://www.drreddys.com/role/InventoriesDetails", "shortName": "Inventories (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rdy:DisclosureOfDetailedInformationAboutInventoriesTextBlock", "ifrs-full:DisclosureOfInventoriesExplanatory", "div", "body", "html" ], "baseRef": "rdy-20220331.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:RawMaterials", "reportCount": 1, "unique": true, "unitRef": "Unit_INR", "xsiNil": "false" } } }, "segmentCount": 426, "tag": { "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "verboseLabel": "United States Country [Member" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetailsTextual", "http://www.drreddys.com/role/SegmentReportingDetails5" ], "xbrltype": "domainItemType" }, "currency_AllCurrenciesDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "All Currencies [Domain]" } } }, "localname": "AllCurrenciesDomain", "nsuri": "http://xbrl.sec.gov/currency/2021", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails3" ], "xbrltype": "domainItemType" }, "currency_INR": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "India, Rupees", "terseLabel": "INR" } } }, "localname": "INR", "nsuri": "http://xbrl.sec.gov/currency/2021", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails3" ], "xbrltype": "domainItemType" }, "dei_AddressTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.", "label": "Address Type [Domain]" } } }, "localname": "AddressTypeDomain", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "dei_AdrMember": { "auth_ref": [ "r423" ], "lang": { "en-us": { "role": { "documentation": "American Depositary Receipt (or American Depositary Share, ADS).", "label": "ADR [Member]", "terseLabel": "American depositary shares [Member]" } } }, "localname": "AdrMember", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage", "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r424", "r425", "r426" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r424", "r425", "r426" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r424", "r425", "r426" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "internationalNameItemType" }, "dei_BusinessContactMember": { "auth_ref": [ "r425", "r426" ], "lang": { "en-us": { "role": { "documentation": "Business contact for the entity", "label": "Business Contact [Member]" } } }, "localname": "BusinessContactMember", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_ContactPersonnelEmailAddress": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Email address of contact personnel.", "label": "Contact Personnel Email Address" } } }, "localname": "ContactPersonnelEmailAddress", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_ContactPersonnelName": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of contact personnel", "label": "Contact Personnel Name" } } }, "localname": "ContactPersonnelName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover Page [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r425" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r424", "r425", "r426" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards.", "label": "Document [Domain]" } } }, "localname": "DocumentDomain", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationDocumentAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.", "label": "Document Information, Document [Axis]" } } }, "localname": "DocumentInformationDocumentAxis", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r419" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r425" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r427" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressesAddressTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.", "label": "Entity Addresses, Address Type [Axis]" } } }, "localname": "EntityAddressesAddressTypeAxis", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r421" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual", "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r421" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r421" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r428" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r421" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r421" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r429" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r424", "r425", "r426" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual", "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r420" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r422" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.drreddys.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember": { "auth_ref": [ "r89", "r100", "r184", "r201", "r204" ], "lang": { "en": { "role": { "documentation": "This member stands for accumulated depreciation, amortisation and impairment. [Refer: Impairment loss; Depreciation and amortisation expense]" } }, "en-us": { "role": { "label": "Accumulated depreciation, amortisation and impairment [member]", "verboseLabel": "Accumulated amortization and impairment [member]" } } }, "localname": "AccumulatedDepreciationAmortisationAndImpairmentMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred": { "auth_ref": [ "r307" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "definitionGuidance": "Consideration on acquisition date", "label": "Consideration transferred, acquisition-date fair value", "totalLabel": "Total consideration" } } }, "localname": "AcquisitiondateFairValueOfTotalConsiderationTransferred", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetails", "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferredAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquisition-date fair value of total consideration transferred [abstract]", "terseLabel": "Assets acquired" } } }, "localname": "AcquisitiondateFairValueOfTotalConsiderationTransferredAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination": { "auth_ref": [ "r310" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of acquisition-related costs recognised as an expense for transactions that are recognised separately from the acquisition of assets and the assumption of liabilities in business combinations. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "Acquisition-related costs recognised as expense for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination", "terseLabel": "Acquisition-related costs recognised as expense for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination" } } }, "localname": "AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r185" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The increase in intangible assets other than goodwill resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Acquisitions through business combinations, intangible assets other than goodwill", "terseLabel": "Assets acquired through business combinations" } } }, "localname": "AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment": { "auth_ref": [ "r92" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The increase in property, plant and equipment resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]" } }, "en-us": { "role": { "label": "Acquisitions through business combinations, property, plant and equipment", "verboseLabel": "Assets acquired through business combinations" } } }, "localname": "AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ActuarialAssumptionOfDiscountRates": { "auth_ref": [ "r116" ], "lang": { "en": { "role": { "documentation": "The discount rate used as the significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit obligation, at present value; Actuarial assumptions [member]]" } }, "en-us": { "role": { "label": "Actuarial assumption of discount rates", "terseLabel": "Discount rate" } } }, "localname": "ActuarialAssumptionOfDiscountRates", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails14", "http://www.drreddys.com/role/EmployeeBenefitsDetails5" ], "xbrltype": "percentItemType" }, "ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases": { "auth_ref": [ "r116" ], "lang": { "en": { "role": { "documentation": "The expected rate of salary increases used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit plans [member]; Defined benefit obligation, at present value; Actuarial assumptions [member]]" } }, "en-us": { "role": { "label": "Actuarial assumption of expected rates of salary increases", "terseLabel": "Rate of compensation increase" } } }, "localname": "ActuarialAssumptionOfExpectedRatesOfSalaryIncreases", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails14", "http://www.drreddys.com/role/EmployeeBenefitsDetails5" ], "xbrltype": "percentItemType" }, "ifrs-full_ActuarialAssumptionsAxis": { "auth_ref": [ "r117" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Actuarial assumptions [axis]" } } }, "localname": "ActuarialAssumptionsAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails13", "http://www.drreddys.com/role/EmployeeBenefitsDetails14", "http://www.drreddys.com/role/EmployeeBenefitsDetails4", "http://www.drreddys.com/role/EmployeeBenefitsDetails5", "http://www.drreddys.com/role/EmployeeBenefitsTables" ], "xbrltype": "stringItemType" }, "ifrs-full_ActuarialAssumptionsMember": { "auth_ref": [ "r117" ], "lang": { "en": { "role": { "documentation": "This member stands for all actuarial assumptions. Actuarial assumptions are the entity\u2019s unbiased and mutually compatible best estimates of the demographic and financial variables that will determine the ultimate cost of providing post-employment benefits. It also represents the standard value for the 'Actuarial assumptions' axis if no other member is used." } }, "en-us": { "role": { "label": "Actuarial assumptions [member]" } } }, "localname": "ActuarialAssumptionsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails13", "http://www.drreddys.com/role/EmployeeBenefitsDetails14", "http://www.drreddys.com/role/EmployeeBenefitsDetails4", "http://www.drreddys.com/role/EmployeeBenefitsDetails5", "http://www.drreddys.com/role/EmployeeBenefitsTables" ], "xbrltype": "domainItemType" }, "ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset": { "auth_ref": [ "r109" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in demographic assumptions that result in remeasurements of the net defined benefit liability (asset). Demographic assumptions deal with matters such as: (a) mortality; (b) rates of employee turnover, disability and early retirement; (c) the proportion of plan members with dependants who will be eligible for benefits; (d) the proportion of plan members who will select each form of payment option available under the plan terms; and (e) claim rates under medical plans. [Refer: Net defined benefit liability (asset)]" } }, "en-us": { "role": { "label": "Actuarial gains (losses) arising from changes in demographic assumptions, net defined benefit liability (asset)", "terseLabel": "Actuarial loss/(gain) due to demographic assumptions" } } }, "localname": "ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset": { "auth_ref": [ "r110" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in financial assumptions that result in remeasurements of the net defined benefit liability (asset). Financial assumptions deal with items such as: (a) the discount rate; (b) benefit levels, excluding any cost of the benefits to be met by employees, and future salary; (c) in the case of medical benefits, future medical costs, including claim handling costs (ie the costs that will be incurred in processing and resolving claims, including legal and adjuster's fees); and (d) taxes payable by the plan on contributions relating to service before the reporting date or on benefits resulting from that service. [Refer: Net defined benefit liability (asset)]" } }, "en-us": { "role": { "label": "Actuarial gains (losses) arising from changes in financial assumptions, net defined benefit liability (asset)", "terseLabel": "Actuarial loss/(gain) due to change in financial assumptions" } } }, "localname": "ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails11", "http://www.drreddys.com/role/EmployeeBenefitsDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset": { "auth_ref": [ "r111" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from experience adjustments that result in remeasurements of the net defined benefit liability (asset). Experience adjustments deal with the effects of differences between the previous actuarial assumptions and what has actually occurred. [Refer: Net defined benefit liability (asset)]" } }, "en-us": { "role": { "label": "Actuarial gains (losses) arising from experience adjustments, net defined benefit liability (asset)", "terseLabel": "Actuarial loss/(gain) due to experience changes", "verboseLabel": "Actuarial loss/(gain) due to experience changes" } } }, "localname": "ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails11", "http://www.drreddys.com/role/EmployeeBenefitsDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets": { "auth_ref": [ "r407" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0 } }, "lang": { "en": { "role": { "documentation": "The amount of additional allowance for credit losses of financial assets recognised in profit or loss. [Refer: Allowance account for credit losses of financial assets]" } }, "en-us": { "role": { "label": "Additional allowance recognised in profit or loss, allowance account for credit losses of financial assets", "terseLabel": "Allowance for credit losses (on trade receivables and other advances)" } } }, "localname": "AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdditionalProvisionsOtherProvisions": { "auth_ref": [ "r176" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of additional other provisions made. [Refer: Other provisions]" } }, "en-us": { "role": { "definitionGuidance": "Provision made during the year, net of reversals", "label": "Additional provisions, other provisions", "verboseLabel": "Provision made during the year, net of reversals" } } }, "localname": "AdditionalProvisionsOtherProvisions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ProvisionsDetails", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails7" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdditionalRecognitionGoodwill": { "auth_ref": [ "r314" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of additional goodwill recognised, except goodwill included in a disposal group that, on acquisition, meets the criteria to be classified as held for sale in accordance with IFRS 5. [Refer: Goodwill; Disposal groups classified as held for sale [member]]" } }, "en-us": { "role": { "label": "Additional recognition, goodwill", "verboseLabel": "Goodwill arising on business combinations" } } }, "localname": "AdditionalRecognitionGoodwill", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/GoodwillDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r185" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Additions other than through business combinations, intangible assets other than goodwill", "terseLabel": "Add: Additions during the year", "verboseLabel": "Additions" } } }, "localname": "AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetails", "http://www.drreddys.com/role/OtherIntangibleAssetsDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": { "auth_ref": [ "r90" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]" } }, "en-us": { "role": { "label": "Additions other than through business combinations, property, plant and equipment", "terseLabel": "Additions" } } }, "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdditionsToRightofuseAssets": { "auth_ref": [ "r285" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of additions to right-of-use assets. [Refer: Right-of-use assets]" } }, "en-us": { "role": { "label": "Additions to right-of-use assets", "terseLabel": "Additions", "verboseLabel": "Additions to right-of-use assets" } } }, "localname": "AdditionsToRightofuseAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails1", "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustedWeightedAverageShares": { "auth_ref": [ "r160" ], "lang": { "en": { "role": { "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } }, "en-us": { "role": { "label": "Adjusted weighted average number of ordinary shares outstanding", "presentationGuidance": "Weighted average number of equity shares \u2013 Diluted" } } }, "localname": "AdjustedWeightedAverageShares", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EarningsPerShareDetails1" ], "xbrltype": "sharesItemType" }, "ifrs-full_AdjustmentsForDecreaseIncreaseInInventories": { "auth_ref": [ "r216" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 17.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for decrease (increase) in inventories", "terseLabel": "Inventories (Refer to Note 10 for inventory write downs)" } } }, "localname": "AdjustmentsForDecreaseIncreaseInInventories", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables": { "auth_ref": [ "r218" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 16.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for decrease (increase) in trade and other receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other receivables; Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for decrease (increase) in trade and other receivables", "verboseLabel": "Trade and other receivables" } } }, "localname": "AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense": { "auth_ref": [ "r217" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for depreciation and amortisation expense", "verboseLabel": "Depreciation and amortization" } } }, "localname": "AdjustmentsForDepreciationAndAmortisationExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForDividendIncome": { "auth_ref": [ "r218" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 15.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "Adjustments for dividend income to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Dividend income; Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for dividend income", "negatedLabel": "Dividend income" } } }, "localname": "AdjustmentsForDividendIncome", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForFairValueGainsLosses": { "auth_ref": [ "r217" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for fair value losses (gains) to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for fair value losses (gains)", "negatedLabel": "Fair value changes and profit on sale of financial instruments measured at FVTPL, net" } } }, "localname": "AdjustmentsForFairValueGainsLosses", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss": { "auth_ref": [ "r217" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Impairment loss (reversal of impairment loss) recognised in profit or loss]" } }, "en-us": { "role": { "label": "Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss", "terseLabel": "Impairment of non-current assets" } } }, "localname": "AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForIncomeTaxExpense": { "auth_ref": [ "r222" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for income tax expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for income tax expense", "verboseLabel": "Tax expense/(benefit), net" } } }, "localname": "AdjustmentsForIncomeTaxExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables": { "auth_ref": [ "r218" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 18.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for increase (decrease) in trade and other payables", "verboseLabel": "Trade and other payables" } } }, "localname": "AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets": { "auth_ref": [ "r207" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for losses (gains) on disposal of non-current assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Non-current assets; Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for losses (gains) on disposal of non-current assets", "terseLabel": "(Gain)/loss on sale or de-recognition of non-current assets, net" } } }, "localname": "AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile profit (loss) [abstract]", "verboseLabel": "Adjustments for:" } } }, "localname": "AdjustmentsForReconcileProfitLossAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "ifrs-full_AdjustmentsForSharebasedPayments": { "auth_ref": [ "r217" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for share-based payments", "verboseLabel": "Equity settled share-based payment expense" } } }, "localname": "AdjustmentsForSharebasedPayments", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains": { "auth_ref": [ "r217", "r232" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for unrealised foreign exchange losses (gains) to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for unrealised foreign exchange losses (gains)", "verboseLabel": "Foreign exchange (gain)/loss, net" } } }, "localname": "AdjustmentsForUnrealisedForeignExchangeLossesGains", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_Advances": { "auth_ref": [ "r33", "r47" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of advances received representing contract liabilities for performance obligations satisfied at a point in time. [Refer: Contract liabilities; Performance obligations satisfied at point in time [member]]" } }, "en-us": { "role": { "label": "Advances received", "verboseLabel": "Advance from customers" } } }, "localname": "Advances", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails8" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AggregatedMeasurementMember": { "auth_ref": [ "r199", "r203", "r265" ], "lang": { "en": { "role": { "documentation": "This member stands for all types of measurement. It also represents the standard value for the 'Measurement' axis if no other member is used." } }, "en-us": { "role": { "label": "Aggregated measurement [member]" } } }, "localname": "AggregatedMeasurementMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetailsTextual", "http://www.drreddys.com/role/EmployeeBenefitsDetails13", "http://www.drreddys.com/role/EmployeeBenefitsDetails4", "http://www.drreddys.com/role/FinancialInstrumentsDetails1", "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual", "http://www.drreddys.com/role/OtherInvestmentsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_AggregatedTimeBandsMember": { "auth_ref": [ "r37", "r118", "r278", "r289", "r290", "r326", "r354", "r362", "r388", "r389", "r391", "r396" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used." } }, "en-us": { "role": { "label": "Aggregated time bands [member]" } } }, "localname": "AggregatedTimeBandsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetailsTextual", "http://www.drreddys.com/role/FinancialInstrumentsDetails4", "http://www.drreddys.com/role/FinancialRiskManagementDetails1", "http://www.drreddys.com/role/FinancialRiskManagementDetails2", "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual", "http://www.drreddys.com/role/LoansAndBorrowingsDetails4", "http://www.drreddys.com/role/LoansAndBorrowingsDetailsTextual", "http://www.drreddys.com/role/OtherLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_AllLevelsOfFairValueHierarchyMember": { "auth_ref": [ "r115", "r266" ], "lang": { "en": { "role": { "documentation": "This member stands for all levels of the fair value hierarchy. It also represents the standard value for the 'Levels of fair value hierarchy' axis if no other member is used." } }, "en-us": { "role": { "label": "All levels of fair value hierarchy [member]" } } }, "localname": "AllLevelsOfFairValueHierarchyMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual", "http://www.drreddys.com/role/FinancialInstrumentsDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets": { "auth_ref": [ "r407" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of an allowance account used to record impairments to financial assets due to credit losses. [Refer: Financial assets]" } }, "en-us": { "role": { "label": "Allowance account for credit losses of financial assets", "negatedLabel": "Less: Allowance for credit losses", "negatedTerseLabel": "Allowance account for credit losses of financial assets", "periodEndLabel": "Balance at the end of the year", "periodStartLabel": "Balance at the beginning of the year" } } }, "localname": "AllowanceAccountForCreditLossesOfFinancialAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetails1", "http://www.drreddys.com/role/TradeAndOtherReceivablesDetails", "http://www.drreddys.com/role/TradeAndOtherReceivablesDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AmortisationExpense": { "auth_ref": [ "r13" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of amortisation expense. Amortisation is the systematic allocation of depreciable amounts of intangible assets over their useful lives." } }, "en-us": { "role": { "label": "Amortisation expense" } } }, "localname": "AmortisationExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/NatureOfExpenseDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r188" ], "lang": { "en": { "role": { "documentation": "The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Amortisation, intangible assets other than goodwill", "verboseLabel": "Amortization for the year" } } }, "localname": "AmortisationIntangibleAssetsOtherThanGoodwill", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AmountsPayableRelatedPartyTransactions": { "auth_ref": [ "r137", "r142" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amounts payable resulting from related party transactions. [Refer: Related parties [member]]" } }, "en-us": { "role": { "label": "Amounts payable, related party transactions" } } }, "localname": "AmountsPayableRelatedPartyTransactions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/RelatedPartiesDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AmountsReceivableRelatedPartyTransactions": { "auth_ref": [ "r137", "r142" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amounts receivable resulting from related party transactions. [Refer: Related parties [member]]" } }, "en-us": { "role": { "label": "Amounts receivable, related party transactions" } } }, "localname": "AmountsReceivableRelatedPartyTransactions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/RelatedPartiesDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AnalysisOfIncomeAndExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Analysis of income and expense [abstract]" } } }, "localname": "AnalysisOfIncomeAndExpenseAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedIncomeStatements" ], "xbrltype": "stringItemType" }, "ifrs-full_ApplicableTaxRate": { "auth_ref": [ "r78" ], "lang": { "en": { "role": { "documentation": "The applicable income tax rate." } }, "en-us": { "role": { "label": "Applicable tax rate", "verboseLabel": "Enacted tax rate in India" } } }, "localname": "ApplicableTaxRate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails2" ], "xbrltype": "percentItemType" }, "ifrs-full_Assets": { "auth_ref": [ "r33", "r265", "r266", "r267", "r371", "r375" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } }, "en-us": { "role": { "definitionGuidance": "Total assets", "label": "Assets", "totalLabel": "Total assets", "verboseLabel": "Total" } } }, "localname": "Assets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition", "http://www.drreddys.com/role/FinancialRiskManagementDetails", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets:", "verboseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition", "http://www.drreddys.com/role/FinancialRiskManagementDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_AtCostMember": { "auth_ref": [ "r199", "r203", "r205" ], "lang": { "en": { "role": { "documentation": "This member stands for measurement based on cost. Cost is the amount of cash or cash equivalents paid or the fair value of the other consideration given to acquire an asset at the time of its acquisition or construction, or, when applicable, the amount attributed to that asset when initially recognised in accordance with the specific requirements of other IFRSs." } }, "en-us": { "role": { "label": "At cost [member]", "verboseLabel": "Cost [member]" } } }, "localname": "AtCostMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherInvestmentsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_AverageEffectiveTaxRate": { "auth_ref": [ "r78" ], "lang": { "en": { "role": { "documentation": "The tax expense (income) divided by the accounting profit. [Refer: Accounting profit]" } }, "en-us": { "role": { "label": "Average effective tax rate", "verboseLabel": "Effective tax rate" } } }, "localname": "AverageEffectiveTaxRate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails2" ], "xbrltype": "percentItemType" }, "ifrs-full_BalancesWithBanks": { "auth_ref": [ "r229" ], "calculation": { "http://www.drreddys.com/role/CashAndCashEquivalentsDetails": { "order": 3.0, "parentTag": "ifrs-full_CashAndCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of cash balances held at banks." } }, "en-us": { "role": { "label": "Balances with banks", "terseLabel": "Balances with banks" } } }, "localname": "BalancesWithBanks", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/CashAndCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_BankOverdraftsClassifiedAsCashEquivalents": { "auth_ref": [ "r229" ], "calculation": { "http://www.drreddys.com/role/CashAndCashEquivalentsDetails": { "order": 1.0, "parentTag": "ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition", "weight": -1.0 }, "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 14.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount that has been withdrawn from an account in excess of existing cash balances. This is considered a short-term extension of credit by the bank. [Refer: Cash and cash equivalents]" } }, "en-us": { "role": { "label": "Bank overdrafts", "terseLabel": "Bank overdraft", "verboseLabel": "Bank overdrafts used for cash management purposes" } } }, "localname": "BankOverdraftsClassifiedAsCashEquivalents", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/CashAndCashEquivalentsDetails", "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition", "http://www.drreddys.com/role/FinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_BasicEarningsLossPerShare": { "auth_ref": [ "r157", "r158" ], "lang": { "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)." } }, "en-us": { "role": { "label": "Basic earnings (loss) per share", "terseLabel": "Basic earnings per share of Rs.5/- each", "verboseLabel": "Earnings per share of par value Rs.5 \u2013 Basic" } } }, "localname": "BasicEarningsLossPerShare", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedIncomeStatements", "http://www.drreddys.com/role/EarningsPerShareDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_BasicEarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basic earnings per share [abstract]" } } }, "localname": "BasicEarningsPerShareAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_Borrowings": { "auth_ref": [ "r33" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of outstanding funds that the entity is obligated to repay." } }, "en-us": { "role": { "label": "Borrowings", "terseLabel": "Long-term borrowings", "verboseLabel": "Borrowings" } } }, "localname": "Borrowings", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails", "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual", "http://www.drreddys.com/role/LoansAndBorrowingsDetails4" ], "xbrltype": "monetaryItemType" }, "ifrs-full_BorrowingsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Borrowings [abstract]" } } }, "localname": "BorrowingsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_BorrowingsByNameAxis": { "auth_ref": [ "r347" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Borrowings by name [axis]" } } }, "localname": "BorrowingsByNameAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual", "http://www.drreddys.com/role/LoansAndBorrowingsDetails", "http://www.drreddys.com/role/LoansAndBorrowingsDetails1", "http://www.drreddys.com/role/LoansAndBorrowingsDetails3", "http://www.drreddys.com/role/LoansAndBorrowingsDetailsTextual" ], "xbrltype": "stringItemType" }, "ifrs-full_BorrowingsByNameMember": { "auth_ref": [ "r347" ], "lang": { "en": { "role": { "documentation": "This member stands for all borrowings when disaggregated by name. It also represents the standard value for the 'Borrowings by name' axis if no other member is used. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Borrowings by name [member]" } } }, "localname": "BorrowingsByNameMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual", "http://www.drreddys.com/role/LoansAndBorrowingsDetails", "http://www.drreddys.com/role/LoansAndBorrowingsDetails1", "http://www.drreddys.com/role/LoansAndBorrowingsDetails3", "http://www.drreddys.com/role/LoansAndBorrowingsDetailsTextual" ], "xbrltype": "domainItemType" }, "ifrs-full_BorrowingsInterestRate": { "auth_ref": [ "r347" ], "lang": { "en": { "role": { "documentation": "The interest rate on borrowings. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Borrowings, interest rate" } } }, "localname": "BorrowingsInterestRate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails1", "http://www.drreddys.com/role/LoansAndBorrowingsDetails3" ], "xbrltype": "percentItemType" }, "ifrs-full_BorrowingsInterestRateBasis": { "auth_ref": [ "r347" ], "lang": { "en": { "role": { "documentation": "The basis (reference rate) used for calculation of the interest rate on borrowings. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Borrowings, interest rate basis" } } }, "localname": "BorrowingsInterestRateBasis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual", "http://www.drreddys.com/role/LoansAndBorrowingsDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_BorrowingsMaturity": { "auth_ref": [ "r347" ], "lang": { "en": { "role": { "documentation": "The maturity of borrowings. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Borrowings, maturity", "terseLabel": "Borrowings maturity" } } }, "localname": "BorrowingsMaturity", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetailsTextual" ], "xbrltype": "stringItemType" }, "ifrs-full_BorrowingsOriginalCurrency": { "auth_ref": [ "r347" ], "lang": { "en": { "role": { "documentation": "The currency in which the borrowings are denominated. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Borrowings, original currency" } } }, "localname": "BorrowingsOriginalCurrency", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails1", "http://www.drreddys.com/role/LoansAndBorrowingsDetails3" ], "xbrltype": "stringItemType" }, "ifrs-full_BottomOfRangeMember": { "auth_ref": [ "r270", "r272", "r274", "r299", "r347", "r391" ], "lang": { "en": { "role": { "documentation": "This member stands for the bottom of a range." } }, "en-us": { "role": { "label": "Bottom of range [member]" } } }, "localname": "BottomOfRangeMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails2", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails4", "http://www.drreddys.com/role/GoodwillDetailsTextual", "http://www.drreddys.com/role/IncomeTaxesDetails2", "http://www.drreddys.com/role/OtherIncomeNetDetailsTextual", "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual", "http://www.drreddys.com/role/SignificantAccountingPoliciesDetails1", "http://www.drreddys.com/role/SignificantAccountingPoliciesDetails2" ], "xbrltype": "domainItemType" }, "ifrs-full_BuildingsMember": { "auth_ref": [ "r87" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of plant, property and equipment representing depreciable buildings and similar structures for use in operations. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Buildings [member]", "terseLabel": "Buildings [member]" } } }, "localname": "BuildingsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails", "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails1", "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetailsTextual" ], "xbrltype": "domainItemType" }, "ifrs-full_BusinessCombinationsAxis": { "auth_ref": [ "r312" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Business combinations [axis]", "terseLabel": "Business combinations [axis]" } } }, "localname": "BusinessCombinationsAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetails", "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual", "http://www.drreddys.com/role/BusinessCombinationsTables", "http://www.drreddys.com/role/EmployeeBenefitsDetailsTextual", "http://www.drreddys.com/role/FinancialInstrumentsDetailsTextual", "http://www.drreddys.com/role/GoodwillDetailsTextual", "http://www.drreddys.com/role/MergerOfDrReddySHoldingsLimitedIntoDrReddySLaboratoriesLimitedDetailsTextual", "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual", "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetailsTextual", "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "stringItemType" }, "ifrs-full_CapitalRedemptionReserve": { "auth_ref": [ "r33" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 21.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "A component of equity representing the reserve for the redemption of the entity's own shares." } }, "en-us": { "role": { "label": "Capital redemption reserve", "verboseLabel": "Capital redemption reserve" } } }, "localname": "CapitalRedemptionReserve", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CapitalRedemptionReserveMember": { "auth_ref": [ "r12" ], "lang": { "en": { "role": { "documentation": "This member stands for a component of equity representing the reserve for the redemption of the entity's own shares." } }, "en-us": { "role": { "label": "Capital redemption reserve [member]", "verboseLabel": "Capital redemption reserve [member]" } } }, "localname": "CapitalRedemptionReserveMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "domainItemType" }, "ifrs-full_CapitalisationRateOfBorrowingCostsEligibleForCapitalisation": { "auth_ref": [ "r132" ], "lang": { "en": { "role": { "documentation": "The weighted average of interest and other costs that an entity incurs in connection with the borrowing of funds applicable to the borrowings of the entity that are outstanding during the period, other than borrowings made specifically for the purpose of obtaining a qualifying asset. [Refer: Weighted average [member]; Borrowings]" } }, "en-us": { "role": { "label": "Capitalisation rate of borrowing costs eligible for capitalisation" } } }, "localname": "CapitalisationRateOfBorrowingCostsEligibleForCapitalisation", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual", "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetailsTextual" ], "xbrltype": "percentItemType" }, "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": { "auth_ref": [ "r89", "r96", "r184", "r190", "r200", "r201", "r202", "r203", "r204", "r317", "r337", "r338", "r411", "r418" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]", "terseLabel": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]" } } }, "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetails", "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails", "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_CarryingAmountMember": { "auth_ref": [ "r96", "r190", "r200", "r202", "r203", "r317", "r337", "r338", "r411", "r417" ], "lang": { "en": { "role": { "documentation": "This member stands for the amount at which an asset is recognised in the statement of financial position (after deducting any accumulated depreciation or amortisation and accumulated impairment losses). It also represents the standard value for the 'Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount' axis if no other member is used. [Refer: Depreciation and amortisation expense; Impairment loss]" } }, "en-us": { "role": { "label": "Carrying amount [member]", "terseLabel": "Carrying amount [member]" } } }, "localname": "CarryingAmountMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetails", "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails", "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_Cash": { "auth_ref": [ "r229" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of cash on hand and demand deposits. [Refer: Cash on hand]" } }, "en-us": { "role": { "label": "Cash" } } }, "localname": "Cash", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashAndCashEquivalents": { "auth_ref": [ "r27", "r229", "r256" ], "calculation": { "http://www.drreddys.com/role/CashAndCashEquivalentsDetails": { "order": 2.0, "parentTag": "ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition", "weight": 1.0 }, "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 37.0, "parentTag": "ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]" } }, "en-us": { "role": { "label": "Cash and cash equivalents", "totalLabel": "Cash and cash equivalents in the statements of financial position", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalents", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/CashAndCashEquivalentsDetails", "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition", "http://www.drreddys.com/role/FinancialInstrumentsDetails", "http://www.drreddys.com/role/FinancialRiskManagementDetails", "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashAndCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents [Abstract]" } } }, "localname": "CashAndCashEquivalentsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition": { "auth_ref": [ "r229" ], "calculation": { "http://www.drreddys.com/role/CashAndCashEquivalentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of cash and cash equivalents in the statement of cash flows when different from the amount of cash and cash equivalents in the statement of financial position. [Refer: Cash and cash equivalents]" } }, "en-us": { "role": { "label": "Cash and cash equivalents if different from statement of financial position", "periodEndLabel": "Cash and cash equivalents at the end of the year (Refer to Note 7)", "periodStartLabel": "Cash and cash equivalents at the beginning of the year", "totalLabel": "Cash and cash equivalents in the statements of cash flow" } } }, "localname": "CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/CashAndCashEquivalentsDetails", "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate": { "auth_ref": [ "r309" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount recognised as of the acquisition date for cash and cash equivalents acquired in a business combination. [Refer: Cash and cash equivalents; Business combinations [member]]" } }, "en-us": { "role": { "label": "Cash and cash equivalents recognised as of acquisition date", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsRecognisedAsOfAcquisitionDate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowHedgesMember": { "auth_ref": [ "r198", "r328", "r329", "r331" ], "lang": { "en": { "role": { "documentation": "This member stands for hedges of the exposure to variability in cash flows that (a) are attributable to a particular risk associated with a recognised asset or liability (such as all or some future interest payments on variable rate debt) or a highly probable forecast transaction; and (b) could affect profit or loss. [Refer: Hedges [member]]" } }, "en-us": { "role": { "label": "Cash flow hedges [member]" } } }, "localname": "CashFlowHedgesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "domainItemType" }, "ifrs-full_CashFlowsFromUsedInFinancingActivities": { "auth_ref": [ "r206", "r231" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 30.0, "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity." } }, "en-us": { "role": { "label": "Cash flows from (used in) financing activities", "totalLabel": "Net cash used in financing activities" } } }, "localname": "CashFlowsFromUsedInFinancingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) financing activities [abstract]", "verboseLabel": "Cash flows used in financing activities:" } } }, "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "ifrs-full_CashFlowsFromUsedInInvestingActivities": { "auth_ref": [ "r206", "r231" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 20.0, "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents." } }, "en-us": { "role": { "label": "Cash flows from (used in) investing activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "CashFlowsFromUsedInInvestingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) investing activities [abstract]", "verboseLabel": "Cash flows used in investing activities:" } } }, "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "ifrs-full_CashFlowsFromUsedInOperatingActivities": { "auth_ref": [ "r206", "r231" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "weight": 1.0 } }, "lang": { "en": { "role": { "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]" } }, "en-us": { "role": { "label": "Cash flows from (used in) operating activities", "totalLabel": "Net cash from operating activities" } } }, "localname": "CashFlowsFromUsedInOperatingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) operating activities [abstract]", "verboseLabel": "Cash flows from operating activities:" } } }, "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "ifrs-full_CashFlowsFromUsedInOperations": { "auth_ref": [ "r218", "r232" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "lang": { "en": { "role": { "documentation": "The cash from (used in) the entity's operations." } }, "en-us": { "role": { "label": "Cash flows from (used in) operations", "totalLabel": "Cash generated from operations" } } }, "localname": "CashFlowsFromUsedInOperations", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities": { "auth_ref": [ "r223" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 29.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The aggregate cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities. [Refer: Subsidiaries [member]]" } }, "en-us": { "role": { "label": "Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities", "negatedTerseLabel": "Payment for acquisition of business (Refer to Note 6)" } } }, "localname": "CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashOnHand": { "auth_ref": [ "r229" ], "calculation": { "http://www.drreddys.com/role/CashAndCashEquivalentsDetails": { "order": 5.0, "parentTag": "ifrs-full_CashAndCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of cash held by the entity. This does not include demand deposits." } }, "en-us": { "role": { "definitionGuidance": "Cash on hand", "label": "Cash on hand" } } }, "localname": "CashOnHand", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/CashAndCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashOutflowForLeases": { "auth_ref": [ "r284" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for leases." } }, "en-us": { "role": { "label": "Cash outflow for leases" } } }, "localname": "CashOutflowForLeases", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashTransferred": { "auth_ref": [ "r304" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "Cash transferred", "terseLabel": "Consideration transferred for acquisition of asset", "verboseLabel": "Cash" } } }, "localname": "CashTransferred", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetails", "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual", "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CategoriesOfFinancialAssetsAxis": { "auth_ref": [ "r351" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Categories of financial assets [axis]", "terseLabel": "Categories of financial assets [axis]" } } }, "localname": "CategoriesOfFinancialAssetsAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_CategoriesOfFinancialLiabilitiesAxis": { "auth_ref": [ "r351" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Categories of financial liabilities [axis]" } } }, "localname": "CategoriesOfFinancialLiabilitiesAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_CategoriesOfRelatedPartiesAxis": { "auth_ref": [ "r141" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Categories of related parties [axis]" } } }, "localname": "CategoriesOfRelatedPartiesAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails", "http://www.drreddys.com/role/EmployeeBenefitsDetails2", "http://www.drreddys.com/role/EmployeeBenefitsDetails9", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails5", "http://www.drreddys.com/role/LoansAndBorrowingsDetails2", "http://www.drreddys.com/role/LoansAndBorrowingsDetailsTextual", "http://www.drreddys.com/role/ProvisionsDetailsTextual", "http://www.drreddys.com/role/RelatedPartiesDetails", "http://www.drreddys.com/role/RelatedPartiesDetails1", "http://www.drreddys.com/role/RelatedPartiesDetails2", "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "stringItemType" }, "ifrs-full_ChangesInEquity": { "auth_ref": [ "r9" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in equity. [Refer: Equity]" } }, "en-us": { "role": { "label": "Increase (decrease) in equity", "terseLabel": "Total transactions with owners of the Company" } } }, "localname": "ChangesInEquity", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ChangesInEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in equity [abstract]", "verboseLabel": "Transactions with owners of the Company" } } }, "localname": "ChangesInEquityAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfAssetsAxis": { "auth_ref": [ "r162", "r165", "r268", "r287" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of assets [axis]" } } }, "localname": "ClassesOfAssetsAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails2", "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails1", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetailsTextual", "http://www.drreddys.com/role/LoansAndBorrowingsDetailsTextual", "http://www.drreddys.com/role/OtherInvestmentsDetails", "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails1", "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetailsTextual", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails5", "http://www.drreddys.com/role/ShareCapitalDetails1", "http://www.drreddys.com/role/TradeAndOtherReceivablesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfAssetsMember": { "auth_ref": [ "r162", "r268", "r287" ], "lang": { "en": { "role": { "documentation": "This member stands for a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of assets' axis if no other member is used." } }, "en-us": { "role": { "label": "Assets [member]" } } }, "localname": "ClassesOfAssetsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails2", "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails1", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetailsTextual", "http://www.drreddys.com/role/LoansAndBorrowingsDetailsTextual", "http://www.drreddys.com/role/OtherInvestmentsDetails", "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails1", "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetailsTextual", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails5", "http://www.drreddys.com/role/ShareCapitalDetails1", "http://www.drreddys.com/role/TradeAndOtherReceivablesDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_ClassesOfFinancialAssetsAxis": { "auth_ref": [ "r345", "r346", "r387", "r399", "r400", "r401" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of financial assets [axis]", "terseLabel": "Classes of financial assets [axis]" } } }, "localname": "ClassesOfFinancialAssetsAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3", "http://www.drreddys.com/role/FinancialInstrumentsDetailsTextual" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfFinancialInstrumentsAxis": { "auth_ref": [ "r337", "r339", "r340", "r342" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of financial instruments [axis]" } } }, "localname": "ClassesOfFinancialInstrumentsAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails", "http://www.drreddys.com/role/FinancialRiskManagementDetails", "http://www.drreddys.com/role/LoansAndBorrowingsDetails3", "http://www.drreddys.com/role/TradeAndOtherReceivablesDetails", "http://www.drreddys.com/role/TradeAndOtherReceivablesDetails1", "http://www.drreddys.com/role/TradeAndOtherReceivablesDetailsTextual" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfFinancialInstrumentsMember": { "auth_ref": [ "r337", "r339", "r340", "r342" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated classes of financial instruments. Financial instruments are contracts that give rise to a financial asset of one entity and a financial liability or equity instrument of another entity. It also represents the standard value for the 'Classes of financial instruments' axis if no other member is used. [Refer: Financial assets; Financial liabilities]" } }, "en-us": { "role": { "label": "Financial instruments, class [member]" } } }, "localname": "ClassesOfFinancialInstrumentsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails", "http://www.drreddys.com/role/FinancialRiskManagementDetails", "http://www.drreddys.com/role/LoansAndBorrowingsDetails3", "http://www.drreddys.com/role/TradeAndOtherReceivablesDetails", "http://www.drreddys.com/role/TradeAndOtherReceivablesDetails1", "http://www.drreddys.com/role/TradeAndOtherReceivablesDetailsTextual" ], "xbrltype": "domainItemType" }, "ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis": { "auth_ref": [ "r191" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of intangible assets and goodwill [axis]" } } }, "localname": "ClassesOfIntangibleAssetsAndGoodwillAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/GoodwillDetailsTextual" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis": { "auth_ref": [ "r191" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of intangible assets other than goodwill [axis]" } } }, "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetails", "http://www.drreddys.com/role/OtherIntangibleAssetsDetails1", "http://www.drreddys.com/role/OtherIntangibleAssetsDetails2", "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual", "http://www.drreddys.com/role/SignificantAccountingPoliciesDetails2" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfInventoriesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Classes of current inventories [abstract]" } } }, "localname": "ClassesOfInventoriesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfOrdinarySharesAxis": { "auth_ref": [ "r157" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of ordinary shares [axis]" } } }, "localname": "ClassesOfOrdinarySharesAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails1", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails2", "http://www.drreddys.com/role/EmployeeStockIncentivePlansTables" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": { "auth_ref": [ "r97" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of property, plant and equipment [axis]" } } }, "localname": "ClassesOfPropertyPlantAndEquipmentAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/GoodwillDetailsTextual", "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails", "http://www.drreddys.com/role/SignificantAccountingPoliciesDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfProvisionsAxis": { "auth_ref": [ "r178" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of other provisions [axis]" } } }, "localname": "ClassesOfProvisionsAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual", "http://www.drreddys.com/role/ProvisionsDetails", "http://www.drreddys.com/role/ProvisionsDetailsTextual" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfShareCapitalAxis": { "auth_ref": [ "r53" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of share capital [axis]" } } }, "localname": "ClassesOfShareCapitalAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetailsTextual" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfShareCapitalMember": { "auth_ref": [ "r53" ], "lang": { "en": { "role": { "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used." } }, "en-us": { "role": { "label": "Share capital [member]" } } }, "localname": "ClassesOfShareCapitalMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetailsTextual" ], "xbrltype": "domainItemType" }, "ifrs-full_ComponentsOfEquityAxis": { "auth_ref": [ "r10" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Components of equity [axis]" } } }, "localname": "ComponentsOfEquityAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetailsTextual", "http://www.drreddys.com/role/ShareCapitalDetails", "http://www.drreddys.com/role/ShareCapitalDetailsTextual" ], "xbrltype": "stringItemType" }, "ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract]", "verboseLabel": "Items that will be reclassified subsequently to the consolidated income statement:" } } }, "localname": "ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "stringItemType" }, "ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Components of other comprehensive income that will not be reclassified to profit or loss, net of tax [abstract]", "verboseLabel": "Items that will not be reclassified to the consolidated income statement:" } } }, "localname": "ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "stringItemType" }, "ifrs-full_ComprehensiveIncome": { "auth_ref": [ "r4", "r56", "r238", "r241", "r248", "r253" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners." } }, "en-us": { "role": { "label": "Comprehensive income", "terseLabel": "Total comprehensive income for the year", "totalLabel": "Total comprehensive income for the year" } } }, "localname": "ComprehensiveIncome", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity", "http://www.drreddys.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Comprehensive income [abstract]", "verboseLabel": "Total comprehensive income" } } }, "localname": "ComprehensiveIncomeAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "stringItemType" }, "ifrs-full_ConsiderationPaidReceived": { "auth_ref": [ "r224" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of consideration paid or received in respect of both obtaining and losing control of subsidiaries or other businesses. [Refer: Subsidiaries [member]]" } }, "en-us": { "role": { "label": "Consideration paid (received)", "terseLabel": "Business combination payment of consideration" } } }, "localname": "ConsiderationPaidReceived", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ConstructionInProgressMember": { "auth_ref": [ "r87" ], "lang": { "en": { "role": { "documentation": "This member stands for expenditure capitalised during the construction of items of property, plant and equipment that are not yet available for use (ie not yet in the location and condition necessary for it to be capable of operating in the manner intended by the management). [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Construction in Progress [Member]", "verboseLabel": "Capital-work-in-progress [Member]" } } }, "localname": "ConstructionInProgressMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate": { "auth_ref": [ "r308" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount, at acquisition date, of contingent consideration arrangements recognised as consideration transferred in a business combination. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "Contingent consideration recognised as of acquisition date", "terseLabel": "Business combination contingent consideration payable" } } }, "localname": "ContingentConsiderationRecognisedAsOfAcquisitionDate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination": { "auth_ref": [ "r313" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of contingent liabilities recognised in a business combination. [Refer: Contingent liabilities [member]; Business combinations [member]]" } }, "en-us": { "role": { "label": "Contingent liabilities recognised in business combination", "terseLabel": "Business Combination consideration payable" } } }, "localname": "ContingentLiabilitiesRecognisedInBusinessCombination", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ContinuingInvolvementInDerecognisedFinancialAssetsByTypeOfTransferAxis": { "auth_ref": [ "r356" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Continuing involvement in derecognised financial assets by type of transfer [axis]" } } }, "localname": "ContinuingInvolvementInDerecognisedFinancialAssetsByTypeOfTransferAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/TradeAndOtherReceivablesDetailsTextual" ], "xbrltype": "stringItemType" }, "ifrs-full_ContractAssets": { "auth_ref": [ "r275", "r277" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of an entity\u2019s right to consideration in exchange for goods or services that the entity has transferred to a customer, when that right is conditioned on something other than the passage of time (for example, the entity\u2019s future performance)." } }, "en-us": { "role": { "label": "Contract assets" } } }, "localname": "ContractAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ContractLiabilities": { "auth_ref": [ "r275", "r277" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of an entity\u2019s obligation to transfer goods or services to a customer for which the entity has received consideration (or the amount is due) from the customer." } }, "en-us": { "role": { "label": "Contract liabilities" } } }, "localname": "ContractLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails8" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment": { "auth_ref": [ "r98" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of contractual commitments for the acquisition of property, plant and equipment. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Contractual commitments for acquisition of property, plant and equipment" } } }, "localname": "ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset": { "auth_ref": [ "r113" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The decrease (increase) in net defined benefit liability (asset) resulting from contributions to a defined benefit plan by the employer. [Refer: Net defined benefit liability (asset); Defined benefit plans [member]]" } }, "en-us": { "role": { "label": "Contributions to plan by employer, net defined benefit liability (asset)", "verboseLabel": "Employer contributions" } } }, "localname": "ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails12", "http://www.drreddys.com/role/EmployeeBenefitsDetails3" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ContributionsToPlanNetDefinedBenefitLiabilityAssetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contributions to plan, net defined benefit liability (asset) [abstract]" } } }, "localname": "ContributionsToPlanNetDefinedBenefitLiabilityAssetAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod": { "auth_ref": [ "r126" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of inventories recognised as an expense during the period. [Refer: Inventories]" } }, "en-us": { "role": { "label": "Cost of inventories recognised as expense during period", "verboseLabel": "Raw materials, consumables and changes in finished goods and work in progress" } } }, "localname": "CostOfInventoriesRecognisedAsExpenseDuringPeriod", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/InventoriesDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CostOfSales": { "auth_ref": [ "r2", "r67" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedIncomeStatements": { "order": 9.0, "parentTag": "ifrs-full_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories." } }, "en-us": { "role": { "label": "Cost of sales", "verboseLabel": "Cost of revenues" } } }, "localname": "CostOfSales", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedIncomeStatements" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CounterpartiesAxis": { "auth_ref": [ "r363" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Counterparties [axis]", "terseLabel": "Counterparties [axis]" } } }, "localname": "CounterpartiesAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetailsTextual", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetailsTextual" ], "xbrltype": "stringItemType" }, "ifrs-full_CounterpartiesMember": { "auth_ref": [ "r363" ], "lang": { "en": { "role": { "documentation": "This member stands for the parties to the transaction other than the entity. It also represents the standard value for the 'Counterparties' axis if no other member is used." } }, "en-us": { "role": { "label": "Counterparties [member]", "terseLabel": "Counterparties [member]" } } }, "localname": "CounterpartiesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetailsTextual", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetailsTextual" ], "xbrltype": "domainItemType" }, "ifrs-full_CountryOfDomicileMember": { "auth_ref": [ "r380", "r381" ], "lang": { "en": { "role": { "documentation": "This member stands for the country in which the entity is registered and where it has its legal address or registered office." } }, "en-us": { "role": { "label": "Country of domicile [member]", "verboseLabel": "Domestic [member]" } } }, "localname": "CountryOfDomicileMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary": { "auth_ref": [ "r149", "r152", "r243", "r245" ], "lang": { "en": { "role": { "documentation": "The country in which a subsidiary of the entity is incorporated. [Refer: Subsidiaries [member]]" } }, "en-us": { "role": { "label": "Country of incorporation of subsidiary", "terseLabel": "Country of Incorporation" } } }, "localname": "CountryOfIncorporationOrResidenceOfSubsidiary", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities": { "auth_ref": [ "r33" ], "calculation": { "http://www.drreddys.com/role/OtherLiabilitiesDetails": { "order": 1.0, "parentTag": "ifrs-full_OtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current accrued expenses and other current liabilities. [Refer: Accruals; Other current liabilities]" } }, "en-us": { "role": { "label": "Current accrued expenses and other current liabilities", "verboseLabel": "Accrued expenses" } } }, "localname": "CurrentAccruedExpensesAndOtherCurrentLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentAdvances": { "auth_ref": [ "r33", "r47" ], "calculation": { "http://www.drreddys.com/role/OtherLiabilitiesDetails": { "order": 5.0, "parentTag": "ifrs-full_OtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current advances received representing current contract liabilities for performance obligations satisfied at a point in time. [Refer: Advances received, representing contract liabilities for performance obligations satisfied at point in time]" } }, "en-us": { "role": { "label": "Current advances received", "terseLabel": "Advance from customers" } } }, "localname": "CurrentAdvances", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity": { "auth_ref": [ "r75" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The aggregate current and deferred tax relating to particular items that are charged or credited directly to equity, for example: (a) an adjustment to the opening balance of retained earnings resulting from either a change in accounting policy that is applied retrospectively or the correction of an error; and (b) amounts arising on initial recognition of the equity component of a compound financial instrument. [Refer: Deferred tax relating to items credited (charged) directly to equity; Retained earnings; Financial instruments, class [member]]" } }, "en-us": { "role": { "label": "Current and deferred tax relating to items credited (charged) directly to equity", "totalLabel": "Current and deferred tax relating to items credited (charged) directly to equity" } } }, "localname": "CurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current and deferred tax relating to items charged or credited directly to equity [abstract]" } } }, "localname": "CurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_CurrentAssets": { "auth_ref": [ "r38", "r248", "r249" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 35.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]" } }, "en-us": { "role": { "label": "Current assets", "totalLabel": "Total current assets", "verboseLabel": "Total current assets" } } }, "localname": "CurrentAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets [abstract]", "verboseLabel": "Current assets" } } }, "localname": "CurrentAssetsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners": { "auth_ref": [ "r38" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 36.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current assets other than non-current assets or disposal groups classified as held for sale or as held for distribution to owners. [Refer: Current assets; Disposal groups classified as held for sale [member]; Non-current assets or disposal groups classified as held for sale; Non-current assets or disposal groups classified as held for distribution to owners]" } }, "en-us": { "role": { "label": "Current assets other than non-current assets or disposal groups classified as held for sale or as held for distribution to owners", "totalLabel": "Total current assets before assets held for sale" } } }, "localname": "CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentDeferredIncomeOtherThanCurrentContractLiabilities": { "auth_ref": [ "r33", "r47" ], "calculation": { "http://www.drreddys.com/role/OtherLiabilitiesDetails": { "order": 4.0, "parentTag": "ifrs-full_OtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current deferred income other than current contract liabilities. [Refer: Deferred income other than contract liabilities]" } }, "en-us": { "role": { "label": "Current deferred income other than current contract liabilities", "terseLabel": "Current", "verboseLabel": "Deferred revenue" } } }, "localname": "CurrentDeferredIncomeOtherThanCurrentContractLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherLiabilitiesDetails", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails5" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentDerivativeFinancialAssets": { "auth_ref": [ "r33" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 41.0, "parentTag": "ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current derivative financial assets. [Refer: Derivative financial assets]" } }, "en-us": { "role": { "label": "Current derivative financial assets", "verboseLabel": "Derivative financial instruments" } } }, "localname": "CurrentDerivativeFinancialAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition", "http://www.drreddys.com/role/FinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentDerivativeFinancialLiabilities": { "auth_ref": [ "r33" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 13.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current derivative financial liabilities. [Refer: Derivative financial liabilities]" } }, "en-us": { "role": { "label": "Current derivative financial liabilities", "verboseLabel": "Derivative financial instruments" } } }, "localname": "CurrentDerivativeFinancialLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition", "http://www.drreddys.com/role/FinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current financial assets at fair value through profit or loss [abstract]" } } }, "localname": "CurrentFinancialAssetsAtFairValueThroughProfitOrLossAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_CurrentInvestments": { "auth_ref": [ "r33" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 38.0, "parentTag": "ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current investments." } }, "en-us": { "role": { "label": "Current investments", "terseLabel": "Current portion", "verboseLabel": "Other investments" } } }, "localname": "CurrentInvestments", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition", "http://www.drreddys.com/role/OtherInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentLeaseLiabilities": { "auth_ref": [ "r281" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]" } }, "en-us": { "role": { "definitionGuidance": "Current lease liabilities", "label": "Current lease liabilities" } } }, "localname": "CurrentLeaseLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentLiabilities": { "auth_ref": [ "r40", "r248", "r251" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 7.0, "parentTag": "ifrs-full_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "Expiry date 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.\nEffective 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period." } }, "en-us": { "role": { "label": "Current liabilities", "terseLabel": "Total current liabilities", "totalLabel": "Total current liabilities" } } }, "localname": "CurrentLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities [abstract]", "verboseLabel": "Current liabilities" } } }, "localname": "CurrentLiabilitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_CurrentPackagingAndStorageMaterials": { "auth_ref": [ "r128" ], "calculation": { "http://www.drreddys.com/role/InventoriesDetails": { "order": 2.0, "parentTag": "ifrs-full_Inventories", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "A classification of current inventory representing the amount of packaging and storage materials. [Refer: Inventories]" } }, "en-us": { "role": { "label": "Current packaging and storage materials", "verboseLabel": "Packing materials, stores and spares" } } }, "localname": "CurrentPackagingAndStorageMaterials", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax": { "auth_ref": [ "r47" ], "calculation": { "http://www.drreddys.com/role/OtherLiabilitiesDetails": { "order": 3.0, "parentTag": "ifrs-full_OtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current payables on social security and taxes other than incomes tax. [Refer: Payables on social security and taxes other than income tax]" } }, "en-us": { "role": { "label": "Current payables on social security and taxes other than income tax", "verboseLabel": "Statutory dues payable" } } }, "localname": "CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentPortionOfLongtermBorrowings": { "auth_ref": [ "r33" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 10.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The current portion of non-current borrowings. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Current portion of non-current borrowings", "terseLabel": "Current portion of non-current borrowings", "verboseLabel": "Long-term borrowings, current portion" } } }, "localname": "CurrentPortionOfLongtermBorrowings", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition", "http://www.drreddys.com/role/LoansAndBorrowingsDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentPrepaidExpenses": { "auth_ref": [ "r13" ], "calculation": { "http://www.drreddys.com/role/OtherAssetsDetails": { "order": 3.0, "parentTag": "ifrs-full_OtherCurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised." } }, "en-us": { "role": { "label": "Current prepaid expenses", "terseLabel": "Prepaid expenses" } } }, "localname": "CurrentPrepaidExpenses", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentProvisionsForEmployeeBenefits": { "auth_ref": [ "r45" ], "calculation": { "http://www.drreddys.com/role/OtherLiabilitiesDetails": { "order": 2.0, "parentTag": "ifrs-full_OtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current provisions for employee benefits. [Refer: Provisions for employee benefits]" } }, "en-us": { "role": { "label": "Current provisions for employee benefits", "verboseLabel": "Employee benefits payable" } } }, "localname": "CurrentProvisionsForEmployeeBenefits", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentReceivablesFromTaxesOtherThanIncomeTax": { "auth_ref": [ "r43" ], "calculation": { "http://www.drreddys.com/role/OtherAssetsDetails": { "order": 1.0, "parentTag": "ifrs-full_OtherCurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current receivables from taxes other than income tax. [Refer: Receivables from taxes other than income tax]" } }, "en-us": { "role": { "label": "Current receivables from taxes other than income tax", "terseLabel": "Balances and receivables from statutory authorities" } } }, "localname": "CurrentReceivablesFromTaxesOtherThanIncomeTax", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentRefundsProvision": { "auth_ref": [ "r180", "r182" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current provision for refunds. [Refer: Refunds provision]" } }, "en-us": { "role": { "label": "Current refunds provision", "verboseLabel": "Current" } } }, "localname": "CurrentRefundsProvision", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails7" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset": { "auth_ref": [ "r107" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from employee service in the current period. [Refer: Net defined benefit liability (asset)]" } }, "en-us": { "role": { "label": "Current service cost, net defined benefit liability (asset)", "terseLabel": "Current service cost", "verboseLabel": "Current service cost" } } }, "localname": "CurrentServiceCostNetDefinedBenefitLiabilityAsset", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails", "http://www.drreddys.com/role/EmployeeBenefitsDetails11", "http://www.drreddys.com/role/EmployeeBenefitsDetails2", "http://www.drreddys.com/role/EmployeeBenefitsDetails9" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentTaxAssetsCurrent": { "auth_ref": [ "r31" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 42.0, "parentTag": "ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The current amount of current tax assets. [Refer: Current tax assets]" } }, "en-us": { "role": { "label": "Current tax assets, current", "verboseLabel": "Tax assets" } } }, "localname": "CurrentTaxAssetsCurrent", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentTaxExpenseIncome": { "auth_ref": [ "r74" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period." } }, "en-us": { "role": { "label": "Current tax expense (income)", "terseLabel": "Current taxes" } } }, "localname": "CurrentTaxExpenseIncome", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current tax expense (income) and adjustments for current tax of prior periods [abstract]", "verboseLabel": "Current taxes" } } }, "localname": "CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_CurrentTaxLiabilitiesCurrent": { "auth_ref": [ "r31" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 12.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The current amount of current tax liabilities. [Refer: Current tax liabilities]" } }, "en-us": { "role": { "label": "Current tax liabilities, current", "verboseLabel": "Tax liabilities" } } }, "localname": "CurrentTaxLiabilitiesCurrent", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentTradeReceivables": { "auth_ref": [ "r39", "r43" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current trade receivables. [Refer: Trade receivables]" } }, "en-us": { "role": { "label": "Current trade receivables", "terseLabel": "Current trade and other receivables, net" } } }, "localname": "CurrentTradeReceivables", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/TradeAndOtherReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CustomerrelatedIntangibleAssetsMember": { "auth_ref": [ "r194" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of intangible assets representing assets related to customers. Such assets may include customer lists, order or production backlog, customer contracts and related customer relationships as well as non-contractual customer relationships." } }, "en-us": { "role": { "label": "Customer-Related Intangible Assets [Member]", "verboseLabel": "Customer related intangibles [member]" } } }, "localname": "CustomerrelatedIntangibleAssetsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment": { "auth_ref": [ "r91" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The decrease in property, plant and equipment through classification as held for sale or inclusion in a disposal group classified as held for sale. [Refer: Disposal groups classified as held for sale [member]; Property, plant and equipment; Disposal groups classified as held for sale [member]]" } }, "en-us": { "role": { "label": "Decrease through classified as held for sale, property, plant and equipment", "negatedLabel": "Assets held for sale" } } }, "localname": "DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised": { "auth_ref": [ "r79" ], "lang": { "en": { "role": { "documentation": "The amount of deductible temporary differences for which no deferred tax asset is recognised in the statement of financial position. [Refer: Temporary differences [member]]" } }, "en-us": { "role": { "label": "Deductible temporary differences for which no deferred tax asset is recognised", "verboseLabel": "Deductible temporary differences, net" } } }, "localname": "DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails3" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DeferredIncomeOtherThanContractLiabilities": { "auth_ref": [ "r33", "r47" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of liabilities representing income that has been received (or the amount is due) but is not yet earned, other than contract liabilities. [Refer: Contract liabilities]" } }, "en-us": { "role": { "label": "Deferred income other than contract liabilities", "periodEndLabel": "Balance as of March 31", "periodStartLabel": "Balance as of April 1" } } }, "localname": "DeferredIncomeOtherThanContractLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails5" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DeferredTaxAssets": { "auth_ref": [ "r32", "r34", "r80" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 33.0, "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]" } }, "en-us": { "role": { "label": "Deferred tax assets", "verboseLabel": "Deferred tax assets" } } }, "localname": "DeferredTaxAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DeferredTaxAssetsRecognisedAsOfAcquisitionDate": { "auth_ref": [ "r309" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount recognised as of the acquisition date for deferred tax assets acquired in a business combination. [Refer: Deferred tax assets; Business combinations [member]]" } }, "en-us": { "role": { "label": "Deferred tax assets recognised as of acquisition date", "terseLabel": "Deferred tax asset" } } }, "localname": "DeferredTaxAssetsRecognisedAsOfAcquisitionDate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DeferredTaxExpenseIncome": { "auth_ref": [ "r81" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]" } }, "en-us": { "role": { "label": "Deferred tax expense (income)", "terseLabel": "Deferred taxes expense/(benefit" } } }, "localname": "DeferredTaxExpenseIncome", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DeferredTaxExpenseIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred tax expense (income) [abstract]", "verboseLabel": "Deferred taxes expense/(benefit" } } }, "localname": "DeferredTaxExpenseIncomeAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss": { "auth_ref": [ "r81" ], "lang": { "en": { "role": { "documentation": "The amount of tax expense or income relating to changes in deferred tax liabilities and deferred tax assets, recognised in profit or loss. [Refer: Deferred tax assets; Deferred tax expense (income); Deferred tax liabilities]" } }, "en-us": { "role": { "label": "Deferred tax expense (income) recognised in profit or loss", "verboseLabel": "Recognized in income statement" } } }, "localname": "DeferredTaxExpenseIncomeRecognisedInProfitOrLoss", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails5" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DeferredTaxLiabilities": { "auth_ref": [ "r32", "r34", "r80" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 4.0, "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]" } }, "en-us": { "role": { "label": "Deferred Tax Liabilities, Net", "verboseLabel": "Deferred tax liabilities" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DeferredTaxLiabilityAsset": { "auth_ref": [ "r80" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]" } }, "en-us": { "role": { "label": "Deferred tax liability (asset)", "terseLabel": "Deferred tax (liability) asset" } } }, "localname": "DeferredTaxLiabilityAsset", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails4" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity": { "auth_ref": [ "r75" ], "lang": { "en": { "role": { "documentation": "The amount of deferred tax related to items credited (charged) directly to equity. [Refer: Deferred tax expense (income)]" } }, "en-us": { "role": { "label": "Deferred tax relating to items credited (charged) directly to equity", "verboseLabel": "Recognized in equity" } } }, "localname": "DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails5" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DefinedBenefitObligationAtPresentValue": { "auth_ref": [ "r121" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The present value, without deducting any plan assets, of expected future payments required to settle the obligation resulting from employee service in the current and prior periods. [Refer: Plan assets, at fair value]" } }, "en-us": { "role": { "label": "Defined benefit obligation, at present value", "periodEndLabel": "Defined benefit obligations at the end of the year", "periodStartLabel": "Defined benefit obligations at the beginning of the year", "terseLabel": "Present value of funded obligations", "verboseLabel": "Defined benefit obligation with projected salary growth" } } }, "localname": "DefinedBenefitObligationAtPresentValue", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails1", "http://www.drreddys.com/role/EmployeeBenefitsDetails10", "http://www.drreddys.com/role/EmployeeBenefitsDetails11", "http://www.drreddys.com/role/EmployeeBenefitsDetails2", "http://www.drreddys.com/role/EmployeeBenefitsDetails4" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DefinedBenefitPlansAxis": { "auth_ref": [ "r105" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Defined benefit plans [axis]" } } }, "localname": "DefinedBenefitPlansAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails", "http://www.drreddys.com/role/EmployeeBenefitsDetails1", "http://www.drreddys.com/role/EmployeeBenefitsDetails10", "http://www.drreddys.com/role/EmployeeBenefitsDetails11", "http://www.drreddys.com/role/EmployeeBenefitsDetails12", "http://www.drreddys.com/role/EmployeeBenefitsDetails13", "http://www.drreddys.com/role/EmployeeBenefitsDetails14", "http://www.drreddys.com/role/EmployeeBenefitsDetails16", "http://www.drreddys.com/role/EmployeeBenefitsDetails17", "http://www.drreddys.com/role/EmployeeBenefitsDetails2", "http://www.drreddys.com/role/EmployeeBenefitsDetails3", "http://www.drreddys.com/role/EmployeeBenefitsDetails4", "http://www.drreddys.com/role/EmployeeBenefitsDetails5", "http://www.drreddys.com/role/EmployeeBenefitsDetails9", "http://www.drreddys.com/role/EmployeeBenefitsTables" ], "xbrltype": "stringItemType" }, "ifrs-full_DefinedBenefitPlansMember": { "auth_ref": [ "r105" ], "lang": { "en": { "role": { "documentation": "This member stands for post-employment benefit plans other than defined contribution plans. Defined contribution plans are post-employment benefit plans under which an entity pays fixed contributions into a separate entity (a fund) and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient assets to pay all employee benefits relating to employee service in the current and prior periods. It also represents the standard value for the 'Defined benefit plans' axis if no other member is used." } }, "en-us": { "role": { "label": "Defined benefit plans [member]" } } }, "localname": "DefinedBenefitPlansMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails", "http://www.drreddys.com/role/EmployeeBenefitsDetails1", "http://www.drreddys.com/role/EmployeeBenefitsDetails10", "http://www.drreddys.com/role/EmployeeBenefitsDetails11", "http://www.drreddys.com/role/EmployeeBenefitsDetails12", "http://www.drreddys.com/role/EmployeeBenefitsDetails13", "http://www.drreddys.com/role/EmployeeBenefitsDetails14", "http://www.drreddys.com/role/EmployeeBenefitsDetails16", "http://www.drreddys.com/role/EmployeeBenefitsDetails17", "http://www.drreddys.com/role/EmployeeBenefitsDetails2", "http://www.drreddys.com/role/EmployeeBenefitsDetails3", "http://www.drreddys.com/role/EmployeeBenefitsDetails4", "http://www.drreddys.com/role/EmployeeBenefitsDetails5", "http://www.drreddys.com/role/EmployeeBenefitsDetails9", "http://www.drreddys.com/role/EmployeeBenefitsTables" ], "xbrltype": "domainItemType" }, "ifrs-full_DepreciationAndAmortisationExpense": { "auth_ref": [ "r1", "r3", "r67", "r257", "r369", "r377" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives." } }, "en-us": { "role": { "label": "Depreciation and amortisation expense" } } }, "localname": "DepreciationAndAmortisationExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SegmentReportingDetails7" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DepreciationExpense": { "auth_ref": [ "r13" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of depreciation expense. Depreciation is the systematic allocation of depreciable amounts of tangible assets over their useful lives." } }, "en-us": { "role": { "label": "Depreciation expense" } } }, "localname": "DepreciationExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/NatureOfExpenseDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DepreciationPropertyPlantAndEquipment": { "auth_ref": [ "r94", "r99" ], "lang": { "en": { "role": { "documentation": "The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]" } }, "en-us": { "role": { "label": "Depreciation, property, plant and equipment", "terseLabel": "Depreciation for the year" } } }, "localname": "DepreciationPropertyPlantAndEquipment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DepreciationRightofuseAssets": { "auth_ref": [ "r282" ], "lang": { "en": { "role": { "documentation": "The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]" } }, "en-us": { "role": { "definitionGuidance": "Depreciation expense of right-of-use assets", "label": "Depreciation, right-of-use assets", "terseLabel": "Depreciation for the year" } } }, "localname": "DepreciationRightofuseAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails1", "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DerivativeFinancialAssets": { "auth_ref": [ "r33" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of financial assets classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]" } }, "en-us": { "role": { "label": "Derivative financial assets" } } }, "localname": "DerivativeFinancialAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DerivativeFinancialLiabilities": { "auth_ref": [ "r33" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of financial liabilities classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]" } }, "en-us": { "role": { "label": "Derivative financial liabilities", "verboseLabel": "Derivative financial instruments" } } }, "localname": "DerivativeFinancialLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetailsTextual", "http://www.drreddys.com/role/FinancialRiskManagementDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DerivativesMember": { "auth_ref": [ "r269", "r271", "r346", "r365" ], "lang": { "en": { "role": { "documentation": "This member stands for financial instruments or other contracts within the scope of IFRS 9 with all three of the following characteristics: (a) Their value changes in response to the change in a specified interest rate, financial instrument price, commodity price, foreign exchange rate, index of prices or rates, credit rating or credit index, or other variable, provided in the case of a non-financial variable that the variable is not specific to a party to the contract (sometimes called the \u2018underlying\u2019); (b) They require no initial net investment or an initial net investment that is smaller than would be required for other types of contracts that would be expected to have a similar response to changes in market factors; (c) They are settled at a future date. [Refer: Financial instruments, class [member]]" } }, "en-us": { "role": { "label": "Derivatives [member]" } } }, "localname": "DerivativesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails2" ], "xbrltype": "domainItemType" }, "ifrs-full_DescriptionAndCarryingAmountOfIntangibleAssetsMaterialToEntity": { "auth_ref": [ "r195" ], "lang": { "en": { "role": { "documentation": "The description of intangible assets that are material to the entity's financial statements. [Refer: Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Description of intangible assets material to entity" } } }, "localname": "DescriptionAndCarryingAmountOfIntangibleAssetsMaterialToEntity", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetails2" ], "xbrltype": "stringItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory": { "auth_ref": [ "r15" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for business combinations. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "Description of accounting policy for business combinations [text block]", "verboseLabel": "Business combinations and goodwill" } } }, "localname": "DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory": { "auth_ref": [ "r15" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for earnings per share." } }, "en-us": { "role": { "label": "Description of accounting policy for earnings per share [text block]", "verboseLabel": "Earnings per share" } } }, "localname": "DescriptionOfAccountingPolicyForEarningsPerShareExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory": { "auth_ref": [ "r15" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for employee benefits. Employee benefits are all forms of consideration given by an entity in exchange for services rendered by employees or for the termination of employment." } }, "en-us": { "role": { "label": "Description of accounting policy for employee benefits [text block]", "verboseLabel": "Employee benefits" } } }, "localname": "DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory": { "auth_ref": [ "r15" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for finance income and costs. [Refer: Finance income (cost)]" } }, "en-us": { "role": { "label": "Description of accounting policy for finance income and costs [text block]", "verboseLabel": "Finance income and expense" } } }, "localname": "DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory": { "auth_ref": [ "r15" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for financial instruments. [Refer: Financial instruments, class [member]]" } }, "en-us": { "role": { "label": "Description of accounting policy for financial instruments [text block]", "verboseLabel": "Financial instruments" } } }, "localname": "DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory": { "auth_ref": [ "r15" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for foreign currency translation." } }, "en-us": { "role": { "label": "Description of accounting policy for foreign currency translation [text block]", "verboseLabel": "Foreign currency" } } }, "localname": "DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants": { "auth_ref": [ "r130" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for government grants, including the methods of presentation adopted in the financial statements. [Refer: Government [member]; Government grants]" } }, "en-us": { "role": { "label": "Description of accounting policy for government grants [text block]", "verboseLabel": "Government grants and incentives" } } }, "localname": "DescriptionOfAccountingPolicyForGovernmentGrants", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory": { "auth_ref": [ "r15" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for the impairment of assets." } }, "en-us": { "role": { "label": "Description of accounting policy for impairment of assets [text block]", "verboseLabel": "Impairment" } } }, "localname": "DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory": { "auth_ref": [ "r15" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for income tax." } }, "en-us": { "role": { "label": "Description of accounting policy for income tax [text block]", "verboseLabel": "Income tax" } } }, "localname": "DescriptionOfAccountingPolicyForIncomeTaxExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory": { "auth_ref": [ "r15" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for intangible assets and goodwill. [Refer: Intangible assets and goodwill]" } }, "en-us": { "role": { "label": "Description of accounting policy for intangible assets and goodwill [text block]", "verboseLabel": "Goodwill and other intangible assets" } } }, "localname": "DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory": { "auth_ref": [ "r15" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time." } }, "en-us": { "role": { "label": "Description of accounting policy for leases [text block]", "verboseLabel": "Leases" } } }, "localname": "DescriptionOfAccountingPolicyForLeasesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories": { "auth_ref": [ "r124" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for measuring inventories. [Refer: Inventories]" } }, "en-us": { "role": { "label": "Description of accounting policy for measuring inventories [text block]", "verboseLabel": "Inventories" } } }, "localname": "DescriptionOfAccountingPolicyForMeasuringInventories", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory": { "auth_ref": [ "r15" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for non-current assets or disposal groups classified as held for sale. [Refer: Non-current assets or disposal groups classified as held for sale]" } }, "en-us": { "role": { "label": "Description of accounting policy for non-current assets or disposal groups classified as held for sale [text block]", "terseLabel": "Non-currents assets held for sale" } } }, "localname": "DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory": { "auth_ref": [ "r15" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for property, plant and equipment. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Description of accounting policy for property, plant and equipment [text block]", "verboseLabel": "Property, plant and equipment" } } }, "localname": "DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory": { "auth_ref": [ "r15" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for provisions. [Refer: Provisions]" } }, "en-us": { "role": { "label": "Description of accounting policy for provisions [text block]", "verboseLabel": "Provisions" } } }, "localname": "DescriptionOfAccountingPolicyForProvisionsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue": { "auth_ref": [ "r15" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for recognising revenue. [Refer: Revenue]" } }, "en-us": { "role": { "label": "Description of accounting policy for recognition of revenue [text block]", "verboseLabel": "Revenue" } } }, "localname": "DescriptionOfAccountingPolicyForRecognitionOfRevenue", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory": { "auth_ref": [ "r15" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for segment reporting." } }, "en-us": { "role": { "label": "Description of accounting policy for segment reporting [text block]", "verboseLabel": "Segment Reporting" } } }, "localname": "DescriptionOfAccountingPolicyForSegmentReportingExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory": { "auth_ref": [ "r15" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]" } }, "en-us": { "role": { "label": "Description of accounting policy for share-based payment transactions [text block]", "terseLabel": "Share based payments" } } }, "localname": "DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory": { "auth_ref": [ "r15" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for treasury shares. [Refer: Treasury shares]" } }, "en-us": { "role": { "label": "Description of accounting policy for treasury shares [text block]", "verboseLabel": "Treasury shares" } } }, "localname": "DescriptionOfAccountingPolicyForTreasurySharesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections": { "auth_ref": [ "r169", "r171" ], "lang": { "en": { "role": { "documentation": "The discount rate applied to cash flow projections for a cash-generating unit (group of units). [Refer: Cash-generating units [member]]" } }, "en-us": { "role": { "label": "Discount rate applied to cash flow projections" } } }, "localname": "DescriptionOfDiscountRatesAppliedToCashFlowProjections", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/GoodwillDetailsTextual" ], "xbrltype": "percentItemType" }, "ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted": { "auth_ref": [ "r301" ], "lang": { "en": { "role": { "documentation": "The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time." } }, "en-us": { "role": { "label": "Expected volatility, share options granted", "verboseLabel": "Expected volatility" } } }, "localname": "DescriptionOfExpectedVolatilityShareOptionsGranted", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails5" ], "xbrltype": "percentItemType" }, "ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections": { "auth_ref": [ "r168", "r170" ], "lang": { "en": { "role": { "documentation": "The growth rate used to extrapolate cash flow projections beyond the period covered by the most recent budgets/forecasts for a cash-generating unit (group of units). [Refer: Cash-generating units [member]]" } }, "en-us": { "role": { "label": "Growth rate used to extrapolate cash flow projections" } } }, "localname": "DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/GoodwillDetailsTextual" ], "xbrltype": "percentItemType" }, "ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted": { "auth_ref": [ "r301" ], "lang": { "en": { "role": { "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]" } }, "en-us": { "role": { "label": "Risk free interest rate, share options granted", "verboseLabel": "Risk-free interest rate" } } }, "localname": "DescriptionOfRiskFreeInterestRateShareOptionsGranted", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails5" ], "xbrltype": "percentItemType" }, "ifrs-full_DilutedEarningsLossPerShare": { "auth_ref": [ "r157", "r158" ], "lang": { "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } }, "en-us": { "role": { "label": "Diluted earnings (loss) per share", "presentationGuidance": "Earnings per share of par value Rs.5 - Diluted", "verboseLabel": "Diluted earnings per share of Rs.5/- each" } } }, "localname": "DilutedEarningsLossPerShare", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedIncomeStatements", "http://www.drreddys.com/role/EarningsPerShareDetails1" ], "xbrltype": "perShareItemType" }, "ifrs-full_DilutedEarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Diluted earnings per share [abstract]" } } }, "localname": "DilutedEarningsPerShareAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares": { "auth_ref": [ "r160" ], "lang": { "en": { "role": { "documentation": "The number of dilutive potential ordinary shares that relate to the assumed exercise of the entity's share options." } }, "en-us": { "role": { "label": "Dilutive effect of share options on number of ordinary shares", "terseLabel": "Dilutive effect of stock options outstanding" } } }, "localname": "DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EarningsPerShareDetails1" ], "xbrltype": "sharesItemType" }, "ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of judgements that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognised in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year. [Refer: Carrying amount [member]]" } }, "en-us": { "role": { "label": "Disclosure of accounting judgements and estimates [text block]", "verboseLabel": "Use of estimates and judgments" } } }, "localname": "DisclosureOfAccountingJudgementsAndEstimatesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BasisOfPreparationOfFinancialStatementsPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of the basis used for the preparation of the financial statements." } }, "en-us": { "role": { "label": "Disclosure of basis of preparation of financial statements [text block]", "verboseLabel": "Basis of preparation of financial statements" } } }, "localname": "DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BasisOfPreparationOfFinancialStatements" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfBorrowingsExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of borrowings. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Disclosure of borrowings [text block]", "verboseLabel": "Loans and borrowings" } } }, "localname": "DisclosureOfBorrowingsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowings" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfBusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about business combination [abstract]" } } }, "localname": "DisclosureOfBusinessCombinationsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfBusinessCombinationsExplanatory": { "auth_ref": [ "r320" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for business combinations." } }, "en-us": { "role": { "label": "Disclosure of business combinations [text block]", "terseLabel": "Business Combinations" } } }, "localname": "DisclosureOfBusinessCombinationsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BusinessCombinations" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfBusinessCombinationsLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of detailed information about business combination [line items]" } } }, "localname": "DisclosureOfBusinessCombinationsLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetails", "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual", "http://www.drreddys.com/role/BusinessCombinationsTables" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfBusinessCombinationsTable": { "auth_ref": [ "r312" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to details of business combinations." } }, "en-us": { "role": { "label": "Disclosure of detailed information about business combination [table]" } } }, "localname": "DisclosureOfBusinessCombinationsTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetails", "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual", "http://www.drreddys.com/role/BusinessCombinationsTables" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]" } }, "en-us": { "role": { "label": "Disclosure of cash and cash equivalents [text block]", "terseLabel": "Cash and cash equivalents" } } }, "localname": "DisclosureOfCashAndCashEquivalentsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/CashAndCashEquivalents" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfClassesOfShareCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of classes of share capital [abstract]" } } }, "localname": "DisclosureOfClassesOfShareCapitalAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory": { "auth_ref": [ "r53" ], "lang": { "en": { "role": { "documentation": "The disclosure of classes of share capital. [Refer: Share capital [member]]" } }, "en-us": { "role": { "label": "Disclosure of classes of share capital [text block]", "verboseLabel": "Share Capital" } } }, "localname": "DisclosureOfClassesOfShareCapitalExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ShareCapital" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfClassesOfShareCapitalLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of classes of share capital [line items]" } } }, "localname": "DisclosureOfClassesOfShareCapitalLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ShareCapitalDetails", "http://www.drreddys.com/role/ShareCapitalDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfClassesOfShareCapitalTable": { "auth_ref": [ "r53" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to classes of share capital." } }, "en-us": { "role": { "label": "Disclosure of classes of share capital [table]" } } }, "localname": "DisclosureOfClassesOfShareCapitalTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ShareCapitalDetails", "http://www.drreddys.com/role/ShareCapitalDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfContingentLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of contingent liabilities [abstract]" } } }, "localname": "DisclosureOfContingentLiabilitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfContingentLiabilitiesExplanatory": { "auth_ref": [ "r179" ], "lang": { "en": { "role": { "documentation": "The disclosure of contingent liabilities. [Refer: Contingent liabilities [member]]" } }, "en-us": { "role": { "label": "Disclosure of contingent liabilities [text block]", "verboseLabel": "Contingencies" } } }, "localname": "DisclosureOfContingentLiabilitiesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/Contingencies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfContingentLiabilitiesLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of contingent liabilities [line items]" } } }, "localname": "DisclosureOfContingentLiabilitiesLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetails", "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfContingentLiabilitiesTable": { "auth_ref": [ "r179" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to contingent liabilities." } }, "en-us": { "role": { "label": "Disclosure of contingent liabilities [table]" } } }, "localname": "DisclosureOfContingentLiabilitiesTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetails", "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfDefinedBenefitPlansAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of defined benefit plans [abstract]" } } }, "localname": "DisclosureOfDefinedBenefitPlansAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfDefinedBenefitPlansLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of defined benefit plans [line items]" } } }, "localname": "DisclosureOfDefinedBenefitPlansLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails", "http://www.drreddys.com/role/EmployeeBenefitsDetails11", "http://www.drreddys.com/role/EmployeeBenefitsDetails2", "http://www.drreddys.com/role/EmployeeBenefitsDetails7" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfDefinedBenefitPlansTable": { "auth_ref": [ "r105" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to defined benefit plans." } }, "en-us": { "role": { "label": "Disclosure of defined benefit plans [table]" } } }, "localname": "DisclosureOfDefinedBenefitPlansTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about borrowings [abstract]" } } }, "localname": "DisclosureOfDetailedInformationAboutBorrowingsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of detailed information about borrowings [line items]" } } }, "localname": "DisclosureOfDetailedInformationAboutBorrowingsLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetailsTextual" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable": { "auth_ref": [ "r347" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to details of borrowings." } }, "en-us": { "role": { "label": "Disclosure of detailed information about borrowings [table]" } } }, "localname": "DisclosureOfDetailedInformationAboutBorrowingsTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails4", "http://www.drreddys.com/role/LoansAndBorrowingsDetailsTextual" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory": { "auth_ref": [ "r321" ], "lang": { "en": { "role": { "documentation": "The disclosure of detailed information about business combinations. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "Disclosure of detailed information about business combination [text block]", "terseLabel": "Summary of fair values of the assets acquired, including goodwill, and liabilities" } } }, "localname": "DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about hedged items [abstract]" } } }, "localname": "DisclosureOfDetailedInformationAboutHedgedItemsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of detailed information about hedged items [line items]" } } }, "localname": "DisclosureOfDetailedInformationAboutHedgedItemsLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails4" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsTable": { "auth_ref": [ "r329" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to details of hedged items." } }, "en-us": { "role": { "label": "Disclosure of detailed information about hedged items [table]" } } }, "localname": "DisclosureOfDetailedInformationAboutHedgedItemsTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails4" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfEarningsPerShareExplanatory": { "auth_ref": [ "r161" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for earnings per share." } }, "en-us": { "role": { "label": "Disclosure of earnings per share [text block]", "verboseLabel": "Earnings per share" } } }, "localname": "DisclosureOfEarningsPerShareExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EarningsPerShare" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfEmployeeBenefitsExplanatory": { "auth_ref": [ "r123" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for employee benefits." } }, "en-us": { "role": { "label": "Disclosure of employee benefits [text block]", "verboseLabel": "Employee benefits" } } }, "localname": "DisclosureOfEmployeeBenefitsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefits" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory": { "auth_ref": [ "r384" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for operating segments." } }, "en-us": { "role": { "label": "Disclosure of entity's operating segments [text block]", "verboseLabel": "Segment reporting" } } }, "localname": "DisclosureOfEntitysReportableSegmentsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SegmentReporting" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": { "auth_ref": [ "r72" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for events after the reporting period." } }, "en-us": { "role": { "label": "Disclosure of events after reporting period [text block]", "verboseLabel": "Subsequent events" } } }, "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfExpensesByNatureExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of expenses by nature. [Refer: Expenses, by nature]" } }, "en-us": { "role": { "label": "Disclosure of expenses by nature [text block]", "verboseLabel": "Nature of Expense" } } }, "localname": "DisclosureOfExpensesByNatureExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/NatureOfExpense" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfFairValueMeasurementExplanatory": { "auth_ref": [ "r273" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for fair value measurement." } }, "en-us": { "role": { "label": "Disclosure of fair value measurement [text block]", "verboseLabel": "Determination of fair values" } } }, "localname": "DisclosureOfFairValueMeasurementExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/DeterminationOfFairValues" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfFairValueOfEachInvestmentInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeExplanatory": { "auth_ref": [ "r323" ], "lang": { "en": { "role": { "documentation": "The disclosure of the fair value of investments in equity instruments that the entity has designated at fair value through other comprehensive income. [Refer: Investments in equity instruments designated at fair value through other comprehensive income]" } }, "en-us": { "role": { "label": "Disclosure of fair value of investments in equity instruments designated at fair value through other comprehensive income [text block]", "terseLabel": "Summary of the details of cost, fair value, and the amount recognized in OCI of the fair value changes" } } }, "localname": "DisclosureOfFairValueOfEachInvestmentInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of fair value of investments in equity instruments designated at fair value through other comprehensive income [abstract]" } } }, "localname": "DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of fair value of investments in equity instruments designated at fair value through other comprehensive income [line items]" } } }, "localname": "DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeTable": { "auth_ref": [ "r323" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to the fair value of investments in equity instruments designated at fair value through other comprehensive income." } }, "en-us": { "role": { "label": "Disclosure of fair value of investments in equity instruments designated at fair value through other comprehensive income [table]" } } }, "localname": "DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfFairValueOfPlanAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of fair value of plan assets [abstract]" } } }, "localname": "DisclosureOfFairValueOfPlanAssetsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory": { "auth_ref": [ "r115" ], "lang": { "en": { "role": { "documentation": "The disclosure of the fair value of defined benefit plan assets. [Refer: Plan assets [member]; Defined benefit plans [member]]" } }, "en-us": { "role": { "label": "Disclosure of fair value of plan assets [text block]" } } }, "localname": "DisclosureOfFairValueOfPlanAssetsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of fair value of plan assets [line items]" } } }, "localname": "DisclosureOfFairValueOfPlanAssetsLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails12", "http://www.drreddys.com/role/EmployeeBenefitsDetails3" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfFairValueOfPlanAssetsTable": { "auth_ref": [ "r115" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to the fair value of defined benefit plan assets." } }, "en-us": { "role": { "label": "Disclosure of fair value of plan assets [table]" } } }, "localname": "DisclosureOfFairValueOfPlanAssetsTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails12" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of finance income (cost). [Refer: Finance income (cost)]" } }, "en-us": { "role": { "label": "Disclosure of finance income (cost) [text block]", "verboseLabel": "Finance income, net" } } }, "localname": "DisclosureOfFinanceIncomeExpenseExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinanceIncomeNet" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfFinancialAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of financial assets [abstract]", "terseLabel": "Assets:" } } }, "localname": "DisclosureOfFinancialAssetsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfFinancialInstrumentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about financial instruments [abstract]", "terseLabel": "Disclosure of detailed information about financial instruments [abstract]" } } }, "localname": "DisclosureOfFinancialInstrumentsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfFinancialInstrumentsExplanatory": { "auth_ref": [ "r366" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for financial instruments." } }, "en-us": { "role": { "label": "Disclosure of financial instruments [text block]", "verboseLabel": "Financial instruments" } } }, "localname": "DisclosureOfFinancialInstrumentsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstruments" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfFinancialInstrumentsLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of detailed information about financial instruments [line items]" } } }, "localname": "DisclosureOfFinancialInstrumentsLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails2" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfFinancialInstrumentsTable": { "auth_ref": [ "r334", "r339", "r347" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to details of financial instruments." } }, "en-us": { "role": { "label": "Disclosure of detailed information about financial instruments [table]" } } }, "localname": "DisclosureOfFinancialInstrumentsTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails2" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfFinancialLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of financial liabilities [abstract]", "terseLabel": "Liabilities:" } } }, "localname": "DisclosureOfFinancialLiabilitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfFinancialRiskManagementExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of the entity's financial risk management practices and policies." } }, "en-us": { "role": { "label": "Disclosure of financial risk management [text block]", "verboseLabel": "Financial risk management" } } }, "localname": "DisclosureOfFinancialRiskManagementExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagement" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfGeographicalAreasAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of geographical areas [abstract]" } } }, "localname": "DisclosureOfGeographicalAreasAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfGeographicalAreasLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of geographical areas [line items]" } } }, "localname": "DisclosureOfGeographicalAreasLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SegmentReportingDetails5", "http://www.drreddys.com/role/SegmentReportingDetails6" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfGeographicalAreasTable": { "auth_ref": [ "r382" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to geographical areas." } }, "en-us": { "role": { "label": "Disclosure of geographical areas [table]" } } }, "localname": "DisclosureOfGeographicalAreasTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SegmentReportingDetails4", "http://www.drreddys.com/role/SegmentReportingDetails5", "http://www.drreddys.com/role/SegmentReportingDetails6" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfGoodwillExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of goodwill. [Refer: Goodwill]" } }, "en-us": { "role": { "label": "Disclosure of goodwill [text block]", "verboseLabel": "Goodwill" } } }, "localname": "DisclosureOfGoodwillExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/Goodwill" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfIncomeTaxExplanatory": { "auth_ref": [ "r83" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for income taxes." } }, "en-us": { "role": { "label": "Disclosure of income tax [text block]", "verboseLabel": "Income taxes" } } }, "localname": "DisclosureOfIncomeTaxExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of information for cash-generating units [abstract]" } } }, "localname": "DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of information for cash-generating units [line items]" } } }, "localname": "DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/GoodwillDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesTable": { "auth_ref": [ "r172" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to cash-generating units." } }, "en-us": { "role": { "label": "Disclosure of information for cash-generating units [table]" } } }, "localname": "DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/GoodwillDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfIntangibleAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about intangible assets [abstract]" } } }, "localname": "DisclosureOfIntangibleAssetsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfIntangibleAssetsExplanatory": { "auth_ref": [ "r197" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for intangible assets." } }, "en-us": { "role": { "label": "Disclosure of intangible assets [text block]", "verboseLabel": "Other intangible assets" } } }, "localname": "DisclosureOfIntangibleAssetsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssets" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of detailed information about intangible assets [line items]" } } }, "localname": "DisclosureOfIntangibleAssetsLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetails", "http://www.drreddys.com/role/OtherIntangibleAssetsDetails1", "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual", "http://www.drreddys.com/role/SignificantAccountingPoliciesDetails2" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of intangible assets material to entity [line items]" } } }, "localname": "DisclosureOfIntangibleAssetsMaterialToEntityLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetails2" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfIntangibleAssetsTable": { "auth_ref": [ "r191" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to details of intangible assets." } }, "en-us": { "role": { "label": "Disclosure of detailed information about intangible assets [table]" } } }, "localname": "DisclosureOfIntangibleAssetsTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetails", "http://www.drreddys.com/role/OtherIntangibleAssetsDetails1", "http://www.drreddys.com/role/OtherIntangibleAssetsDetails2", "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual", "http://www.drreddys.com/role/SignificantAccountingPoliciesDetails2" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfInterestsInOtherEntitiesExplanatory": { "auth_ref": [ "r242" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for interests in other entities." } }, "en-us": { "role": { "label": "Disclosure of interests in other entities [text block]" } } }, "localname": "DisclosureOfInterestsInOtherEntitiesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfInventoriesExplanatory": { "auth_ref": [ "r129" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for inventories." } }, "en-us": { "role": { "label": "Disclosure of inventories [text block]", "verboseLabel": "Inventories" } } }, "localname": "DisclosureOfInventoriesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/Inventories" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of investments accounted for using the equity method. [Refer: Investments accounted for using equity method]" } }, "en-us": { "role": { "label": "Disclosure of investments accounted for using equity method [text block]", "verboseLabel": "Investment in equity accounted investees" } } }, "localname": "DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/InvestmentInEquityAccountedInvestees" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of investments other than investments accounted for using the equity method. [Refer: Investments other than investments accounted for using equity method]" } }, "en-us": { "role": { "label": "Disclosure of investments other than investments accounted for using equity method [text block]", "verboseLabel": "Other investments" } } }, "localname": "DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherInvestments" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfMajorCustomersAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of major customers [abstract]" } } }, "localname": "DisclosureOfMajorCustomersAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfMajorCustomersLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of major customers [line items]" } } }, "localname": "DisclosureOfMajorCustomersLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SegmentReportingDetailsTextual" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfMajorCustomersTable": { "auth_ref": [ "r383" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to the entity's major customers." } }, "en-us": { "role": { "label": "Disclosure of major customers [table]" } } }, "localname": "DisclosureOfMajorCustomersTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SegmentReportingDetailsTextual" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of net defined benefit liability (asset) [abstract]" } } }, "localname": "DisclosureOfNetDefinedBenefitLiabilityAssetAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsTables" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory": { "auth_ref": [ "r106" ], "lang": { "en": { "role": { "documentation": "The disclosure of a net defined benefit liability (asset). [Refer: Net defined benefit liability (asset)]" } }, "en-us": { "role": { "label": "Disclosure of net defined benefit liability (asset) [text block]", "verboseLabel": "Disclosure of net defined benefit liability (asset) [Table Text Block]" } } }, "localname": "DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of net defined benefit liability (asset) [line items]" } } }, "localname": "DisclosureOfNetDefinedBenefitLiabilityAssetLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails1", "http://www.drreddys.com/role/EmployeeBenefitsDetails10", "http://www.drreddys.com/role/EmployeeBenefitsDetails9", "http://www.drreddys.com/role/EmployeeBenefitsTables" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable": { "auth_ref": [ "r106" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to the net defined benefit liability (asset)." } }, "en-us": { "role": { "label": "Disclosure of net defined benefit liability (asset) [table]" } } }, "localname": "DisclosureOfNetDefinedBenefitLiabilityAssetTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails10", "http://www.drreddys.com/role/EmployeeBenefitsDetails11", "http://www.drreddys.com/role/EmployeeBenefitsDetails2", "http://www.drreddys.com/role/EmployeeBenefitsDetails3", "http://www.drreddys.com/role/EmployeeBenefitsDetails9", "http://www.drreddys.com/role/EmployeeBenefitsTables" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of non-adjusting events after reporting period [line items]" } } }, "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable": { "auth_ref": [ "r70" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to non-adjusting events after the reporting period." } }, "en-us": { "role": { "label": "Disclosure of non-adjusting events after reporting period [table]" } } }, "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of number and weighted average remaining contractual life of outstanding share options [abstract]" } } }, "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable": { "auth_ref": [ "r299" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to the number and weighted average remaining contractual life of outstanding share options." } }, "en-us": { "role": { "label": "Disclosure of number and weighted average remaining contractual life of outstanding share options [table]" } } }, "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfOperatingSegmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of operating segments [abstract]" } } }, "localname": "DisclosureOfOperatingSegmentsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfOperatingSegmentsLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of operating segments [line items]" } } }, "localname": "DisclosureOfOperatingSegmentsLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SegmentReportingDetails", "http://www.drreddys.com/role/SegmentReportingDetails2", "http://www.drreddys.com/role/SegmentReportingDetails7", "http://www.drreddys.com/role/SegmentReportingTables" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfOperatingSegmentsTable": { "auth_ref": [ "r371" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to operating segments." } }, "en-us": { "role": { "label": "Disclosure of operating segments [table]" } } }, "localname": "DisclosureOfOperatingSegmentsTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SegmentReportingDetails", "http://www.drreddys.com/role/SegmentReportingDetails2", "http://www.drreddys.com/role/SegmentReportingDetails3", "http://www.drreddys.com/role/SegmentReportingDetails7", "http://www.drreddys.com/role/SegmentReportingTables" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfOtherAssetsExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of other assets. [Refer: Other assets]" } }, "en-us": { "role": { "label": "Disclosure of other assets [text block]", "verboseLabel": "Other assets" } } }, "localname": "DisclosureOfOtherAssetsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherAssets" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfOtherLiabilitiesExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of other liabilities. [Refer: Other liabilities]" } }, "en-us": { "role": { "label": "Disclosure of other liabilities [text block]", "verboseLabel": "Other liabilities" } } }, "localname": "DisclosureOfOtherLiabilitiesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherLiabilities" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of other operating income or expense. [Refer: Other operating income (expense)]" } }, "en-us": { "role": { "label": "Disclosure of other operating income (expense) [text block]", "verboseLabel": "Other income, net" } } }, "localname": "DisclosureOfOtherOperatingIncomeExpenseExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherIncomeNet" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfOtherProvisionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of other provisions [abstract]" } } }, "localname": "DisclosureOfOtherProvisionsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfOtherProvisionsExplanatory": { "auth_ref": [ "r178" ], "lang": { "en": { "role": { "documentation": "The disclosure of other provisions. [Refer: Other provisions]" } }, "en-us": { "role": { "label": "Disclosure of other provisions [text block]", "verboseLabel": "Provisions" } } }, "localname": "DisclosureOfOtherProvisionsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/Provisions" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfOtherProvisionsLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of other provisions [line items]" } } }, "localname": "DisclosureOfOtherProvisionsLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ProvisionsDetails", "http://www.drreddys.com/role/ProvisionsDetailsTextual" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfOtherProvisionsTable": { "auth_ref": [ "r178" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to other provisions." } }, "en-us": { "role": { "label": "Disclosure of other provisions [table]" } } }, "localname": "DisclosureOfOtherProvisionsTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ProvisionsDetails", "http://www.drreddys.com/role/ProvisionsDetailsTextual" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about property, plant and equipment [abstract]" } } }, "localname": "DisclosureOfPropertyPlantAndEquipmentAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory": { "auth_ref": [ "r101" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for property, plant and equipment." } }, "en-us": { "role": { "label": "Disclosure of property, plant and equipment [text block]", "verboseLabel": "Property, plant and equipment" } } }, "localname": "DisclosureOfPropertyPlantAndEquipmentExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipment" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of detailed information about property, plant and equipment [line items]" } } }, "localname": "DisclosureOfPropertyPlantAndEquipmentLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails", "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetailsTextual", "http://www.drreddys.com/role/SignificantAccountingPoliciesDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r97" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to details of property, plant and equipment." } }, "en-us": { "role": { "label": "Disclosure of detailed information about property, plant and equipment [table]" } } }, "localname": "DisclosureOfPropertyPlantAndEquipmentTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails", "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetailsTextual", "http://www.drreddys.com/role/SignificantAccountingPoliciesDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of quantitative information about right-of-use assets [line items]" } } }, "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable": { "auth_ref": [ "r287" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to right-of-use assets." } }, "en-us": { "role": { "label": "Disclosure of quantitative information about right-of-use assets [table]" } } }, "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of reconciliation of changes in goodwill [abstract]" } } }, "localname": "DisclosureOfReconciliationOfChangesInGoodwillAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of reconciliation of changes in goodwill [line items]" } } }, "localname": "DisclosureOfReconciliationOfChangesInGoodwillLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/GoodwillDetailsTextual" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable": { "auth_ref": [ "r317" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to the reconciliation of changes in goodwill." } }, "en-us": { "role": { "label": "Disclosure of reconciliation of changes in goodwill [table]" } } }, "localname": "DisclosureOfReconciliationOfChangesInGoodwillTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/GoodwillDetailsTextual" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory": { "auth_ref": [ "r228" ], "lang": { "en": { "role": { "documentation": "The disclosure of the reconciliation of liabilities arising from financing activities. [Refer: Liabilities arising from financing activities]" } }, "en-us": { "role": { "label": "Disclosure of reconciliation of liabilities arising from financing activities [text block]", "terseLabel": "Disclosure of reconciliation of liabilities arising from financing activities" } } }, "localname": "DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of reconciliation of liabilities arising from financing activities [line items]" } } }, "localname": "DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails5" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfReimbursementRightsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of reimbursement rights [abstract]" } } }, "localname": "DisclosureOfReimbursementRightsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfRelatedPartyExplanatory": { "auth_ref": [ "r145" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for related parties." } }, "en-us": { "role": { "label": "Disclosure of related party [text block]", "verboseLabel": "Related parties" } } }, "localname": "DisclosureOfRelatedPartyExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/RelatedParties" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfRevenueExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for revenue." } }, "en-us": { "role": { "label": "Disclosure of revenue [text block]", "terseLabel": "Revenue from contracts with customers and trade receivables" } } }, "localname": "DisclosureOfRevenueExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of sensitivity analysis for actuarial assumptions [abstract]" } } }, "localname": "DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory": { "auth_ref": [ "r117" ], "lang": { "en": { "role": { "documentation": "The disclosure of a sensitivity analysis for significant actuarial assumptions used to determine the present value of a defined benefit obligation. [Refer: Actuarial assumptions [member]; Defined benefit obligation, at present value]" } }, "en-us": { "role": { "label": "Disclosure of sensitivity analysis for actuarial assumptions [text block]" } } }, "localname": "DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of sensitivity analysis for actuarial assumptions [line items]", "verboseLabel": "Disclosure Of Sensitivity Analysis For Actuarial Assumptions [Line Items]" } } }, "localname": "DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails13", "http://www.drreddys.com/role/EmployeeBenefitsDetails4" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable": { "auth_ref": [ "r117" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to the sensitivity analysis for actuarial assumptions." } }, "en-us": { "role": { "label": "Disclosure of sensitivity analysis for actuarial assumptions [table]" } } }, "localname": "DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails4", "http://www.drreddys.com/role/EmployeeBenefitsDetails5", "http://www.drreddys.com/role/EmployeeBenefitsDetails7" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory": { "auth_ref": [ "r291" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for share-based payment arrangements." } }, "en-us": { "role": { "label": "Disclosure of share-based payment arrangements [text block]", "verboseLabel": "Employee stock incentive plans" } } }, "localname": "DisclosureOfSharebasedPaymentArrangementsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlans" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of subsidiaries [abstract]" } } }, "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of subsidiaries [line items]" } } }, "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable": { "auth_ref": [ "r151", "r154", "r262" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to subsidiaries." } }, "en-us": { "role": { "label": "Disclosure of subsidiaries [table]" } } }, "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory": { "auth_ref": [ "r16" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for significant accounting policies applied by the entity." } }, "en-us": { "role": { "label": "Disclosure of significant accounting policies [text block]", "verboseLabel": "Significant accounting policies" } } }, "localname": "DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [abstract]" } } }, "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [line items]" } } }, "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails2", "http://www.drreddys.com/role/IncomeTaxesDetails3" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable": { "auth_ref": [ "r82" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to temporary differences, unused tax losses and unused tax credits." } }, "en-us": { "role": { "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [table]" } } }, "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails2", "http://www.drreddys.com/role/IncomeTaxesDetails3" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of terms and conditions of share-based payment arrangement [abstract]" } } }, "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansTables" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of trade and other payables. [Refer: Trade and other payables]" } }, "en-us": { "role": { "label": "Disclosure of trade and other payables [text block]", "verboseLabel": "Trade and other payables" } } }, "localname": "DisclosureOfTradeAndOtherPayablesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/TradeAndOtherPayables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of trade and other receivables. [Refer: Trade and other receivables]" } }, "en-us": { "role": { "label": "Disclosure of trade and other receivables [text block]", "verboseLabel": "Trade and other receivables" } } }, "localname": "DisclosureOfTradeAndOtherReceivablesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/TradeAndOtherReceivables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of transactions between related parties [abstract]" } } }, "localname": "DisclosureOfTransactionsBetweenRelatedPartiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory": { "auth_ref": [ "r138" ], "lang": { "en": { "role": { "documentation": "The disclosure of transactions between the entity and its related parties. [Refer: Related parties [member]]" } }, "en-us": { "role": { "label": "Disclosure of transactions between related parties [text block]" } } }, "localname": "DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/RelatedPartiesTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of transactions between related parties [line items]" } } }, "localname": "DisclosureOfTransactionsBetweenRelatedPartiesLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/RelatedPartiesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable": { "auth_ref": [ "r141" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to transactions between related parties." } }, "en-us": { "role": { "label": "Disclosure of transactions between related parties [table]" } } }, "localname": "DisclosureOfTransactionsBetweenRelatedPartiesTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/RelatedPartiesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r190" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The decrease in intangible assets other than goodwill resulting from disposals and retirements. [Refer: Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Disposals and retirements, intangible assets other than goodwill", "negatedLabel": "Less: Disposals/De-recognitions", "terseLabel": "Disposals and retirements, intangible assets other than goodwill" } } }, "localname": "DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetails1", "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r186" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The decrease in intangible assets other than goodwill resulting from disposals. [Refer: Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Disposals, intangible assets other than goodwill", "negatedTerseLabel": "Disposals/De-recognitions" } } }, "localname": "DisposalsIntangibleAssetsOtherThanGoodwill", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DisposalsPropertyPlantAndEquipment": { "auth_ref": [ "r91" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Disposals, property, plant and equipment", "negatedTerseLabel": "Disposals" } } }, "localname": "DisposalsPropertyPlantAndEquipment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DividendsPaid": { "auth_ref": [ "r11" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of dividends recognised as distributions to owners." } }, "en-us": { "role": { "label": "Dividends recognised as distributions to owners", "negatedLabel": "Dividend paid", "verboseLabel": "Dividend paid during the year" } } }, "localname": "DividendsPaid", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity", "http://www.drreddys.com/role/ShareCapitalDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DividendsPaidClassifiedAsFinancingActivities": { "auth_ref": [ "r221" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 33.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for dividends paid by the entity, classified as financing activities." } }, "en-us": { "role": { "label": "Dividends paid, classified as financing activities", "negatedLabel": "Dividend paid (March 31, 2020 including corporate dividend tax)" } } }, "localname": "DividendsPaidClassifiedAsFinancingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwners": { "auth_ref": [ "r17", "r69" ], "lang": { "en": { "role": { "documentation": "The amount of dividends proposed or declared after the reporting period but before financial statements are authorised for issue. Such dividends are not recognised as a liability at the end of the reporting period because no obligation exists at that time." } }, "en-us": { "role": { "label": "Dividends proposed or declared before financial statements authorised for issue but not recognised as distribution to owners" } } }, "localname": "DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwners", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ShareCapitalDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwnersPerShare": { "auth_ref": [ "r17" ], "lang": { "en": { "role": { "documentation": "The amount, per share, of dividends proposed or declared before financial statements were authorised for issue but not recognised as distribution to owners." } }, "en-us": { "role": { "label": "Dividends proposed or declared before financial statements authorised for issue but not recognised as distribution to owners per share" } } }, "localname": "DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwnersPerShare", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ShareCapitalDetailsTextual" ], "xbrltype": "perShareItemType" }, "ifrs-full_DividendsReceivedFromInvestmentsAccountedForUsingEquityMethodClassifiedAsInvestingActivities": { "auth_ref": [ "r210" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 28.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow representing dividends received from investments that are accounted for using the equity method, classified as investing activities. [Refer: Investments accounted for using equity method; Dividends received]" } }, "en-us": { "role": { "label": "Dividends received from investments accounted for using equity method, classified as investing activities", "terseLabel": "Dividends received from investments accounted for using equity method", "verboseLabel": "Dividends received from equity accounted investees" } } }, "localname": "DividendsReceivedFromInvestmentsAccountedForUsingEquityMethodClassifiedAsInvestingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DividendsRecognisedAsDistributionsToOwnersPerShare": { "auth_ref": [ "r11" ], "lang": { "en": { "role": { "documentation": "The amount, per share, of dividends recognised as distributions to owners." } }, "en-us": { "role": { "label": "Dividends recognised as distributions to owners per share", "verboseLabel": "Dividend per share (in absolute Rs.)" } } }, "localname": "DividendsRecognisedAsDistributionsToOwnersPerShare", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ShareCapitalDetails1" ], "xbrltype": "perShareItemType" }, "ifrs-full_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "verboseLabel": "Earnings per share:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedIncomeStatements" ], "xbrltype": "stringItemType" }, "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": { "auth_ref": [ "r219", "r220" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]" } }, "en-us": { "role": { "label": "Effect of exchange rate changes on cash and cash equivalents", "verboseLabel": "Effect of exchange rate changes on cash and cash equivalents" } } }, "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EffectOfOverlayApproachReclassificationAxis": { "auth_ref": [ "r402" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Effect of overlay approach reclassification [axis]" } } }, "localname": "EffectOfOverlayApproachReclassificationAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/TradeAndOtherReceivablesDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_EmployeeBenefitsExpense": { "auth_ref": [ "r1", "r3", "r67" ], "calculation": { "http://www.drreddys.com/role/RelatedPartiesDetails2": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The expense of all forms of consideration given by an entity in exchange for a service rendered by employees or for the termination of employment." } }, "en-us": { "role": { "label": "Employee benefits expense", "terseLabel": "Employee benefits", "totalLabel": "Total" } } }, "localname": "EmployeeBenefitsExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetailsTextual", "http://www.drreddys.com/role/NatureOfExpenseDetails", "http://www.drreddys.com/role/RelatedPartiesDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EntitysTotalForBusinessCombinationsMember": { "auth_ref": [ "r312", "r318" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Business combinations' axis if no other member is used." } }, "en-us": { "role": { "label": "Entity's total for business combinations [member]", "terseLabel": "Entity's total for business combinations [member]" } } }, "localname": "EntitysTotalForBusinessCombinationsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetails", "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual", "http://www.drreddys.com/role/BusinessCombinationsTables", "http://www.drreddys.com/role/EmployeeBenefitsDetailsTextual", "http://www.drreddys.com/role/FinancialInstrumentsDetailsTextual", "http://www.drreddys.com/role/GoodwillDetailsTextual", "http://www.drreddys.com/role/MergerOfDrReddySHoldingsLimitedIntoDrReddySLaboratoriesLimitedDetailsTextual", "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual", "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetailsTextual", "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "domainItemType" }, "ifrs-full_EntitysTotalForCashgeneratingUnitsMember": { "auth_ref": [ "r172", "r174" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Cash-generating units' axis if no other member is used." } }, "en-us": { "role": { "label": "Entity's total for cash-generating units [member]" } } }, "localname": "EntitysTotalForCashgeneratingUnitsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/GoodwillDetails1", "http://www.drreddys.com/role/GoodwillDetailsTextual", "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual", "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetailsTextual" ], "xbrltype": "domainItemType" }, "ifrs-full_EntitysTotalForImpairmentOfFinancialAssetsMember": { "auth_ref": [ "r412" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Impairment of financial assets' axis if no other member is used." } }, "en-us": { "role": { "label": "Entity's total for impairment of financial assets [member]" } } }, "localname": "EntitysTotalForImpairmentOfFinancialAssetsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetails1", "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "domainItemType" }, "ifrs-full_EntitysTotalForJointVenturesMember": { "auth_ref": [ "r151", "r154", "r263", "r403", "r406" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Joint ventures' axis if no other member is used." } }, "en-us": { "role": { "label": "Entity's total for joint ventures [member]" } } }, "localname": "EntitysTotalForJointVenturesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails1", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails2", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetailsTextual", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesTables" ], "xbrltype": "domainItemType" }, "ifrs-full_EntitysTotalForRelatedPartiesMember": { "auth_ref": [ "r141" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used." } }, "en-us": { "role": { "label": "Entity's total for related parties [member]" } } }, "localname": "EntitysTotalForRelatedPartiesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails", "http://www.drreddys.com/role/EmployeeBenefitsDetails2", "http://www.drreddys.com/role/EmployeeBenefitsDetails9", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails5", "http://www.drreddys.com/role/LoansAndBorrowingsDetails2", "http://www.drreddys.com/role/LoansAndBorrowingsDetailsTextual", "http://www.drreddys.com/role/ProvisionsDetailsTextual", "http://www.drreddys.com/role/RelatedPartiesDetails", "http://www.drreddys.com/role/RelatedPartiesDetails1", "http://www.drreddys.com/role/RelatedPartiesDetails2", "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "domainItemType" }, "ifrs-full_EntitysTotalForSubsidiariesMember": { "auth_ref": [ "r151", "r154", "r262" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Subsidiaries' axis if no other member is used." } }, "en-us": { "role": { "label": "Entity's total for subsidiaries [member]" } } }, "localname": "EntitysTotalForSubsidiariesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual", "http://www.drreddys.com/role/IncomeTaxesDetailsTextual", "http://www.drreddys.com/role/LoansAndBorrowingsDetailsTextual", "http://www.drreddys.com/role/OrganizationalStructureDetails", "http://www.drreddys.com/role/OrganizationalStructureDetailsTextual", "http://www.drreddys.com/role/OtherIncomeNetDetailsTextual" ], "xbrltype": "domainItemType" }, "ifrs-full_EntitysTotalForUnconsolidatedStructuredEntitiesMember": { "auth_ref": [ "r264" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Unconsolidated structured entities' axis if no other member is used." } }, "en-us": { "role": { "label": "Entity's total for unconsolidated structured entities [member]" } } }, "localname": "EntitysTotalForUnconsolidatedStructuredEntitiesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual", "http://www.drreddys.com/role/OtherInvestmentsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_Equity": { "auth_ref": [ "r33", "r46", "r237", "r240", "r265", "r266", "r267" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 16.0, "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities." } }, "en-us": { "role": { "label": "Equity", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "terseLabel": "Equity", "totalLabel": "Total equity" } } }, "localname": "Equity", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity", "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]", "verboseLabel": "Equity" } } }, "localname": "EquityAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_EquityAndLiabilities": { "auth_ref": [ "r33" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]" } }, "en-us": { "role": { "label": "Equity and liabilities", "presentationGuidance": "Total equity and liabilities", "totalLabel": "Total liabilities and equity" } } }, "localname": "EquityAndLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EquityAndLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity and liabilities [abstract]", "verboseLabel": "LIABILITIES AND EQUITY" } } }, "localname": "EquityAndLiabilitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_EquityInterestsOfAcquirer": { "auth_ref": [ "r306" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The fair value, at the acquisition date, of equity interests of the acquirer transferred as consideration in a business combination. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "Equity interests of acquirer", "totalLabel": "Total consideration" } } }, "localname": "EquityInterestsOfAcquirer", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EquityMember": { "auth_ref": [ "r10" ], "lang": { "en": { "role": { "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used." } }, "en-us": { "role": { "label": "Equity [Member]" } } }, "localname": "EquityMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetailsTextual", "http://www.drreddys.com/role/ShareCapitalDetails", "http://www.drreddys.com/role/ShareCapitalDetailsTextual" ], "xbrltype": "domainItemType" }, "ifrs-full_ExercisePriceOfOutstandingShareOptions2019": { "auth_ref": [ "r299" ], "lang": { "en": { "role": { "documentation": "The exercise price of outstanding share options." } }, "en-us": { "role": { "label": "Exercise price of outstanding share options", "periodEndLabel": "Range of exercise prices, Outstanding at the end of the year", "periodStartLabel": "Range of exercise prices, Outstanding at the beginning of the year" } } }, "localname": "ExercisePriceOfOutstandingShareOptions2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails2", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails4" ], "xbrltype": "perShareItemType" }, "ifrs-full_ExercisePriceShareOptionsGranted2019": { "auth_ref": [ "r301" ], "lang": { "en": { "role": { "documentation": "The exercise price of share options granted." } }, "en-us": { "role": { "label": "Exercise price, share options granted", "terseLabel": "Exercise price", "verboseLabel": "Exercise price of share" } } }, "localname": "ExercisePriceShareOptionsGranted2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails5", "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "perShareItemType" }, "ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted": { "auth_ref": [ "r301" ], "lang": { "en": { "role": { "documentation": "The percentage of an expected dividend used to calculate the fair value of share options granted." } }, "en-us": { "role": { "label": "Expected dividend as percentage, share options granted", "verboseLabel": "Expected dividends" } } }, "localname": "ExpectedDividendAsPercentageShareOptionsGranted", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails5" ], "xbrltype": "percentItemType" }, "ifrs-full_ExpenseByNatureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expenses by nature [abstract]" } } }, "localname": "ExpenseByNatureAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_ExpenseFromCashsettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets": { "auth_ref": [ "r13" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense arising from cash-settled share-based payment transactions in which the goods or services received did not qualify for recognition as assets. [Refer: Expense from share-based payment transactions]" } }, "en-us": { "role": { "label": "Expense from cash-settled share-based payment transactions in which goods or services received did not qualify for recognition as assets", "verboseLabel": "Cash settled share-based payment expense" } } }, "localname": "ExpenseFromCashsettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails6" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees": { "auth_ref": [ "r13" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]" } }, "en-us": { "role": { "label": "Expense from share-based payment transactions with employees", "verboseLabel": "Share-based payment expense" } } }, "localname": "ExpenseFromSharebasedPaymentTransactionsWithEmployees", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails6" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ExplanationOfMeasurementBasesUsedInPreparingFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en": { "role": { "documentation": "The explanation of the measurement basis (or bases) used in preparing the financial statements." } }, "en-us": { "role": { "label": "Explanation of measurement bases used in preparing financial statements [text block]", "verboseLabel": "Basis of measurement" } } }, "localname": "ExplanationOfMeasurementBasesUsedInPreparingFinancialStatements", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BasisOfPreparationOfFinancialStatementsPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_FactoringOfReceivablesMember": { "auth_ref": [ "r356" ], "lang": { "en": { "role": { "documentation": "This member stands for transactions in which an entity transfers its receivables to another party (the factor)." } }, "en-us": { "role": { "label": "Factoring of receivables [member]" } } }, "localname": "FactoringOfReceivablesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/TradeAndOtherReceivablesDetailsTextual" ], "xbrltype": "domainItemType" }, "ifrs-full_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome": { "auth_ref": [ "r323", "r350" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of investments in equity instruments that the entity has designated at fair value through other comprehensive income. [Refer: At fair value [member]; Other comprehensive income]" } }, "en-us": { "role": { "label": "Investments in equity instruments designated at fair value through other comprehensive income", "terseLabel": "Fair value" } } }, "localname": "FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FinanceCosts": { "auth_ref": [ "r58" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedIncomeStatements": { "order": 4.0, "parentTag": "ifrs-full_FinanceIncomeCost", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of costs associated with financing activities of the entity." } }, "en-us": { "role": { "label": "Finance costs", "negatedLabel": "Finance expense" } } }, "localname": "FinanceCosts", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedIncomeStatements", "http://www.drreddys.com/role/FinanceIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FinanceIncome": { "auth_ref": [ "r61" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedIncomeStatements": { "order": 3.0, "parentTag": "ifrs-full_FinanceIncomeCost", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of income associated with interest and other financing activities of the entity." } }, "en-us": { "role": { "label": "Finance income", "verboseLabel": "Finance income" } } }, "localname": "FinanceIncome", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedIncomeStatements", "http://www.drreddys.com/role/FinanceIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FinanceIncomeCost": { "auth_ref": [ "r61" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedIncomeStatements": { "order": 2.0, "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of income or cost associated with interest and other financing activities of the entity." } }, "en-us": { "role": { "label": "Finance income (cost)", "terseLabel": "Finance income, net", "totalLabel": "Finance income, net (B)", "verboseLabel": "Finance income, net" } } }, "localname": "FinanceIncomeCost", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedIncomeStatements", "http://www.drreddys.com/role/FinanceIncomeNetDetails", "http://www.drreddys.com/role/SegmentReportingDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FinancialAssets": { "auth_ref": [ "r333", "r337", "r338", "r340", "r341" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose the entity\u2019s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]" } }, "en-us": { "role": { "label": "Financial assets", "terseLabel": "Total" } } }, "localname": "FinancialAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncome": { "auth_ref": [ "r350" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of financial assets at fair value through other comprehensive income. [Refer: At fair value [member]; Financial assets; Other comprehensive income]" } }, "en-us": { "role": { "label": "Financial assets at fair value through other comprehensive income", "verboseLabel": "FVTOCI - Financial asset" } } }, "localname": "FinancialAssetsAtFairValueThroughOtherComprehensiveIncome", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss": { "auth_ref": [ "r348" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of financial assets that are measured at fair value and for which gains (losses) are recognised in profit or loss. A financial asset shall be measured at fair value through profit or loss unless it is measured at amortised cost or at fair value through other comprehensive income. A gain (loss) on a financial asset measured at fair value shall be recognised in profit or loss unless it is part of a hedging relationship, it is an investment in an equity instrument for which the entity has elected to present gains and losses in other comprehensive income or it is a financial asset measured at fair value through other comprehensive income. [Refer: At fair value [member]; Financial assets]" } }, "en-us": { "role": { "label": "Financial assets at fair value through profit or loss", "verboseLabel": "FVTPL - Financial asset" } } }, "localname": "FinancialAssetsAtFairValueThroughProfitOrLoss", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FinancialAssetsAvailableforsale": { "auth_ref": [ "r413" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of non-derivative financial assets that are designated as available for sale or are not classified as (a) loans and receivables; (b) held-to-maturity investments; or (c) financial assets at fair value through profit or loss. [Refer: Derivative financial assets; Financial assets at fair value through profit or loss; Held-to-maturity investments]" } }, "en-us": { "role": { "label": "Investment Mutual funds" } } }, "localname": "FinancialAssetsAvailableforsale", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FinancialAssetsCategoryMember": { "auth_ref": [ "r351" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated categories of financial assets. It also represents the standard value for the 'Categories of financial assets' axis if no other member is used. [Refer: Financial assets]" } }, "en-us": { "role": { "label": "Financial assets, category [member]", "terseLabel": "Financial assets, category [member]" } } }, "localname": "FinancialAssetsCategoryMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_FinancialAssetsMember": { "auth_ref": [ "r345", "r346", "r387", "r399", "r400", "r401" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated classes of financial assets. It also represents the standard value for the 'Classes of financial assets' axis if no other member is used. [Refer: Financial assets]" } }, "en-us": { "role": { "label": "Financial assets, class [member]", "terseLabel": "Financial assets, class [member]" } } }, "localname": "FinancialAssetsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3", "http://www.drreddys.com/role/FinancialInstrumentsDetailsTextual" ], "xbrltype": "domainItemType" }, "ifrs-full_FinancialAssetsPastDueButNotImpairedMember": { "auth_ref": [ "r410" ], "lang": { "en": { "role": { "documentation": "This member stands for financial assets that are past due but not impaired. A financial asset is past due when a counterparty has failed to make a payment when contractually due. [Refer: Financial assets]" } }, "en-us": { "role": { "label": "Financial assets past due but not impaired [member]" } } }, "localname": "FinancialAssetsPastDueButNotImpairedMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_FinancialEffectOfTransitionFromPreviousGAAPToIFRSsAxis": { "auth_ref": [ "r239" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Financial effect of transition from previous GAAP to IFRSs [axis]" } } }, "localname": "FinancialEffectOfTransitionFromPreviousGAAPToIFRSsAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity", "http://www.drreddys.com/role/TradeAndOtherReceivablesDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_FinancialLiabilities": { "auth_ref": [ "r333" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]" } }, "en-us": { "role": { "label": "Financial liabilities", "terseLabel": "Total" } } }, "localname": "FinancialLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLoss": { "auth_ref": [ "r349" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of financial liabilities that meet either of the following conditions: (a) they meet the definition of held for trading; or (b) upon initial recognition they are designated by the entity as at fair value through profit or loss. An entity may use this designation only when permitted by paragraph 4.3.5 of IFRS 9 (embedded derivatives) or when doing so results in more relevant information, because either: (a) it eliminates or significantly reduces a measurement or recognition inconsistency (sometimes referred to as \u2018an accounting mismatch\u2019) that would otherwise arise from measuring assets or liabilities or recognising the gains and losses on them on different bases; or (b) a group of financial liabilities or financial assets and financial liabilities is managed and its performance is evaluated on a fair value basis, in accordance with a documented risk management or investment strategy, and information about the group is provided internally on that basis to the entity\u2019s key management personnel (as defined in IAS 24). [Refer: At fair value [member]; Key management personnel of entity or parent [member]; Derivatives [member]; Financial assets; Financial liabilities]" } }, "en-us": { "role": { "label": "Financial liabilities at fair value through profit or loss", "terseLabel": "FVTPL- Contingent consideration" } } }, "localname": "FinancialLiabilitiesAtFairValueThroughProfitOrLoss", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FinancialLiabilitiesCategoryMember": { "auth_ref": [ "r351" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated categories of financial liabilities. It also represents the standard value for the 'Categories of financial liabilities' axis if no other member is used. [Refer: Financial assets]" } }, "en-us": { "role": { "label": "Financial liabilities, category [member]" } } }, "localname": "FinancialLiabilitiesCategoryMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_FinishedGoods": { "auth_ref": [ "r44", "r128" ], "calculation": { "http://www.drreddys.com/role/InventoriesDetails": { "order": 4.0, "parentTag": "ifrs-full_Inventories", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "A classification of current inventory representing the amount of goods that have completed the production process and are held for sale in the ordinary course of business. [Refer: Inventories]" } }, "en-us": { "role": { "label": "Current finished goods", "verboseLabel": "Finished goods (includes stock-in-trade)" } } }, "localname": "FinishedGoods", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FixturesAndFittingsMember": { "auth_ref": [ "r85" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing fixtures and fittings that are not permanently attached to real property. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Fixtures and fittings [member]", "terseLabel": "Furniture, fixtures and office equipment [Member]" } } }, "localname": "FixturesAndFittingsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SignificantAccountingPoliciesDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_FloatingInterestRateMember": { "auth_ref": [ "r343" ], "lang": { "en": { "role": { "documentation": "This member stands for a non-fixed interest rate. [Refer: Interest rate risk [member]]" } }, "en-us": { "role": { "label": "Floating interest rate [member]" } } }, "localname": "FloatingInterestRateMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "domainItemType" }, "ifrs-full_ForeignCountriesMember": { "auth_ref": [ "r380", "r381" ], "lang": { "en": { "role": { "documentation": "This member stands for countries outside the entity's country of domicile. [Refer: Country of domicile [member]]" } }, "en-us": { "role": { "label": "Foreign countries [member]", "verboseLabel": "Foreign [member]" } } }, "localname": "ForeignCountriesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_FuelAndEnergyExpense": { "auth_ref": [ "r13" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense arising from the consumption of fuel and energy." } }, "en-us": { "role": { "label": "Fuel and energy expense" } } }, "localname": "FuelAndEnergyExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAssetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income [abstract]", "terseLabel": "Re-measurements due to:" } } }, "localname": "GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAssetAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails11", "http://www.drreddys.com/role/EmployeeBenefitsDetails2", "http://www.drreddys.com/role/EmployeeBenefitsDetails3" ], "xbrltype": "stringItemType" }, "ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax": { "auth_ref": [ "r64", "r409" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 9.0, "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The gains (losses) recognised in other comprehensive income on cash flow hedges, before tax, before reclassification adjustments. [Refer: Cash flow hedges [member]]" } }, "en-us": { "role": { "label": "Gains (losses) on cash flow hedges, before tax", "terseLabel": "Net gain/(loss) recognized in equity in respect of hedges of highly probable forecast transactions", "verboseLabel": "Effective portion of changes in fair value of cash flow hedges, net" } } }, "localname": "GainsLossesOnCashFlowHedgesBeforeTax", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfComprehensiveIncome", "http://www.drreddys.com/role/FinancialInstrumentsDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GainsLossesOnCashFlowHedgesNetOfTax": { "auth_ref": [ "r63", "r330", "r332", "r409" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The gains (losses) recognised in other comprehensive income on cash flow hedges, net of tax, before reclassification adjustments. [Refer: Cash flow hedges [member]]" } }, "en-us": { "role": { "label": "Gains (losses) on cash flow hedges, net of tax", "verboseLabel": "Effective portion of changes in fair value of cash flow hedges, net of tax (expense)/benefit" } } }, "localname": "GainsLossesOnCashFlowHedgesNetOfTax", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity", "http://www.drreddys.com/role/FinancialInstrumentsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GainsLossesOnDisposalsOfNoncurrentAssets": { "auth_ref": [ "r13" ], "calculation": { "http://www.drreddys.com/role/OtherIncomeNetDetails": { "order": 1.0, "parentTag": "ifrs-full_OtherOperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The gains (losses) on disposals of non-current assets. [Refer: Non-current assets]" } }, "en-us": { "role": { "label": "Gains (losses) on disposals of non-current assets", "negatedTerseLabel": "Loss/(gain) on sale/disposal of non-current assets, net" } } }, "localname": "GainsLossesOnDisposalsOfNoncurrentAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax": { "auth_ref": [ "r64" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 8.0, "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The gains (losses) recognised in other comprehensive income on exchange differences on the translation of financial statements of foreign operations, before tax, before reclassification adjustments. [Refer: Other comprehensive income]" } }, "en-us": { "role": { "label": "Gains (losses) on exchange differences on translation, before tax", "verboseLabel": "Foreign currency translation adjustments" } } }, "localname": "GainsLossesOnExchangeDifferencesOnTranslationBeforeTax", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax": { "auth_ref": [ "r63" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The gains (losses) recognised in other comprehensive income on exchange differences on the translation of financial statements of foreign operations, net of tax, before reclassification adjustments. [Refer: Other comprehensive income]" } }, "en-us": { "role": { "label": "Gains (losses) on exchange differences on translation, net of tax", "verboseLabel": "Foreign currency translation adjustments, net of tax (expense)/benefit" } } }, "localname": "GainsLossesOnExchangeDifferencesOnTranslationNetOfTax", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GeographicalAreasAxis": { "auth_ref": [ "r103", "r280", "r382", "r397" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Geographical areas [axis]" } } }, "localname": "GeographicalAreasAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails4", "http://www.drreddys.com/role/SegmentReportingDetails4", "http://www.drreddys.com/role/SegmentReportingDetails5", "http://www.drreddys.com/role/SegmentReportingDetails6" ], "xbrltype": "stringItemType" }, "ifrs-full_GeographicalAreasMember": { "auth_ref": [ "r103", "r280", "r382", "r397" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated geographical areas. It also represents the standard value for the 'Geographical areas' axis if no other member is used." } }, "en-us": { "role": { "label": "Geographical areas [member]" } } }, "localname": "GeographicalAreasMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails4", "http://www.drreddys.com/role/SegmentReportingDetails4", "http://www.drreddys.com/role/SegmentReportingDetails5", "http://www.drreddys.com/role/SegmentReportingDetails6" ], "xbrltype": "domainItemType" }, "ifrs-full_Goodwill": { "auth_ref": [ "r22", "r167", "r173", "r317" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 28.0, "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "definitionGuidance": "Total goodwill", "label": "Goodwill", "terseLabel": "Closing balance", "verboseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual", "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition", "http://www.drreddys.com/role/GoodwillDetails", "http://www.drreddys.com/role/GoodwillDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GoodwillRecognisedAsOfAcquisitionDate": { "auth_ref": [ "r312", "r319" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount recognised as of the business combination's acquisition date for goodwill. [Refer: Goodwill; Business combinations [member]]" } }, "en-us": { "role": { "label": "Goodwill recognised as of acquisition date", "terseLabel": "Goodwill", "verboseLabel": "Goodwill recognized as of acquisition date" } } }, "localname": "GoodwillRecognisedAsOfAcquisitionDate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetails", "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GrossCarryingAmountMember": { "auth_ref": [ "r89", "r184", "r201", "r204", "r317", "r338", "r340", "r341", "r411", "r418" ], "lang": { "en": { "role": { "documentation": "This member stands for the amount at which an asset is recognised before deducting any accumulated depreciation (amortisation) and accumulated impairment losses thereon. [Refer: Depreciation and amortisation expense; Impairment loss]" } }, "en-us": { "role": { "label": "Gross carrying amount [member]", "terseLabel": "Gross carrying amount [member]" } } }, "localname": "GrossCarryingAmountMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetails", "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails", "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_GrossLeaseLiabilities": { "auth_ref": [ "r288", "r355" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of contractual undiscounted cash flows in relation to lease liabilities before deducting finance charges. [Refer: Lease liabilities]" } }, "en-us": { "role": { "label": "Gross lease liabilities", "terseLabel": "Obligations under leases" } } }, "localname": "GrossLeaseLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails4" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GrossProfit": { "auth_ref": [ "r2" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedIncomeStatements": { "order": 7.0, "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]" } }, "en-us": { "role": { "label": "Gross Profit", "terseLabel": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedIncomeStatements", "http://www.drreddys.com/role/SegmentReportingDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_HedgingInstrumentsAxis": { "auth_ref": [ "r325", "r328" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Hedging instruments [axis]" } } }, "localname": "HedgingInstrumentsAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "stringItemType" }, "ifrs-full_HedgingInstrumentsMember": { "auth_ref": [ "r325", "r328" ], "lang": { "en": { "role": { "documentation": "This member stands for hedging instruments. A hedging instrument can be a designated: (a) derivative measured at fair value through profit or loss, except for some written options (see paragraph B6.2.4 of IFRS 9); (b) non-derivative financial asset or non-derivative financial liability measured at fair value through profit or loss, unless it is a financial liability designated as at fair value through profit or loss for which the amount of its change in fair value that is attributable to changes in the credit risk of that liability is presented in other comprehensive income in accordance with paragraph 5.7.7 of IFRS 9. For a hedge of foreign currency risk, the foreign currency risk component of a non-derivative financial asset or a non-derivative financial liability may be designated as a hedging instrument provided that it is not an investment in an equity instrument for which an entity has elected to present changes in fair value in other comprehensive income in accordance with paragraph 5.7.5 of IFRS 9. This member also represents the standard value for the 'Hedging instruments' axis if no other member is used." } }, "en-us": { "role": { "label": "Hedging instruments [member]" } } }, "localname": "HedgingInstrumentsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "ifrs-full_IFRSsMember": { "auth_ref": [ "r239" ], "lang": { "en": { "role": { "documentation": "This member stands for Standards and Interpretations issued by the International Accounting Standards Board (IASB), which comprise (a) International Financial Reporting Standards; (b) International Accounting Standards; (c) IFRIC Interpretations; and (d) SIC Interpretations. It also represents the standard value for the 'Financial effect of transition from previous GAAP to IFRSs' axis if no other member is used." } }, "en-us": { "role": { "label": "IFRSs [member]" } } }, "localname": "IFRSsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity", "http://www.drreddys.com/role/TradeAndOtherReceivablesDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed": { "auth_ref": [ "r309", "r319" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount recognised as of the acquisition date for net identifiable assets acquired or liabilities assumed in a business combination. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "Identifiable assets acquired (liabilities assumed)", "totalLabel": "Total net assets", "verboseLabel": "Assets (transferred)/acquired" } } }, "localname": "IdentifiableAssetsAcquiredLiabilitiesAssumed", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetails", "http://www.drreddys.com/role/EmployeeBenefitsDetails3" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate": { "auth_ref": [ "r309", "r319" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount recognised as of the acquisition date for identifiable intangible assets acquired in a business combination. [Refer: Intangible assets other than goodwill; Business combinations [member]]" } }, "en-us": { "role": { "label": "Identifiable intangible assets recognised as of acquisition date", "terseLabel": "Other intangible assets" } } }, "localname": "IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ImpairmentLoss": { "auth_ref": [ "r164", "r165" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount recognised as a reduction of the carrying amount of an asset or cash-generating unit to its recoverable amount. [Refer: Carrying amount [member]]" } }, "en-us": { "role": { "label": "Impairment loss" } } }, "localname": "ImpairmentLoss", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill": { "auth_ref": [ "r315" ], "lang": { "en": { "role": { "documentation": "The amount of impairment loss recognised in profit or loss for goodwill. [Refer: Impairment loss recognised in profit or loss; Goodwill]" } }, "en-us": { "role": { "label": "Impairment loss recognised in profit or loss, goodwill", "terseLabel": "Impairment of goodwill" } } }, "localname": "ImpairmentLossRecognisedInProfitOrLossGoodwill", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/GoodwillDetailsTextual", "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r187" ], "lang": { "en": { "role": { "documentation": "The amount of impairment loss recognised in profit or loss for intangible assets other than goodwill. [Refer: Impairment loss recognised in profit or loss; Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Impairment loss recognised in profit or loss, intangible assets other than goodwill", "negatedTerseLabel": "Less: Impairments during the year", "terseLabel": "Impairment loss" } } }, "localname": "ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetails", "http://www.drreddys.com/role/OtherIntangibleAssetsDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment": { "auth_ref": [ "r66", "r93" ], "lang": { "en": { "role": { "documentation": "The amount of impairment loss recognised in profit or loss for property, plant and equipment. [Refer: Impairment loss recognised in profit or loss; Property, plant and equipment]" } }, "en-us": { "role": { "label": "Impairment loss recognised in profit or loss, property, plant and equipment", "presentationGuidance": "Impairment" } } }, "localname": "ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails", "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss": { "auth_ref": [ "r67" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedIncomeStatements": { "order": 14.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of impairment loss or reversal of impairment loss recognised in profit or loss. [Refer: Impairment loss recognised in profit or loss; Reversal of impairment loss recognised in profit or loss]" } }, "en-us": { "role": { "label": "Impairment loss (reversal of impairment loss) recognised in profit or loss", "terseLabel": "Impairment of non-current assets", "verboseLabel": "Impairment of non-current assets" } } }, "localname": "ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedIncomeStatements", "http://www.drreddys.com/role/SegmentReportingDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ImpairmentOfFinancialAssetsAxis": { "auth_ref": [ "r412" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Impairment of financial assets [axis]" } } }, "localname": "ImpairmentOfFinancialAssetsAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetails1", "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "stringItemType" }, "ifrs-full_InAccordanceWithIFRS9Member": { "auth_ref": [ "r402" ], "lang": { "en": { "role": { "documentation": "This member stands for the information reported in accordance with IFRS 9." } }, "en-us": { "role": { "label": "In accordance with IFRS 9 [member]" } } }, "localname": "InAccordanceWithIFRS9Member", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/TradeAndOtherReceivablesDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_IncomeTaxExpenseContinuingOperations": { "auth_ref": [ "r59", "r73", "r77", "r78", "r148", "r259", "r370" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedIncomeStatements": { "order": 15.0, "parentTag": "ifrs-full_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]" } }, "en-us": { "role": { "definitionGuidance": "Tax (expense)/benefit, net", "label": "Tax expense (income), continuing operations", "presentationGuidance": "Tax expense / (benefit), net", "totalLabel": "Tax expense/(benefit), net", "verboseLabel": "Income tax expense/(benefit)" } } }, "localname": "IncomeTaxExpenseContinuingOperations", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedIncomeStatements", "http://www.drreddys.com/role/IncomeTaxesDetails", "http://www.drreddys.com/role/IncomeTaxesDetails2", "http://www.drreddys.com/role/SegmentReportingDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncomeTaxRelatingToAvailableforsaleFinancialAssetsOfOtherComprehensiveIncome": { "auth_ref": [ "r404", "r405" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of income tax relating to amounts recognised in other comprehensive income in relation to available-for-sale financial assets. [Refer: Financial assets available-for-sale; Other comprehensive income]" } }, "en-us": { "role": { "label": "Income tax relating to available-for-sale financial assets of other comprehensive income", "terseLabel": "Tax effect on changes in fair value of other investments" } } }, "localname": "IncomeTaxRelatingToAvailableforsaleFinancialAssetsOfOtherComprehensiveIncome", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome": { "auth_ref": [ "r62", "r76" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of income tax relating to amounts recognised in other comprehensive income in relation to cash flow hedges. [Refer: Cash flow hedges [member]; Other comprehensive income]" } }, "en-us": { "role": { "label": "Income tax relating to cash flow hedges of other comprehensive income", "negatedLabel": "Tax effect on effective portion of change in fair value of cash flow hedges" } } }, "localname": "IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquityParenthetical" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss": { "auth_ref": [ "r65" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 10.0, "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of income tax relating to amounts recognised in other comprehensive income that will be reclassified to profit or loss. [Refer: Income tax relating to components of other comprehensive income]" } }, "en-us": { "role": { "label": "Income tax relating to components of other comprehensive income that will be reclassified to profit or loss", "negatedTerseLabel": "Tax impact on above items" } } }, "localname": "IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss": { "auth_ref": [ "r65" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 4.0, "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of income tax relating to amounts recognised in other comprehensive income that will not be reclassified to profit or loss. [Refer: Income tax relating to components of other comprehensive income]" } }, "en-us": { "role": { "label": "Income tax relating to components of other comprehensive income that will not be reclassified to profit or loss", "negatedTerseLabel": "Tax impact on above items" } } }, "localname": "IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncomeTaxRelatingToExchangeDifferencesOnTranslationOfOtherComprehensiveIncome": { "auth_ref": [ "r62", "r76" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of income tax relating to amounts recognised in other comprehensive income in relation to exchange differences on the translation of financial statements of foreign operations. [Refer: Other comprehensive income; Reserve of exchange differences on translation]" } }, "en-us": { "role": { "label": "Income tax relating to exchange differences on translation of other comprehensive income", "terseLabel": "Tax effect on foreign currency translation differences" } } }, "localname": "IncomeTaxRelatingToExchangeDifferencesOnTranslationOfOtherComprehensiveIncome", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome": { "auth_ref": [ "r62", "r76" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of income tax relating to amounts recognised in other comprehensive income in relation to remeasurements of defined benefit plans. [Refer: Other comprehensive income; Reserve of remeasurements of defined benefit plans; Defined benefit plans [member]]" } }, "en-us": { "role": { "label": "Income tax relating to remeasurements of defined benefit plans of other comprehensive income", "negatedLabel": "Tax effect on actuarial gains/losses on defined benefit obligations", "verboseLabel": "Tax effect on actuarial gain on post-employment benefit obligations" } } }, "localname": "IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquityParenthetical", "http://www.drreddys.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities": { "auth_ref": [ "r222" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for income taxes paid, classified as operating activities." } }, "en-us": { "role": { "label": "Income taxes paid, classified as operating activities", "negatedLabel": "Income tax paid, net" } } }, "localname": "IncomeTaxesPaidClassifiedAsOperatingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges": { "auth_ref": [ "r229" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in cash and cash equivalents before the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]" } }, "en-us": { "role": { "label": "Increase (decrease) in cash and cash equivalents before effect of exchange rate changes", "totalLabel": "Net (decrease)/increase in cash and cash equivalents" } } }, "localname": "IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseInExistingProvisionsOtherProvisions": { "auth_ref": [ "r176" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase in existing other provisions. [Refer: Other provisions]" } }, "en-us": { "role": { "label": "Increase in existing provisions, other provisions", "verboseLabel": "Provisions and adjustments relating to sales in prior years" } } }, "localname": "IncreaseDecreaseInExistingProvisionsOtherProvisions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails6" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued": { "auth_ref": [ "r13" ], "lang": { "en": { "role": { "documentation": "The increase (decrease) in the number of ordinary shares issued. [Refer: Ordinary shares [member]]" } }, "en-us": { "role": { "label": "Increase (decrease) in number of ordinary shares issued", "verboseLabel": "Effect of equity shares issued on exercise of stock options" } } }, "localname": "IncreaseDecreaseInNumberOfOrdinarySharesIssued", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding": { "auth_ref": [ "r51" ], "lang": { "en": { "role": { "documentation": "The increase (decrease) in the number of shares outstanding. [Refer: Number of shares outstanding]" } }, "en-us": { "role": { "label": "Increase (decrease) in number of shares outstanding", "terseLabel": "Add: Equity shares issued pursuant to employee stock option plan" } } }, "localname": "IncreaseDecreaseInNumberOfSharesOutstanding", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ShareCapitalDetails" ], "xbrltype": "sharesItemType" }, "ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset": { "auth_ref": [ "r112" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from changes in foreign exchange rates. [Refer: Net defined benefit liability (asset)]" } }, "en-us": { "role": { "label": "Increase (decrease) through changes in foreign exchange rates, net defined benefit liability (asset)", "verboseLabel": "Foreign exchanges differences" } } }, "localname": "IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails12" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities": { "auth_ref": [ "r225" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from the effect of changes in foreign exchange rates. [Refer: Liabilities arising from financing activities]" } }, "en-us": { "role": { "label": "Increase (decrease) through effect of changes in foreign exchange rates, liabilities arising from financing activities", "verboseLabel": "Effect of changes in foreign exchange rates" } } }, "localname": "IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails5" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseThroughExerciseOfOptions": { "auth_ref": [ "r9" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in equity resulting from the exercise of options." } }, "en-us": { "role": { "label": "Increase (decrease) through exercise of options, equity", "verboseLabel": "Issue of equity shares on exercise of options" } } }, "localname": "IncreaseDecreaseThroughExerciseOfOptions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesGoodwill": { "auth_ref": [ "r316" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in goodwill resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Goodwill]" } }, "en-us": { "role": { "label": "Increase (decrease) through net exchange differences, goodwill", "terseLabel": "Effect of translation adjustments" } } }, "localname": "IncreaseDecreaseThroughNetExchangeDifferencesGoodwill", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/GoodwillDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r189" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in intangible assets other than goodwill resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Increase (decrease) through net exchange differences, intangible assets other than goodwill", "terseLabel": "Effect of changes in exchange rates", "verboseLabel": "Effect of changes in foreign exchange rates" } } }, "localname": "IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetails", "http://www.drreddys.com/role/OtherIntangibleAssetsDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions": { "auth_ref": [ "r178" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in other provisions resulting from foreign currency exchange rate changes on provisions measured in a currency different from the entity's presentation currency. [Refer: Other provisions]" } }, "en-us": { "role": { "label": "Increase (decrease) through net exchange differences, other provisions", "terseLabel": "Effect of changes in foreign exchange rates", "verboseLabel": "Effect of changes in foreign exchange rates" } } }, "localname": "IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ProvisionsDetails", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails7" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment": { "auth_ref": [ "r95" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in property, plant and equipment resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Increase (decrease) through net exchange differences, property, plant and equipment", "terseLabel": "Effect of changes in foreign exchange rates" } } }, "localname": "IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": { "auth_ref": [ "r8" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]" } }, "en-us": { "role": { "label": "Increase (decrease) through share-based payment transactions, equity", "verboseLabel": "Share-based payment expense" } } }, "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions": { "auth_ref": [ "r9" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in equity resulting from treasury share transactions. [Refer: Equity; Treasury shares]" } }, "en-us": { "role": { "label": "Increase (decrease) through treasury share transactions, equity", "terseLabel": "Purchase of treasury shares" } } }, "localname": "IncreaseDecreaseThroughTreasuryShareTransactions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities": { "auth_ref": [ "r226", "r232" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase in liabilities arising from financing activities resulting from new leases. [Refer: Liabilities arising from financing activities]" } }, "en-us": { "role": { "label": "Increase through new leases, liabilities arising from financing activities", "terseLabel": "Recognition of right-of-use liability during the year" } } }, "localname": "IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails5" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis": { "auth_ref": [ "r172" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Cash-generating units [axis]" } } }, "localname": "IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/GoodwillDetails1", "http://www.drreddys.com/role/GoodwillDetailsTextual", "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual", "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetailsTextual" ], "xbrltype": "stringItemType" }, "ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember": { "auth_ref": [ "r172" ], "lang": { "en": { "role": { "documentation": "This member stands for the smallest identifiable group of assets that generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets." } }, "en-us": { "role": { "label": "Cash-generating units [member]" } } }, "localname": "IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/GoodwillDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_IntangibleAssetsAndGoodwillMember": { "auth_ref": [ "r191" ], "lang": { "en": { "role": { "documentation": "This member stands for intangible assets and goodwill. It also represents the standard value for the 'Classes of intangible assets and goodwill' axis if no other member is used. [Refer: Goodwill; Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Intangible assets and goodwill [member]" } } }, "localname": "IntangibleAssetsAndGoodwillMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/GoodwillDetailsTextual" ], "xbrltype": "domainItemType" }, "ifrs-full_IntangibleAssetsMaterialToEntity": { "auth_ref": [ "r195" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of intangible assets that are material to the entity\u2019s financial statements. [Refer: Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Intangible assets material to entity" } } }, "localname": "IntangibleAssetsMaterialToEntity", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IntangibleAssetsMaterialToEntityAxis": { "auth_ref": [ "r195" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Intangible assets material to entity [axis]", "terseLabel": "Intangible assets material to entity [axis]" } } }, "localname": "IntangibleAssetsMaterialToEntityAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual" ], "xbrltype": "stringItemType" }, "ifrs-full_IntangibleAssetsMaterialToEntityMember": { "auth_ref": [ "r195" ], "lang": { "en": { "role": { "documentation": "This member stands for intangible assets material to the entity. It also represents the standard value for the 'Intangible assets material to entity' axis if no other member is used. [Refer: Intangible assets material to entity]" } }, "en-us": { "role": { "label": "Intangible assets material to entity [member]", "terseLabel": "Intangible assets material to entity [member]" } } }, "localname": "IntangibleAssetsMaterialToEntityMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual" ], "xbrltype": "domainItemType" }, "ifrs-full_IntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r22", "r190" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 29.0, "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]" } }, "en-us": { "role": { "label": "Intangible assets other than goodwill", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "verboseLabel": "Other intangible assets" } } }, "localname": "IntangibleAssetsOtherThanGoodwill", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition", "http://www.drreddys.com/role/OtherIntangibleAssetsDetails", "http://www.drreddys.com/role/OtherIntangibleAssetsDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IntangibleAssetsOtherThanGoodwillMember": { "auth_ref": [ "r163", "r191", "r287" ], "lang": { "en": { "role": { "documentation": "This member stands for intangible assets other than goodwill. It also represents the standard value for the 'Classes of intangible assets other than goodwill' axis if no other member is used. [Refer: Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Intangible assets other than goodwill [member]" } } }, "localname": "IntangibleAssetsOtherThanGoodwillMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetails", "http://www.drreddys.com/role/OtherIntangibleAssetsDetails1", "http://www.drreddys.com/role/OtherIntangibleAssetsDetails2", "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual", "http://www.drreddys.com/role/SignificantAccountingPoliciesDetails2" ], "xbrltype": "domainItemType" }, "ifrs-full_IntangibleAssetsUnderDevelopmentMember": { "auth_ref": [ "r193" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of intangible assets representing such assets under development. [Refer: Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Intangible assets under development [member]", "verboseLabel": "In-process research and development assets [member]" } } }, "localname": "IntangibleAssetsUnderDevelopmentMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetails1", "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual" ], "xbrltype": "domainItemType" }, "ifrs-full_InterestCostsCapitalised": { "auth_ref": [ "r13" ], "lang": { "en": { "role": { "documentation": "The amount of interest costs that an entity incurs in connection with the borrowing of funds that are directly attributable to the acquisition, construction or production of a qualifying asset and which form part of the cost of that asset." } }, "en-us": { "role": { "label": "Interest costs capitalised" } } }, "localname": "InterestCostsCapitalised", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual", "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InterestExpense": { "auth_ref": [ "r258", "r368", "r377" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense arising from interest." } }, "en-us": { "role": { "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinanceIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset": { "auth_ref": [ "r108" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from the passage of time. [Refer: Interest expense; Net defined benefit liability (asset)]" } }, "en-us": { "role": { "label": "Interest expense (income), net defined benefit liability (asset)", "terseLabel": "Interest on defined benefit liability", "verboseLabel": "Interest on defined benefit liability" } } }, "localname": "InterestExpenseIncomeNetDefinedBenefitLiabilityAsset", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails", "http://www.drreddys.com/role/EmployeeBenefitsDetails9" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InterestExpenseOnLeaseLiabilities": { "auth_ref": [ "r283" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of interest expense on lease liabilities. [Refer: Lease liabilities]" } }, "en-us": { "role": { "label": "Interest expense on lease liabilities", "terseLabel": "Interest expense on lease liabilities" } } }, "localname": "InterestExpenseOnLeaseLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InterestPaidClassifiedAsFinancingActivities": { "auth_ref": [ "r221" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 34.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for interest paid, classified as financing activities." } }, "en-us": { "role": { "label": "Interest paid, classified as financing activities", "negatedLabel": "Interest paid" } } }, "localname": "InterestPaidClassifiedAsFinancingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InterestRateSwapContractMember": { "auth_ref": [ "r13" ], "lang": { "en": { "role": { "documentation": "This member stands for an interest rate swap contract. [Refer: Swap contract [member]]" } }, "en-us": { "role": { "label": "Interest rate swap contract [member]", "terseLabel": "Interest rate swap contract [member]" } } }, "localname": "InterestRateSwapContractMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetailsTextual" ], "xbrltype": "domainItemType" }, "ifrs-full_InterestRateTypesMember": { "auth_ref": [ "r343" ], "lang": { "en": { "role": { "documentation": "This member stands for all types of interest rates. It also represents the standard value for the 'Types of interest rates' axis if no other member is used. [Refer: Interest rate risk [member]]" } }, "en-us": { "role": { "label": "Interest rate types [member]" } } }, "localname": "InterestRateTypesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "domainItemType" }, "ifrs-full_InterestRevenueExpense": { "auth_ref": [ "r61", "r371", "r377" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of income or expense arising from interest. [Refer: Interest expense; Interest income]" } }, "en-us": { "role": { "label": "Interest income (expense)", "negatedLabel": "Interest (income)/expense, net" } } }, "localname": "InterestRevenueExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_Inventories": { "auth_ref": [ "r25", "r39", "r125" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 40.0, "parentTag": "ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners", "weight": 1.0 }, "http://www.drreddys.com/role/InventoriesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current inventories. [Refer: Inventories]" } }, "en-us": { "role": { "label": "Current inventories", "totalLabel": "Total Inventories", "verboseLabel": "Inventories" } } }, "localname": "Inventories", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition", "http://www.drreddys.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InventoryRecognisedAsOfAcquisitionDate": { "auth_ref": [ "r309", "r319" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount recognised as of the acquisition date for inventory acquired in a business combination. [Refer: Inventories; Business combinations [member]]" } }, "en-us": { "role": { "label": "Inventory recognised as of acquisition date", "terseLabel": "Inventories" } } }, "localname": "InventoryRecognisedAsOfAcquisitionDate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InventoryWritedown2011": { "auth_ref": [ "r66", "r127" ], "lang": { "en": { "role": { "documentation": "The amount of expense recognised related to the write-down of inventories to net realisable value. [Refer: Inventories]" } }, "en-us": { "role": { "label": "Inventory write-down", "verboseLabel": "Inventory write-downs" } } }, "localname": "InventoryWritedown2011", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/InventoriesDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InvestmentAccountedForUsingEquityMethod": { "auth_ref": [ "r24", "r260", "r372" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 31.0, "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of investments accounted for using the equity method. The equity method is a method of accounting whereby the investment is initially recognised at cost and adjusted thereafter for the post-acquisition change in the investor's share of net assets of the investee. The investor's profit or loss includes its share of the profit or loss of the investee. The investor's other comprehensive income includes its share of the other comprehensive income of the investee. [Refer: At cost [member]]" } }, "en-us": { "role": { "definitionGuidance": "Carrying value of the Company's investment", "label": "Investments accounted for using equity method", "terseLabel": "Carrying value of the Company's investment", "verboseLabel": "Investment in equity accounted investees" } } }, "localname": "InvestmentAccountedForUsingEquityMethod", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails1", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InvestmentFundsMember": { "auth_ref": [ "r261" ], "lang": { "en": { "role": { "documentation": "This member stands for investment funds." } }, "en-us": { "role": { "label": "Investment funds [member]", "verboseLabel": "Investment in mutual funds [member]" } } }, "localname": "InvestmentFundsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherInvestmentsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_InvestmentIncome": { "auth_ref": [ "r61", "r146" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of investment income, such as interest and dividends." } }, "en-us": { "role": { "label": "Investment income", "verboseLabel": "Interest income" } } }, "localname": "InvestmentIncome", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinanceIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InvestmentPropertyMember": { "auth_ref": [ "r13", "r269", "r271" ], "lang": { "en": { "role": { "documentation": "This member stands for investment property. It also represents the standard value for the 'Types of investment property' axis if no other member is used. [Refer: Investment property]" } }, "en-us": { "role": { "label": "Investment property [member]" } } }, "localname": "InvestmentPropertyMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails2" ], "xbrltype": "domainItemType" }, "ifrs-full_InvestmentsAccountedForUsingEquityMethodAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments accounted for using equity method [abstract]" } } }, "localname": "InvestmentsAccountedForUsingEquityMethodAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod": { "auth_ref": [ "r33" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of investments other than investments accounted for using the equity method. [Refer: Investments accounted for using equity method]" } }, "en-us": { "role": { "label": "Investments other than investments accounted for using equity method", "terseLabel": "Other investments", "verboseLabel": "Other investments" } } }, "localname": "InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails", "http://www.drreddys.com/role/FinancialRiskManagementDetails", "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IssuedCapital": { "auth_ref": [ "r46" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 17.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The nominal value of capital issued." } }, "en-us": { "role": { "label": "Issued capital", "periodEndLabel": "Closing number of equity shares/share capital", "periodStartLabel": "Opening number of equity shares/share capital", "verboseLabel": "Share capital" } } }, "localname": "IssuedCapital", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition", "http://www.drreddys.com/role/ShareCapitalDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IssuedCapitalMember": { "auth_ref": [ "r10" ], "lang": { "en": { "role": { "documentation": "This member stands for a component of equity representing issued capital." } }, "en-us": { "role": { "label": "Issued capital [member]", "verboseLabel": "Share capital[member]" } } }, "localname": "IssuedCapitalMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "domainItemType" }, "ifrs-full_JointVenturesAxis": { "auth_ref": [ "r151", "r154", "r263", "r403", "r406" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Joint ventures [axis]" } } }, "localname": "JointVenturesAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails1", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails2", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetailsTextual", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesTables" ], "xbrltype": "stringItemType" }, "ifrs-full_KeyManagementPersonnelCompensation": { "auth_ref": [ "r136" ], "calculation": { "http://www.drreddys.com/role/RelatedPartiesDetails2": { "order": 1.0, "parentTag": "ifrs-full_EmployeeBenefitsExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]" } }, "en-us": { "role": { "label": "Key management personnel compensation", "terseLabel": "Salaries to relatives of Key Management Personnel", "verboseLabel": "Salaries and other benefits" } } }, "localname": "KeyManagementPersonnelCompensation", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/RelatedPartiesDetails", "http://www.drreddys.com/role/RelatedPartiesDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits": { "auth_ref": [ "r134" ], "calculation": { "http://www.drreddys.com/role/RelatedPartiesDetails2": { "order": 2.0, "parentTag": "ifrs-full_EmployeeBenefitsExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of compensation to key management personnel in the form of post-employment benefits. [Refer: Key management personnel of entity or parent [member]]" } }, "en-us": { "role": { "label": "Key management personnel compensation, post-employment benefits", "verboseLabel": "Contributions to defined contribution plans" } } }, "localname": "KeyManagementPersonnelCompensationPostemploymentBenefits", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/RelatedPartiesDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment": { "auth_ref": [ "r135" ], "calculation": { "http://www.drreddys.com/role/RelatedPartiesDetails2": { "order": 4.0, "parentTag": "ifrs-full_EmployeeBenefitsExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]" } }, "en-us": { "role": { "label": "Key management personnel compensation, share-based payment", "verboseLabel": "Share-based payments expense" } } }, "localname": "KeyManagementPersonnelCompensationSharebasedPayment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/RelatedPartiesDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits": { "auth_ref": [ "r133" ], "calculation": { "http://www.drreddys.com/role/RelatedPartiesDetails2": { "order": 3.0, "parentTag": "ifrs-full_EmployeeBenefitsExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]" } }, "en-us": { "role": { "label": "Key management personnel compensation, short-term employee benefits", "verboseLabel": "Commission to directors" } } }, "localname": "KeyManagementPersonnelCompensationShorttermEmployeeBenefits", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/RelatedPartiesDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_KeyManagementPersonnelOfEntityOrParentMember": { "auth_ref": [ "r139" ], "lang": { "en": { "role": { "documentation": "This member stands for those persons having authority and responsibility for planning, directing and controlling the activities of the entity, directly or indirectly, including any director (whether executive or otherwise) of that entity." } }, "en-us": { "role": { "label": "Key management personnel of entity or parent [member]", "verboseLabel": "Key management personnel (towards rent deposits)" } } }, "localname": "KeyManagementPersonnelOfEntityOrParentMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/RelatedPartiesDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_LandMember": { "auth_ref": [ "r84" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing land held by the entity for use in operations. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Land [Member]", "terseLabel": "Land [Member]" } } }, "localname": "LandMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails", "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_LaterThanFiveYearsMember": { "auth_ref": [ "r289", "r290", "r354", "r361", "r364", "r396" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of later than five years." } }, "en-us": { "role": { "definitionGuidance": "Thereafter", "label": "Later than five years [member]" } } }, "localname": "LaterThanFiveYearsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails4" ], "xbrltype": "domainItemType" }, "ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember": { "auth_ref": [ "r13", "r289", "r290", "r354", "r364", "r396" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of later than four years and not later than five years." } }, "en-us": { "role": { "label": "Later than four years and not later than five years [member]", "verboseLabel": "4-5 years" } } }, "localname": "LaterThanFourYearsAndNotLaterThanFiveYearsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails4" ], "xbrltype": "domainItemType" }, "ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember": { "auth_ref": [ "r353", "r358", "r364" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of later than one month and not later than three months." } }, "en-us": { "role": { "label": "Later than one month and not later than three months [member]" } } }, "localname": "LaterThanOneMonthAndNotLaterThanThreeMonthsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails4" ], "xbrltype": "domainItemType" }, "ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember": { "auth_ref": [ "r13", "r289", "r290", "r354", "r364", "r396" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of later than one year and not later than two years." } }, "en-us": { "role": { "label": "Later than one year and not later than two years [member]", "verboseLabel": "1-2 years" } } }, "localname": "LaterThanOneYearAndNotLaterThanTwoYearsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails4" ], "xbrltype": "domainItemType" }, "ifrs-full_LaterThanOneYearMember": { "auth_ref": [ "r36", "r410", "r416" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of later than one year." } }, "en-us": { "role": { "label": "Later than one year [member]" } } }, "localname": "LaterThanOneYearMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember": { "auth_ref": [ "r354", "r360", "r364", "r410", "r415" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of later than six months and not later than one year." } }, "en-us": { "role": { "label": "Later than six months and not later than one year [member]" } } }, "localname": "LaterThanSixMonthsAndNotLaterThanOneYearMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails4" ], "xbrltype": "domainItemType" }, "ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember": { "auth_ref": [ "r354", "r359", "r364", "r410", "r414" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of later than three months and not later than six months." } }, "en-us": { "role": { "label": "Later than three months and not later than six months [member]" } } }, "localname": "LaterThanThreeMonthsAndNotLaterThanSixMonthsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails4" ], "xbrltype": "domainItemType" }, "ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember": { "auth_ref": [ "r13", "r289", "r290", "r354", "r364", "r396" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of later than three years and not later than four years." } }, "en-us": { "role": { "label": "Later than three years and not later than four years [member]", "verboseLabel": "3-4 years" } } }, "localname": "LaterThanThreeYearsAndNotLaterThanFourYearsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetails2", "http://www.drreddys.com/role/LoansAndBorrowingsDetails4" ], "xbrltype": "domainItemType" }, "ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember": { "auth_ref": [ "r13", "r289", "r290", "r354", "r364", "r396" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of later than two years and not later than three years." } }, "en-us": { "role": { "label": "Later than two years and not later than three years [member]", "verboseLabel": "2-3 years" } } }, "localname": "LaterThanTwoYearsAndNotLaterThanThreeYearsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetails2", "http://www.drreddys.com/role/LoansAndBorrowingsDetails4" ], "xbrltype": "domainItemType" }, "ifrs-full_LegalProceedingsProvision": { "auth_ref": [ "r180", "r181" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of provision for legal proceedings. [Refer: Other provisions]" } }, "en-us": { "role": { "label": "Legal proceedings provision", "terseLabel": "Provision for potential liability" } } }, "localname": "LegalProceedingsProvision", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LegalProceedingsProvisionMember": { "auth_ref": [ "r180", "r181" ], "lang": { "en": { "role": { "documentation": "This member stands for a provision for legal proceedings. [Refer: Other provisions [member]]" } }, "en-us": { "role": { "label": "Legal proceedings provision [member]", "verboseLabel": "Legal and others provision [Member]" } } }, "localname": "LegalProceedingsProvisionMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ProvisionsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_Level1OfFairValueHierarchyMember": { "auth_ref": [ "r115", "r266" ], "lang": { "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date." } }, "en-us": { "role": { "label": "Level 1 of fair value hierarchy [member]" } } }, "localname": "Level1OfFairValueHierarchyMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_Level2OfFairValueHierarchyMember": { "auth_ref": [ "r266" ], "lang": { "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly." } }, "en-us": { "role": { "label": "Level 2 of fair value hierarchy [member]" } } }, "localname": "Level2OfFairValueHierarchyMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_Level3OfFairValueHierarchyMember": { "auth_ref": [ "r266" ], "lang": { "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are unobservable inputs for the asset or liability. Unobservable inputs are inputs for which market data are not available and that are developed using the best information available about the assumptions that the market participants would use when pricing the asset or liability." } }, "en-us": { "role": { "label": "Level 3 of fair value hierarchy [member]" } } }, "localname": "Level3OfFairValueHierarchyMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual", "http://www.drreddys.com/role/FinancialInstrumentsDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_LevelsOfFairValueHierarchyAxis": { "auth_ref": [ "r115", "r266" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Levels of fair value hierarchy [axis]" } } }, "localname": "LevelsOfFairValueHierarchyAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual", "http://www.drreddys.com/role/FinancialInstrumentsDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_Liabilities": { "auth_ref": [ "r33", "r265", "r266", "r267", "r371", "r376" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 1.0, "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } }, "en-us": { "role": { "label": "Liabilities", "totalLabel": "Total liabilities", "verboseLabel": "Total" } } }, "localname": "Liabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition", "http://www.drreddys.com/role/FinancialRiskManagementDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "terseLabel": "Liabilities:" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_LiabilitiesArisingFromFinancingActivities": { "auth_ref": [ "r228" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of liabilities for which cash flows were, or future cash flows will be, classified in the statement of cash flows as cash flows from financing activities. [Refer: Cash flows from (used in) financing activities; Liabilities]" } }, "en-us": { "role": { "label": "Liabilities arising from financing activities", "periodEndLabel": "Closing balance", "periodStartLabel": "Opening balance" } } }, "localname": "LiabilitiesArisingFromFinancingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails5" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis": { "auth_ref": [ "r228" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Liabilities arising from financing activities [axis]" } } }, "localname": "LiabilitiesArisingFromFinancingActivitiesAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails5" ], "xbrltype": "stringItemType" }, "ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember": { "auth_ref": [ "r228" ], "lang": { "en": { "role": { "documentation": "This member stands for liabilities arising from financing activities. It also represents the standard value for the 'Liabilities arising from financing activities' axis if no other member is used. [Refer: Liabilities arising from financing activities]" } }, "en-us": { "role": { "label": "Liabilities arising from financing activities [member]" } } }, "localname": "LiabilitiesArisingFromFinancingActivitiesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails5" ], "xbrltype": "domainItemType" }, "ifrs-full_LiabilitiesIncurred": { "auth_ref": [ "r305" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The fair value, at acquisition date, of liabilities incurred (for example, a liability for contingent consideration) as consideration transferred in a business combination. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "Liabilities incurred", "verboseLabel": "Liabilities (transferred)/assumed" } } }, "localname": "LiabilitiesIncurred", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails2", "http://www.drreddys.com/role/EmployeeBenefitsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LiabilityAssetOfDefinedBenefitPlans": { "auth_ref": [ "r106" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of deficit or surplus in a defined benefit plan, adjusted for any effect of limiting a net defined benefit asset to the asset ceiling. [Refer: Defined benefit plans [member]]" } }, "en-us": { "role": { "label": "Net defined benefit liability (asset)", "positiveLabel": "Defined benefit obligation with projected salary growth" } } }, "localname": "LiabilityAssetOfDefinedBenefitPlans", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails13" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LicenceFeeIncome": { "auth_ref": [ "r13" ], "calculation": { "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails": { "order": 3.0, "parentTag": "ifrs-full_Revenue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of income arising from licence fees." } }, "en-us": { "role": { "label": "Licence fee income", "terseLabel": "Licence fee", "verboseLabel": "License fees" } } }, "localname": "LicenceFeeIncome", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LongtermBorrowings": { "auth_ref": [ "r33" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 3.0, "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The non-current portion of non-current borrowings. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Non-current portion of non-current borrowings", "terseLabel": "Long-term borrowings", "verboseLabel": "Long-term borrowings" } } }, "localname": "LongtermBorrowings", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition", "http://www.drreddys.com/role/FinancialRiskManagementDetails", "http://www.drreddys.com/role/LoansAndBorrowingsDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LongtermBorrowingsMember": { "auth_ref": [ "r227", "r233" ], "lang": { "en": { "role": { "documentation": "This member stands for long-term borrowings. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Long-term borrowings [member]" } } }, "localname": "LongtermBorrowingsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails5" ], "xbrltype": "domainItemType" }, "ifrs-full_LongtermDeposits": { "auth_ref": [ "r33" ], "calculation": { "http://www.drreddys.com/role/OtherAssetsDetails": { "order": 5.0, "parentTag": "ifrs-full_OtherNoncurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of long-term deposits held by the entity." } }, "en-us": { "role": { "label": "Long-term deposits", "verboseLabel": "Security deposits" } } }, "localname": "LongtermDeposits", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_MajorBusinessCombinationMember": { "auth_ref": [ "r71" ], "lang": { "en": { "role": { "documentation": "This member stands for major business combinations. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "Major business combination [member]" } } }, "localname": "MajorBusinessCombinationMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual" ], "xbrltype": "domainItemType" }, "ifrs-full_MajorCustomersMember": { "auth_ref": [ "r383" ], "lang": { "en": { "role": { "documentation": "This member stands for customers. It also represents the standard value for the 'Major customers' axis if no other member is used." } }, "en-us": { "role": { "label": "Customers [member]" } } }, "localname": "MajorCustomersMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetailsTextual", "http://www.drreddys.com/role/SegmentReportingDetailsTextual" ], "xbrltype": "domainItemType" }, "ifrs-full_MaturityAxis": { "auth_ref": [ "r37", "r118", "r278", "r289", "r290", "r326", "r344", "r354", "r388", "r389", "r391", "r396" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Maturity [axis]" } } }, "localname": "MaturityAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetailsTextual", "http://www.drreddys.com/role/FinancialInstrumentsDetails4", "http://www.drreddys.com/role/FinancialRiskManagementDetails1", "http://www.drreddys.com/role/FinancialRiskManagementDetails2", "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual", "http://www.drreddys.com/role/LoansAndBorrowingsDetails4", "http://www.drreddys.com/role/LoansAndBorrowingsDetailsTextual", "http://www.drreddys.com/role/OtherLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_MeasurementAxis": { "auth_ref": [ "r199", "r203", "r265" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Measurement [axis]" } } }, "localname": "MeasurementAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetailsTextual", "http://www.drreddys.com/role/EmployeeBenefitsDetails13", "http://www.drreddys.com/role/EmployeeBenefitsDetails4", "http://www.drreddys.com/role/FinancialInstrumentsDetails1", "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual", "http://www.drreddys.com/role/OtherInvestmentsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_MiscellaneousCurrentAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Miscellaneous current assets [abstract]", "terseLabel": "Current" } } }, "localname": "MiscellaneousCurrentAssetsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherAssetsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_MiscellaneousCurrentLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Miscellaneous current liabilities [abstract]", "verboseLabel": "Current" } } }, "localname": "MiscellaneousCurrentLiabilitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_MiscellaneousLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Miscellaneous liabilities [abstract]" } } }, "localname": "MiscellaneousLiabilitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_MiscellaneousNoncurrentAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Miscellaneous non-current assets [abstract]", "terseLabel": "Non-current" } } }, "localname": "MiscellaneousNoncurrentAssetsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherAssetsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_MiscellaneousNoncurrentLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Miscellaneous non-current liabilities [abstract]", "verboseLabel": "Non-current" } } }, "localname": "MiscellaneousNoncurrentLiabilitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_MiscellaneousOtherOperatingIncome": { "auth_ref": [ "r13" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of miscellaneous other operating income. [Refer: Other operating income (expense)]" } }, "en-us": { "role": { "label": "Miscellaneous other operating income", "terseLabel": "Miscellaneous income, net", "verboseLabel": "Miscellaneous income, net" } } }, "localname": "MiscellaneousOtherOperatingIncome", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinanceIncomeNetDetails", "http://www.drreddys.com/role/OtherIncomeNetDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NetDeferredTaxAssets": { "auth_ref": [ "r80" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of deferred tax assets net of deferred tax liabilities, when the absolute amount of deferred tax assets is greater than the absolute amount of deferred tax liabilities. [Refer: Deferred tax assets; Deferred tax liabilities]" } }, "en-us": { "role": { "label": "Net deferred tax assets", "periodEndLabel": "Balance, at the end", "periodStartLabel": "Balance, at the beginning" } } }, "localname": "NetDeferredTaxAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails5" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NetDefinedBenefitLiabilityAssetAxis": { "auth_ref": [ "r106" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Net defined benefit liability (asset) [axis]" } } }, "localname": "NetDefinedBenefitLiabilityAssetAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails11", "http://www.drreddys.com/role/EmployeeBenefitsDetails12", "http://www.drreddys.com/role/EmployeeBenefitsDetails16", "http://www.drreddys.com/role/EmployeeBenefitsDetails2", "http://www.drreddys.com/role/EmployeeBenefitsDetails3", "http://www.drreddys.com/role/EmployeeBenefitsDetails7", "http://www.drreddys.com/role/EmployeeBenefitsDetails8", "http://www.drreddys.com/role/EmployeeBenefitsDetailsTextual", "http://www.drreddys.com/role/EmployeeBenefitsTables" ], "xbrltype": "stringItemType" }, "ifrs-full_NetDefinedBenefitLiabilityAssetMember": { "auth_ref": [ "r106" ], "lang": { "en": { "role": { "documentation": "This member stands for the net defined benefit liability (asset). It also represents the standard value for the 'Net defined benefit liability (asset)' axis if no other member is used. [Refer: Net defined benefit liability (asset)]" } }, "en-us": { "role": { "label": "Net defined benefit liability (asset) [member]" } } }, "localname": "NetDefinedBenefitLiabilityAssetMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails11", "http://www.drreddys.com/role/EmployeeBenefitsDetails12", "http://www.drreddys.com/role/EmployeeBenefitsDetails16", "http://www.drreddys.com/role/EmployeeBenefitsDetails2", "http://www.drreddys.com/role/EmployeeBenefitsDetails3", "http://www.drreddys.com/role/EmployeeBenefitsDetails7", "http://www.drreddys.com/role/EmployeeBenefitsDetails8", "http://www.drreddys.com/role/EmployeeBenefitsDetailsTextual", "http://www.drreddys.com/role/EmployeeBenefitsTables" ], "xbrltype": "domainItemType" }, "ifrs-full_NetForeignExchangeGain": { "auth_ref": [ "r20", "r131" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The net gain arising from exchange differences recognised in profit or loss, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: Foreign exchange gain (loss)]" } }, "en-us": { "role": { "label": "Net foreign exchange gain", "verboseLabel": "Foreign exchange gain" } } }, "localname": "NetForeignExchangeGain", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinanceIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NewProvisionsOtherProvisions": { "auth_ref": [ "r176" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount recognised for new other provisions. [Refer: Other provisions]" } }, "en-us": { "role": { "label": "New provisions, other provisions", "terseLabel": "Current provisions relating to sales during the year" } } }, "localname": "NewProvisionsOtherProvisions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails6" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NominalAmountOfHedgingInstrument": { "auth_ref": [ "r326", "r327" ], "lang": { "en": { "role": { "documentation": "The nominal amount of a hedging instrument. [Refer: Hedging instruments [member]]" } }, "en-us": { "role": { "label": "Nominal amount of hedging instrument" } } }, "localname": "NominalAmountOfHedgingInstrument", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetailsTextual" ], "xbrltype": "decimalItemType" }, "ifrs-full_NonadjustingEventsAfterReportingPeriodAxis": { "auth_ref": [ "r70" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Non-adjusting events after reporting period [axis]" } } }, "localname": "NonadjustingEventsAfterReportingPeriodAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual", "http://www.drreddys.com/role/ContingenciesDetailsTextual", "http://www.drreddys.com/role/MergerOfDrReddySHoldingsLimitedIntoDrReddySLaboratoriesLimitedDetailsTextual", "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "stringItemType" }, "ifrs-full_NonadjustingEventsMember": { "auth_ref": [ "r70" ], "lang": { "en": { "role": { "documentation": "This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used." } }, "en-us": { "role": { "label": "Non-adjusting events after reporting period [member]" } } }, "localname": "NonadjustingEventsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual", "http://www.drreddys.com/role/ContingenciesDetailsTextual", "http://www.drreddys.com/role/MergerOfDrReddySHoldingsLimitedIntoDrReddySLaboratoriesLimitedDetailsTextual", "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "domainItemType" }, "ifrs-full_NoncurrentAssets": { "auth_ref": [ "r38", "r248", "r250" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 26.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]" } }, "en-us": { "role": { "label": "Long-Lived Assets", "totalLabel": "Total non-current assets", "verboseLabel": "Total non-current assets" } } }, "localname": "NoncurrentAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-current assets [abstract]", "verboseLabel": "Non-current assets" } } }, "localname": "NoncurrentAssetsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners": { "auth_ref": [ "r28" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 44.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of non-current assets or disposal groups classified as held for sale or as held for distribution to owners. [Refer: Non-current assets or disposal groups classified as held for distribution to owners; Non-current assets or disposal groups classified as held for sale]" } }, "en-us": { "role": { "label": "Non-current assets or disposal groups classified as held for sale or as held for distribution to owners", "verboseLabel": "Assets held for sale" } } }, "localname": "NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts": { "auth_ref": [ "r381" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of non-current assets other than financial instruments, deferred tax assets, post-employment benefit assets and rights arising under insurance contracts. [Refer: Deferred tax assets; Financial instruments, class [member]; Non-current assets; Types of insurance contracts [member]]" } }, "en-us": { "role": { "label": "Non-current assets other than financial instruments, deferred tax assets, post-employment benefit assets, and rights arising under insurance contracts" } } }, "localname": "NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SegmentReportingDetails5" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentDeferredIncomeOtherThanNoncurrentContractLiabilities": { "auth_ref": [ "r33", "r47" ], "calculation": { "http://www.drreddys.com/role/OtherLiabilitiesDetails": { "order": 8.0, "parentTag": "ifrs-full_OtherNoncurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of non-current deferred income other than non-current contract liabilities. [Refer: Deferred income other than contract liabilities]" } }, "en-us": { "role": { "label": "Non-current deferred income other than non-current contract liabilities", "terseLabel": "Non-current", "verboseLabel": "Deferred revenue" } } }, "localname": "NoncurrentDeferredIncomeOtherThanNoncurrentContractLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherLiabilitiesDetails", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails5" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod": { "auth_ref": [ "r33" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 32.0, "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of non-current investments other than investments accounted for using the equity method. [Refer: Investments accounted for using equity method; Non-current assets; Investments other than investments accounted for using equity method]" } }, "en-us": { "role": { "label": "Non-current investments other than investments accounted for using equity method", "presentationGuidance": "Non-current portion", "verboseLabel": "Other investments" } } }, "localname": "NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition", "http://www.drreddys.com/role/OtherInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentLeaseLiabilities": { "auth_ref": [ "r281" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]" } }, "en-us": { "role": { "label": "Non-current lease liabilities" } } }, "localname": "NoncurrentLeaseLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentLiabilities": { "auth_ref": [ "r40", "r248", "r252" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 2.0, "parentTag": "ifrs-full_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]" } }, "en-us": { "role": { "label": "Non-current liabilities", "totalLabel": "Total non-current liabilities" } } }, "localname": "NoncurrentLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-current liabilities [abstract]", "verboseLabel": "Non-current liabilities" } } }, "localname": "NoncurrentLiabilitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "definitionGuidance": "Non-current portion", "label": "Non-current portion of non-current borrowings, by type [abstract]" } } }, "localname": "NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails2" ], "xbrltype": "stringItemType" }, "ifrs-full_NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued": { "auth_ref": [ "r13" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The non-current portion of non-current notes and debentures issued. [Refer: Notes and debentures issued]" } }, "en-us": { "role": { "label": "Non-current portion of non-current notes and debentures issued", "terseLabel": "Non current debentures issued" } } }, "localname": "NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentReceivables": { "auth_ref": [ "r26", "r43" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 30.0, "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of non-current trade receivables and non-current other receivables. [Refer: Non-current trade receivables; Other non-current receivables]" } }, "en-us": { "role": { "label": "Trade and other non-current receivables", "verboseLabel": "Trade and other receivables" } } }, "localname": "NoncurrentReceivables", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentRefundsProvision": { "auth_ref": [ "r180", "r182" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of non-current provision for refunds. [Refer: Refunds provision]" } }, "en-us": { "role": { "label": "Non-current refunds provision", "terseLabel": "Non-current" } } }, "localname": "NoncurrentRefundsProvision", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails7" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentTradeReceivables": { "auth_ref": [ "r43" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of non-current trade receivables. [Refer: Trade receivables]" } }, "en-us": { "role": { "label": "Non-current trade receivables", "terseLabel": "Non-current trade and other receivables, net" } } }, "localname": "NoncurrentTradeReceivables", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/TradeAndOtherReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NotLaterThanOneMonthMember": { "auth_ref": [ "r352", "r357", "r364" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of not later than one month." } }, "en-us": { "role": { "label": "Not later than one month [member]" } } }, "localname": "NotLaterThanOneMonthMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails4" ], "xbrltype": "domainItemType" }, "ifrs-full_NotLaterThanOneYearMember": { "auth_ref": [ "r35", "r289", "r290", "r354", "r364", "r396" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of not later than one year." } }, "en-us": { "role": { "label": "Not later than one year [member]", "verboseLabel": "Less than 1 year" } } }, "localname": "NotLaterThanOneYearMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetails1", "http://www.drreddys.com/role/FinancialRiskManagementDetails2", "http://www.drreddys.com/role/LoansAndBorrowingsDetails4" ], "xbrltype": "domainItemType" }, "ifrs-full_NotionalAmount": { "auth_ref": [ "r13" ], "lang": { "en": { "role": { "documentation": "The nominal or face amount of a financial instrument, used to calculate payments made on that instrument." } }, "en-us": { "role": { "label": "Notional amount" } } }, "localname": "NotionalAmount", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NumberOfEmployees": { "auth_ref": [ "r13" ], "lang": { "en": { "role": { "documentation": "The number of personnel employed by the entity at a date." } }, "en-us": { "role": { "label": "Number of employees", "terseLabel": "Number of employees engaged in operations of the acquired Business Undertaking" } } }, "localname": "NumberOfEmployees", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfOutstandingShareOptions": { "auth_ref": [ "r292", "r296", "r299" ], "lang": { "en": { "role": { "documentation": "The number of share options outstanding in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of share options outstanding in share-based payment arrangement", "periodEndLabel": "Shares arising out of options, Outstanding at the end of the year", "periodStartLabel": "Shares arising out of options, Outstanding at the beginning of the year" } } }, "localname": "NumberOfOutstandingShareOptions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails1", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails2", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails4" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement": { "auth_ref": [ "r297" ], "lang": { "en": { "role": { "documentation": "The number of share options exercisable in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of share options exercisable in share-based payment arrangement", "terseLabel": "Shares arising out of options, Exercisable at the end of the year", "verboseLabel": "Shares arising out of options, Exercisable at the end of the year" } } }, "localname": "NumberOfShareOptionsExercisableInSharebasedPaymentArrangement", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails1", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails2", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails4" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement": { "auth_ref": [ "r294" ], "lang": { "en": { "role": { "documentation": "The number of share options exercised in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of share options exercised in share-based payment arrangement", "negatedLabel": "Shares arising out of options, Exercised during the year", "negatedTerseLabel": "Shares arising out of options, Exercised during the year", "terseLabel": "Number of share options exercised" } } }, "localname": "NumberOfShareOptionsExercisedInSharebasedPaymentArrangement", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails1", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails2", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails4", "http://www.drreddys.com/role/ShareCapitalDetailsTextual" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement": { "auth_ref": [ "r293" ], "lang": { "en": { "role": { "documentation": "The number of share options granted in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of share options granted in share-based payment arrangement", "terseLabel": "Shares arising out of options, Granted during the year", "verboseLabel": "Shares arising out of options, Granted during the year" } } }, "localname": "NumberOfShareOptionsGrantedInSharebasedPaymentArrangement", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails1", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails2", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails4" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfSharesAuthorised": { "auth_ref": [ "r48" ], "lang": { "en": { "role": { "documentation": "The number of shares authorised." } }, "en-us": { "role": { "label": "Number of shares authorised", "verboseLabel": "Authorized share capital" } } }, "localname": "NumberOfSharesAuthorised", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ShareCapitalDetails" ], "xbrltype": "sharesItemType" }, "ifrs-full_NumberOfSharesIssued": { "auth_ref": [ "r9" ], "lang": { "en": { "role": { "documentation": "The number of shares issued by the entity." } }, "en-us": { "role": { "label": "Number of shares issued", "terseLabel": "Number of equity shares allocated to employees" } } }, "localname": "NumberOfSharesIssued", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetails", "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "sharesItemType" }, "ifrs-full_NumberOfSharesIssuedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of shares issued [abstract]", "terseLabel": "Fully Paid Up Share Capital" } } }, "localname": "NumberOfSharesIssuedAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ShareCapitalDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_NumberOfSharesIssuedAndFullyPaid": { "auth_ref": [ "r49" ], "lang": { "en": { "role": { "documentation": "The number of shares issued by the entity, for which full payment has been received." } }, "en-us": { "role": { "label": "Number of shares issued and fully paid", "periodEndLabel": "Closing number of equity shares/share capital", "periodStartLabel": "Opening number of equity shares/share capital" } } }, "localname": "NumberOfSharesIssuedAndFullyPaid", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ShareCapitalDetails" ], "xbrltype": "sharesItemType" }, "ifrs-full_NumberOfSharesOutstanding": { "auth_ref": [ "r51" ], "lang": { "en": { "role": { "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]" } }, "en-us": { "role": { "label": "Number of shares outstanding", "terseLabel": "Number of equity shares at the beginning of the year (excluding treasury shares)" } } }, "localname": "NumberOfSharesOutstanding", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "ifrs-full_OfficeEquipmentMember": { "auth_ref": [ "r86" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing equipment used to support office functions, not specifically used in the production process. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Office Equipment [Member]", "verboseLabel": "Furniture, fixtures and office equipment [member]" } } }, "localname": "OfficeEquipmentMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_OperatingExpense": { "auth_ref": [ "r61" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedIncomeStatements": { "order": 10.0, "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of all operating expenses." } }, "en-us": { "role": { "label": "Operating expense", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedIncomeStatements" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OrdinarySharesMember": { "auth_ref": [ "r53", "r157" ], "lang": { "en": { "role": { "documentation": "This member stands for equity instruments that are subordinate to all other classes of equity instruments. It also represents the standard value for the 'Classes of ordinary shares' axis if no other member is used." } }, "en-us": { "role": { "label": "Ordinary shares [member]" } } }, "localname": "OrdinarySharesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails1", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails2", "http://www.drreddys.com/role/EmployeeStockIncentivePlansTables", "http://www.drreddys.com/role/ShareCapitalDetails", "http://www.drreddys.com/role/ShareCapitalDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_OtherAssets": { "auth_ref": [ "r33" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of assets that the entity does not separately disclose in the same statement or note." } }, "en-us": { "role": { "label": "Other Assets", "verboseLabel": "Other assets" } } }, "localname": "OtherAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherComprehensiveIncome": { "auth_ref": [ "r7", "r55", "r63", "r255" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 1.0, "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]" } }, "en-us": { "role": { "label": "Other comprehensive income", "totalLabel": "Other comprehensive (loss)/income for the year, net of tax" } } }, "localname": "OtherComprehensiveIncome", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other comprehensive income [abstract]", "verboseLabel": "Other comprehensive income/(loss)" } } }, "localname": "OtherComprehensiveIncomeAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "stringItemType" }, "ifrs-full_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans": { "auth_ref": [ "r41", "r64", "r102" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 3.0, "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of other comprehensive income, before tax, related to gains (losses) on remeasurements of defined benefit plans, which comprise actuarial gains and losses; the return on plan assets, excluding amounts included in net interest on the net defined benefit liability (asset); and any change in the effect of the asset ceiling, excluding amounts included in net interest on the net defined benefit liability (asset). [Refer: Other comprehensive income; Defined benefit plans [member]; Plan assets [member]; Net defined benefit liability (asset)] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income]" } }, "en-us": { "role": { "label": "Other comprehensive income, before tax, gains (losses) on remeasurements of defined benefit plans", "verboseLabel": "Actuarial (losses)/gains on post-employment benefit obligations" } } }, "localname": "OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherComprehensiveIncomeNetOfTaxCashFlowHedges": { "auth_ref": [ "r41", "r63" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of other comprehensive income, net of tax, after reclassification adjustments, related to cash flow hedges. [Refer: Cash flow hedges [member]; Other comprehensive income]" } }, "en-us": { "role": { "label": "Other comprehensive income, net of tax, cash flow hedges" } } }, "localname": "OtherComprehensiveIncomeNetOfTaxCashFlowHedges", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherComprehensiveIncomeNetOfTaxFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome": { "auth_ref": [ "r41", "r63" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 7.0, "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of other comprehensive income, net of tax, after reclassification adjustments, related to financial assets measured at fair value through other comprehensive income applying paragraph 4.1.2A of IFRS 9. [Refer: Financial assets measured at fair value through other comprehensive income; Other comprehensive income]" } }, "en-us": { "role": { "label": "Other comprehensive income, net of tax, financial assets measured at fair value through other comprehensive income", "verboseLabel": "Changes in fair value of financial instruments" } } }, "localname": "OtherComprehensiveIncomeNetOfTaxFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments": { "auth_ref": [ "r41", "r63" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 5.0, "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of other comprehensive income, net of tax, related to gains (losses) from changes in the fair value of investments in equity instruments that the entity has designated at fair value through other comprehensive income applying paragraph 5.7.5 of IFRS 9. [Refer: Other comprehensive income]" } }, "en-us": { "role": { "label": "Other comprehensive income, net of tax, gains (losses) from investments in equity instruments", "terseLabel": "Changes in the fair value of financial instruments" } } }, "localname": "OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans": { "auth_ref": [ "r41", "r63", "r102" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of other comprehensive income, net of tax, related to gains (losses) on remeasurements of defined benefit plans, which comprise actuarial gains and losses; the return on plan assets, excluding amounts included in net interest on the net defined benefit liability (asset); and any change in the effect of the asset ceiling, excluding amounts included in net interest on the net defined benefit liability (asset). [Refer: Other comprehensive income; Defined benefit plans [member]; Plan assets [member]; Net defined benefit liability (asset)] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income]" } }, "en-us": { "role": { "label": "Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans", "verboseLabel": "Actuarial loss on post-employment benefit obligations, net of tax (expense)/benefit" } } }, "localname": "OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax": { "auth_ref": [ "r60", "r68" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 6.0, "parentTag": "ifrs-full_OtherComprehensiveIncome", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of other comprehensive income that will be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]" } }, "en-us": { "role": { "label": "Other comprehensive income that will be reclassified to profit or loss, net of tax", "totalLabel": "Total of items that will be reclassified subsequently to the consolidated income statement" } } }, "localname": "OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax": { "auth_ref": [ "r60", "r68" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 2.0, "parentTag": "ifrs-full_OtherComprehensiveIncome", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of other comprehensive income that will not be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]" } }, "en-us": { "role": { "label": "Other comprehensive income that will not be reclassified to profit or loss, net of tax", "totalLabel": "Total of items that will not be reclassified to the consolidated income statement" } } }, "localname": "OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherCurrentAssets": { "auth_ref": [ "r33" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 43.0, "parentTag": "ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners", "weight": 1.0 }, "http://www.drreddys.com/role/OtherAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current assets that the entity does not separately disclose in the same statement or note. [Refer: Current assets]" } }, "en-us": { "role": { "label": "Other current assets", "totalLabel": "Other Assets" } } }, "localname": "OtherCurrentAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition", "http://www.drreddys.com/role/OtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherCurrentLiabilities": { "auth_ref": [ "r33" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 15.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 }, "http://www.drreddys.com/role/OtherLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Current liabilities]" } }, "en-us": { "role": { "label": "Other current liabilities", "terseLabel": "Other current liabilities", "totalLabel": "Current liabilities" } } }, "localname": "OtherCurrentLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition", "http://www.drreddys.com/role/OtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherEnvironmentRelatedProvisionMember": { "auth_ref": [ "r178" ], "lang": { "en": { "role": { "documentation": "This member stands for an environment-related provision that the entity does not separately disclose in the same statement or note. [Refer: Other provisions [member]]" } }, "en-us": { "role": { "label": "Other environment related provision [member]", "terseLabel": "Environmental liability provisions [Member]" } } }, "localname": "OtherEnvironmentRelatedProvisionMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ProvisionsDetails", "http://www.drreddys.com/role/ProvisionsDetailsTextual" ], "xbrltype": "domainItemType" }, "ifrs-full_OtherExpenseByFunction": { "auth_ref": [ "r2", "r67", "r147" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expenses that the entity does not separately disclose in the same statement or note when the entity uses the 'function of expense' form for its analysis of expenses." } }, "en-us": { "role": { "label": "Other expense, by function", "terseLabel": "Expenses" } } }, "localname": "OtherExpenseByFunction", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherFinancialAssets": { "auth_ref": [ "r23" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of financial assets that the entity does not separately disclose in the same statement or note. [Refer: Financial assets]" } }, "en-us": { "role": { "label": "Other financial assets", "verboseLabel": "Other assets" } } }, "localname": "OtherFinancialAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherFinancialLiabilities": { "auth_ref": [ "r30" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Financial liabilities]" } }, "en-us": { "role": { "label": "Other financial liabilities", "verboseLabel": "Other liabilities and provisions" } } }, "localname": "OtherFinancialLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherIntangibleAssetsMember": { "auth_ref": [ "r194" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of intangible assets that the entity does not separately disclose in the same statement or note. [Refer: Intangible assets other than goodwill]" } }, "en-us": { "role": { "definitionGuidance": "Others [Member]", "label": "Other Intangible Assets [Member]", "verboseLabel": "Other intangibles [Member]" } } }, "localname": "OtherIntangibleAssetsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetails", "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual", "http://www.drreddys.com/role/SignificantAccountingPoliciesDetails2" ], "xbrltype": "domainItemType" }, "ifrs-full_OtherLiabilities": { "auth_ref": [ "r33" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of liabilities that the entity does not separately disclose in the same statement or note." } }, "en-us": { "role": { "label": "Other Liabilities", "terseLabel": "Other liabilities and provisions" } } }, "localname": "OtherLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetails", "http://www.drreddys.com/role/FinancialRiskManagementDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherLongtermProvisions": { "auth_ref": [ "r45" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 5.0, "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of non-current provisions other than provisions for employee benefits. [Refer: Non-current provisions]" } }, "en-us": { "role": { "label": "Other non-current provisions", "periodEndLabel": "Non-current", "verboseLabel": "Provisions" } } }, "localname": "OtherLongtermProvisions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition", "http://www.drreddys.com/role/ProvisionsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherNoncurrentAssets": { "auth_ref": [ "r33" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 34.0, "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0 }, "http://www.drreddys.com/role/OtherAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]" } }, "en-us": { "role": { "label": "Other non-current assets", "totalLabel": "Other non-current assets", "verboseLabel": "Other non-current assets" } } }, "localname": "OtherNoncurrentAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition", "http://www.drreddys.com/role/OtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherNoncurrentLiabilities": { "auth_ref": [ "r33" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 6.0, "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0 }, "http://www.drreddys.com/role/OtherLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of non-current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Non-current liabilities]" } }, "en-us": { "role": { "label": "Other non-current liabilities", "totalLabel": "Non-current liabilities", "verboseLabel": "Other non-current liabilities" } } }, "localname": "OtherNoncurrentLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition", "http://www.drreddys.com/role/OtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherNonfinancialAssets": { "auth_ref": [ "r33" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of non-financial assets that the entity does not separately disclose in the same statement or note. [Refer: Financial assets]" } }, "en-us": { "role": { "label": "Other non-financial assets" } } }, "localname": "OtherNonfinancialAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherNonfinancialLiabilities": { "auth_ref": [ "r33" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of non-financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities]" } }, "en-us": { "role": { "label": "Other non-financial liabilities" } } }, "localname": "OtherNonfinancialLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherOperatingIncomeExpense": { "auth_ref": [ "r61" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedIncomeStatements": { "order": 13.0, "parentTag": "ifrs-full_OperatingExpense", "weight": -1.0 }, "http://www.drreddys.com/role/OtherIncomeNetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of operating income (expense) that the entity does not separately disclose in the same statement or note." } }, "en-us": { "role": { "label": "Other operating income (expense)", "negatedLabel": "Other income, net", "negatedTotalLabel": "Other (income)/expense, net" } } }, "localname": "OtherOperatingIncomeExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedIncomeStatements", "http://www.drreddys.com/role/OtherIncomeNetDetails", "http://www.drreddys.com/role/SegmentReportingDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherPayables": { "auth_ref": [ "r33" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "Amounts payable that the entity does not separately disclose in the same statement or note." } }, "en-us": { "role": { "label": "Other payables", "verboseLabel": "Due to creditors for expenses" } } }, "localname": "OtherPayables", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/TradeAndOtherPayablesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherProvisions": { "auth_ref": [ "r45", "r175" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of provisions other than provisions for employee benefits. [Refer: Provisions]" } }, "en-us": { "role": { "definitionGuidance": "Carrying value", "label": "Other provisions", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance" } } }, "localname": "OtherProvisions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual", "http://www.drreddys.com/role/ProvisionsDetails", "http://www.drreddys.com/role/ProvisionsDetailsTextual", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails6" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherProvisionsMember": { "auth_ref": [ "r178" ], "lang": { "en": { "role": { "documentation": "This member stands for provisions other than provisions for employee benefits. It also represents the standard value for the 'Classes of other provisions' axis if no other member is used. [Refer: Provisions]" } }, "en-us": { "role": { "label": "Other provisions [member]" } } }, "localname": "OtherProvisionsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual", "http://www.drreddys.com/role/ProvisionsDetails", "http://www.drreddys.com/role/ProvisionsDetailsTextual" ], "xbrltype": "domainItemType" }, "ifrs-full_OtherRelatedPartiesMember": { "auth_ref": [ "r140" ], "lang": { "en": { "role": { "documentation": "This member stands for related parties that the entity does not separately disclose in the same statement or note. [Refer: Related parties [member]]" } }, "en-us": { "role": { "label": "Other related parties [member]", "verboseLabel": "Other related parties" } } }, "localname": "OtherRelatedPartiesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/RelatedPartiesDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_OtherReserves": { "auth_ref": [ "r46" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 25.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "A component of equity representing reserves within equity, not including retained earnings. [Refer: Retained earnings]" } }, "en-us": { "role": { "label": "Other reserves", "verboseLabel": "Other components of equity" } } }, "localname": "OtherReserves", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherShorttermProvisions": { "auth_ref": [ "r45" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 11.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current provisions other than provisions for employee benefits. [Refer: Provisions]" } }, "en-us": { "role": { "label": "Other current provisions", "periodEndLabel": "Current", "verboseLabel": "Provisions" } } }, "localname": "OtherShorttermProvisions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition", "http://www.drreddys.com/role/ProvisionsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome": { "auth_ref": [ "r77" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that the entity does not separately disclose in the same statement or note. [Refer: Accounting profit; Applicable tax rate]" } }, "en-us": { "role": { "label": "Other tax effects for reconciliation between accounting profit and tax expense (income)", "terseLabel": "Others" } } }, "localname": "OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherTemporaryDifferencesMember": { "auth_ref": [ "r82" ], "lang": { "en": { "role": { "documentation": "This member stands for temporary differences that the entity does not separately disclose in the same statement or note. [Refer: Temporary differences [member]]" } }, "en-us": { "role": { "label": "Other temporary differences [member]", "verboseLabel": "Others [Member]" } } }, "localname": "OtherTemporaryDifferencesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails4" ], "xbrltype": "domainItemType" }, "ifrs-full_OutstandingBalancesForRelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Outstanding balances for related party transactions [abstract]" } } }, "localname": "OutstandingBalancesForRelatedPartyTransactionsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_ParValuePerShare": { "auth_ref": [ "r50" ], "lang": { "en": { "role": { "documentation": "The nominal value per share." } }, "en-us": { "role": { "label": "Par value per share", "terseLabel": "Face value per share" } } }, "localname": "ParValuePerShare", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EarningsPerShareDetailsTextual", "http://www.drreddys.com/role/MergerOfDrReddySHoldingsLimitedIntoDrReddySLaboratoriesLimitedDetailsTextual", "http://www.drreddys.com/role/ShareCapitalDetailsTextual" ], "xbrltype": "perShareItemType" }, "ifrs-full_PayablesForPurchaseOfNoncurrentAssets": { "auth_ref": [ "r47" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of payables for the purchase of non-current assets. [Refer: Non-current assets]" } }, "en-us": { "role": { "label": "Payables for purchase of non-current assets", "verboseLabel": "Due to capital creditors" } } }, "localname": "PayablesForPurchaseOfNoncurrentAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/TradeAndOtherPayablesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset": { "auth_ref": [ "r114" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The decrease (increase) in the net defined benefit liability (asset) resulting from payments from the plan. [Refer: Net defined benefit liability (asset)]" } }, "en-us": { "role": { "label": "Decrease (increase) in net defined benefit liability (asset) resulting from payments from plan", "negatedLabel": "Benefits paid" } } }, "localname": "PaymentsFromPlanNetDefinedBenefitLiabilityAsset", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails11", "http://www.drreddys.com/role/EmployeeBenefitsDetails12", "http://www.drreddys.com/role/EmployeeBenefitsDetails2", "http://www.drreddys.com/role/EmployeeBenefitsDetails3" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PaymentsToAcquireOrRedeemEntitysShares": { "auth_ref": [ "r211" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 35.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow to acquire or redeem entity's shares." } }, "en-us": { "role": { "label": "Payments to acquire or redeem entity's shares", "negatedLabel": "Purchase of treasury shares" } } }, "localname": "PaymentsToAcquireOrRedeemEntitysShares", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PercentageOfEntitysRevenue": { "auth_ref": [ "r383" ], "lang": { "en": { "role": { "documentation": "The percentage of the entity's revenue. [Refer: Revenue]" } }, "en-us": { "role": { "label": "Percentage of entity's revenue" } } }, "localname": "PercentageOfEntitysRevenue", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetailsTextual", "http://www.drreddys.com/role/SegmentReportingDetailsTextual" ], "xbrltype": "percentItemType" }, "ifrs-full_PercentageOfVotingEquityInterestsAcquired": { "auth_ref": [ "r303" ], "lang": { "en": { "role": { "documentation": "The percentage of voting equity interests acquired in a business combination. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "Percentage of voting equity interests acquired", "terseLabel": "Business combination percentage of voting equity interests acquired" } } }, "localname": "PercentageOfVotingEquityInterestsAcquired", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual" ], "xbrltype": "percentItemType" }, "ifrs-full_PlanAssetsAtFairValue": { "auth_ref": [ "r121" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The fair value of defined benefit plan assets. Plan assets comprise assets held by a long-term employee benefit fund and qualifying insurance policies. [Refer: At fair value [member]]" } }, "en-us": { "role": { "label": "Plan assets, at fair value", "negatedLabel": "Fair value of plan assets", "negatedTerseLabel": "Fair value of plan assets", "periodEndLabel": "Plan assets at the end of the year", "periodStartLabel": "Fair value of plan assets at the beginning of the year" } } }, "localname": "PlanAssetsAtFairValue", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails1", "http://www.drreddys.com/role/EmployeeBenefitsDetails10", "http://www.drreddys.com/role/EmployeeBenefitsDetails12", "http://www.drreddys.com/role/EmployeeBenefitsDetails3" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans": { "auth_ref": [ "r102", "r119" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of post-employment benefit expense included in profit or loss relating to defined benefit plans. [Refer: Profit (loss); Defined benefit plans [member]] [Contrast: Increase (decrease) in net defined benefit liability (asset) resulting from expense (income) in profit or loss]" } }, "en-us": { "role": { "label": "Post-employment benefit expense, defined benefit plans", "terseLabel": "Total cost recognized in income statement", "verboseLabel": "Gratuity cost recognized in income statement" } } }, "localname": "PostemploymentBenefitExpenseDefinedBenefitPlans", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails", "http://www.drreddys.com/role/EmployeeBenefitsDetails9" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans": { "auth_ref": [ "r120" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of post-employment benefit expense relating to defined contribution plans. Defined contribution plans are post-employment benefit plans under which an entity pays fixed contributions into a separate entity (a fund) and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient assets to pay all employee benefits relating to employee service in the current and prior periods." } }, "en-us": { "role": { "label": "Post-employment benefit expense, defined contribution plans" } } }, "localname": "PostemploymentBenefitExpenseDefinedContributionPlans", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities": { "auth_ref": [ "r212" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow from borrowings obtained. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Proceeds from borrowings, classified as financing activities", "verboseLabel": "Borrowings made during the year" } } }, "localname": "ProceedsFromBorrowingsClassifiedAsFinancingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails5" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProceedsFromCurrentBorrowings": { "auth_ref": [ "r214" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 31.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow from current borrowings obtained. [Refer: Current borrowings]" } }, "en-us": { "role": { "label": "Proceeds from current borrowings", "verboseLabel": "Proceeds from short-term borrowings, net (Refer to Note 17)" } } }, "localname": "ProceedsFromCurrentBorrowings", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProceedsFromExerciseOfOptions": { "auth_ref": [ "r214" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 36.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow from the exercise of options." } }, "en-us": { "role": { "label": "Proceeds from exercise of options", "verboseLabel": "Proceeds from issuance of equity shares (including treasury shares)" } } }, "localname": "ProceedsFromExerciseOfOptions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProceedsFromNoncurrentBorrowings": { "auth_ref": [ "r214" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 37.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow from non-current borrowings obtained. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Proceeds from non-current borrowings", "verboseLabel": "Proceeds from long-term borrowings (Refer to Note 17)" } } }, "localname": "ProceedsFromNoncurrentBorrowings", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities": { "auth_ref": [ "r209" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 27.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow from sales of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Proceeds from sales of intangible assets, classified as investing activities", "verboseLabel": "Proceeds from sale of other intangible assets" } } }, "localname": "ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod": { "auth_ref": [ "r210" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 25.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow from sales of investments other than investments accounted for using the equity method. [Refer: Investments accounted for using equity method; Investments other than investments accounted for using equity method]" } }, "en-us": { "role": { "label": "Proceeds from sales of investments other than investments accounted for using equity method", "verboseLabel": "Proceeds from sale of other investments" } } }, "localname": "ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "auth_ref": [ "r209" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 22.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow from sales of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Proceeds from sales of property, plant and equipment, classified as investing activities", "verboseLabel": "Proceeds from sale of property, plant and equipment" } } }, "localname": "ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProductsAndServicesAxis": { "auth_ref": [ "r279", "r379" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Products and services [axis]" } } }, "localname": "ProductsAndServicesAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails2", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails3", "http://www.drreddys.com/role/SegmentReportingDetails2", "http://www.drreddys.com/role/SegmentReportingDetails3" ], "xbrltype": "stringItemType" }, "ifrs-full_ProductsAndServicesMember": { "auth_ref": [ "r279", "r379" ], "lang": { "en": { "role": { "documentation": "This member stands for the entity's products and services. It also represents the standard value for the 'Products and services' axis if no other member is used." } }, "en-us": { "role": { "label": "Products and services [member]" } } }, "localname": "ProductsAndServicesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails2", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails3", "http://www.drreddys.com/role/SegmentReportingDetails2", "http://www.drreddys.com/role/SegmentReportingDetails3" ], "xbrltype": "domainItemType" }, "ifrs-full_ProfitLoss": { "auth_ref": [ "r6", "r54", "r215", "r238", "r241", "r248", "r371", "r374", "r390", "r402" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedIncomeStatements": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0 }, "http://www.drreddys.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 11.0, "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]" } }, "en-us": { "role": { "label": "Profit (loss)", "terseLabel": "Profit for the year", "totalLabel": "Profit for the year", "verboseLabel": "Profit for the year" } } }, "localname": "ProfitLoss", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedIncomeStatements", "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows", "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity", "http://www.drreddys.com/role/ConsolidatedStatementsOfComprehensiveIncome", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails1", "http://www.drreddys.com/role/SegmentReportingDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProfitLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Profit (loss) [abstract]" } } }, "localname": "ProfitLossAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity": { "auth_ref": [ "r159" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The profit (loss) attributable to ordinary equity holders of the parent entity. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Profit (loss), attributable to ordinary equity holders of parent entity" } } }, "localname": "ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EarningsPerShareDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProfitLossBeforeTax": { "auth_ref": [ "r1", "r2", "r322", "r371", "r374" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedIncomeStatements": { "order": 1.0, "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The profit (loss) before tax expense or income. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Profit (loss) before tax", "terseLabel": "Profit before income taxes", "totalLabel": "Profit before tax [(A)+(B)+(C)]", "verboseLabel": "Profit before tax" } } }, "localname": "ProfitLossBeforeTax", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedIncomeStatements", "http://www.drreddys.com/role/IncomeTaxesDetails2", "http://www.drreddys.com/role/SegmentReportingDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProfitLossFromOperatingActivities": { "auth_ref": [ "r61", "r156" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedIncomeStatements": { "order": 6.0, "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Profit (loss) from operating activities", "totalLabel": "Results from operating activities (A)", "verboseLabel": "Results from operating activities" } } }, "localname": "ProfitLossFromOperatingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedIncomeStatements", "http://www.drreddys.com/role/SegmentReportingDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PropertyPlantAndEquipment": { "auth_ref": [ "r21", "r96" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 27.0, "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period." } }, "en-us": { "role": { "label": "Property, plant and equipment", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "verboseLabel": "Property, plant and equipment" } } }, "localname": "PropertyPlantAndEquipment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition", "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PropertyPlantAndEquipmentMember": { "auth_ref": [ "r97", "r163", "r287" ], "lang": { "en": { "role": { "documentation": "This member stands for property, plant and equipment. It also represents the standard value for the 'Classes of property, plant and equipment' axis if no other member is used. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Property, Plant and Equipment [Member]" } } }, "localname": "PropertyPlantAndEquipmentMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/GoodwillDetailsTextual", "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails", "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetailsTextual", "http://www.drreddys.com/role/SignificantAccountingPoliciesDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate": { "auth_ref": [ "r309", "r319" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount recognised as of the acquisition date for plant, property and equipment acquired in a business combination. [Refer: Property, plant and equipment; Business combinations [member]]" } }, "en-us": { "role": { "label": "Property, plant and equipment recognised as of acquisition date", "terseLabel": "Property, plant and equipment" } } }, "localname": "PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProportionOfOwnershipInterestInJointVenture": { "auth_ref": [ "r150", "r153", "r247" ], "lang": { "en": { "role": { "documentation": "The proportion of ownership interest in a joint venture attributable to the entity. [Refer: Joint ventures [member]]" } }, "en-us": { "role": { "label": "Proportion of ownership interest in joint venture", "verboseLabel": "Ownership" } } }, "localname": "ProportionOfOwnershipInterestInJointVenture", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails1", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetailsTextual" ], "xbrltype": "percentItemType" }, "ifrs-full_ProportionOfOwnershipInterestInSubsidiary": { "auth_ref": [ "r150", "r153", "r246" ], "lang": { "en": { "role": { "documentation": "The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]]" } }, "en-us": { "role": { "label": "Proportion of ownership interest in subsidiary", "terseLabel": "Percentage of Direct/Indirect Ownership Interest" } } }, "localname": "ProportionOfOwnershipInterestInSubsidiary", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails", "http://www.drreddys.com/role/OrganizationalStructureDetailsTextual" ], "xbrltype": "percentItemType" }, "ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests": { "auth_ref": [ "r244" ], "lang": { "en": { "role": { "documentation": "The proportion of ownership interests in a subsidiary held by non-controlling interests. [Refer: Subsidiaries [member]; Non-controlling interests]" } }, "en-us": { "role": { "label": "Proportion of ownership interests held by non-controlling interests", "verboseLabel": "Ownership interests held by promoter group in the entity" } } }, "localname": "ProportionOfOwnershipInterestsHeldByNoncontrollingInterests", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/MergerOfDrReddySHoldingsLimitedIntoDrReddySLaboratoriesLimitedDetailsTextual" ], "xbrltype": "percentItemType" }, "ifrs-full_ProvisionUsedOtherProvisions": { "auth_ref": [ "r177" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount used (ie incurred and charged against the provision) for other provisions. [Refer: Other provisions]" } }, "en-us": { "role": { "label": "Provision used, other provisions", "negatedLabel": "Credits and payments", "negatedTerseLabel": "Provision used during the year" } } }, "localname": "ProvisionUsedOtherProvisions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ProvisionsDetails", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails6", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails7" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities": { "auth_ref": [ "r208" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 23.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Purchase of intangible assets, classified as investing activities", "negatedLabel": "Expenditures on other intangible assets", "terseLabel": "Payment for the purchase of intellectual property rights" } } }, "localname": "PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows", "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod": { "auth_ref": [ "r210" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 24.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for the purchase of investments other than investments accounted for using equity method. [Refer: Investments accounted for using equity method; Investments other than investments accounted for using equity method]" } }, "en-us": { "role": { "label": "Purchase of investments other than investments accounted for using equity method", "negatedLabel": "Purchase of other investments" } } }, "localname": "PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "auth_ref": [ "r208" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 21.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Purchase of property, plant and equipment, classified as investing activities", "negatedLabel": "Expenditures on property, plant and equipment" } } }, "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RangeAxis": { "auth_ref": [ "r270", "r272", "r274", "r299", "r347", "r391" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Range [axis]" } } }, "localname": "RangeAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails2", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails4", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails5", "http://www.drreddys.com/role/GoodwillDetailsTextual", "http://www.drreddys.com/role/IncomeTaxesDetails2", "http://www.drreddys.com/role/LoansAndBorrowingsDetailsTextual", "http://www.drreddys.com/role/OtherIncomeNetDetailsTextual", "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual", "http://www.drreddys.com/role/SignificantAccountingPoliciesDetails1", "http://www.drreddys.com/role/SignificantAccountingPoliciesDetails2" ], "xbrltype": "stringItemType" }, "ifrs-full_RangesMember": { "auth_ref": [ "r270", "r272", "r274", "r299", "r347", "r391" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used." } }, "en-us": { "role": { "label": "Ranges [member]" } } }, "localname": "RangesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails2", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails4", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails5", "http://www.drreddys.com/role/GoodwillDetailsTextual", "http://www.drreddys.com/role/IncomeTaxesDetails2", "http://www.drreddys.com/role/LoansAndBorrowingsDetailsTextual", "http://www.drreddys.com/role/OtherIncomeNetDetailsTextual", "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual", "http://www.drreddys.com/role/SignificantAccountingPoliciesDetails1", "http://www.drreddys.com/role/SignificantAccountingPoliciesDetails2" ], "xbrltype": "domainItemType" }, "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis": { "auth_ref": [ "r299" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Ranges of exercise prices for outstanding share options [axis]" } } }, "localname": "RangesOfExercisePricesForOutstandingShareOptionsAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember": { "auth_ref": [ "r299" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated ranges of exercise prices for outstanding share options that are meaningful for assessing the number and timing of additional shares that may be issued and the cash that may be received upon exercise of those options. It also represents the standard value for the 'Ranges of exercise prices for outstanding share options' axis if no other member is used. [Refer: Ranges [member]]" } }, "en-us": { "role": { "label": "Ranges of exercise prices for outstanding share options [member]" } } }, "localname": "RangesOfExercisePricesForOutstandingShareOptionsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_RawMaterials": { "auth_ref": [ "r44", "r128" ], "calculation": { "http://www.drreddys.com/role/InventoriesDetails": { "order": 1.0, "parentTag": "ifrs-full_Inventories", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "A classification of current inventory representing the amount of assets to be consumed in the production process or in the rendering of services. [Refer: Inventories]" } }, "en-us": { "role": { "label": "Current raw materials", "verboseLabel": "Raw materials" } } }, "localname": "RawMaterials", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RecipesFormulaeModelsDesignsAndPrototypesMember": { "auth_ref": [ "r192" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of intangible assets representing recipes, formulae, models, designs and prototypes. [Refer: Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Recipes, formulae, models, designs and prototypes [member]", "terseLabel": "Product related intangibles [member]", "verboseLabel": "Product related intangibles [member]" } } }, "localname": "RecipesFormulaeModelsDesignsAndPrototypesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetails", "http://www.drreddys.com/role/SignificantAccountingPoliciesDetails2" ], "xbrltype": "domainItemType" }, "ifrs-full_ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Reconciliation of average effective tax rate and applicable tax rate [abstract]" } } }, "localname": "ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails2" ], "xbrltype": "stringItemType" }, "ifrs-full_ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Reconciliation of changes in allowance account for credit losses of financial assets [abstract]" } } }, "localname": "ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/TradeAndOtherReceivablesDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_RecoverableAmountOfAssetOrCashgeneratingUnit": { "auth_ref": [ "r166" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The higher of an asset\u2019s (or cash-generating unit\u2019s) fair value less costs of disposal and its value in use. [Refer: Cash-generating units [member]]" } }, "en-us": { "role": { "label": "Recoverable amount of asset or cash-generating unit", "terseLabel": "Carrying value of the asset" } } }, "localname": "RecoverableAmountOfAssetOrCashgeneratingUnit", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RecurringFairValueMeasurementMember": { "auth_ref": [ "r265" ], "lang": { "en": { "role": { "documentation": "This member stands for fair value measurements which other IFRSs require or permit in the statement of financial position at the end of each reporting period. [Refer: IFRSs [member]]" } }, "en-us": { "role": { "label": "Recurring fair value measurement [member]" } } }, "localname": "RecurringFairValueMeasurementMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_RefundsProvision": { "auth_ref": [ "r180", "r182" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of provision for refunds to be made by the entity to its customers. [Refer: Other provisions]" } }, "en-us": { "role": { "label": "Refunds provision", "periodEndLabel": "Balance at the closing of the year", "periodStartLabel": "Balance at the beginning of the year" } } }, "localname": "RefundsProvision", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails7", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RefundsProvisionMember": { "auth_ref": [ "r180", "r182" ], "lang": { "en": { "role": { "documentation": "This member stands for a provision for refunds to be made by the entity to its customers. [Refer: Other provisions [member]]" } }, "en-us": { "role": { "definitionGuidance": "Refund Liability [member]", "label": "Refunds provision [member]" } } }, "localname": "RefundsProvisionMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ProvisionsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities": { "auth_ref": [ "r213" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Repayments of borrowings, classified as financing activities", "negatedTerseLabel": "Borrowings repaid during the year" } } }, "localname": "RepaymentsOfBorrowingsClassifiedAsFinancingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails5" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RepaymentsOfNoncurrentBorrowings": { "auth_ref": [ "r214" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 32.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for repayments of non-current borrowings. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Repayments of non-current borrowings", "negatedLabel": "Repayment of long-term borrowings (Refer to Note 17)" } } }, "localname": "RepaymentsOfNoncurrentBorrowings", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ReportableSegmentsMember": { "auth_ref": [ "r104", "r276", "r371", "r398" ], "lang": { "en": { "role": { "documentation": "This member stands for operating segments for which IFRS 8 requires information to be disclosed. The entity shall report separately information about an operating segment that meets any of the following quantitative thresholds: (a) reported revenue, including both sales to external customers and intersegment sales or transfers, is 10 per cent or more of the combined revenue, internal and external, of all operating segments; (b) the absolute amount of its reported profit or loss is 10 per cent or more of the greater, in absolute amount, of (i) the combined reported profit of all operating segments that did not report a loss and (ii) the combined reported loss of all operating segments that reported a loss; or (c) assets are 10 per cent or more of the combined assets of all operating segments. Additionally operating segments that do not meet any of the quantitative thresholds may be considered reportable, and separately disclosed, if management believes that information about the segment would be useful to users of the financial statements. [Refer: Operating segments [member]]" } }, "en-us": { "role": { "label": "Reportable segments [member]" } } }, "localname": "ReportableSegmentsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SegmentReportingTables" ], "xbrltype": "domainItemType" }, "ifrs-full_ResearchAndDevelopmentExpense": { "auth_ref": [ "r196" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedIncomeStatements": { "order": 12.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expenditure directly attributable to research or development activities, recognised in profit or loss." } }, "en-us": { "role": { "label": "Research and Development Expense", "verboseLabel": "Research and development expenses" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedIncomeStatements", "http://www.drreddys.com/role/SegmentReportingDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ReserveOfCashFlowHedges": { "auth_ref": [ "r46", "r385" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "A component of equity representing the accumulated portion of gain (loss) on a hedging instrument that is determined to be an effective hedge for cash flow hedges. [Refer: Cash flow hedges [member]]" } }, "en-us": { "role": { "label": "Reserve of cash flow hedges" } } }, "localname": "ReserveOfCashFlowHedges", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ReserveOfCashFlowHedgesMember": { "auth_ref": [ "r12", "r385" ], "lang": { "en": { "role": { "documentation": "This member stands for a component of equity representing the accumulated portion of gain (loss) on a hedging instrument that is determined to be an effective hedge for cash flow hedges. [Refer: Cash flow hedges [member]]" } }, "en-us": { "role": { "label": "Reserve of cash flow hedges [member]", "verboseLabel": "Hedging reserve [member]" } } }, "localname": "ReserveOfCashFlowHedgesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "domainItemType" }, "ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember": { "auth_ref": [ "r12", "r386" ], "lang": { "en": { "role": { "documentation": "This member stands for a component of equity representing the accumulated change in the value of foreign currency basis spreads of financial instruments when excluding them from the designation of these financial instruments as hedging instruments." } }, "en-us": { "role": { "label": "Reserve of change in value of foreign currency basis spreads [member]", "verboseLabel": "Foreign currency translation reserve [member]" } } }, "localname": "ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "domainItemType" }, "ifrs-full_ReserveOfSharebasedPayments": { "auth_ref": [ "r46" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 20.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "A component of equity resulting from share-based payments." } }, "en-us": { "role": { "label": "Reserve of share-based payments", "verboseLabel": "Share-based payment reserve" } } }, "localname": "ReserveOfSharebasedPayments", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ReserveOfSharebasedPaymentsMember": { "auth_ref": [ "r12" ], "lang": { "en": { "role": { "documentation": "This member stands for a component of equity resulting from share-based payments." } }, "en-us": { "role": { "label": "Reserve of share-based payments [member]", "verboseLabel": "Share based payments reserve [member]" } } }, "localname": "ReserveOfSharebasedPaymentsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "domainItemType" }, "ifrs-full_RestatedMember": { "auth_ref": [ "r5", "r19", "r234", "r235", "r236", "r390" ], "lang": { "en": { "role": { "documentation": "This member stands for the information currently stated in the financial statements. It also represents the standard value for the 'Retrospective application and retrospective restatement' and 'Departure from requirement of IFRS' axes if no other member is used." } }, "en-us": { "role": { "label": "Currently stated [member]" } } }, "localname": "RestatedMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetailsTextual", "http://www.drreddys.com/role/TradeAndOtherReceivablesDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_RestrictedCashAndCashEquivalents": { "auth_ref": [ "r33" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of cash and cash equivalents whose use or withdrawal is restricted. [Refer: Cash and cash equivalents]" } }, "en-us": { "role": { "label": "Restricted Cash and Cash Equivalents", "verboseLabel": "Other restricted cash balances" } } }, "localname": "RestrictedCashAndCashEquivalents", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/CashAndCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RetainedEarnings": { "auth_ref": [ "r46", "r68" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 24.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit." } }, "en-us": { "role": { "label": "Retained earnings", "verboseLabel": "Retained earnings" } } }, "localname": "RetainedEarnings", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RetainedEarningsMember": { "auth_ref": [ "r10", "r12" ], "lang": { "en": { "role": { "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit." } }, "en-us": { "role": { "label": "Retained Earnings [Member]", "verboseLabel": "Retained earnings [member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "domainItemType" }, "ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis": { "auth_ref": [ "r5", "r234", "r235", "r236" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Retrospective application and retrospective restatement [axis]" } } }, "localname": "RetrospectiveApplicationAndRetrospectiveRestatementAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetailsTextual", "http://www.drreddys.com/role/TradeAndOtherReceivablesDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_Revenue": { "auth_ref": [ "r1", "r2", "r57", "r248", "r254", "r322", "r367", "r373", "r379", "r380", "r383" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedIncomeStatements": { "order": 8.0, "parentTag": "ifrs-full_GrossProfit", "weight": 1.0 }, "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims." } }, "en-us": { "role": { "label": "Revenue", "terseLabel": "Revenues", "totalLabel": "Revenue", "verboseLabel": "Revenues" } } }, "localname": "Revenue", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedIncomeStatements", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails1", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails1", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails2", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails3", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails4", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetailsTextual", "http://www.drreddys.com/role/SegmentReportingDetails", "http://www.drreddys.com/role/SegmentReportingDetails2", "http://www.drreddys.com/role/SegmentReportingDetails3", "http://www.drreddys.com/role/SegmentReportingDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RevenueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue [abstract]" } } }, "localname": "RevenueAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_RevenueFromRenderingOfServices": { "auth_ref": [ "r13" ], "calculation": { "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails": { "order": 2.0, "parentTag": "ifrs-full_Revenue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of revenue arising from the rendering of services. [Refer: Revenue]" } }, "en-us": { "role": { "label": "Revenue from rendering of services", "verboseLabel": "Service income" } } }, "localname": "RevenueFromRenderingOfServices", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RevenueFromRenderingOfServicesRelatedPartyTransactions": { "auth_ref": [ "r144" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of revenue arising from the rendering of services in related party transactions. [Refer: Revenue; Related parties [member]]" } }, "en-us": { "role": { "label": "Revenue from rendering of services, related party transactions", "verboseLabel": "Research and development services provided" } } }, "localname": "RevenueFromRenderingOfServicesRelatedPartyTransactions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/RelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RevenueFromSaleOfGoods": { "auth_ref": [ "r13" ], "calculation": { "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails": { "order": 1.0, "parentTag": "ifrs-full_Revenue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of revenue arising from the sale of goods. [Refer: Revenue]" } }, "en-us": { "role": { "label": "Revenue from sale of goods", "verboseLabel": "Sales" } } }, "localname": "RevenueFromSaleOfGoods", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions": { "auth_ref": [ "r143" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of revenue arising from the sale of goods in related party transactions. [Refer: Revenue; Related parties [member]]" } }, "en-us": { "role": { "label": "Revenue from sale of goods, related party transactions", "terseLabel": "Sale of goods" } } }, "localname": "RevenueFromSaleOfGoodsRelatedPartyTransactions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/RelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RevenueOfAcquiree": { "auth_ref": [ "r311" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of revenue of the acquiree since the acquisition date included in the consolidated statement of comprehensive income. [Refer: Revenue]" } }, "en-us": { "role": { "label": "Revenue of acquiree since acquisition date", "terseLabel": "Revenue of acquiree since acquisition date" } } }, "localname": "RevenueOfAcquiree", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RightofuseAssets": { "auth_ref": [ "r286" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee." } }, "en-us": { "role": { "label": "Right-of-use assets", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "RightofuseAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RightsPreferencesAndRestrictionsAttachingToClassOfShareCapital": { "auth_ref": [ "r52" ], "lang": { "en": { "role": { "documentation": "The description of the rights, preferences and restrictions attaching to a class of share capital including restrictions on the distribution of dividends and the repayment of capital. [Refer: Share capital [member]]" } }, "en-us": { "role": { "label": "Rights, preferences and restrictions attaching to class of share capital" } } }, "localname": "RightsPreferencesAndRestrictionsAttachingToClassOfShareCapital", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ShareCapitalDetailsTextual" ], "xbrltype": "stringItemType" }, "ifrs-full_SegmentsAxis": { "auth_ref": [ "r104", "r165", "r276", "r371", "r398" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Segments [axis]", "terseLabel": "Segments [axis]" } } }, "localname": "SegmentsAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual", "http://www.drreddys.com/role/OtherIncomeNetDetailsTextual", "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails1", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails2", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails3", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetailsTextual", "http://www.drreddys.com/role/SegmentReportingDetails", "http://www.drreddys.com/role/SegmentReportingDetails2", "http://www.drreddys.com/role/SegmentReportingDetails3", "http://www.drreddys.com/role/SegmentReportingDetails7", "http://www.drreddys.com/role/SegmentReportingTables" ], "xbrltype": "stringItemType" }, "ifrs-full_SegmentsMember": { "auth_ref": [ "r104", "r165", "r276", "r378", "r398" ], "lang": { "en": { "role": { "documentation": "This member stands for all segments of an entity. It also represents the standard value for the 'Segments' axis if no other member is used." } }, "en-us": { "role": { "label": "Segments [member]", "terseLabel": "Segments [member]" } } }, "localname": "SegmentsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual", "http://www.drreddys.com/role/OtherIncomeNetDetailsTextual", "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails1", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails2", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails3", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetailsTextual", "http://www.drreddys.com/role/SegmentReportingDetails", "http://www.drreddys.com/role/SegmentReportingDetails2", "http://www.drreddys.com/role/SegmentReportingDetails3", "http://www.drreddys.com/role/SegmentReportingDetails7", "http://www.drreddys.com/role/SegmentReportingTables" ], "xbrltype": "domainItemType" }, "ifrs-full_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r61" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedIncomeStatements": { "order": 11.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense relating to selling, general and administrative activities of the entity." } }, "en-us": { "role": { "label": "Selling, General and Administrative Expense", "verboseLabel": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedIncomeStatements", "http://www.drreddys.com/role/SegmentReportingDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_SellingGeneralAndAdministrativeExpenseMember": { "auth_ref": [ "r3", "r13" ], "lang": { "en": { "role": { "documentation": "This member stands for the amount of expense relating to selling, general and administrative activities of the entity. This member is used to attribute an expense by nature to a functional line item in the statement of profit or loss." } }, "en-us": { "role": { "label": "Selling, general and administrative expense [member]", "terseLabel": "Selling General And Administrative Expense [Member]" } } }, "localname": "SellingGeneralAndAdministrativeExpenseMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "domainItemType" }, "ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod": { "auth_ref": [ "r61" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The entity's share of the profit (loss) of associates accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Profit (loss)]" } }, "en-us": { "role": { "definitionGuidance": "Company's share of profits for the year", "label": "Share of profit (loss) of associates accounted for using equity method", "negatedTerseLabel": "Share of profit of equity accounted investees", "verboseLabel": "Company's share of profits for the year" } } }, "localname": "ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails1", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share of profit (loss) of associates and joint ventures accounted for using equity method [abstract]" } } }, "localname": "ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod": { "auth_ref": [ "r61" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedIncomeStatements": { "order": 5.0, "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The entity's share of the profit (loss) of joint ventures accounted for using the equity method. [Refer: Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]" } }, "en-us": { "role": { "label": "Share of profit (loss) of joint ventures accounted for using equity method", "terseLabel": "Share of profit of equity accounted investees, net of tax", "verboseLabel": "Share of profit of equity accounted investees, net of tax (C)" } } }, "localname": "ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedIncomeStatements", "http://www.drreddys.com/role/SegmentReportingDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_SharePremium": { "auth_ref": [ "r46" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 19.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount received or receivable from the issuance of the entity's shares in excess of nominal value." } }, "en-us": { "role": { "label": "Share premium", "verboseLabel": "Share premium" } } }, "localname": "SharePremium", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_SharePremiumMember": { "auth_ref": [ "r10" ], "lang": { "en": { "role": { "documentation": "This member stands for the amount received or receivable from issuance of the entity's shares in excess of nominal value." } }, "en-us": { "role": { "label": "Share premium [member]" } } }, "localname": "SharePremiumMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "domainItemType" }, "ifrs-full_SharebasedPaymentArrangementsMember": { "auth_ref": [ "r300" ], "lang": { "en": { "role": { "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used." } }, "en-us": { "role": { "label": "Share-based payment arrangements [member]" } } }, "localname": "SharebasedPaymentArrangementsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ShareCapitalDetailsTextual" ], "xbrltype": "domainItemType" }, "ifrs-full_ShorttermBorrowings": { "auth_ref": [ "r33" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 9.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current borrowings. [Refer: Borrowings]" } }, "en-us": { "role": { "definitionGuidance": "Current borrowings", "label": "Short-term Debt", "terseLabel": "Short-term borrowings", "verboseLabel": "Short-term borrowings" } } }, "localname": "ShorttermBorrowings", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition", "http://www.drreddys.com/role/FinancialInstrumentsDetails", "http://www.drreddys.com/role/FinancialRiskManagementDetails", "http://www.drreddys.com/role/LoansAndBorrowingsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ShorttermBorrowingsMember": { "auth_ref": [ "r227", "r233" ], "lang": { "en": { "role": { "documentation": "This member stands for short-term borrowings. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Short-term borrowings [member]" } } }, "localname": "ShorttermBorrowingsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails5" ], "xbrltype": "domainItemType" }, "ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents": { "auth_ref": [ "r229" ], "calculation": { "http://www.drreddys.com/role/CashAndCashEquivalentsDetails": { "order": 4.0, "parentTag": "ifrs-full_CashAndCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "A classification of cash equivalents representing short-term deposits. [Refer: Cash equivalents]" } }, "en-us": { "role": { "label": "Short-term deposits, classified as cash equivalents", "terseLabel": "Term deposits with banks (original maturities less than 3 months)" } } }, "localname": "ShorttermDepositsClassifiedAsCashEquivalents", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/CashAndCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_SignificantInvestmentsInSubsidiariesAxis": { "auth_ref": [ "r151", "r154", "r262" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Subsidiaries [axis]" } } }, "localname": "SignificantInvestmentsInSubsidiariesAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual", "http://www.drreddys.com/role/IncomeTaxesDetailsTextual", "http://www.drreddys.com/role/LoansAndBorrowingsDetailsTextual", "http://www.drreddys.com/role/OrganizationalStructureDetails", "http://www.drreddys.com/role/OrganizationalStructureDetailsTextual", "http://www.drreddys.com/role/OtherIncomeNetDetailsTextual" ], "xbrltype": "stringItemType" }, "ifrs-full_SocialSecurityContributions": { "auth_ref": [ "r122" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "A class of employee benefits expense that represents social security contributions. [Refer: Employee benefits expense]" } }, "en-us": { "role": { "label": "Social security contributions" } } }, "localname": "SocialSecurityContributions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_StatementOfChangesInEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of changes in equity [abstract]" } } }, "localname": "StatementOfChangesInEquityAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_StatementOfChangesInEquityLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Statement of changes in equity [line items]" } } }, "localname": "StatementOfChangesInEquityLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "stringItemType" }, "ifrs-full_StatementOfChangesInEquityTable": { "auth_ref": [ "r10" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to changes in equity." } }, "en-us": { "role": { "label": "Statement of changes in equity [table]" } } }, "localname": "StatementOfChangesInEquityTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "stringItemType" }, "ifrs-full_StatementOfComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of comprehensive income [abstract]" } } }, "localname": "StatementOfComprehensiveIncomeAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of financial position [abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_StatementOfIFRSCompliance": { "auth_ref": [ "r18" ], "lang": { "en": { "role": { "documentation": "An explicit and unreserved statement of compliance with all the requirements of IFRSs." } }, "en-us": { "role": { "label": "Statement of IFRS compliance [text block]", "verboseLabel": "Statement of compliance" } } }, "localname": "StatementOfIFRSCompliance", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BasisOfPreparationOfFinancialStatementsPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subclassifications of assets, liabilities and equities [abstract]" } } }, "localname": "SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_SurplusDeficitInPlan": { "auth_ref": [ "r121" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The fair value of any plan assets, less the present value of the defined benefit obligation. [Refer: Plan assets [member]]" } }, "en-us": { "role": { "label": "Surplus (deficit) in plan", "negatedLabel": "Net defined benefit liability recognized", "terseLabel": "Net defined benefit liability recognized" } } }, "localname": "SurplusDeficitInPlan", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails1", "http://www.drreddys.com/role/EmployeeBenefitsDetails10" ], "xbrltype": "monetaryItemType" }, "ifrs-full_SurplusDeficitInPlanAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Surplus (deficit) in plan [abstract]" } } }, "localname": "SurplusDeficitInPlanAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_TaxEffectFromChangeInTaxRate": { "auth_ref": [ "r77" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to changes in the tax rate. [Refer: Accounting profit]" } }, "en-us": { "role": { "label": "Tax effect from change in tax rate", "terseLabel": "Effect of change in tax rate" } } }, "localname": "TaxEffectFromChangeInTaxRate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss": { "auth_ref": [ "r77" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to expenses not deductible in determining taxable profit (tax loss). [Refer: Accounting profit]" } }, "en-us": { "role": { "label": "Tax effect of expense not deductible in determining taxable profit (tax loss)", "terseLabel": "Expenses not deductible for tax purposes" } } }, "localname": "TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TaxEffectOfForeignTaxRates": { "auth_ref": [ "r77" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to foreign tax rates. [Refer: Accounting profit]" } }, "en-us": { "role": { "label": "Tax effect of foreign tax rates", "verboseLabel": "Differences between Indian and foreign tax rates" } } }, "localname": "TaxEffectOfForeignTaxRates", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TaxEffectOfRevenuesExemptFromTaxation2011": { "auth_ref": [ "r77" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to revenues that are exempt from taxation. [Refer: Accounting profit]" } }, "en-us": { "role": { "label": "Tax effect of revenues exempt from taxation", "negatedLabel": "Income exempt from income taxes" } } }, "localname": "TaxEffectOfRevenuesExemptFromTaxation2011", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TaxExpenseIncomeAtApplicableTaxRate": { "auth_ref": [ "r77" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]" } }, "en-us": { "role": { "label": "Tax expense (income) at applicable tax rate", "negatedLabel": "Computed expected tax expense" } } }, "localname": "TaxExpenseIncomeAtApplicableTaxRate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis": { "auth_ref": [ "r82" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Temporary difference, unused tax losses and unused tax credits [axis]" } } }, "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual", "http://www.drreddys.com/role/IncomeTaxesDetails3", "http://www.drreddys.com/role/IncomeTaxesDetails4", "http://www.drreddys.com/role/IncomeTaxesDetailsTextual" ], "xbrltype": "stringItemType" }, "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember": { "auth_ref": [ "r82" ], "lang": { "en": { "role": { "documentation": "This member stands for temporary differences, unused tax losses and unused tax credits. It also represents the standard value for the 'Temporary difference, unused tax losses and unused tax credits' axis if no other member is used. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]" } }, "en-us": { "role": { "label": "Temporary difference, unused tax losses and unused tax credits [member]" } } }, "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual", "http://www.drreddys.com/role/IncomeTaxesDetails3", "http://www.drreddys.com/role/IncomeTaxesDetails4", "http://www.drreddys.com/role/IncomeTaxesDetailsTextual" ], "xbrltype": "domainItemType" }, "ifrs-full_TopOfRangeMember": { "auth_ref": [ "r270", "r272", "r274", "r299", "r347", "r391" ], "lang": { "en": { "role": { "documentation": "This member stands for top of a range." } }, "en-us": { "role": { "label": "Top of range [member]" } } }, "localname": "TopOfRangeMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails2", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails4", "http://www.drreddys.com/role/GoodwillDetailsTextual", "http://www.drreddys.com/role/IncomeTaxesDetails2", "http://www.drreddys.com/role/OtherIncomeNetDetailsTextual", "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual", "http://www.drreddys.com/role/SignificantAccountingPoliciesDetails1", "http://www.drreddys.com/role/SignificantAccountingPoliciesDetails2" ], "xbrltype": "domainItemType" }, "ifrs-full_TradeAndOtherCurrentPayables": { "auth_ref": [ "r29" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 8.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]" } }, "en-us": { "role": { "label": "Trade and other current payables", "terseLabel": "Trade and other payables", "verboseLabel": "Trade and other payables" } } }, "localname": "TradeAndOtherCurrentPayables", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition", "http://www.drreddys.com/role/FinancialInstrumentsDetails", "http://www.drreddys.com/role/FinancialRiskManagementDetails", "http://www.drreddys.com/role/TradeAndOtherPayablesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TradeAndOtherCurrentPayablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Trade and other current payables [abstract]" } } }, "localname": "TradeAndOtherCurrentPayablesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers": { "auth_ref": [ "r42", "r47" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]" } }, "en-us": { "role": { "label": "Current trade payables", "verboseLabel": "Trade payables" } } }, "localname": "TradeAndOtherCurrentPayablesToTradeSuppliers", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/TradeAndOtherPayablesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TradeAndOtherCurrentReceivables": { "auth_ref": [ "r26", "r43" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 39.0, "parentTag": "ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]" } }, "en-us": { "role": { "label": "Trade and other current receivables", "verboseLabel": "Trade and other receivables" } } }, "localname": "TradeAndOtherCurrentReceivables", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TradeAndOtherPayables": { "auth_ref": [ "r29" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of trade payables and other payables. [Refer: Trade payables; Other payables]" } }, "en-us": { "role": { "label": "Trade and other payables", "terseLabel": "Trade and other payables" } } }, "localname": "TradeAndOtherPayables", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TradeAndOtherPayablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Trade and other payables [abstract]" } } }, "localname": "TradeAndOtherPayablesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate": { "auth_ref": [ "r309" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount recognised as of the acquisition date for trade and other payables assumed in a business combination. [Refer: Trade and other payables; Business combinations [member]]" } }, "en-us": { "role": { "label": "Trade and other payables recognised as of acquisition date", "negatedLabel": "Trade payables" } } }, "localname": "TradeAndOtherPayablesRecognisedAsOfAcquisitionDate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TradeAndOtherReceivables": { "auth_ref": [ "r26", "r43" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of trade receivables and other receivables. [Refer: Trade receivables; Other receivables]" } }, "en-us": { "role": { "label": "Trade and other receivables", "verboseLabel": "Trade and other receivables" } } }, "localname": "TradeAndOtherReceivables", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetails", "http://www.drreddys.com/role/FinancialRiskManagementDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TradeAndOtherReceivablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Trade and other receivables [abstract]" } } }, "localname": "TradeAndOtherReceivablesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_TradeReceivables": { "auth_ref": [ "r43" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount due from customers for goods and services sold." } }, "en-us": { "role": { "label": "Trade receivables", "verboseLabel": "Trade and other receivables" } } }, "localname": "TradeReceivables", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TreasuryShares": { "auth_ref": [ "r46", "r155" ], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 18.0, "parentTag": "ifrs-full_Equity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "An entity\u2019s own equity instruments, held by the entity or other members of the consolidated group." } }, "en-us": { "role": { "label": "Treasury shares", "negatedLabel": "Treasury shares" } } }, "localname": "TreasuryShares", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition", "http://www.drreddys.com/role/ShareCapitalDetails", "http://www.drreddys.com/role/ShareCapitalDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TreasurySharesMember": { "auth_ref": [ "r10" ], "lang": { "en": { "role": { "documentation": "This member stands for the entity\u2019s own equity instruments, held by the entity or other members of the consolidated group." } }, "en-us": { "role": { "label": "Treasury shares [member]" } } }, "localname": "TreasurySharesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "domainItemType" }, "ifrs-full_TypesOfHedgesAxis": { "auth_ref": [ "r328", "r329", "r331", "r408" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Types of hedges [axis]" } } }, "localname": "TypesOfHedgesAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3", "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual", "http://www.drreddys.com/role/LoansAndBorrowingsDetails3", "http://www.drreddys.com/role/LoansAndBorrowingsDetailsTextual" ], "xbrltype": "stringItemType" }, "ifrs-full_TypesOfHedgesMember": { "auth_ref": [ "r328", "r329", "r331", "r408" ], "lang": { "en": { "role": { "documentation": "This member stands for all types of hedges. It also represents the standard value for the 'Types of hedges' axis if no other member is used." } }, "en-us": { "role": { "label": "Hedges [member]" } } }, "localname": "TypesOfHedgesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3", "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual", "http://www.drreddys.com/role/LoansAndBorrowingsDetails3", "http://www.drreddys.com/role/LoansAndBorrowingsDetailsTextual" ], "xbrltype": "domainItemType" }, "ifrs-full_TypesOfInterestRatesAxis": { "auth_ref": [ "r343" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Types of interest rates [axis]" } } }, "localname": "TypesOfInterestRatesAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "stringItemType" }, "ifrs-full_TypesOfInvestmentPropertyAxis": { "auth_ref": [ "r13" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Types of investment property [axis]" } } }, "localname": "TypesOfInvestmentPropertyAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails2" ], "xbrltype": "stringItemType" }, "ifrs-full_TypesOfRisksAxis": { "auth_ref": [ "r324", "r335", "r336", "r392", "r393", "r394", "r395" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Types of risks [axis]", "terseLabel": "Types of risks [axis]" } } }, "localname": "TypesOfRisksAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetailsTextual" ], "xbrltype": "stringItemType" }, "ifrs-full_TypesOfRisksMember": { "auth_ref": [ "r324", "r335", "r336", "r392", "r393", "r394", "r395" ], "lang": { "en": { "role": { "documentation": "This member stands for all types of risks. It also represents the standard value for the 'Types of risks' axis if no other member is used." } }, "en-us": { "role": { "label": "Risks [member]", "terseLabel": "Risks [member]" } } }, "localname": "TypesOfRisksMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetailsTextual" ], "xbrltype": "domainItemType" }, "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": { "auth_ref": [ "r300" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Types of share-based payment arrangements [axis]" } } }, "localname": "TypesOfSharebasedPaymentArrangementsAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ShareCapitalDetailsTextual" ], "xbrltype": "stringItemType" }, "ifrs-full_TypesOfTransferMember": { "auth_ref": [ "r356" ], "lang": { "en": { "role": { "documentation": "This member stands for all types of transfers of financial instruments. It also represents the standard value for the 'Continuing involvement in derecognised financial assets by type of transfer' axis if no other member is used." } }, "en-us": { "role": { "label": "Types of transfer [member]" } } }, "localname": "TypesOfTransferMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/TradeAndOtherReceivablesDetailsTextual" ], "xbrltype": "domainItemType" }, "ifrs-full_UnconsolidatedStructuredEntitiesAxis": { "auth_ref": [ "r264" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Unconsolidated structured entities [axis]" } } }, "localname": "UnconsolidatedStructuredEntitiesAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual", "http://www.drreddys.com/role/OtherInvestmentsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_UndrawnBorrowingFacilities": { "auth_ref": [ "r230" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of undrawn borrowing facilities that may be available for future operating activities and to settle capital commitments. [Refer: Capital commitments]" } }, "en-us": { "role": { "label": "Undrawn borrowing facilities", "verboseLabel": "uncommitted lines of credit" } } }, "localname": "UndrawnBorrowingFacilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual", "http://www.drreddys.com/role/LoansAndBorrowingsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised": { "auth_ref": [ "r79" ], "lang": { "en": { "role": { "documentation": "The amount of unused tax losses for which no deferred tax asset is recognised in the statement of financial position. [Refer: Unused tax losses [member]]" } }, "en-us": { "role": { "label": "Unused tax losses for which no deferred tax asset recognised", "terseLabel": "Unused tax losses for which no deferred tax asset recognised", "verboseLabel": "Operating tax loss carry-forward" } } }, "localname": "UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails3", "http://www.drreddys.com/role/IncomeTaxesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r183" ], "lang": { "en": { "role": { "documentation": "The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Useful life measured as period of time, intangible assets other than goodwill" } } }, "localname": "UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SignificantAccountingPoliciesDetails2" ], "xbrltype": "durationItemType" }, "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment": { "auth_ref": [ "r88" ], "lang": { "en": { "role": { "documentation": "The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Useful life measured as period of time, property, plant and equipment" } } }, "localname": "UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/SignificantAccountingPoliciesDetails1" ], "xbrltype": "durationItemType" }, "ifrs-full_UtilisationAllowanceAccountForCreditLossesOfFinancialAssets": { "auth_ref": [ "r407" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The decrease in an allowance account for credit losses of financial assets resulting from the utilisation of the allowance. [Refer: Allowance account for credit losses of financial assets]" } }, "en-us": { "role": { "label": "Utilisation, allowance account for credit losses of financial assets", "negatedLabel": "Trade and other receivables written off & exchange differences" } } }, "localname": "UtilisationAllowanceAccountForCreditLossesOfFinancialAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/TradeAndOtherReceivablesDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_VehiclesMember": { "auth_ref": [ "r87" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing vehicles used in the entity's operations, specifically to include aircraft, motor vehicles and ships. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Vehicles [Member]", "terseLabel": "Vehicles [Member]" } } }, "localname": "VehiclesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails", "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails1", "http://www.drreddys.com/role/SignificantAccountingPoliciesDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019": { "auth_ref": [ "r297" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price of share options exercisable in share-based payment arrangement", "verboseLabel": "Weighted average exercise price, Exercisable at the end of the year" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails1", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails2", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails4" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019": { "auth_ref": [ "r294" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price of share options exercised in share-based payment arrangement", "terseLabel": "Weighted average exercise price of share options exercised in share-based payment arrangement", "verboseLabel": "Weighted average exercise price, Exercised during the year" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails1", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails2", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails4", "http://www.drreddys.com/role/ShareCapitalDetailsTextual" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019": { "auth_ref": [ "r295" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options expired in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price of share options expired in share-based payment arrangement", "terseLabel": "Weighted average exercise price, expired/forfeited during the year" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails2" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019": { "auth_ref": [ "r293" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price of share options granted in share-based payment arrangement", "verboseLabel": "Weighted average exercise price, Granted during the year" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails1", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails2", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails4" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019": { "auth_ref": [ "r298" ], "lang": { "en": { "role": { "documentation": "The weighted average share price at the date of exercise for share options that are exercised in a share-based payment arrangement. [Refer: Share-based payment arrangements [member]; Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average share price for share options in share-based payment arrangement exercised during period at date of exercise" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetailsTextual" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019": { "auth_ref": [ "r292", "r296" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price of share options outstanding in share-based payment arrangement", "periodEndLabel": "Weighted average exercise price, Outstanding at the end of the year", "periodStartLabel": "Weighted average exercise price, Outstanding at the beginning of the year" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails1", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails2", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails4" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted": { "auth_ref": [ "r302" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The weighted average fair value of share options granted during the period at the measurement date. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average fair value at measurement date, share options granted" } } }, "localname": "WeightedAverageFairValueAtMeasurementDateShareOptionsGranted", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetailsTextual" ], "xbrltype": "monetaryItemType" }, "ifrs-full_WeightedAverageSharePrice2019": { "auth_ref": [ "r298" ], "lang": { "en": { "role": { "documentation": "The weighted average share price. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average share price", "terseLabel": "Weighted average share price" } } }, "localname": "WeightedAverageSharePrice2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/ShareCapitalDetailsTextual" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019": { "auth_ref": [ "r301" ], "lang": { "en": { "role": { "documentation": "The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average share price, share options granted", "verboseLabel": "Grant date share price" } } }, "localname": "WeightedAverageSharePriceShareOptionsGranted2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails5" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageShares": { "auth_ref": [ "r160" ], "lang": { "en": { "role": { "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor." } }, "en-us": { "role": { "label": "Weighted average number of ordinary shares outstanding", "presentationGuidance": "Weighted average number of equity shares \u2013 Basic", "terseLabel": "Weighted average number of equity shares \u2013 Basic" } } }, "localname": "WeightedAverageShares", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/EarningsPerShareDetails", "http://www.drreddys.com/role/EarningsPerShareDetails1" ], "xbrltype": "sharesItemType" }, "ifrs-full_WorkInProgress": { "auth_ref": [ "r44", "r128" ], "calculation": { "http://www.drreddys.com/role/InventoriesDetails": { "order": 3.0, "parentTag": "ifrs-full_Inventories", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "A classification of current inventory representing the amount of assets currently in production, which require further processes to be converted into finished goods or services. [Refer: Current finished goods; Inventories]" } }, "en-us": { "role": { "label": "Current work in progress", "verboseLabel": "Work-in-progress" } } }, "localname": "WorkInProgress", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://www.drreddys.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "rdy_AaaicdrArbitrationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "AAAICDR Arbitration [Member]", "terseLabel": "AAA-ICDR Arbitration [Member]" } } }, "localname": "AaaicdrArbitrationMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_AccumulatedDepreciationAndImpairmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accumulated depreciation and impairment [Member].", "label": "Accumulated Depreciation And Impairment [Member]", "terseLabel": "Accumulated depreciation and impairment [member]" } } }, "localname": "AccumulatedDepreciationAndImpairmentMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "rdy_AccumulatedDepreciationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accumulated Depreciation [Member].", "label": "Accumulated Depreciation [Member]", "terseLabel": "Accumulated depreciation [member]" } } }, "localname": "AccumulatedDepreciationMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails1" ], "xbrltype": "domainItemType" }, "rdy_AcquireeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquiree [Axis]" } } }, "localname": "AcquireeAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_AcquireeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquiree [Member]" } } }, "localname": "AcquireeMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_AcquirerOfIntangibleAssetsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Acquirer of intangible assets.", "label": "Acquirer Of Intangible Assets [Axis]" } } }, "localname": "AcquirerOfIntangibleAssetsAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_AcquirerOfIntangibleAssetsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Acquirer of intangible assets.", "label": "Acquirer Of Intangible Assets [Domain]" } } }, "localname": "AcquirerOfIntangibleAssetsDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_ActuarialAssumptionOfExpectedSalaryIncreases": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of actuarial assumption of expected salary increases.", "label": "Actuarial Assumption Of Expected Salary Increases", "terseLabel": "Add: Effect of salary growth", "verboseLabel": "Add: Effect of salary growth" } } }, "localname": "ActuarialAssumptionOfExpectedSalaryIncreases", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails13", "http://www.drreddys.com/role/EmployeeBenefitsDetails4" ], "xbrltype": "monetaryItemType" }, "rdy_ActuarialAssumptionsToDetermineBenefitObligationsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Actuarial assumptions to determine benefit obligations [Line Items]" } } }, "localname": "ActuarialAssumptionsToDetermineBenefitObligationsLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails14", "http://www.drreddys.com/role/EmployeeBenefitsDetails5" ], "xbrltype": "stringItemType" }, "rdy_ActuarialGainsLossesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Actuarial gains -losses [Member]", "verboseLabel": "Actuarial gains/ (losses) [member]" } } }, "localname": "ActuarialGainsLossesMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "domainItemType" }, "rdy_AdditionalAllowanceRecognisedInProfitOrLossProvisionMadeDuringTheYearNetOfReversals": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of additional allowance recognised in profit or loss provision made during the year net of reversals.", "label": "Additional Allowance Recognised In Profit Or Loss Provision Made During The Year Net Of Reversals", "verboseLabel": "Provision made during the year, net of reversals" } } }, "localname": "AdditionalAllowanceRecognisedInProfitOrLossProvisionMadeDuringTheYearNetOfReversals", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/TradeAndOtherReceivablesDetails1" ], "xbrltype": "monetaryItemType" }, "rdy_AdditionalDepositAmountAgainstPenalty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Additional deposit amount against penalty.", "label": "Additional deposit amount against penalty" } } }, "localname": "AdditionalDepositAmountAgainstPenalty", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_AdditionalPaymentsReceivableOnAchievementOfMilestones": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Additional payments receivable on achievement of milestones.", "label": "Additional Payments Receivable On Achievement Of Milestones", "terseLabel": "Additional payments receivable on achievement of milestones" } } }, "localname": "AdditionalPaymentsReceivableOnAchievementOfMilestones", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherIncomeNetDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_AdjustedEffectiveTaxRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Adjusted effective tax rate.", "label": "Adjusted Effective Tax Rate", "terseLabel": "Adjusted Effective Tax Rate" } } }, "localname": "AdjustedEffectiveTaxRate", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetailsTextual" ], "xbrltype": "percentItemType" }, "rdy_AdjustmentsForDecreaseIncreaseInOtherAssetsAndLiabilities": { "auth_ref": [], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 19.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Adjustments for decrease (increase) in other assets and liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities.", "label": "Adjustments for decrease increase in other assets and liabilities", "verboseLabel": "Other assets and other liabilities, net" } } }, "localname": "AdjustmentsForDecreaseIncreaseInOtherAssetsAndLiabilities", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "rdy_AdjustmentsForFairValueIncreaseDecreaseAndGainsLossesOnSaleOfFinancialInstrumentsMeasuredAtFairValueThroughProfitLossNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Adjustments For Fair Value Increase Decrease And Gains Losses On Sale Of Financial Instruments Measured At Fair Value Through Profit Loss Net.", "label": "Adjustments For Fair Value Increase Decrease And Gains Losses On Sale Of Financial Instruments Measured At Fair Value Through Profit Loss Net", "terseLabel": "Fair value changes and profit on sale of financial instruments measured at FVTPL, net" } } }, "localname": "AdjustmentsForFairValueIncreaseDecreaseAndGainsLossesOnSaleOfFinancialInstrumentsMeasuredAtFairValueThroughProfitLossNet", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinanceIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "rdy_AfterTaxMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "After tax [Member]" } } }, "localname": "AfterTaxMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/GoodwillDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_AfterYear5Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "After Year 5 [Member]", "verboseLabel": "Thereafter" } } }, "localname": "AfterYear5Member", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails8" ], "xbrltype": "domainItemType" }, "rdy_AfterYearFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "After Year Five [Member]", "verboseLabel": "Thereafter" } } }, "localname": "AfterYearFiveMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails17" ], "xbrltype": "domainItemType" }, "rdy_AgreementAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement", "label": "Agreement [Axis]" } } }, "localname": "AgreementAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetails1", "http://www.drreddys.com/role/ContingenciesDetailsTextual", "http://www.drreddys.com/role/LoansAndBorrowingsDetailsTextual", "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetailsTextual", "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_AgreementDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement.", "label": "Agreement [Domain]" } } }, "localname": "AgreementDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetails1", "http://www.drreddys.com/role/ContingenciesDetailsTextual", "http://www.drreddys.com/role/LoansAndBorrowingsDetailsTextual", "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetailsTextual", "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_AliumJscMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Alium jsc.", "label": "Alium JSC [Member]", "terseLabel": "Alium JSC [member]" } } }, "localname": "AliumJscMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_AllowanceAccountForCreditLossesOfFinancialNonCurrentAssets": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Allowance account for credit losses of financial non current assets.", "label": "Allowance Account For Credit Losses Of Financial Non Current Assets", "verboseLabel": "Less: Allowance for credit losses" } } }, "localname": "AllowanceAccountForCreditLossesOfFinancialNonCurrentAssets", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/TradeAndOtherReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "rdy_AllowanceForCreditLossesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Allowance for credit losses.", "label": "Allowance For Credit Losses [Table Text Block]", "terseLabel": "Allowance For Credit Losses [Table Text Block]" } } }, "localname": "AllowanceForCreditLossesTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/TradeAndOtherReceivablesTables" ], "xbrltype": "textBlockItemType" }, "rdy_AllowanceForDoubtfulTradeReceivableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Allowance For Doubtful Trade Receivable [Abstract]" } } }, "localname": "AllowanceForDoubtfulTradeReceivableAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_AllowanceForDoubtfulTradeReceivableLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Allowance For Doubtful Trade Receivable [Line Items]", "terseLabel": "Factoring of receivables [Line Items]" } } }, "localname": "AllowanceForDoubtfulTradeReceivableLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/TradeAndOtherReceivablesDetails1", "http://www.drreddys.com/role/TradeAndOtherReceivablesDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_AllowanceForDoubtfulTradeReceivableTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Allowance For Doubtful Trade Receivable [Table]" } } }, "localname": "AllowanceForDoubtfulTradeReceivableTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/TradeAndOtherReceivablesDetails1", "http://www.drreddys.com/role/TradeAndOtherReceivablesDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_AmendmentToCollaborationAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Amendment to Collaboration Agreement [Member]" } } }, "localname": "AmendmentToCollaborationAgreementMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetails1" ], "xbrltype": "domainItemType" }, "rdy_AmortisedCostOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortised cost of investments in equity instruments designated as measured at fair value through other comprehensive income.", "label": "Amortised Cost Of Investments In Equity Instruments Designated As Measured At Fair Value Through Other Comprehensive Income", "terseLabel": "Cost" } } }, "localname": "AmortisedCostOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetails1" ], "xbrltype": "monetaryItemType" }, "rdy_AmountAwardedAgainstTheArbitrationLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount awarded against the arbitration liability.", "label": "Amount Awarded Against The Arbitration Liability", "terseLabel": "Amount awarded against the arbitration liability" } } }, "localname": "AmountAwardedAgainstTheArbitrationLiability", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_AmountDirectedToBeDepositedByCourt": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount directed to be deposited by court.", "label": "Amount Directed to be Deposited by Court" } } }, "localname": "AmountDirectedToBeDepositedByCourt", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_AmountDischargedAgainstPenalty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of penalty discharged by the company for the recovery of the price charged by the Company for sales of Norfloxacin in excess of the maximum selling price fixed by the NPPA.", "label": "Amount discharged against Penalty" } } }, "localname": "AmountDischargedAgainstPenalty", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_AmountOfSharesAuthorised": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of shares authorised.", "label": "Amount of shares authorised" } } }, "localname": "AmountOfSharesAuthorised", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ShareCapitalDetails" ], "xbrltype": "monetaryItemType" }, "rdy_AnalysisOfAgeOfTradeAndOtherReceivablesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of analysis of age of trade and other receivables.", "label": "Analysis of Age of Trade And Other Receivables [Table Text Block]" } } }, "localname": "AnalysisOfAgeOfTradeAndOtherReceivablesTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementTables" ], "xbrltype": "textBlockItemType" }, "rdy_AncillaryStructuresMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ancillary structures [Member]" } } }, "localname": "AncillaryStructuresMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SignificantAccountingPoliciesDetails1" ], "xbrltype": "domainItemType" }, "rdy_AntiInfectiveOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Anti-Infective", "label": "Anti Infective One [Member]", "verboseLabel": "Anti-Infective [Member]" } } }, "localname": "AntiInfectiveOneMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SegmentReportingDetails3" ], "xbrltype": "domainItemType" }, "rdy_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmounts": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Securities that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share Amounts", "terseLabel": "Antidilutive Securities Excluded From Computation Of Earnings Per Share Amounts" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmounts", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EarningsPerShareDetailsTextual" ], "xbrltype": "sharesItemType" }, "rdy_AntiinfectiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Anti-Infective [Member]", "terseLabel": "Anti-Infective [member]" } } }, "localname": "AntiinfectiveMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails2", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails3", "http://www.drreddys.com/role/SegmentReportingDetails2" ], "xbrltype": "domainItemType" }, "rdy_ArbitationDemandRecordedTowardsMilestonePayments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Arbitation demand for milestone payments.", "label": "Arbitation Demand Recorded Towards Milestone Payments", "terseLabel": "Arbitation demand for milestone payments" } } }, "localname": "ArbitationDemandRecordedTowardsMilestonePayments", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_AssetAcquisitionConsiderationPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Asset acquisition consideration payable.", "label": "Asset Acquisition Consideration Payable", "terseLabel": "Asset acquisition consideration payable" } } }, "localname": "AssetAcquisitionConsiderationPayable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_AssetCategoryAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Asset Category [Axis]" } } }, "localname": "AssetCategoryAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails16", "http://www.drreddys.com/role/EmployeeBenefitsDetails7", "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_AssetCategoryDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Asset Category [Domain]" } } }, "localname": "AssetCategoryDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails16", "http://www.drreddys.com/role/EmployeeBenefitsDetails7", "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_AssetPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Asset Purchase Agreement [Member]", "terseLabel": "Asset Purchase Agreement [Member]" } } }, "localname": "AssetPurchaseAgreementMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_AssetTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Asset Type [Axis]" } } }, "localname": "AssetTypeAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherAssetsDetails" ], "xbrltype": "stringItemType" }, "rdy_AssetTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Asset Type [Domain]" } } }, "localname": "AssetTypeDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherAssetsDetails" ], "xbrltype": "domainItemType" }, "rdy_AssetTypeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Asset Type [Member]", "verboseLabel": "Current" } } }, "localname": "AssetTypeMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherAssetsDetails" ], "xbrltype": "domainItemType" }, "rdy_AssociatedTaxImpactMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Associated tax impact.", "label": "Associated Tax Impact [Member]", "terseLabel": "Associated Tax Impact [Member]" } } }, "localname": "AssociatedTaxImpactMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_AssociationAndDisputeResolutionAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Association And Dispute Resolution [Axis]" } } }, "localname": "AssociationAndDisputeResolutionAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_AssociationAndDisputeResolutionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Association And Dispute Resolution [Domain]" } } }, "localname": "AssociationAndDisputeResolutionDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_AssumptionTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assumption Type [Axis]" } } }, "localname": "AssumptionTypeAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails14", "http://www.drreddys.com/role/EmployeeBenefitsDetails5" ], "xbrltype": "stringItemType" }, "rdy_AssumptionTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assumption Type [Domain]" } } }, "localname": "AssumptionTypeDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails14", "http://www.drreddys.com/role/EmployeeBenefitsDetails5" ], "xbrltype": "domainItemType" }, "rdy_AtFairValueOrAmortizedCostMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "At Fair Value Or Amortized Cost [Member]", "terseLabel": "Fair value / amortized cost [Member]" } } }, "localname": "AtFairValueOrAmortizedCostMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherInvestmentsDetails" ], "xbrltype": "domainItemType" }, "rdy_AurigeneDiscoveryTechnologiesInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aurigene Discovery Technologies, Inc.", "label": "Aurigene Discovery Technologies, Inc. [Member]" } } }, "localname": "AurigeneDiscoveryTechnologiesInc.Member", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_AurigeneDiscoveryTechnologiesIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Aurigene Discovery Technologies Inc. [Member]", "terseLabel": "Aurigene Discovery Technologies Inc. [member]" } } }, "localname": "AurigeneDiscoveryTechnologiesIncMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_AurigeneDiscoveryTechnologiesLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Aurigene Discovery Technologies Limited [Member]", "terseLabel": "Aurigene Discovery Technologies Limited [member]" } } }, "localname": "AurigeneDiscoveryTechnologiesLimitedMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_AurigeneDiscoveryTechnologiesMalaysiaSdnBhdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Aurigene Discovery Technologies Malaysia Sdn. Bhd. [Member]", "terseLabel": "Aurigene Discovery Technologies (Malaysia) Sdn. Bhd. [member]" } } }, "localname": "AurigeneDiscoveryTechnologiesMalaysiaSdnBhdMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_AurigenePharmaceuticalServicesLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Aurigene Pharmaceutical Services Limited [Member]", "terseLabel": "Aurigene Pharmaceutical Services Limited (from September 16, 2019) [Member]", "verboseLabel": "Non-convertible debentures by the APSL subsidiary [Member]" } } }, "localname": "AurigenePharmaceuticalServicesLimitedMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails2", "http://www.drreddys.com/role/LoansAndBorrowingsDetailsTextual", "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_AustralianDollarsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Australian Dollars [Member]" } } }, "localname": "AustralianDollarsMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails4" ], "xbrltype": "domainItemType" }, "rdy_AwardAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Award [Axis]" } } }, "localname": "AwardAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails6", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_AwardDateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Award date.", "label": "Award Date [Axis]" } } }, "localname": "AwardDateAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails5" ], "xbrltype": "stringItemType" }, "rdy_AwardDateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Award date.", "label": "Award Date [Member]" } } }, "localname": "AwardDateMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails5" ], "xbrltype": "domainItemType" }, "rdy_AwardDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Award [Domain]" } } }, "localname": "AwardDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails6", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_BalanceInUnclaimedDividendAndDebentureInterestAccount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "definitionGuidance": "Balance in unclaimed dividend and debenture interest account", "documentation": "Balance in unclaimed dividend and debenture interest account.", "label": "Balance In Unclaimed Dividend And Debenture Interest Account" } } }, "localname": "BalanceInUnclaimedDividendAndDebentureInterestAccount", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/CashAndCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "rdy_BalanceOfSharesThatCanBeAllottedOnExerciseOfOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares in the entity that can be allotted on exercise of options.", "label": "Balance of shares that can be allotted on exercise of options", "verboseLabel": "Balance of shares that can be allotted on exercise of options (B)" } } }, "localname": "BalanceOfSharesThatCanBeAllottedOnExerciseOfOptions", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails" ], "xbrltype": "sharesItemType" }, "rdy_BankGuarantee": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents the amount of bank guarantee.", "label": "Bank Guarantee" } } }, "localname": "BankGuarantee", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_BankGuaranteeDirectedByDelhiHighCourtToBeFurnished": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents the amount of bank guarantee directed by delhi high court.", "label": "Bank Guarantee Directed by Delhi High Court to be Furnished" } } }, "localname": "BankGuaranteeDirectedByDelhiHighCourtToBeFurnished", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_BankOverdraftAndShortTermBorrowings": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of bank overdraft and short term borrowings .", "label": "Bank Overdraft And Short Term Borrowings", "terseLabel": "Bank overdraft, short-term loans and borrowings" } } }, "localname": "BankOverdraftAndShortTermBorrowings", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetails2" ], "xbrltype": "monetaryItemType" }, "rdy_BasicAndDilutedEarningsPerSharesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Basic and diluted earnings per share.", "label": "Basic and Diluted Earnings Per Shares [Abstract]" } } }, "localname": "BasicAndDilutedEarningsPerSharesAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_BasicEarningsPerShareTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).", "label": "Basic Earnings Per Share [Table Text Block]" } } }, "localname": "BasicEarningsPerShareTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "rdy_BasisOfPreparationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basis of preparation of financial statements [Abstract]" } } }, "localname": "BasisOfPreparationOfFinancialStatementsAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_BeforeTaxMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Before tax [Member]" } } }, "localname": "BeforeTaxMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/GoodwillDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_BetaInstitutGemeinnutzigeGmbhMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "beta Institut gemeinnutzige GmbH [Member]" } } }, "localname": "BetaInstitutGemeinnutzigeGmbhMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_BetapharmArzneimittelGmbhMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "betapharm Arzneimittel GmbH [Member]", "terseLabel": "betapharm Arzneimittel GmbH [member]" } } }, "localname": "BetapharmArzneimittelGmbhMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_BioDeliverySciencesInternationalIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bio delivery sciences international inc.", "label": "Bio Delivery Sciences International Inc [Member]", "terseLabel": "Bio delivery sciences international inc [member]" } } }, "localname": "BioDeliverySciencesInternationalIncMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_BondMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Bond [Member]", "terseLabel": "Investment in Bonds [Member]" } } }, "localname": "BondMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherInvestmentsDetails" ], "xbrltype": "domainItemType" }, "rdy_BrandedAndGenericInjectableProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Branded and generic injectable products.", "label": "Branded And Generic Injectable Products [Member]" } } }, "localname": "BrandedAndGenericInjectableProductsMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_BusinessCombinationConsiderationPayableForWorkingCapitalAdjustments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business combination consideration payable for working capital adjustments.", "label": "Business Combination Consideration Payable For Working Capital Adjustments", "terseLabel": "Acquisition date consideration payable for working capital adjustments and other statutory dues" } } }, "localname": "BusinessCombinationConsiderationPayableForWorkingCapitalAdjustments", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_BusinessCombinationContingentConsiderationLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business combination contingent consideration liability.", "label": "Business Combination Contingent Consideration Liability", "terseLabel": "Business combination contingent consideration liability" } } }, "localname": "BusinessCombinationContingentConsiderationLiability", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_BusinessCombinationHoldbackAmountTransferredOrTransferrable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business combination holdback amount transferred or transferrable.", "label": "Business Combination Holdback Amount Transferred Or Transferrable", "terseLabel": "Contingent consideration (Holdback Amount)" } } }, "localname": "BusinessCombinationHoldbackAmountTransferredOrTransferrable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "rdy_BusinessCombinationTimeLimitWithinWhichEarnoutShallBeSettled": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business combination time within which earnout shall be settled.", "label": "Business Combination Time Limit Within Which Earnout Shall Be Settled", "terseLabel": "Business combination time within which earnout shall be settled" } } }, "localname": "BusinessCombinationTimeLimitWithinWhichEarnoutShallBeSettled", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual" ], "xbrltype": "durationItemType" }, "rdy_CardiovascularMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cardiovascular [Member]", "terseLabel": "Cardiovascular [member]" } } }, "localname": "CardiovascularMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails2", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails3", "http://www.drreddys.com/role/SegmentReportingDetails2", "http://www.drreddys.com/role/SegmentReportingDetails3" ], "xbrltype": "domainItemType" }, "rdy_CarryingValueAndFairValueOfFinancialInstrumentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of carrying value and fair value of financial instruments.", "label": "Carrying value and fair value of financial instruments [Table Text Block]", "terseLabel": "Carrying value and fair value of financial instruments" } } }, "localname": "CarryingValueAndFairValueOfFinancialInstrumentsTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "rdy_CashAndCashEquivalentsTableTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The table disclosing entire cash and cash equivalents.", "label": "Cash And Cash Equivalents [Table Text Block]", "verboseLabel": "Cash And Cash Equivalents [Text Block]" } } }, "localname": "CashAndCashEquivalentsTableTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/CashAndCashEquivalentsTables" ], "xbrltype": "textBlockItemType" }, "rdy_CashSettledSharebasedPaymentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Settled Share-based Payment [Member]" } } }, "localname": "CashSettledSharebasedPaymentMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails6", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_CategoriesAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Categories A [Member]" } } }, "localname": "CategoriesAMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_CategoriesBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Categories B [Member]" } } }, "localname": "CategoriesBMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_CategoryAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Category [Axis]" } } }, "localname": "CategoryAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_CategoryBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Category B [Member]" } } }, "localname": "CategoryBMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails" ], "xbrltype": "domainItemType" }, "rdy_CategoryBParValueOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Category B Par Value Options [Member]" } } }, "localname": "CategoryBParValueOptionsMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails1" ], "xbrltype": "domainItemType" }, "rdy_CategoryDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Category [Domain]" } } }, "localname": "CategoryDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_CategoryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Category A [Member]" } } }, "localname": "CategoryMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails2", "http://www.drreddys.com/role/EmployeeStockIncentivePlansTables" ], "xbrltype": "domainItemType" }, "rdy_CateringExpensesPaid": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represent the catering expenses paid.", "label": "Catering Expenses Paid", "verboseLabel": "Catering expenses paid" } } }, "localname": "CateringExpensesPaid", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "rdy_CentralNervousSystemMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Central Nervous System [Member]", "terseLabel": "Nervous System [member]", "verboseLabel": "Nervous System [Member]" } } }, "localname": "CentralNervousSystemMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails3", "http://www.drreddys.com/role/SegmentReportingDetails2", "http://www.drreddys.com/role/SegmentReportingDetails3" ], "xbrltype": "domainItemType" }, "rdy_ChangesInOperatingAssetsAndLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes In operating Assets And Liabilities [Abstract]", "verboseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "ChangesInOperatingAssetsAndLiabilitiesAbstract", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "rdy_ChargebacksMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Chargebacks [Member]" } } }, "localname": "ChargebacksMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails6" ], "xbrltype": "domainItemType" }, "rdy_CheminorEmployeesWelfareTrustsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cheminor Employees Welfare Trusts [Member]", "terseLabel": "Cheminor Employees Welfare Trust [member]" } } }, "localname": "CheminorEmployeesWelfareTrustsMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_CheminorInvestmentsLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cheminor Investments Limited [Member]", "terseLabel": "Cheminor Investments Limited [member]" } } }, "localname": "CheminorInvestmentsLimitedMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_ChirotechTechnologyLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Chirotech Technology Limited [Member]", "terseLabel": "Chirotech Technology Limited [member]" } } }, "localname": "ChirotechTechnologyLimitedMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_CitiusPharmaceuticalsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Citius pharmaceuticals.", "label": "Citius Pharmaceuticals [Member]" } } }, "localname": "CitiusPharmaceuticalsMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_CivilLitigationAndArbitrationWithHatchtechPtyLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Civil Litigation and Arbitration with Hatchtech Pty Limited.", "label": "Civil Litigation and Arbitration with Hatchtech Pty Limited [Member]", "terseLabel": "Civil Litigation and Arbitration with Hatchtech Pty Limited [Member]" } } }, "localname": "CivilLitigationAndArbitrationWithHatchtechPtyLimitedMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_CivilWorks": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represent the civil works.", "label": "Civil works" } } }, "localname": "CivilWorks", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "rdy_ClassOfIntangibleAssetsOtherThanGoodwillOneAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of intangible assets other than goodwill one.", "label": "Class Of Intangible Assets Other Than Goodwill One [Axis]" } } }, "localname": "ClassOfIntangibleAssetsOtherThanGoodwillOneAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_ClassOfIntangibleAssetsOtherThanGoodwillOneDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of Intangible assets other than goodwill one.", "label": "Class Of Intangible Assets Other Than Goodwill One [Domain]" } } }, "localname": "ClassOfIntangibleAssetsOtherThanGoodwillOneDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_ClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of stock.", "label": "Class Of Stock [Axis]" } } }, "localname": "ClassOfStockAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_ClassOfStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of stock.", "label": "Class Of Stock [Member]" } } }, "localname": "ClassOfStockMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_CollaborationAgreementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Collaboration Agreement [Line Items]" } } }, "localname": "CollaborationAgreementLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisInc", "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncTables" ], "xbrltype": "stringItemType" }, "rdy_CollaborationAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Collaboration Agreement [Member]" } } }, "localname": "CollaborationAgreementMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetails1" ], "xbrltype": "domainItemType" }, "rdy_CollaborationLicenseAndOptionAgreementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Collaboration, License and Option Agreement [Abstract]" } } }, "localname": "CollaborationLicenseAndOptionAgreementAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_CollaborationLicenseAndOptionAgreementTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of\u00a0 Collaboration License and Option Agreement", "label": "Collaboration License and Option Agreement [Text Block]", "terseLabel": "Collaboration, License and Option Agreement\u00a0with Curis, Inc" } } }, "localname": "CollaborationLicenseAndOptionAgreementTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisInc" ], "xbrltype": "textBlockItemType" }, "rdy_CompensatedAbsencesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Compensated Absences [Member]" } } }, "localname": "CompensatedAbsencesMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_CompensationAbsenceLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Compensation absence liability.", "label": "Compensation Absence Liability", "terseLabel": "Compensation absence liability" } } }, "localname": "CompensationAbsenceLiability", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_ComponentAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Component [Axis]", "terseLabel": "Component [axis]" } } }, "localname": "ComponentAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_ComponentDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Component [Domain]", "terseLabel": "Component [domain]" } } }, "localname": "ComponentDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_ConsiderationReceivable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Consideration receivable.", "label": "Consideration Receivable", "terseLabel": "Consideration receivable" } } }, "localname": "ConsiderationReceivable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_ConsiderationReceivablePeriodAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consideration receivable period.", "label": "Consideration Receivable Period [Axis]", "terseLabel": "Consideration receivable period [axis" } } }, "localname": "ConsiderationReceivablePeriodAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_ConsiderationReceivablePeriodDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consideration receivable period.", "label": "Consideration Receivable Period [Domain]", "terseLabel": "Consideration receivable period [domain]" } } }, "localname": "ConsiderationReceivablePeriodDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_ConsiderationReceivedForTransferOfXeglyzeProduct": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Consideration received for transfer of Xeglyze Product .", "label": "Consideration Received For Transfer Of Xeglyze Product", "terseLabel": "Consideration Received For Transfer Of Xeglyze Product" } } }, "localname": "ConsiderationReceivedForTransferOfXeglyzeProduct", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_ConsumerProductSafetyCommissionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consumer Product Safety Commission [Member]" } } }, "localname": "ConsumerProductSafetyCommissionMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_ContingentConsiderationpursuantToTheBusinessTransferAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contingent ConsiderationPursuant to the Business Transfer Agreement [Member]" } } }, "localname": "ContingentConsiderationpursuantToTheBusinessTransferAgreementMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails1" ], "xbrltype": "domainItemType" }, "rdy_ContingentPayments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Contingent payments.", "label": "Contingent Payments", "verboseLabel": "Contingent payments" } } }, "localname": "ContingentPayments", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_ContractEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contract Eight [Member]" } } }, "localname": "ContractEightMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ContractEighteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contract Eighteen [Member]", "terseLabel": "Contract Eighteen [Member]" } } }, "localname": "ContractEighteenMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ContractElevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contract Eleven [Member]", "terseLabel": "Contract Eleven [Member]" } } }, "localname": "ContractElevenMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ContractFifteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contract Fifteen [Member]", "terseLabel": "Contract Fifteen [Member]" } } }, "localname": "ContractFifteenMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ContractFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contract Five [Member]" } } }, "localname": "ContractFiveMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ContractFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contract Four [Member]" } } }, "localname": "ContractFourMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ContractFourteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contract Fourteen [Member]", "terseLabel": "Contract Fourteen [Member]" } } }, "localname": "ContractFourteenMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ContractNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contract Nine [Member]", "terseLabel": "Contract Nine [Member]" } } }, "localname": "ContractNineMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ContractNineteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contract Nineteen [Member]", "terseLabel": "Contract Nineteen [Member]" } } }, "localname": "ContractNineteenMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ContractOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contract One [Member]" } } }, "localname": "ContractOneMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ContractSevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contract Seven [Member]" } } }, "localname": "ContractSevenMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ContractSeventeenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contract Seventeen [Member]", "terseLabel": "Contract Seventeen [Member]" } } }, "localname": "ContractSeventeenMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ContractSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contract Six [Member]" } } }, "localname": "ContractSixMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ContractSixteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contract Sixteen [Member]", "terseLabel": "Contract Sixteen [Member]" } } }, "localname": "ContractSixteenMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ContractTenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contract Ten [Member]", "terseLabel": "Contract Ten [Member]" } } }, "localname": "ContractTenMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ContractThirteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contract Thirteen [Member]", "terseLabel": "Contract Thirteen [Member]" } } }, "localname": "ContractThirteenMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ContractThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contract Three [Member]" } } }, "localname": "ContractThreeMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ContractTwelveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contract Twelve [Member]", "terseLabel": "Contract Twelve [Member]" } } }, "localname": "ContractTwelveMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ContractTwentyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contract Twenty Four [Member]" } } }, "localname": "ContractTwentyFourMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ContractTwentyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contract Twenty [Member]", "terseLabel": "Contract Twenty [Member]" } } }, "localname": "ContractTwentyMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ContractTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contract Twenty One [Member]", "terseLabel": "Contract Twenty One [Member]" } } }, "localname": "ContractTwentyOneMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ContractTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contract Twenty Three [Member]" } } }, "localname": "ContractTwentyThreeMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ContractTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contract Twenty Two [Member]" } } }, "localname": "ContractTwentyTwoMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ContractTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contract Two [Member]" } } }, "localname": "ContractTwoMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ContributionTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contribution Type [Axis]" } } }, "localname": "ContributionTypeAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_ContributionTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contribution Type [Domain]" } } }, "localname": "ContributionTypeDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_ContributionTypeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contribution Type [Table]" } } }, "localname": "ContributionTypeTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_ContributionsToPlanByPlanParticipantsDefinedContributionsPlan": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage shows employee and employer contributions for provident fund.", "label": "Contributions to Plan By Plan Participants Defined Contributions Plan", "verboseLabel": "Contributions to Plan By Plan Participants Defined Contributions Plan (Percentage)" } } }, "localname": "ContributionsToPlanByPlanParticipantsDefinedContributionsPlan", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetailsTextual" ], "xbrltype": "percentItemType" }, "rdy_ContributionsTowardsSocialDevelopmentRelatedPartyTransactions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "It represents the amount of contributions towards social development related party transactions.", "label": "Contributions Towards Social Development Related Party Transactions", "verboseLabel": "Contributions towards social development" } } }, "localname": "ContributionsTowardsSocialDevelopmentRelatedPartyTransactions", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "rdy_ConvenienceTranslationRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the convenience translation rate used by the entity.", "label": "Convenience Translation rate" } } }, "localname": "ConvenienceTranslationRate", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/BasisOfPreparationOfFinancialStatementsDetailsTextual" ], "xbrltype": "decimalItemType" }, "rdy_ConvenienceTranslationRates": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the convenience translation rate used by the entity.", "label": "Convenience Translation Rates", "verboseLabel": "Convenience translation into U.S.$ (See note 2(d))" } } }, "localname": "ConvenienceTranslationRates", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "rdy_CostOfRevenuesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cost of Revenues [Member]", "verboseLabel": "Cost of revenues [Member]" } } }, "localname": "CostOfRevenuesMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/NatureOfExpenseDetails", "http://www.drreddys.com/role/SegmentReportingDetails7" ], "xbrltype": "domainItemType" }, "rdy_CostRecognizedInIncomeStatementTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Components of cost recognized in the income statement.", "label": "Cost Recognized in the Income Statement [Text Block]" } } }, "localname": "CostRecognizedInIncomeStatementTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsTables" ], "xbrltype": "textBlockItemType" }, "rdy_CurisIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Curis, Inc. [Member]" } } }, "localname": "CurisIncMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetails", "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetails1", "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetailsTextual", "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncTables" ], "xbrltype": "domainItemType" }, "rdy_CurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Current.", "label": "Current [Abstract]", "terseLabel": "Current" } } }, "localname": "CurrentAbstract", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/TradeAndOtherReceivablesDetails" ], "xbrltype": "stringItemType" }, "rdy_CurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The current and deferred tax relating to items charged or credited directly to equity", "label": "Current and deferred tax relating to items charged or credited directly to equity [Table Text Block]" } } }, "localname": "CurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquityTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "rdy_CurrentAndNonCurrentClassificationPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Current and non current classification", "label": "Current and non current classification [Policy Text Block]", "verboseLabel": "Current and non-current classification" } } }, "localname": "CurrentAndNonCurrentClassificationPolicyTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/BasisOfPreparationOfFinancialStatementsPolicies" ], "xbrltype": "textBlockItemType" }, "rdy_CurrentPortionOfNoncurrentBorrowingsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current portion of non-current borrowings [Abstract]", "terseLabel": "Current portion" } } }, "localname": "CurrentPortionOfNoncurrentBorrowingsAbstract", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails2" ], "xbrltype": "stringItemType" }, "rdy_CurrentTradeAndOtherReceivableGross": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Current trade and other receivable gross.", "label": "Current Trade And Other Receivable Gross", "terseLabel": "Current trade and other receivables, gross" } } }, "localname": "CurrentTradeAndOtherReceivableGross", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/TradeAndOtherReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "rdy_DRANULLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DRANU LLC", "label": "DRANU LLC [Member]" } } }, "localname": "DRANULLCMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_DRL2018PlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DRL 2018 Plan [Member]" } } }, "localname": "DRL2018PlanMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails3", "http://www.drreddys.com/role/EmployeeStockIncentivePlansTables" ], "xbrltype": "domainItemType" }, "rdy_DRLPlanNameAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DRL Plan Name [Axis]" } } }, "localname": "DRLPlanNameAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansTables" ], "xbrltype": "stringItemType" }, "rdy_DRLPlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DRL Plan Name [Domain]" } } }, "localname": "DRLPlanNameDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansTables" ], "xbrltype": "domainItemType" }, "rdy_DebentureRedemptionReserve": { "auth_ref": [], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 22.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debenture redemption reserve.", "label": "Debenture Redemption Reserve", "terseLabel": "Debenture redemption reserve" } } }, "localname": "DebentureRedemptionReserve", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "rdy_DebentureRedemptionReserveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debenture Redemption Reserve [Member]", "label": "Debenture Redemption Reserve [Member]", "terseLabel": "Debenture Redemption Reserve [Member]" } } }, "localname": "DebentureRedemptionReserveMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "domainItemType" }, "rdy_DecreaseInHedgingReserveSensitivityAnalysis": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount represent the decrease in the hedging reserve sensitivity analysis.", "label": "Decrease In Hedging Reserve Sensitivity Analysis" } } }, "localname": "DecreaseInHedgingReserveSensitivityAnalysis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_DecreaseInProfitFromContractsSensitivityAnalysis": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount represent the decrease in profit from contracts sensitivity analysis.", "label": "Decrease In Profit From Contracts Sensitivity Analysis" } } }, "localname": "DecreaseInProfitFromContractsSensitivityAnalysis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_DeferredIncomeTaxesNotRecognizedOnUndistributedEarningsOfSubsidiaries": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "It represents the amount of deferred income taxes not recognized on undistributed earnings of subsidiaries.", "label": "Deferred Income Taxes Not Recognized On Undistributed Earnings Of Subsidiaries", "verboseLabel": "Deferred income taxes not recognized on undistributed earnings of subsidiaries" } } }, "localname": "DeferredIncomeTaxesNotRecognizedOnUndistributedEarningsOfSubsidiaries", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_DeferredTaxAssetsAndLiabilitiesAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred tax assets and liabilities [Axis]" } } }, "localname": "DeferredTaxAssetsAndLiabilitiesAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails5" ], "xbrltype": "stringItemType" }, "rdy_DeferredTaxAssetsAndLiabilitiesDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred tax assets and liabilities [Domain]" } } }, "localname": "DeferredTaxAssetsAndLiabilitiesDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails5" ], "xbrltype": "domainItemType" }, "rdy_DefinedBenefitObligationAtPresentValueWithoutEffectOfSalaryGrowth": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of defined benefit obligation at present value without effect of salary growth.", "label": "Defined benefit obligation at present value without effect of salary growth", "verboseLabel": "Defined benefit obligation without effect of projected salary growth" } } }, "localname": "DefinedBenefitObligationAtPresentValueWithoutEffectOfSalaryGrowth", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails13", "http://www.drreddys.com/role/EmployeeBenefitsDetails4" ], "xbrltype": "monetaryItemType" }, "rdy_DefinedBenefitObligationDueToReasonablyPossibleChangeInActuarialAssumption": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of defined benefit obligation due to reasonably possible change in actuarial assumption.", "label": "Defined Benefit Obligation Due To Reasonably Possible Change In Actuarial Assumption", "terseLabel": "Defined benefit obligation", "verboseLabel": "Defined benefit obligation" } } }, "localname": "DefinedBenefitObligationDueToReasonablyPossibleChangeInActuarialAssumption", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails13", "http://www.drreddys.com/role/EmployeeBenefitsDetails4" ], "xbrltype": "monetaryItemType" }, "rdy_DefinedBenefitObligationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined benefit obligations [Abstract]" } } }, "localname": "DefinedBenefitObligationsAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_DefinedBenefitObligationsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined benefit obligations [Table]" } } }, "localname": "DefinedBenefitObligationsTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails14" ], "xbrltype": "stringItemType" }, "rdy_DemandMadeByCommercialTaxesDepartmentToCompanyExcludingPenaltyAndInterest": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Demand made by Commercial Taxes Department to the company excluding penalty and interest.", "label": "Demand made by Commercial Taxes Department to the company excluding penalty and interest", "terseLabel": "Amount demanded" } } }, "localname": "DemandMadeByCommercialTaxesDepartmentToCompanyExcludingPenaltyAndInterest", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "rdy_DemandMadeByIndianSalesTaxAuthoritiesToCompany": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Demand made by Indian Sales Tax Authorities to the company.", "label": "Demand made by Indian Sales Tax Authorities to the company" } } }, "localname": "DemandMadeByIndianSalesTaxAuthoritiesToCompany", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_DepositMadeOnDemand": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of deposit made on demand.", "label": "Deposit Made On Demand" } } }, "localname": "DepositMadeOnDemand", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_DepositOnDemandForRemediationFee": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of deposit on demand for remediation fee.", "label": "Deposit On Demand For Remediation Fee", "verboseLabel": "Deposit On Demand For Remediation Fee" } } }, "localname": "DepositOnDemandForRemediationFee", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_DerivativeFinanicialAssetsAndLiabilties": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of The amount financial assets and liabilities classified as derivative instruments.", "label": "Derivative Finanicial Assets And Liabilties" } } }, "localname": "DerivativeFinanicialAssetsAndLiabilties", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails1" ], "xbrltype": "monetaryItemType" }, "rdy_DermatologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dermatology [Member]", "terseLabel": "Dermatology [member]" } } }, "localname": "DermatologyMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails2", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails3", "http://www.drreddys.com/role/SegmentReportingDetails2", "http://www.drreddys.com/role/SegmentReportingDetails3" ], "xbrltype": "domainItemType" }, "rdy_DescriptionOfAccountingPolicyForInitialApplicationOfStandardsOrInterpretationsExplanatoryPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description Of Accounting Policy For Initial Application Of Standards Or Interpretations Explanatory .", "label": "Description Of Accounting Policy For Initial Application Of Standards Or Interpretations Explanatory [Policy Text Block]", "verboseLabel": "New Standards adopted by the Company" } } }, "localname": "DescriptionOfAccountingPolicyForInitialApplicationOfStandardsOrInterpretationsExplanatoryPolicyTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "rdy_DescriptionOfAccountingPolicyForShippingAndHandlingCostTextBlockTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the classification of shipping and handling costs.", "label": "Description of accounting policy for Shipping and Handling Cost [Text Block]", "verboseLabel": "Shipping and handling costs" } } }, "localname": "DescriptionOfAccountingPolicyForShippingAndHandlingCostTextBlockTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "rdy_DescriptionOfBusinessAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Description Of Business [Abstract]" } } }, "localname": "DescriptionOfBusinessAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_DescriptionOfConvenienceTranslationIntoUsDollarsTextBlockTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The description of convenience translation into U.S. dollars.", "label": "Description of convenience translation into U.S. dollars [Text Block]", "verboseLabel": "Convenience translation (unaudited)" } } }, "localname": "DescriptionOfConvenienceTranslationIntoUsDollarsTextBlockTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/BasisOfPreparationOfFinancialStatementsPolicies" ], "xbrltype": "textBlockItemType" }, "rdy_DescriptionOfOptionLifeShareOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description Of Option Life Share Options", "label": "Description Of Option Life Share Options", "terseLabel": "Option life" } } }, "localname": "DescriptionOfOptionLifeShareOptions", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails5" ], "xbrltype": "durationItemType" }, "rdy_DescriptionOfSignificantSeparatelyAcquiredIntangibleAssetsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about significant separately acquired Intangible Assets.", "label": "Description Of Significant separately acquired Intangible Assets [Text Block]", "terseLabel": "Description of significant separately acquired Intangible Assets [text block]" } } }, "localname": "DescriptionOfSignificantSeparatelyAcquiredIntangibleAssetsTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "rdy_DetailedInformationAboutEmployeeBenefitPlansLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Detailed Information About Employee Benefit Plans [Line Items]" } } }, "localname": "DetailedInformationAboutEmployeeBenefitPlansLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_DetailsOfDeferredRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Details of deferred revenue.", "label": "Details of Deferred Revenue [Line Items]", "terseLabel": "Details of Deferred revenue" } } }, "localname": "DetailsOfDeferredRevenueLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails5" ], "xbrltype": "stringItemType" }, "rdy_DetailsOfEquityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Details of Equity [Line Items]" } } }, "localname": "DetailsOfEquityLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ShareCapitalDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_DetailsOfEquityTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Details of Equity [Table]" } } }, "localname": "DetailsOfEquityTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ShareCapitalDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_DiabetologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Diabetology [Member]", "label": "Diabetology [Member]" } } }, "localname": "DiabetologyMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails3", "http://www.drreddys.com/role/SegmentReportingDetails3" ], "xbrltype": "domainItemType" }, "rdy_DilutedEarningsPerShareTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares.", "label": "Diluted Earnings Per Share [Table Text Block]" } } }, "localname": "DilutedEarningsPerShareTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisaggregationOfRevenueByGeographicalAreasTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of revenue by different geographic areas.", "label": "Disaggregation Of Revenue By Geographical Areas [Table Text Block]", "verboseLabel": "Analysis of revenues by geography [Table Text block]" } } }, "localname": "DisaggregationOfRevenueByGeographicalAreasTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesTables", "http://www.drreddys.com/role/SegmentReportingTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisallowanceAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disallowance [Axis]" } } }, "localname": "DisallowanceAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_DisallowanceDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disallowance [Domain]" } } }, "localname": "DisallowanceDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_DisclosureAndDetailsAbout2018PlanTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of 2018 plan and its relevent disclosures including fair market value underlying shares.", "label": "Disclosure And Details About 2018 Plan Table Text Block", "terseLabel": "Disclosure And Details About 2018 Plan" } } }, "localname": "DisclosureAndDetailsAbout2018PlanTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureAndDetailsAboutRevenueFromTherapeuticsAreasTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure about revenue from therapeutics areas.", "label": "Disclosure And Details About Revenue From Therapeutics Areas [Table Text Block]", "verboseLabel": "Analysis of revenues within the PSAI segment [Table Text Block]" } } }, "localname": "DisclosureAndDetailsAboutRevenueFromTherapeuticsAreasTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesTables", "http://www.drreddys.com/role/SegmentReportingTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureAndDetailsAboutRevenueWithInGlobalGenericSegmentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure about revenue with in global generic segments.", "label": "Disclosure And Details About Revenue With In Global Generic Segments [Table Text Block]", "terseLabel": "Analysis of revenues within the Global Generics segment [Table Text Block]" } } }, "localname": "DisclosureAndDetailsAboutRevenueWithInGlobalGenericSegmentsTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesTables", "http://www.drreddys.com/role/SegmentReportingTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureEmployeeStockIncentivePlansLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Employee stock incentive plans [Line Items]" } } }, "localname": "DisclosureEmployeeStockIncentivePlansLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansTables" ], "xbrltype": "stringItemType" }, "rdy_DisclosureInterestRateOfShortTermBorrowingsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Interest Rate of Short Term Borrowings [Abstract]" } } }, "localname": "DisclosureInterestRateOfShortTermBorrowingsAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_DisclosureInterestRateOfShortTermBorrowingsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Interest Rate of Short Term Borrowings [Line Items]" } } }, "localname": "DisclosureInterestRateOfShortTermBorrowingsLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails1" ], "xbrltype": "stringItemType" }, "rdy_DisclosureInterestRateOfShortTermBorrowingsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Interest Rate of Short Term Borrowings [Table]" } } }, "localname": "DisclosureInterestRateOfShortTermBorrowingsTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails1" ], "xbrltype": "stringItemType" }, "rdy_DisclosureMergerOfDrReddysHoldingsLimitedIntoDrReddysLaboratoriesLimitedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure merger of dr reddys holdings limited into dr reddys laboratories limited.", "label": "Disclosure Merger Of Dr Reddys Holdings Limited Into Dr Reddys Laboratories Limited [Abstract]" } } }, "localname": "DisclosureMergerOfDrReddysHoldingsLimitedIntoDrReddysLaboratoriesLimitedAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_DisclosureMergerOfDrReddysHoldingsLimitedIntoDrReddysLaboratoriesLimitedLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure Merger of Dr Reddys Holdings Limited into Dr Reddys Laboratories Limited.", "label": "Disclosure Merger of Dr Reddys Holdings Limited into Dr Reddys Laboratories Limited [Line Items]" } } }, "localname": "DisclosureMergerOfDrReddysHoldingsLimitedIntoDrReddysLaboratoriesLimitedLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/MergerOfDrReddySHoldingsLimitedIntoDrReddySLaboratoriesLimitedDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_DisclosureMergerOfDrReddysHoldingsLimitedIntoDrReddysLaboratoriesLimitedTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure Merger of Dr Reddys Holdings Limited into Dr Reddys Laboratories Limited.", "label": "Disclosure Merger of Dr Reddys Holdings Limited into Dr Reddys Laboratories Limited [Table]" } } }, "localname": "DisclosureMergerOfDrReddysHoldingsLimitedIntoDrReddysLaboratoriesLimitedTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/MergerOfDrReddySHoldingsLimitedIntoDrReddySLaboratoriesLimitedDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_DisclosureNotionalAmountOfOutstandingForeignExchangeDerivativeContractsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure notional amount of outstanding foreign exchange derivative contracts [Abstract]" } } }, "localname": "DisclosureNotionalAmountOfOutstandingForeignExchangeDerivativeContractsAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_DisclosureNotionalAmountOfOutstandingForeignExchangeDerivativeContractsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure notional amount of outstanding foreign exchange derivative contracts [Line Items]" } } }, "localname": "DisclosureNotionalAmountOfOutstandingForeignExchangeDerivativeContractsLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "stringItemType" }, "rdy_DisclosureNotionalAmountOfOutstandingForeignExchangeDerivativeContractsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure notional amount of outstanding foreign exchange derivative contracts [Table]" } } }, "localname": "DisclosureNotionalAmountOfOutstandingForeignExchangeDerivativeContractsTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "stringItemType" }, "rdy_DisclosureOfAccrualForTheCompanysNorthAmericaOperationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents tabular disclosure accrual for the companys north america operation.", "label": "Disclosure Of Accrual For The Companys North America Operation [Table Text Block]", "terseLabel": "Details of significant gross to net adjustments relating to Company's North America Generics business [Table Text Block]" } } }, "localname": "DisclosureOfAccrualForTheCompanysNorthAmericaOperationTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfAgingOfTradeAndOtherReceivablesPastDueButNotImpairedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of Aging of trade and other receivables past due but not impaired [Abstract]" } } }, "localname": "DisclosureOfAgingOfTradeAndOtherReceivablesPastDueButNotImpairedAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_DisclosureOfAgingOfTradeAndOtherReceivablesPastDueButNotImpairedLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of Aging of trade and other receivables past due but not impaired [Line Items]" } } }, "localname": "DisclosureOfAgingOfTradeAndOtherReceivablesPastDueButNotImpairedLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetails1" ], "xbrltype": "stringItemType" }, "rdy_DisclosureOfAgingOfTradeAndOtherReceivablesPastDueButNotImpairedTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of Aging of trade and other receivables past due but not impaired [Table]" } } }, "localname": "DisclosureOfAgingOfTradeAndOtherReceivablesPastDueButNotImpairedTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetails1" ], "xbrltype": "stringItemType" }, "rdy_DisclosureOfAnalysisOfCompanysNoncurrentAssetsOtherThanFinancialInstrumentsAndDeferredTaxAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of analysis of Company's non-current assets (other than financial instruments and deferred tax assets).", "label": "Disclosure Of Analysis Of Companys Noncurrent Assets Other Than Financial Instruments And Deferred Tax Assets [Table Text Block]", "terseLabel": "Disclosure of analysis of Company's non-current assets (other than financial instruments and deferred tax assets)[Table Text Block]" } } }, "localname": "DisclosureOfAnalysisOfCompanysNoncurrentAssetsOtherThanFinancialInstrumentsAndDeferredTaxAssetsTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SegmentReportingTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfAnalysisOfDepreciationAndAmortizationIncludedInCostOfRevenuesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It Represents Disclosure of Analysis of depreciation and amortization, included in cost of revenues.", "label": "Disclosure of Analysis of depreciation and amortization, included in cost of revenues [Table Text Block]" } } }, "localname": "DisclosureOfAnalysisOfDepreciationAndAmortizationIncludedInCostOfRevenuesTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SegmentReportingTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfAssumptionsUsedToDetermineBenefitObligationsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of assumptions used to determine benefit obligations.", "label": "Disclosure of assumptions used to determine benefit obligations [Table Text Block]" } } }, "localname": "DisclosureOfAssumptionsUsedToDetermineBenefitObligationsTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfAssumptionsUsedToDetermineDefinedBenefitCostTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of assumptions used to determine the defined benefit cost.", "label": "Disclosure of assumptions used to determine the defined benefit cost [Table Text Block]" } } }, "localname": "DisclosureOfAssumptionsUsedToDetermineDefinedBenefitCostTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfBasisOfConsolidationExplanatoryPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of the basis used for consolidation.", "label": "Disclosure Of Basis Of Consolidation Explanatory [Policy Text Block]", "terseLabel": "Basis of consolidation" } } }, "localname": "DisclosureOfBasisOfConsolidationExplanatoryPolicyTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfBorrowingsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of Borrowings [Line Items]" } } }, "localname": "DisclosureOfBorrowingsLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails2" ], "xbrltype": "stringItemType" }, "rdy_DisclosureOfClassesOfShareCapitalTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of classes of share capital.", "label": "Disclosure Of Classes Of Share Capital [Table Text Block]", "terseLabel": "Disclosure Of Classes Of Share Capital [Text Block]" } } }, "localname": "DisclosureOfClassesOfShareCapitalTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ShareCapitalTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfCollaborationAgreementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Collaboration Agreement [Line Items]" } } }, "localname": "DisclosureOfCollaborationAgreementLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_DisclosureOfCompensationPaidOrPayableToKeyManagementPersonnelTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure Of Compensation Paid Or Payable To Key Management Personnel.", "label": "Disclosure Of Compensation Paid Or Payable To Key Management Personnel [Table Text Block]" } } }, "localname": "DisclosureOfCompensationPaidOrPayableToKeyManagementPersonnelTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RelatedPartiesTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfContractLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of contract liabilities.", "label": "Disclosure Of Contract Liabilities Table Text Block", "terseLabel": "Details of contract liabilities [Table Text Block]" } } }, "localname": "DisclosureOfContractLiabilitiesTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfContractualMaturitiesOfLongTermBorrowingsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of Contractual maturities of Long Term Borrowings [Abstract]" } } }, "localname": "DisclosureOfContractualMaturitiesOfLongTermBorrowingsAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_DisclosureOfContractualMaturitiesOfLongTermBorrowingsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of Contractual maturities of Long Term Borrowings [Line Items]" } } }, "localname": "DisclosureOfContractualMaturitiesOfLongTermBorrowingsLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails4" ], "xbrltype": "stringItemType" }, "rdy_DisclosureOfContractualMaturitiesOfLongTermBorrowingsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of contractual maturities of Long Term Borrowings.", "label": "Disclosure of Contractual maturities of Long-term Borrowings [Table Text Block]", "terseLabel": "Disclosure of Contractual maturities of Long-term Borrowings" } } }, "localname": "DisclosureOfContractualMaturitiesOfLongTermBorrowingsTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfContractualMaturitiesOfSignificantFinancialLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of Contractual Maturities of Significant Financial Liabilities [Abstract]" } } }, "localname": "DisclosureOfContractualMaturitiesOfSignificantFinancialLiabilitiesAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_DisclosureOfContractualMaturitiesOfSignificantFinancialLiabilitiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of Contractual Maturities of Significant Financial Liabilities [Line Items]" } } }, "localname": "DisclosureOfContractualMaturitiesOfSignificantFinancialLiabilitiesLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetails2" ], "xbrltype": "stringItemType" }, "rdy_DisclosureOfContractualMaturitiesOfSignificantFinancialLiabilitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of Contractual Maturities of Significant Financial Liabilities [Table]" } } }, "localname": "DisclosureOfContractualMaturitiesOfSignificantFinancialLiabilitiesTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetails2" ], "xbrltype": "stringItemType" }, "rdy_DisclosureOfDetailInformationAboutOfInventoriesRecognizedInConsolidatedIncomeStatementTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of information of inventories recognized in consolidated income statement.", "label": "Disclosure of detail information about of inventories recognized in consolidated income statement [Text Block]" } } }, "localname": "DisclosureOfDetailInformationAboutOfInventoriesRecognizedInConsolidatedIncomeStatementTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfDetailedInformationAboutDividendsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of detailed information about dividends.", "label": "Disclosure of detailed information about dividends [Table Text Block]" } } }, "localname": "DisclosureOfDetailedInformationAboutDividendsTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ShareCapitalTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfDetailedInformationAboutFairValueMeasurementOfAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about fair value measurement of assets and liabilities.", "label": "Disclosure of detailed information about Fair Value Measurement Of Assets And Liabilities [Table Text Block]", "terseLabel": "Disclosure of detailed information about Fair Value Measurement Of Assets And Liabilities" } } }, "localname": "DisclosureOfDetailedInformationAboutFairValueMeasurementOfAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfDetailedInformationAboutHighlyProbableForecastTransactionsHedgedItemsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of detailed information about highly probable forecast transactions hedged items.", "label": "Disclosure Of Detailed Information About Highly Probable Forecast Transactions Hedged Items [Table Text Block]", "terseLabel": "Disclosure Of Detailed Information About Highly Probable Forecast Transactions Hedged Items" } } }, "localname": "DisclosureOfDetailedInformationAboutHighlyProbableForecastTransactionsHedgedItemsTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatoryTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about intangible assets.", "label": "Disclosure of detailed information about intangible assets explanatory [Text Block]", "verboseLabel": "Disclosure of detailed information about intangible assets explanatory [text block]" } } }, "localname": "DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatoryTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfDetailedInformationAboutIntangibleAssetsUnderDevelopmentTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of detailed information about Intangible assets under development.", "label": "Disclosure Of Detailed Information About Intangible Assets Under Development [Text Block]" } } }, "localname": "DisclosureOfDetailedInformationAboutIntangibleAssetsUnderDevelopmentTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfDetailedInformationAboutInventoriesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about inventories.", "label": "Disclosure of detailed information about inventories [Text Block]" } } }, "localname": "DisclosureOfDetailedInformationAboutInventoriesTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfDetailedInformationAboutJointVentureTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about joint ventures.", "label": "Disclosure of detailed information about joint venture [Table Text Block]" } } }, "localname": "DisclosureOfDetailedInformationAboutJointVentureTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfDetailedInformationAboutOfGainlossRecognizedInRespectOfDerivativeContractsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about of gain/(loss) recognized in Respect of derivative contracts.", "label": "Disclosure of detailed information about of gainloss recognized in Respect of derivative contracts [Table Text Block]", "terseLabel": "Disclosure of detailed information about of gain/loss recognized in Respect of derivative contracts" } } }, "localname": "DisclosureOfDetailedInformationAboutOfGainlossRecognizedInRespectOfDerivativeContractsTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfDetailedInformationAboutOtherAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure Of Detailed Information About Other Assets", "label": "Disclosure Of Detailed Information About Other Assets [Table Text Block]", "verboseLabel": "Disclosure Of Detailed Information About Other Assets [Text Block]" } } }, "localname": "DisclosureOfDetailedInformationAboutOtherAssetsTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherAssetsTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatoryTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about property, plant and equipement.", "label": "Disclosure of detailed information about property plant and equipment explanatory [Text Block]", "terseLabel": "Summary of detailed information about property plant and equipment explanatory" } } }, "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatoryTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfDetailedInformationAboutShareBasedPaymentExpenseLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about share based payment expense [Line Items]" } } }, "localname": "DisclosureOfDetailedInformationAboutShareBasedPaymentExpenseLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails6" ], "xbrltype": "stringItemType" }, "rdy_DisclosureOfDetailedInformationAboutShareBasedPaymentExpenseTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about share based payment expense.", "label": "Disclosure of detailed information about share based payment expense [Text Block]", "terseLabel": "Disclosure of detailed information about share based payment expense" } } }, "localname": "DisclosureOfDetailedInformationAboutShareBasedPaymentExpenseTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfDetailedInformationOfPartialConsiderationUnderCollaborationLicenseAndOptionAgreementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Detailed Information Of Partial Consideration Under Collaboration License And Option Agreement [Abstract]" } } }, "localname": "DisclosureOfDetailedInformationOfPartialConsiderationUnderCollaborationLicenseAndOptionAgreementAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_DisclosureOfDetailedInformationOfPartialConsiderationUnderCollaborationLicenseAndOptionAgreementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Detailed Information Of Partial Consideration Under Collaboration License And Option Agreement [Line Items]" } } }, "localname": "DisclosureOfDetailedInformationOfPartialConsiderationUnderCollaborationLicenseAndOptionAgreementLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetails" ], "xbrltype": "stringItemType" }, "rdy_DisclosureOfDetailedInformationOfPartialConsiderationUnderCollaborationLicenseAndOptionAgreementTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Detailed Information Of Partial Consideration Under Collaboration License And Option Agreement [Table]" } } }, "localname": "DisclosureOfDetailedInformationOfPartialConsiderationUnderCollaborationLicenseAndOptionAgreementTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetails" ], "xbrltype": "stringItemType" }, "rdy_DisclosureOfDetailedInformationOfPartialConsiderationUnderCollaborationLicenseAndOptionAgreementTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of detailed information of partial consideration under collaboration license and option agreement", "label": "Disclosure Of Detailed Information Of Partial Consideration Under Collaboration License and Option Agreement [Text Block]", "verboseLabel": "Summary of partail consideration received under collaboration license and option agreement" } } }, "localname": "DisclosureOfDetailedInformationOfPartialConsiderationUnderCollaborationLicenseAndOptionAgreementTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfDisaggregationOfPlanAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of disaggregation of plan assets.", "label": "Disclosure of Disaggregation of Plan Assets [Table Text Block]" } } }, "localname": "DisclosureOfDisaggregationOfPlanAssetsTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfDistributionOfCompanysPropertyPlantAndEquipmentAcquiredByCountryTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of distribution of the Company's property, plant and equipment acquired by country.", "label": "Disclosure Of Distribution Of Companys Property Plant And Equipment Acquired By Country [Table Text Block]", "terseLabel": "Disclosure of analysis of distribution of the Company's property, plant and equipment including capital work in progress and intangible assets acquired during the year (other than goodwill arising on business combination) [Table Text Block]" } } }, "localname": "DisclosureOfDistributionOfCompanysPropertyPlantAndEquipmentAcquiredByCountryTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SegmentReportingTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfEquitySharesHeldInEquityAccountedInvesteesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about equity shares held in equity accounted investees.", "label": "Disclosure Of Equity Shares Held In Equity Accounted Investees [Table Text Block]" } } }, "localname": "DisclosureOfEquitySharesHeldInEquityAccountedInvesteesTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfEventsAfterReportingPeriodAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Events After Reporting Period [Abstract]" } } }, "localname": "DisclosureOfEventsAfterReportingPeriodAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_DisclosureOfExpectedContributionToPostEmploymentBenefitPlansAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Expected Contribution To Post Employment Benefit Plans [Abstract]" } } }, "localname": "DisclosureOfExpectedContributionToPostEmploymentBenefitPlansAbstract", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails17", "http://www.drreddys.com/role/EmployeeBenefitsDetails8" ], "xbrltype": "stringItemType" }, "rdy_DisclosureOfExpectedContributionToPostEmploymentBenefitPlansLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Expected Contribution To Post Employment Benefit Plans [Line Items]" } } }, "localname": "DisclosureOfExpectedContributionToPostEmploymentBenefitPlansLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails8" ], "xbrltype": "stringItemType" }, "rdy_DisclosureOfExpectedFutureBenefitPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Expected Future Benefit Payments [Abstract]" } } }, "localname": "DisclosureOfExpectedFutureBenefitPaymentsAbstract", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails17", "http://www.drreddys.com/role/EmployeeBenefitsDetails8" ], "xbrltype": "stringItemType" }, "rdy_DisclosureOfExpectedFutureCashFlowsInRespectOfGratuityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of Expected future Cash Flows in respect of Gratuity [Abstract]" } } }, "localname": "DisclosureOfExpectedFutureCashFlowsInRespectOfGratuityAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_DisclosureOfExpectedFutureCashFlowsInRespectOfGratuityTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of Expected future Cash Flows in respect of Gratuity [Table]" } } }, "localname": "DisclosureOfExpectedFutureCashFlowsInRespectOfGratuityTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails8" ], "xbrltype": "stringItemType" }, "rdy_DisclosureOfExpectedFutureCashFlowsInRespectOfPostemploymentBenefitsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of expected future cash flows in respect of post-employment benefits", "label": "Disclosure Of Expected Future Cash Flows In Respect Of Post-employment Benefits [Text Block]" } } }, "localname": "DisclosureOfExpectedFutureCashFlowsInRespectOfPostemploymentBenefitsTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Fair Value Measurement Of Assets And Liabilities [Abstract]" } } }, "localname": "DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_DisclosureOfFinancialRiskManagementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Financial Risk Management [Abstract]" } } }, "localname": "DisclosureOfFinancialRiskManagementAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_DisclosureOfForeignCurrencyRiskFromNonderivativeFinancialInstrumentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of foreign currency risk from non-derivative financial instruments [Abstract]" } } }, "localname": "DisclosureOfForeignCurrencyRiskFromNonderivativeFinancialInstrumentsAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_DisclosureOfForeignCurrencyRiskFromNonderivativeFinancialInstrumentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of foreign currency risk from non-derivative financial instruments [Line Items]" } } }, "localname": "DisclosureOfForeignCurrencyRiskFromNonderivativeFinancialInstrumentsLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetails" ], "xbrltype": "stringItemType" }, "rdy_DisclosureOfForeignCurrencyRiskFromNonderivativeFinancialInstrumentsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of foreign currency risk from non-derivative financial instruments [Table]" } } }, "localname": "DisclosureOfForeignCurrencyRiskFromNonderivativeFinancialInstrumentsTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetails" ], "xbrltype": "stringItemType" }, "rdy_DisclosureOfForeignCurrencyRiskFromNonderivativeFinancialInstrumentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of foreign currency risk from non-derivative financial instruments.", "label": "Disclosure of foreign currency risk from non-derivative financial instruments [Table Text Block]" } } }, "localname": "DisclosureOfForeignCurrencyRiskFromNonderivativeFinancialInstrumentsTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfFutureCashFlowsInRespectOfPostemploymentBenefitPlansTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of future cash flows in respect of post-employment benefit plans [Table]" } } }, "localname": "DisclosureOfFutureCashFlowsInRespectOfPostemploymentBenefitPlansTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails17" ], "xbrltype": "stringItemType" }, "rdy_DisclosureOfImpactOfCovid19Abstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of Impact of COVID19", "label": "Disclosure of Impact of COVID19 [Abstract]" } } }, "localname": "DisclosureOfImpactOfCovid19Abstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_DisclosureOfImpactOfCovid19AndMilitaryConflictBetweenRussiaAndUkraineExplanatoryTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for impact of covid-19 and military conflict between Russia and Ukraine", "label": "Disclosure Of Impact Of COVID 19 and military conflict between Russia and Ukraine Explanatory [Text Block]", "verboseLabel": "Impact of COVID-19 and military conflict between Russia and Ukraine" } } }, "localname": "DisclosureOfImpactOfCovid19AndMilitaryConflictBetweenRussiaAndUkraineExplanatoryTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ImpactOfCovid19AndMilitaryConflictBetweenRussiaAndUkraine" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfIncomeTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of income tax [Abstract]" } } }, "localname": "DisclosureOfIncomeTaxAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_DisclosureOfIncomeTaxLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of income tax [Line Items]" } } }, "localname": "DisclosureOfIncomeTaxLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "rdy_DisclosureOfIncomeTaxTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of income tax [Table]" } } }, "localname": "DisclosureOfIncomeTaxTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "rdy_DisclosureOfIncomeTaxTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of income tax recorded in the income statement.", "label": "Disclosure of income tax [Table Text Block]" } } }, "localname": "DisclosureOfIncomeTaxTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfInformationForCashGeneratingUnitsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule disclosing information related to cash-generating units.", "label": "Disclosure of Information for Cash generating Units [Table Text Block]" } } }, "localname": "DisclosureOfInformationForCashGeneratingUnitsTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/GoodwillTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfIntangibleAssetsAcquiredAsPartOfCollaborationAgreementTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Intangible Assets Acquired As Part Of Collaboration Agreement [Table]" } } }, "localname": "DisclosureOfIntangibleAssetsAcquiredAsPartOfCollaborationAgreementTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_DisclosureOfInterestRateProfileOfLongTermBorrowingsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of Interest Rate Profile of Long Term Borrowings [Line Items]" } } }, "localname": "DisclosureOfInterestRateProfileOfLongTermBorrowingsLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails3" ], "xbrltype": "stringItemType" }, "rdy_DisclosureOfInterestRateProfileOfLongtermBorrowingsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of interest rate profile of long-term borrowings.", "label": "Disclosure of interest rate profile of long-term borrowings [Table Text Block]", "terseLabel": "Disclosure of interest rate profile of long-term borrowings" } } }, "localname": "DisclosureOfInterestRateProfileOfLongtermBorrowingsTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfInterestRateProfileOfShortTermBorrowingsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for interest rate profile of short term borrowings.", "label": "Disclosure of Interest Rate Profile of Short-term Borrowings [Table Text Block]", "terseLabel": "Disclosure of Interest Rate Profile of Short-term Borrowings" } } }, "localname": "DisclosureOfInterestRateProfileOfShortTermBorrowingsTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of investments other than investments accounted for using equity method [Abstract]" } } }, "localname": "DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of investments other than investments accounted for using equity method.", "label": "Disclosure of investments other than investments accounted for using equity method [Table Text Block]" } } }, "localname": "DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherInvestmentsTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfKeyManagementPersonnelCompensationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Key Management Personnel Compensation [Abstract]" } } }, "localname": "DisclosureOfKeyManagementPersonnelCompensationAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_DisclosureOfKeyManagementPersonnelCompensationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Key Management Personnel Compensation [Line Items]" } } }, "localname": "DisclosureOfKeyManagementPersonnelCompensationLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RelatedPartiesDetails2" ], "xbrltype": "stringItemType" }, "rdy_DisclosureOfKeyManagementPersonnelCompensationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Key Management Personnel Compensation [Table]" } } }, "localname": "DisclosureOfKeyManagementPersonnelCompensationTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RelatedPartiesDetails2" ], "xbrltype": "stringItemType" }, "rdy_DisclosureOfLongTermBorrowingsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of Long Term Borrowings [Abstract]" } } }, "localname": "DisclosureOfLongTermBorrowingsAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_DisclosureOfLongTermBorrowingsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of Long Term Borrowings [Table]" } } }, "localname": "DisclosureOfLongTermBorrowingsTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails2", "http://www.drreddys.com/role/LoansAndBorrowingsDetails3" ], "xbrltype": "stringItemType" }, "rdy_DisclosureOfLongTermBorrowingsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for Long Term Borrowings.", "label": "Disclosure of Long-term Borrowings [Table Text Block]", "terseLabel": "Disclosure of Long-term Borrowings" } } }, "localname": "DisclosureOfLongTermBorrowingsTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfMergerOfDrReddysHoldingsLimitedInToDrReddysLaboratoriesLimitedExplanatoryTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure Of Merger Of Dr ReddyS Holdings Limited Into Dr ReddyS Laboratories Limited Explanatory.", "label": "Disclosure Of Merger Of Dr ReddyS Holdings Limited In To Dr ReddyS Laboratories Limited Explanatory [Text Block]", "verboseLabel": "Merger of Dr. Reddy's Holdings Limited into Dr. Reddy's Laboratories Limited" } } }, "localname": "DisclosureOfMergerOfDrReddysHoldingsLimitedInToDrReddysLaboratoriesLimitedExplanatoryTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/MergerOfDrReddySHoldingsLimitedIntoDrReddySLaboratoriesLimited" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfMovementInDeferredTaxAssetsAndLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Movement in deferred tax assets and liabilities [Abstract]" } } }, "localname": "DisclosureOfMovementInDeferredTaxAssetsAndLiabilitiesAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_DisclosureOfMovementInDeferredTaxAssetsAndLiabilitiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Movement in deferred tax assets and liabilities [Line Items]" } } }, "localname": "DisclosureOfMovementInDeferredTaxAssetsAndLiabilitiesLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails5", "http://www.drreddys.com/role/IncomeTaxesDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_DisclosureOfMovementInDeferredTaxAssetsAndLiabilitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Movement in deferred tax assets and liabilities [Table]" } } }, "localname": "DisclosureOfMovementInDeferredTaxAssetsAndLiabilitiesTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails5", "http://www.drreddys.com/role/IncomeTaxesDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_DisclosureOfMovementInDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of movement in deferred tax assets and liabilities.", "label": "Disclosure Of Movement in deferred tax assets and liabilities [Table Text Block]" } } }, "localname": "DisclosureOfMovementInDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfNatureOfBusinessExplanatoryTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of the nature of business explanatory.", "label": "Disclosure Of Nature Of Business Explanatory [Text Block]", "verboseLabel": "Disclosure Of Nature Of Business Explanatory" } } }, "localname": "DisclosureOfNatureOfBusinessExplanatoryTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ReportingEntity" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfNotionalAmountOfOutstandingForeignExchangeDerivativeContractsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of notional amount of outstanding foreign exchange derivative contracts.", "label": "Disclosure of notional amount of outstanding foreign exchange derivative contracts [Table Text Block]", "terseLabel": "Disclosure of notional amount of outstanding foreign exchange derivative contracts" } } }, "localname": "DisclosureOfNotionalAmountOfOutstandingForeignExchangeDerivativeContractsTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfNumberOfOptionsReservedTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of number of options reserved.", "label": "Disclosure Of Number Of Options Reserved [Table Text Block]", "terseLabel": "Disclosure of Number of Options Reserved" } } }, "localname": "DisclosureOfNumberOfOptionsReservedTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfNumberOfShareOptionsWeightedAverageExercisePriceRangeOfExercisePricesAndWeightedAverageRemainingContractualLifeTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of the number, weighted average exercise price, range of exercise prices and weighted average remaining contractual life of outstanding share options", "label": "Disclosure Of Number Of Share Options, Weighted Average Exercise Price, Range Of Exercise Prices And Weighted Average Remaining Contractual Life [Text Block]", "terseLabel": "Disclosure Of Number Of Share Options, Weighted Average Exercise Price, Range Of Exercise Prices And Weighted Average Remaining Contractual Life" } } }, "localname": "DisclosureOfNumberOfShareOptionsWeightedAverageExercisePriceRangeOfExercisePricesAndWeightedAverageRemainingContractualLifeTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfOperatingSegmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Operating Segment [Line Items]" } } }, "localname": "DisclosureOfOperatingSegmentLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SegmentReportingDetails3" ], "xbrltype": "stringItemType" }, "rdy_DisclosureOfOperatingSegmentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating segments.", "label": "Disclosure of operating segments [Table Text Block]" } } }, "localname": "DisclosureOfOperatingSegmentsTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SegmentReportingTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfOtherLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of Other Liabilities [Abstract]" } } }, "localname": "DisclosureOfOtherLiabilitiesAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_DisclosureOfProvisionTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of provision.", "label": "Disclosure of Provision [Table Text Block]", "verboseLabel": "Disclosure of Provision" } } }, "localname": "DisclosureOfProvisionTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ProvisionsTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfReconciliationOfChangesInGoodwillTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule disclosing information related to the reconciliation of changes in goodwill.", "label": "Disclosure of reconciliation of changes in goodwill [Table Text Block]" } } }, "localname": "DisclosureOfReconciliationOfChangesInGoodwillTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/GoodwillTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfReconciliationOfDeferredRevenueTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents tabular disclosure reconciliation of deferred revenue.", "label": "Disclosure Of Reconciliation Of Deferred Revenue [Table Text Block]", "terseLabel": "Details of deferred revenue [Table Text Block]" } } }, "localname": "DisclosureOfReconciliationOfDeferredRevenueTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfRegulatoryInspectionOfFacilitiesExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of regulatory inspection of facilities explanatory text Block.", "label": "Disclosure Of Regulatory Inspection Of Facilities Explanatory", "terseLabel": "Regulatory Inspection of facilities" } } }, "localname": "DisclosureOfRegulatoryInspectionOfFacilitiesExplanatory", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RegulatoryInspectionOfFacilities" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfRevenueBySegmentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of revenue by segments.", "label": "Disclosure Of Revenue By Segments [Table Text Block]", "terseLabel": "Analysis of revenues by segments [Table Text Block]" } } }, "localname": "DisclosureOfRevenueBySegmentsTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfSensitivityAnalysisForActuarialAssumptionTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Sensitivity Analysis For Actuarial Assumption [Table]" } } }, "localname": "DisclosureOfSensitivityAnalysisForActuarialAssumptionTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails13" ], "xbrltype": "stringItemType" }, "rdy_DisclosureOfShareBasedPaymentArrangementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Share based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfShareBasedPaymentArrangementAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_DisclosureOfShareCapitalExplanatoryAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of Share Capital Explanatory [Abstract]" } } }, "localname": "DisclosureOfShareCapitalExplanatoryAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_DisclosureOfShortTermBorrowingsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of Short Term Borrowings [Abstract]" } } }, "localname": "DisclosureOfShortTermBorrowingsAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_DisclosureOfShortTermBorrowingsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of Short Term Borrowings [Line Items]" } } }, "localname": "DisclosureOfShortTermBorrowingsLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails" ], "xbrltype": "stringItemType" }, "rdy_DisclosureOfShortTermBorrowingsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of Short Term Borrowings [Table]" } } }, "localname": "DisclosureOfShortTermBorrowingsTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails", "http://www.drreddys.com/role/LoansAndBorrowingsDetails5" ], "xbrltype": "stringItemType" }, "rdy_DisclosureOfShortTermBorrowingsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of short term borrowings.", "label": "Disclosure of Short Term Borrowings [Table Text Block]", "terseLabel": "Disclosure of Short Term Borrowings" } } }, "localname": "DisclosureOfShortTermBorrowingsTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfShowCauseNoticesIssuedByCommercialTaxesDepartmentRegardingVatInputCreditTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosures of the show cause notices issued by Commercial Taxes Department regarding VAT input credit.", "label": "Disclosure of the show cause notices issued by Commercial Taxes Department regarding VAT input credit [Table Text Block]" } } }, "localname": "DisclosureOfShowCauseNoticesIssuedByCommercialTaxesDepartmentRegardingVatInputCreditTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfSignificantInvestmentsInSubsidiariesAssociatesAndJointVenturesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Significant Investments In Subsidiaries Associates And Joint Ventures [Abstract]" } } }, "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesAssociatesAndJointVenturesAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_DisclosureOfSignificantInvestmentsInSubsidiariesAssociatesAndJointVenturesExplanatoryTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organizational structure.", "label": "Disclosure Of Significant Investments In Subsidiaries Associates And Joint Ventures Explanatory [Text Block]", "verboseLabel": "Organizational structure" } } }, "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesAssociatesAndJointVenturesExplanatoryTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructure" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatoryAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Summary Of Significant Accounting Policies Explanatory [Abstract]" } } }, "localname": "DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatoryAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_DisclosureOfTaxEffectsOfSignificantTemporaryDifferencesThatResultedInDeferredTaxTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of tax effects of significant temporary differences that resulted in deferred tax.", "label": "Disclosure of Tax Effects of Significant Temporary Differences That Resulted In Deferred Tax [Table Text Block]" } } }, "localname": "DisclosureOfTaxEffectsOfSignificantTemporaryDifferencesThatResultedInDeferredTaxTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfTemporaryDifferencesInDeferredTaxAssetsAndLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of temporary differences in deferred tax assets and liabilities [Abstract]" } } }, "localname": "DisclosureOfTemporaryDifferencesInDeferredTaxAssetsAndLiabilitiesAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_DisclosureOfTemporaryDifferencesInDeferredTaxAssetsAndLiabilitiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of temporary differences in deferred tax assets and liabilities [Line Items]" } } }, "localname": "DisclosureOfTemporaryDifferencesInDeferredTaxAssetsAndLiabilitiesLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails4" ], "xbrltype": "stringItemType" }, "rdy_DisclosureOfTemporaryDifferencesInDeferredTaxAssetsAndLiabilitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of temporary differences in deferred tax assets and liabilities [Table]" } } }, "localname": "DisclosureOfTemporaryDifferencesInDeferredTaxAssetsAndLiabilitiesTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails4" ], "xbrltype": "stringItemType" }, "rdy_DisclosureOfTheCodeOnSocialSecurity2020Abstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of the code on social security 2020.", "label": "Disclosure Of The Code on Social Security 2020 [Abstract]" } } }, "localname": "DisclosureOfTheCodeOnSocialSecurity2020Abstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_DisclosureOfTheCodeOnSocialSecurity2020TextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of the code on social security 2020.", "label": "Disclosure Of The Code on Social Security 2020 [Text Block]", "verboseLabel": "The Code on Social Security, 2020" } } }, "localname": "DisclosureOfTheCodeOnSocialSecurity2020TextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/TheCodeOnSocialSecurity2020" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfUnrecognisedDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of unrecognized deferred tax assets and liabilities", "label": "Disclosure of Unrecognised Deferred Tax Assets and Liabilities [Table Text Block]" } } }, "localname": "DisclosureOfUnrecognisedDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfUsefulLivesOrAmortisationRatesIntangibleAssetsOtherThanGoodwillTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of useful lives or amortisation rates, intangible assets other than goodwill.", "label": "Disclosure of useful lives or amortisation rates, intangible assets other than goodwill [Table Text Block]" } } }, "localname": "DisclosureOfUsefulLivesOrAmortisationRatesIntangibleAssetsOtherThanGoodwillTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfUsefulLivesOrDepreciationRatesPropertyPlantAndEquipmentTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of useful lives or depreciation rates, property, plant and equipment.", "label": "Disclosure of useful lives or depreciation rates, property, plant and equipment [Table Text Block]" } } }, "localname": "DisclosureOfUsefulLivesOrDepreciationRatesPropertyPlantAndEquipmentTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureOfupdateOnCyberIncidentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about \u00a0update on cyber incident.", "label": "Disclosure of Update on Cyber Incident [Abstract]" } } }, "localname": "DisclosureOfupdateOnCyberIncidentAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_DisclosureOfupdateOnCyberIncidentTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about \u00a0update on cyber incident.", "label": "Disclosure of Update on Cyber Incident [Text Block]", "terseLabel": "Update on Cyber Incident" } } }, "localname": "DisclosureOfupdateOnCyberIncidentTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/UpdateOnCyberIncident" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosureWeightedAverageInputsUsedFairValueOfOptionsGrantedTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure weighted average inputs used fair value of options granted [Table]" } } }, "localname": "DisclosureWeightedAverageInputsUsedFairValueOfOptionsGrantedTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails5" ], "xbrltype": "stringItemType" }, "rdy_DisclosureofChangesInPresentValueOfDefinedBenefitObligationsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosureof changes in the present value of defined benefit obligations", "label": "Disclosureof changes in the present value of defined benefit obligations [Table Text Block]", "verboseLabel": "Disclosure of changes in the present value of defined benefit obligations [Text Block]" } } }, "localname": "DisclosureofChangesInPresentValueOfDefinedBenefitObligationsTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsTables" ], "xbrltype": "textBlockItemType" }, "rdy_DisclosuresOfGeographicalAreasLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosures Of Geographical Areas [Line Items]" } } }, "localname": "DisclosuresOfGeographicalAreasLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SegmentReportingDetails4" ], "xbrltype": "stringItemType" }, "rdy_DiscountRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Discount rate [Member]", "verboseLabel": "Discount rate" } } }, "localname": "DiscountRateMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails13", "http://www.drreddys.com/role/EmployeeBenefitsDetails4" ], "xbrltype": "domainItemType" }, "rdy_DisposalsAndDerecognitionsIntangibleAssetsOtherThanGoodwillUponSettlementOfCivilLitigationAndArbitationRelatingToAcquisitionOfProduct": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Disposals And Derecognitions Intangible Assets Other Than Goodwill Upon Settlement Of Civil Litigation And Arbitation Relating To Acquisition Of Product.", "label": "Disposals And Derecognitions Intangible Assets Other Than Goodwill Upon Settlement Of Civil Litigation And Arbitation Relating To Acquisition Of Product", "terseLabel": "Disposals and derecognitions intangible assets other than goodwill upon settlement of civil litigation and arbitation relating to acquisition of product" } } }, "localname": "DisposalsAndDerecognitionsIntangibleAssetsOtherThanGoodwillUponSettlementOfCivilLitigationAndArbitationRelatingToAcquisitionOfProduct", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_DisposalsRightofuseAssets": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The decrease in right-of-use assets resulting from disposals.", "label": "Disposals Rightofuse Assets", "terseLabel": "Disposals" } } }, "localname": "DisposalsRightofuseAssets", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails1" ], "xbrltype": "monetaryItemType" }, "rdy_DividendDistributionTaxOnDividendPaid": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of dividend distribution tax calculated on dividend paid for the year.", "label": "Dividend distribution tax on the dividend paid", "verboseLabel": "Dividend distribution tax on the dividend paid" } } }, "localname": "DividendDistributionTaxOnDividendPaid", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ShareCapitalDetails1" ], "xbrltype": "monetaryItemType" }, "rdy_Dr.ReddysLaboratoriesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dr. Reddy's Laboratories LLC member.", "label": "Dr. Reddys Laboratories LLC [Member]" } } }, "localname": "Dr.ReddysLaboratoriesLlcMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_DrReddysBeijingPharmaceuticalCoLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dr reddys beijing pharmaceutical co limited .", "label": "Dr Reddys Beijing Pharmaceutical Co Limited [Member]", "terseLabel": "Dr. Reddy's (Beijing) Pharmaceutical Co. Limited (from August 19, 2020)" } } }, "localname": "DrReddysBeijingPharmaceuticalCoLimitedMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_DrReddysEmployeesStockOptionScheme2018Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dr Reddys Employees Stock Option Scheme 2018 [Member]" } } }, "localname": "DrReddysEmployeesStockOptionScheme2018Member", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ShareCapitalDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_DrReddysFormulationsLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dr reddys formulations limited.", "label": "Dr. Reddy's Formulations Limited (from March 11, 2021)" } } }, "localname": "DrReddysFormulationsLimitedMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_DrReddysHoldingsLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dr. Reddy's Holdings Limited.", "label": "Dr Reddys Holdings Limited [Member]", "verboseLabel": "Dr Reddys Holdings Limited [Member]" } } }, "localname": "DrReddysHoldingsLimitedMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/MergerOfDrReddySHoldingsLimitedIntoDrReddySLaboratoriesLimitedDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_DrReddysLaboratoriesBvFormerlyEuobridgeConsultingBvMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dr Reddys Laboratories BV Formerly Euobridge Consulting BV [Member]", "terseLabel": "Dr. Reddys Laboratories B.V." } } }, "localname": "DrReddysLaboratoriesBvFormerlyEuobridgeConsultingBvMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_DrReddysLaboratoriesChileSpaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dr. Reddy's Laboratories Chile SPA. [Member]", "verboseLabel": "Dr. Reddy's Laboratories Chile SPA. [Member]" } } }, "localname": "DrReddysLaboratoriesChileSpaMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_DrReddysLaboratoriesEsosTrustMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dr Reddys Laboratories ESOS Trust [Member]", "verboseLabel": "Dr. Reddy's Employees ESOS Trust (from July 27, 2018)" } } }, "localname": "DrReddysLaboratoriesEsosTrustMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_DrReddysLaboratoriesJapanKkMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dr. Reddy's Laboratories Japan KK [Member]", "terseLabel": "Dr. Reddy's Laboratories Japan KK [member]" } } }, "localname": "DrReddysLaboratoriesJapanKkMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_DrReddysLaboratoriesKazakhstanLlpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dr Reddys Laboratories Kazakhstan LLP [Member]" } } }, "localname": "DrReddysLaboratoriesKazakhstanLlpMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_DrReddysLaboratoriesMalaysiaSdnBhdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dr. Reddy's Laboratories Malaysia Sdn. Bhd. [Member]" } } }, "localname": "DrReddysLaboratoriesMalaysiaSdnBhdMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_DrReddysLaboratoriesPhilippinesMemberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dr Reddys Laboratories Philippines Member [Member]", "verboseLabel": "Dr. Reddy's Laboratories Philippines Inc." } } }, "localname": "DrReddysLaboratoriesPhilippinesMemberMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_DrReddysLaboratoriesSasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dr. Reddy's laboratories sas [Member]", "terseLabel": "Dr. Reddy's Laboratories SAS [member]" } } }, "localname": "DrReddysLaboratoriesSasMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_DrReddysLaboratoriesTaiwanLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dr. Reddy's Laboratories Taiwan Limited [Member]", "verboseLabel": "Dr. Reddy's Laboratories Taiwan Limited [Member]" } } }, "localname": "DrReddysLaboratoriesTaiwanLimitedMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_DrReddysLaboratoriesThailandMemberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dr Reddys LaboratoriesThailand Member [Member]", "verboseLabel": "Dr. Reddy's Laboratories (Thailand) Limited" } } }, "localname": "DrReddysLaboratoriesThailandMemberMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_DrReddysSrlMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dr Reddys SRL [Member]", "terseLabel": "Dr. Reddy's SRL [member]" } } }, "localname": "DrReddysSrlMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_DrReddyswuxiPharmaceuticalCompanyLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dr Reddys WUXI Pharmaceutical Company Limited [Member]", "verboseLabel": "Dr. Reddy's (WUXI) Pharmaceutical Company Limited [member]" } } }, "localname": "DrReddyswuxiPharmaceuticalCompanyLimitedMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_DresEnergyPrivateLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DRES energy private limited [Member]", "terseLabel": "DRES Energy Private Limited [member]" } } }, "localname": "DresEnergyPrivateLimitedMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails2", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesTables", "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_Drl2002PlanAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DRL 2002 Plan [Axis]" } } }, "localname": "Drl2002PlanAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails1", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetailsTextual", "http://www.drreddys.com/role/EmployeeStockIncentivePlansTables" ], "xbrltype": "stringItemType" }, "rdy_Drl2002PlanDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DRL 2002 Plan [Domain]" } } }, "localname": "Drl2002PlanDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails1", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetailsTextual", "http://www.drreddys.com/role/EmployeeStockIncentivePlansTables" ], "xbrltype": "domainItemType" }, "rdy_Drl2002PlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DRL 2002 Plan [Member]", "terseLabel": "DRL 2002 Plan [Member]" } } }, "localname": "Drl2002PlanMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails1", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetailsTextual", "http://www.drreddys.com/role/EmployeeStockIncentivePlansTables", "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_Drl2007PlanAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DRL 2007 Plan [Axis]" } } }, "localname": "Drl2007PlanAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails1", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails2", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetailsTextual", "http://www.drreddys.com/role/EmployeeStockIncentivePlansTables" ], "xbrltype": "stringItemType" }, "rdy_Drl2007PlanDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DRL 2007 Plan [Domain]" } } }, "localname": "Drl2007PlanDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails1", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails2", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetailsTextual", "http://www.drreddys.com/role/EmployeeStockIncentivePlansTables" ], "xbrltype": "domainItemType" }, "rdy_Drl2007PlansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DRL 2007 Plans [Member]" } } }, "localname": "Drl2007PlansMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetailsTextual", "http://www.drreddys.com/role/EmployeeStockIncentivePlansTables", "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_Drl2018PlanNameAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Drl 2018 Plan Name [Axis]" } } }, "localname": "Drl2018PlanNameAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails4", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_Drl2018PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DRL 2018 Plan Name [Domain]" } } }, "localname": "Drl2018PlanNameDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails4", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_DrlAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DRL [Axis]" } } }, "localname": "DrlAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails" ], "xbrltype": "stringItemType" }, "rdy_DrlDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DRL [Domain]" } } }, "localname": "DrlDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails" ], "xbrltype": "domainItemType" }, "rdy_DrlImpexLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DRL Impex Limited [Member]", "terseLabel": "DRL Impex Limited [member]" } } }, "localname": "DrlImpexLimitedMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_DrlTwoThousandEighteenPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Drl Two Thousand Eighteen Plan [Member]", "terseLabel": "DRL Two Thousand Eighteen Plan [Member]" } } }, "localname": "DrlTwoThousandEighteenPlanMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails4", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_DrlTwoThousandSevenPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DRL Two Thousand Seven Plan [Member]", "terseLabel": "DRL 2007 Plan [Member]", "verboseLabel": "DRL 2007 Plan [Member]" } } }, "localname": "DrlTwoThousandSevenPlanMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails1", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails2" ], "xbrltype": "domainItemType" }, "rdy_DrreddysBiosciencesLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dr. Reddy's Bio-Sciences Limited [Member]", "terseLabel": "Dr. Reddy's Bio-Sciences Limited [member]" } } }, "localname": "DrreddysBiosciencesLimitedMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_DrreddysFarmaceuticaDoBrasilLtdaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dr. Reddy's Farmaceutica Do Brasil Ltda. [Member]", "terseLabel": "Dr. Reddy's Farmaceutica Do Brasil Ltda. [member]" } } }, "localname": "DrreddysFarmaceuticaDoBrasilLtdaMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_DrreddysLaboratoriesAustraliaPtyLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dr. Reddy's Laboratories Australia Pty. Limited [Member]", "terseLabel": "Dr. Reddy's Laboratories (Australia) Pty. Limited [member]" } } }, "localname": "DrreddysLaboratoriesAustraliaPtyLimitedMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_DrreddysLaboratoriesCanadaIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dr. Reddy's Laboratories Canada, Inc. [Member]", "terseLabel": "Dr. Reddy's Laboratories Canada, Inc. [member]" } } }, "localname": "DrreddysLaboratoriesCanadaIncMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_DrreddysLaboratoriesEuLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dr. Reddy's Laboratories EU Limited [Member]", "terseLabel": "Dr. Reddy's Laboratories (EU) Limited [member]" } } }, "localname": "DrreddysLaboratoriesEuLimitedMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_DrreddysLaboratoriesIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dr. Reddy's Laboratories Inc. [Member]", "terseLabel": "Dr. Reddy's Laboratories Inc. [member]" } } }, "localname": "DrreddysLaboratoriesIncMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_DrreddysLaboratoriesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dr. Reddy's Laboratories, LLC [Member]", "terseLabel": "Dr. Reddy's Laboratories, LLC [member]" } } }, "localname": "DrreddysLaboratoriesLlcMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_DrreddysLaboratoriesLouisianaLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dr. Reddy's Laboratories Louisiana LLC [Member]", "terseLabel": "Dr. Reddy's Laboratories Louisiana LLC [member]" } } }, "localname": "DrreddysLaboratoriesLouisianaLlcMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_DrreddysLaboratoriesNewYorkIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dr. Reddy's Laboratories New York, Inc. [Member]", "terseLabel": "Dr. Reddy's Laboratories New York, Inc. [member]" } } }, "localname": "DrreddysLaboratoriesNewYorkIncMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_DrreddysLaboratoriesProprietaryLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dr. Reddy's Laboratories Proprietary Limited [Member]", "terseLabel": "Dr. Reddy's Laboratories (Proprietary) Limited [member]" } } }, "localname": "DrreddysLaboratoriesProprietaryLimitedMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_DrreddysLaboratoriesRomaniaSrlMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dr. Reddy's Laboratories Romania S.R.L. [Member]", "terseLabel": "Dr. Reddy's Laboratories Romania S.R.L. [member]" } } }, "localname": "DrreddysLaboratoriesRomaniaSrlMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_DrreddysLaboratoriesSaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dr. Reddy's Laboratories SA [Member]", "terseLabel": "Dr. Reddy's Laboratories SA [member]" } } }, "localname": "DrreddysLaboratoriesSaMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_DrreddysLaboratoriesUkLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dr. Reddy's Laboratories UK Limited [Member]", "terseLabel": "Dr. Reddy's Laboratories (UK) Limited [member]" } } }, "localname": "DrreddysLaboratoriesUkLimitedMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_DrreddysNewZealandLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dr. Reddy's New Zealand Limited. [Member]", "terseLabel": "Dr. Reddy's New Zealand Limited. [member]" } } }, "localname": "DrreddysNewZealandLimitedMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_DrreddysResearchAndDevelopmentBvFormerlyOctoplusBvMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dr. Reddy's Research and Development B.V. formerly Octoplus B.V. [Member]", "terseLabel": "Dr. Reddy's Research and Development B.V." } } }, "localname": "DrreddysResearchAndDevelopmentBvFormerlyOctoplusBvMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_DrreddysResearchFoundationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dr. Reddy's research foundation [Member]", "terseLabel": "Dr. Reddy's Research Foundation [member]" } } }, "localname": "DrreddysResearchFoundationMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_DrreddysVenezuelaCaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dr. Reddy's Venezuela, C.A. [Member]", "terseLabel": "Dr. Reddy's Venezuela, C.A. [member]" } } }, "localname": "DrreddysVenezuelaCaMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_DrsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DRS LLC member.", "label": "DRS LLC [Member]" } } }, "localname": "DrsLlcMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_DueToCreditorsForExpenses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount represents creditors araised for operating expenses.", "label": "Due To Creditors For Expenses", "verboseLabel": "Due To Creditors For Expenses" } } }, "localname": "DueToCreditorsForExpenses", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ProvisionsDetails" ], "xbrltype": "monetaryItemType" }, "rdy_EarningPerShareAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earning per share [Axis]" } } }, "localname": "EarningPerShareAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ConsolidatedIncomeStatements" ], "xbrltype": "stringItemType" }, "rdy_EarningPerShareDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earning per share [Domain]" } } }, "localname": "EarningPerShareDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ConsolidatedIncomeStatements" ], "xbrltype": "domainItemType" }, "rdy_EmployeeBenefitObligationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Employee benefit obligations [Member]" } } }, "localname": "EmployeeBenefitObligationsMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails14", "http://www.drreddys.com/role/EmployeeBenefitsDetails5" ], "xbrltype": "domainItemType" }, "rdy_EmployeeBenefitsRecognizedAsOfAcquisitionDate": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Employee benefits recognized as of acquisition date.", "label": "Employee Benefits Recognized As Of Acquisition Date", "terseLabel": "Employee benefits (Gratuity-Rs.70 and Compensated absences- Rs.75)" } } }, "localname": "EmployeeBenefitsRecognizedAsOfAcquisitionDate", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "rdy_EmployeeStockIncentivePlanAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Employee stock incentive plan [Abstract]" } } }, "localname": "EmployeeStockIncentivePlanAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_EmployeeStockIncentivePlanLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Employee stock incentive plan [Line Items]" } } }, "localname": "EmployeeStockIncentivePlanLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_EmployeeStockIncentivePlanTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Employee stock incentive plan [Table]" } } }, "localname": "EmployeeStockIncentivePlanTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_EmployeeStockIncentivePlansAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Employee stock incentive plans [Abstract]" } } }, "localname": "EmployeeStockIncentivePlansAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_EmployeeStockIncentivePlansTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Employee stock incentive plans [Table]" } } }, "localname": "EmployeeStockIncentivePlansTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansTables" ], "xbrltype": "stringItemType" }, "rdy_EmployeeStockOptionTreasurySharesPurchased": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of share ESOS trust purchase from secondary market.", "label": "Employee Stock Option Treasury Shares Purchased" } } }, "localname": "EmployeeStockOptionTreasurySharesPurchased", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetailsTextual" ], "xbrltype": "decimalItemType" }, "rdy_EmployeesServiceSharebasedCompensationNonvestedAwardsCompensationCostNotYetRecognized": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of unrecognized cost of unvested share-based compensation awards.", "label": "Employees Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized" } } }, "localname": "EmployeesServiceSharebasedCompensationNonvestedAwardsCompensationCostNotYetRecognized", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_EquitySettledShareBasedPaymentExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Settled Share Based Payment Expense [Member]", "terseLabel": "Equity settled share based payment expense [Member]" } } }, "localname": "EquitySettledShareBasedPaymentExpenseMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_EquitySharedPaymentSettledMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Shared payment Settled [Member]" } } }, "localname": "EquitySharedPaymentSettledMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails6" ], "xbrltype": "domainItemType" }, "rdy_EquitySharesAfterStockSplit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of equity shares after reverse stock split.", "label": "Equity Shares After Stock Split" } } }, "localname": "EquitySharesAfterStockSplit", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetailsTextual" ], "xbrltype": "sharesItemType" }, "rdy_Equitypaymenttransactionswithemployees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "It represents equity payment transactions with employees .", "label": "EquityPaymentTransactionsWithEmployees", "terseLabel": "Equity settled share-based payment expense" } } }, "localname": "Equitypaymenttransactionswithemployees", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails6" ], "xbrltype": "monetaryItemType" }, "rdy_EscrowDeposit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Escrow deposit.", "label": "Escrow Deposit", "terseLabel": "Balances in Escrow account pursuant to the Business Transfer Agreement with Wockhardt Limited (refer to note 6 for details)" } } }, "localname": "EscrowDeposit", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/CashAndCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "rdy_EscrowDepositOne": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Escrow deposit one.", "label": "Escrow Deposit One", "terseLabel": "Balances in Escrow account pursuant to the Business Transfer Agreement with Nimbus Health GmbH (refer to note 6 for details)" } } }, "localname": "EscrowDepositOne", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/CashAndCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "rdy_EstimatedRevenueOfProductSalesOfTheAcquireePostBusinessCombination": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Estimated revenue of product sales of the acquiree post business combination.", "label": "Estimated Revenue Of Product Sales Of The Acquiree Post Business Combination", "terseLabel": "Estimated revenue from sales of the acquiree post business combination" } } }, "localname": "EstimatedRevenueOfProductSalesOfTheAcquireePostBusinessCombination", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_EtonPharmaceuticalsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Eton pharmaceuticals, inc.", "label": "Eton Pharmaceuticals, Inc [Member]" } } }, "localname": "EtonPharmaceuticalsIncMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_EurosMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Euros [Member]", "verboseLabel": "Euro [Member]" } } }, "localname": "EurosMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetails" ], "xbrltype": "domainItemType" }, "rdy_EventsAfterReportingPeriodMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Events after reporting period member.", "label": "Events After Reporting Period [Member]" } } }, "localname": "EventsAfterReportingPeriodMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/MergerOfDrReddySHoldingsLimitedIntoDrReddySLaboratoriesLimitedDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_ExchangeDifferencesOnForeignCurrencyTranslationsRecognisedInIncomeStatementOnDeferredTax": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of exchange differences arising on foreign currency translations recognised in income statement on deferred tax.", "label": "Exchange Differences on Foreign Currency translations Recognised In Income Statement On Deferred Tax" } } }, "localname": "ExchangeDifferencesOnForeignCurrencyTranslationsRecognisedInIncomeStatementOnDeferredTax", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_ExcludingCapitalworkinprogressMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Excluding Capital-work-in-progress [Member]" } } }, "localname": "ExcludingCapitalworkinprogressMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "rdy_ExercisePriceAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise price.", "label": "Exercise Price [Axis]" } } }, "localname": "ExercisePriceAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_ExercisePriceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise price.", "label": "Exercise Price [Member]" } } }, "localname": "ExercisePriceMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_ExercisePriceOfGrantedShareOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise price of granted share options.", "label": "Exercise Price Of Granted Share Options", "verboseLabel": "Range of exercise prices, Granted during the year" } } }, "localname": "ExercisePriceOfGrantedShareOptions", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails2" ], "xbrltype": "perShareItemType" }, "rdy_ExercisePriceOfThreeSixSevenNinePerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise price of three six seven nine per share.", "label": "Exercise Price Of Three Six Seven Nine Per Share [Member]" } } }, "localname": "ExercisePriceOfThreeSixSevenNinePerShareMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_ExercisePriceOfTwoEightOneFourPerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise price of two eight one four per share.", "label": "Exercise Price Of Two Eight One Four Per Share [Member]" } } }, "localname": "ExercisePriceOfTwoEightOneFourPerShareMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_ExercisePriceRangeOptionExercisableAtTheEndOfTheYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents exercise price range option exercisable at the end of the year.", "label": "Exercise Price Range Option Exercisable At The End Of The Year", "verboseLabel": "Range of exercise prices, Exercisable at the end of the year" } } }, "localname": "ExercisePriceRangeOptionExercisableAtTheEndOfTheYear", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails4" ], "xbrltype": "perShareItemType" }, "rdy_ExercisePriceRangeOptionExercisableAtTheEndOfTheYears": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise price range option exercisable at the end of the year.", "label": "Exercise Price Range Option Exercisable At The End Of The Years", "terseLabel": "Range of exercise prices, Exercisable at the end of the year" } } }, "localname": "ExercisePriceRangeOptionExercisableAtTheEndOfTheYears", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails2" ], "xbrltype": "perShareItemType" }, "rdy_ExercisePriceRangeOptionExercisedDuringTheYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The range of exercise price of share options expired in a share-based payment arrangement.", "label": "Exercise price range option exercised during the year", "verboseLabel": "Range of exercise prices, Exercised during the year" } } }, "localname": "ExercisePriceRangeOptionExercisedDuringTheYear", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails4" ], "xbrltype": "perShareItemType" }, "rdy_ExercisePriceRangeOptionGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The range of exercise price of share options expired and forfeited in a share-based payment arrangement.", "label": "Exercise Price Range Option Granted", "verboseLabel": "Range of exercise prices, Granted during the year" } } }, "localname": "ExercisePriceRangeOptionGranted", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails4" ], "xbrltype": "perShareItemType" }, "rdy_ExercisepricesRs5Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Prices Rs 5 [Member]" } } }, "localname": "ExercisepricesRs5Member", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails1" ], "xbrltype": "domainItemType" }, "rdy_ExpectedContribution": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represent the expected contribution.", "label": "Expected Contribution" } } }, "localname": "ExpectedContribution", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails17", "http://www.drreddys.com/role/EmployeeBenefitsDetails8" ], "xbrltype": "monetaryItemType" }, "rdy_ExpectedFutureBenefitPayments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represent the expected future benefit payments.", "label": "Expected Future Benefit Payments" } } }, "localname": "ExpectedFutureBenefitPayments", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails17", "http://www.drreddys.com/role/EmployeeBenefitsDetails8" ], "xbrltype": "monetaryItemType" }, "rdy_ExpectedIncreaseOrDecreaseInNetProfitFromExchangeRate": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of Expected increase or (decrease) in the net profit from Exchange Rate.", "label": "Expected increase or decrease in the net profit from Exchange Rate", "verboseLabel": "Expected increase or decrease in the net profit from fluctuation in Exchange Rate by 10%" } } }, "localname": "ExpectedIncreaseOrDecreaseInNetProfitFromExchangeRate", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_ExpectedIncreaseOrDecreaseInNetProfitFromFloatingInterestRate": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of expected increase/(decrease) in the net profit from floating interest rate.", "label": "Expected increase or decrease in the net profit from floating interest rate", "verboseLabel": "Expected increase or decrease in the net profit from floating interest rate fluctuation by 10%" } } }, "localname": "ExpectedIncreaseOrDecreaseInNetProfitFromFloatingInterestRate", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_ExpensesByNatureDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expenses by Nature [Domain]" } } }, "localname": "ExpensesByNatureDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/NatureOfExpenseDetails", "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual", "http://www.drreddys.com/role/SegmentReportingDetails7" ], "xbrltype": "domainItemType" }, "rdy_ExportBenefitReceivableCurrent": { "auth_ref": [], "calculation": { "http://www.drreddys.com/role/OtherAssetsDetails": { "order": 2.0, "parentTag": "ifrs-full_OtherCurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current receivable from various government authorities of India towards incentives on export sales made by the Company.", "label": "Export Benefit Receivable Current", "verboseLabel": "Export benefits receivable" } } }, "localname": "ExportBenefitReceivableCurrent", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "rdy_FacilityManagementServicesPaid": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represent the facility management services paid.", "label": "Facility Management Services Paid", "verboseLabel": "Facility management services paid" } } }, "localname": "FacilityManagementServicesPaid", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "rdy_FactoryAndAdministrativeBuildingsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Factory and administrative buildings [Member]" } } }, "localname": "FactoryAndAdministrativeBuildingsMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SignificantAccountingPoliciesDetails1" ], "xbrltype": "domainItemType" }, "rdy_FairValueGainsLossesOnInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value gains losses on investments in equity instruments designated as measured at fair value through other comprehensive income", "label": "Fair Value Gains Losses On Investments In Equity Instruments Designated As Measured At Fair Value Through Other Comprehensive Income", "terseLabel": "Unrealized loss" } } }, "localname": "FairValueGainsLossesOnInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetails1" ], "xbrltype": "monetaryItemType" }, "rdy_FairValueHierarchyOfAssetsAndLiabilitiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy Of Assets And Liabilities [Line Items]", "verboseLabel": "Fair value hierarchy of assets and liabilities [Line Items]" } } }, "localname": "FairValueHierarchyOfAssetsAndLiabilitiesLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails1" ], "xbrltype": "stringItemType" }, "rdy_FairValueHierarchyOfAssetsAndLiabilitiesOnRecurringBasisTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair value hierarchy of assets and liabilities on a recurring basis [Table]" } } }, "localname": "FairValueHierarchyOfAssetsAndLiabilitiesOnRecurringBasisTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails1" ], "xbrltype": "stringItemType" }, "rdy_FairValueOfInstrumentsOrInterests": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The fair value of instruments on the date of acquisition.", "label": "Fair value of instruments or interests" } } }, "localname": "FairValueOfInstrumentsOrInterests", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetails" ], "xbrltype": "monetaryItemType" }, "rdy_FairValueReserveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair value reserve [Member]" } } }, "localname": "FairValueReserveMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "domainItemType" }, "rdy_FiftyBasisPointsDecreaseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fifty basis points decrease [Member]", "verboseLabel": "50 basis points decrease" } } }, "localname": "FiftyBasisPointsDecreaseMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails13", "http://www.drreddys.com/role/EmployeeBenefitsDetails4" ], "xbrltype": "domainItemType" }, "rdy_FiftyBasisPointsIncreaseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fifty basis points increase [Member]", "verboseLabel": "50 basis points increase" } } }, "localname": "FiftyBasisPointsIncreaseMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails13", "http://www.drreddys.com/role/EmployeeBenefitsDetails4" ], "xbrltype": "domainItemType" }, "rdy_FinanceExpenseIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finance expense income [Abstract]", "terseLabel": "Finance income, net" } } }, "localname": "FinanceExpenseIncomeAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_FinanceLeaseAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finance Lease [Axis]" } } }, "localname": "FinanceLeaseAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails2" ], "xbrltype": "stringItemType" }, "rdy_FinanceLeaseDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finance Lease [Domain]" } } }, "localname": "FinanceLeaseDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails2" ], "xbrltype": "domainItemType" }, "rdy_FinancialInstrumentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial instruments [Line Items]", "terseLabel": "Financial instruments [Line Items]" } } }, "localname": "FinancialInstrumentsLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_FinancialRiskManagementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial risk management [Abstract]" } } }, "localname": "FinancialRiskManagementAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_FinancialRiskManagementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial Risk Management [Line Items]" } } }, "localname": "FinancialRiskManagementLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_FinancialRiskManagementTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial Risk Management [Table]" } } }, "localname": "FinancialRiskManagementTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_ForeignCurrencyRiskFromNonderivativeFinancialInstrumentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Foreign Currency Risk from Non-derivative Financial Instruments [Member]" } } }, "localname": "ForeignCurrencyRiskFromNonderivativeFinancialInstrumentsMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetails" ], "xbrltype": "domainItemType" }, "rdy_ForeignExchangeDifferences": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represent the foreign exchange differences.", "label": "Foreign Exchange Differences", "verboseLabel": "Foreign exchanges differences" } } }, "localname": "ForeignExchangeDifferences", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails11" ], "xbrltype": "monetaryItemType" }, "rdy_ForeignExchangeDifferencesOnIncomeTaxes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "It represents the amount of foreign exchange differences on income taxes", "label": "Foreign exchange differences on income taxes", "verboseLabel": "Foreign exchange differences" } } }, "localname": "ForeignExchangeDifferencesOnIncomeTaxes", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails2" ], "xbrltype": "monetaryItemType" }, "rdy_ForwardContractAudInrSellsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Forward Contract AUD INR Sells [Member]", "verboseLabel": "Forward contract| AUD - INR| Sell [Member]" } } }, "localname": "ForwardContractAudInrSellsMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ForwardContractChfInrSellMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Forward contract CHF INR Sell [Member]", "terseLabel": "Forward contract| CHF - INR| Sell [Member]" } } }, "localname": "ForwardContractChfInrSellMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ForwardContractChfUsBuyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Forward contract CHF US Buy [Member]", "terseLabel": "Forward contract| CHF - US$| Buy [Member]" } } }, "localname": "ForwardContractChfUsBuyMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ForwardContractEurGbpSellMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Forward contract EUR GBP Sell [Member]", "terseLabel": "Forward contract| EUR - GBP| Sell [Member]" } } }, "localname": "ForwardContractEurGbpSellMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ForwardContractEurInrSellMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Forward contract eur inr sell.", "label": "Forward Contract EUR INR Sell [Member]", "terseLabel": "Forward Contract| EUR - INR| Sell [Member]" } } }, "localname": "ForwardContractEurInrSellMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ForwardContractEurUsBuyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Forward contract EUR US Buy [Member]", "verboseLabel": "Forward contract| EUR - US$| Buy [Member]" } } }, "localname": "ForwardContractEurUsBuyMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ForwardContractGbpUsBuyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Forward contract GBP - US Buy [Member]", "terseLabel": "Forward contract| GBP - US$| Buy [Member]" } } }, "localname": "ForwardContractGbpUsBuyMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ForwardContractGbpinrSellMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Forward Contract GBPINR Sell [Member]", "verboseLabel": "Forward contract| GBP - INR| Sell [Member]" } } }, "localname": "ForwardContractGbpinrSellMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ForwardContractRubInrSellMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Forward contract RUB - INR Sell [Member]", "verboseLabel": "Forward contract| RUB - INR| Sell [Member]" } } }, "localname": "ForwardContractRubInrSellMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ForwardContractUsAudBuyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Forward contract US AUD Buy [Member]", "terseLabel": "Forward contract| US$ - AUD| Buy [Member]" } } }, "localname": "ForwardContractUsAudBuyMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ForwardContractUsBrlBuyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Forward contract US BRL Buy [Member]", "terseLabel": "Forward contract| US$ - BRL| Buy [Member]" } } }, "localname": "ForwardContractUsBrlBuyMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ForwardContractUsClpBuyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Forward contract US CLP Buy [Member]", "terseLabel": "Forward contract| US$ - CLP| Buy [Member]" } } }, "localname": "ForwardContractUsClpBuyMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ForwardContractUsCopBuyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Forward contract US COP Buy [Member]", "terseLabel": "Forward contract| US$ - COP| Buy [Member]" } } }, "localname": "ForwardContractUsCopBuyMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ForwardContractUsInrSellMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Forward contract US - INR Sell [Member]", "terseLabel": "Forward contract| US$ - INR| Sell [Member]" } } }, "localname": "ForwardContractUsInrSellMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ForwardContractUsKztBuyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Forward contract US KZT Buy [Member]", "terseLabel": "Forward contract| US$ - KZT| Buy [Member]" } } }, "localname": "ForwardContractUsKztBuyMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ForwardContractUsMxnBuyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Forward contract US MXN Buy [Member]", "terseLabel": "Forward contract| US$ - MXN| Buy [Member]" } } }, "localname": "ForwardContractUsMxnBuyMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ForwardContractUsRonBuyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Forward contract US - RON Buy [Member]", "verboseLabel": "Forward contract| US$ - RON| Buy [Member]" } } }, "localname": "ForwardContractUsRonBuyMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ForwardContractUsRubBuyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Forward contract US - RUB Buy [Member]", "terseLabel": "Forward contract| US$ - RUB| Buy [Member]" } } }, "localname": "ForwardContractUsRubBuyMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ForwardContractUsThbBuyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Forward contract us thb buy.", "label": "Forward Contract US THB Buy [Member]", "terseLabel": "Forward contract| US$ - THB| Buy [Member]" } } }, "localname": "ForwardContractUsThbBuyMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ForwardContractUsUahBuyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Forward contract US UAH Buy [Member]", "terseLabel": "Forward contract| US$ - UAH| Buy [Member]" } } }, "localname": "ForwardContractUsUahBuyMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_ForwardContractZarInrSellMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Forward contract ZAR INR Sell [Member]", "terseLabel": "Forward contract| ZAR - INR| Sell [Member]" } } }, "localname": "ForwardContractZarInrSellMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_FuelSurchargeAdjustmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fuel Surcharge Adjustments [Member]" } } }, "localname": "FuelSurchargeAdjustmentsMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_FundsManagedByInsurersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Funds managed by Insurers [Member]", "terseLabel": "Funds managed by Insurers [Member]" } } }, "localname": "FundsManagedByInsurersMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails16", "http://www.drreddys.com/role/EmployeeBenefitsDetails7" ], "xbrltype": "domainItemType" }, "rdy_FurnitureFixturesAndOfficeEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Furniture, fixtures and office equipment [Member].", "label": "Furniture Fixtures And Office Equipment [Member]", "terseLabel": "Furniture Fixtures And Office Equipment [Member]" } } }, "localname": "FurnitureFixturesAndOfficeEquipmentMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails1" ], "xbrltype": "domainItemType" }, "rdy_FutureCashFlowsInRespectOfPostemploymentBenefitPlansAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Future cash flows in respect of post-employment benefit plans [Abstract]" } } }, "localname": "FutureCashFlowsInRespectOfPostemploymentBenefitPlansAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_GainOnSaleOfIntangibleAssets": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gain on sale of intangible assets.", "label": "Gain On Sale Of Intangible Assets", "terseLabel": "Gain on sale of intangible assets" } } }, "localname": "GainOnSaleOfIntangibleAssets", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherIncomeNetDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_GainsLossesOnScrapSales": { "auth_ref": [], "calculation": { "http://www.drreddys.com/role/OtherIncomeNetDetails": { "order": 3.0, "parentTag": "ifrs-full_OtherOperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gains (losses) on scrap sale.", "label": "Gains losses on scrap sales", "negatedLabel": "Scrap sales" } } }, "localname": "GainsLossesOnScrapSales", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "rdy_GastrointestinalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Gastrointestinal [Member]", "verboseLabel": "Gastrointestinal" } } }, "localname": "GastrointestinalMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails2", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails3", "http://www.drreddys.com/role/SegmentReportingDetails2", "http://www.drreddys.com/role/SegmentReportingDetails3" ], "xbrltype": "domainItemType" }, "rdy_GenitourinaryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Genitourinary [Member]", "label": "Genitourinary [Member]" } } }, "localname": "GenitourinaryMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails3", "http://www.drreddys.com/role/SegmentReportingDetails3" ], "xbrltype": "domainItemType" }, "rdy_GermanyCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Germany Country [Member]" } } }, "localname": "GermanyCountryMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SegmentReportingDetails5" ], "xbrltype": "domainItemType" }, "rdy_GlenmarkPharmaceuticalsLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Glenmark pharmaceuticals limited.", "label": "Glenmark Pharmaceuticals Limited [Member]" } } }, "localname": "GlenmarkPharmaceuticalsLimitedMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetails2" ], "xbrltype": "domainItemType" }, "rdy_GlobalGenericMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Global Generic [Member]" } } }, "localname": "GlobalGenericMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SegmentReportingDetails2", "http://www.drreddys.com/role/SegmentReportingDetails7" ], "xbrltype": "domainItemType" }, "rdy_GlobalGenericsAndProperietaryProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Global Generics and Properietary Products [Member]" } } }, "localname": "GlobalGenericsAndProperietaryProductsMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_GlobalGenericsBrandedFormulationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Global Generics - Branded Formulations [Member]", "terseLabel": "Global Generics-Branded Formulations [Member]" } } }, "localname": "GlobalGenericsBrandedFormulationsMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/GoodwillDetails1" ], "xbrltype": "domainItemType" }, "rdy_GlobalGenericsComplexInjectablesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Global Generics - Complex Injectables [Member]", "terseLabel": "Global Generics-Complex Injectables [Member]" } } }, "localname": "GlobalGenericsComplexInjectablesMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/GoodwillDetails1", "http://www.drreddys.com/role/GoodwillDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_GlobalGenericsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "definitionGuidance": "Global Generics", "label": "Global Generics [Member]", "terseLabel": "Global Generics [Member]" } } }, "localname": "GlobalGenericsMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails1", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails2", "http://www.drreddys.com/role/SegmentReportingDetails" ], "xbrltype": "domainItemType" }, "rdy_GlobalGenericsNorthAmericaOperationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Global Generics- North America Operations [Member]", "verboseLabel": "Global Generics-North America Operations [Member]" } } }, "localname": "GlobalGenericsNorthAmericaOperationsMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/GoodwillDetails1", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_GlobalGenericsOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Global Generics One [Member]", "verboseLabel": "Global Generics [Member]" } } }, "localname": "GlobalGenericsOneMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_GlobalgenericscomplexinjectablesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Global Generics Complex Injectables", "label": "GlobalGenericsComplexInjectables [Member]", "terseLabel": "Global Generics-Complex Injectables [Member]" } } }, "localname": "GlobalgenericscomplexinjectablesMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_GnuvaringMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "gNuvaring [Member].", "label": "gNuvaring [Member]", "terseLabel": "gNuvaring [Member]" } } }, "localname": "GnuvaringMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_GoodwillGrossBalance": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill Gross Balance", "terseLabel": "Opening balance, gross" } } }, "localname": "GoodwillGrossBalance", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/GoodwillDetails" ], "xbrltype": "monetaryItemType" }, "rdy_GratuityBenefitsOfParentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Gratuity Benefits Of Parent [Member]" } } }, "localname": "GratuityBenefitsOfParentMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails3", "http://www.drreddys.com/role/EmployeeBenefitsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_GratuityPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gratuity payable.", "label": "Gratuity Payable", "terseLabel": "Gratuity payable" } } }, "localname": "GratuityPayable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_HatchtechPtyLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Hatchtech Pty Limited [Member]", "terseLabel": "Hatchtech Pty Limited [Member]" } } }, "localname": "HatchtechPtyLimitedMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual", "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_HedgesOfHighlyProbableForecastedTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Hedges of highly probable forecasted transactions [Member]" } } }, "localname": "HedgesOfHighlyProbableForecastedTransactionsMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_HedgesOfRecognisedAssetsAndLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Hedges of recognised assets and liabilities [Member]" } } }, "localname": "HedgesOfRecognisedAssetsAndLiabilitiesMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_HematologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hematology.", "label": "Hematology [Member]" } } }, "localname": "HematologyMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails2", "http://www.drreddys.com/role/SegmentReportingDetails2" ], "xbrltype": "domainItemType" }, "rdy_HigherThanExpectedPriceErosionAndIncreasedCompetitionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Higher than expected price erosion and increased competition.", "label": "Higher Than Expected Price Erosion And Increased Competition [Member]" } } }, "localname": "HigherThanExpectedPriceErosionAndIncreasedCompetitionMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_HotelExpensesPaid": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represent the hotel expenses paid.", "label": "Hotel Expenses Paid", "terseLabel": "Hotel expenses paid" } } }, "localname": "HotelExpensesPaid", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "rdy_Idea2enterprisesIndiaPvtLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Idea2Enterprises India Pvt. Limited [Member]", "terseLabel": "Idea2Enterprises (India) Pvt. Limited [member]" } } }, "localname": "Idea2enterprisesIndiaPvtLimitedMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_ImpairedAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Impaired [Axis]" } } }, "localname": "ImpairedAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetails1" ], "xbrltype": "stringItemType" }, "rdy_ImpairedDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Impaired [Domain]" } } }, "localname": "ImpairedDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetails1" ], "xbrltype": "domainItemType" }, "rdy_ImpairmentLossOfCapitalWorkInProgress": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Impairment loss of capital work in progress", "label": "Impairment Loss Of Capital Work In Progress", "terseLabel": "Impairment loss of capital work in progress" } } }, "localname": "ImpairmentLossOfCapitalWorkInProgress", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_ImpairmentLossRecordedInGoodwillTillDate": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of impairment loss recorded in goodwill till date.", "label": "Impairment Loss Recorded In Goodwill Till Date", "negatedTerseLabel": "Impairment loss", "terseLabel": "Impairment loss" } } }, "localname": "ImpairmentLossRecordedInGoodwillTillDate", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/GoodwillDetails", "http://www.drreddys.com/role/GoodwillDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_ImpairmentOfCapitalWorkInProgress": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Impairment of capital work in progress.", "label": "Impairment of Capital Work In Progress", "terseLabel": "Less: Impairment of Capital-work-in-progress" } } }, "localname": "ImpairmentOfCapitalWorkInProgress", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "rdy_ImpairmentOfNoncurrentAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Impairment of NonCurrent Assets [Member]", "terseLabel": "Impairment of Non-Current Assets [Member]" } } }, "localname": "ImpairmentOfNoncurrentAssetsMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_ImperialCreditPrivateLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Imperial Credit Private Limited [Member]" } } }, "localname": "ImperialCreditPrivateLimitedMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_IncomeStatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INCOME STATEMENT [Line Items]" } } }, "localname": "IncomeStatementLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ConsolidatedIncomeStatements" ], "xbrltype": "stringItemType" }, "rdy_IncomeStatementLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual", "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_IncomeStatementLocationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual", "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_IncomeStatementNatureOfExpenseLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement Nature of Expense [Line Items]" } } }, "localname": "IncomeStatementNatureOfExpenseLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/NatureOfExpenseDetails" ], "xbrltype": "stringItemType" }, "rdy_IncomeStatementTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INCOME STATEMENT [Table]" } } }, "localname": "IncomeStatementTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ConsolidatedIncomeStatements" ], "xbrltype": "stringItemType" }, "rdy_IncomeTaxReconcilationTaxEffectOfIncomeFromDisposalOfCapitalGains": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Income tax reconcilation tax effect of income from disposal of capital gains.", "label": "Income Tax Reconcilation Tax Effect Of Income From Disposal Of Capital Gains", "verboseLabel": "Income from sale of capital assets" } } }, "localname": "IncomeTaxReconcilationTaxEffectOfIncomeFromDisposalOfCapitalGains", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails2" ], "xbrltype": "monetaryItemType" }, "rdy_IncomeTaxRelatingToInvestmentsInEquityInstrumentsAndFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIncludedInOtherComprehensiveIncome": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Income tax relating to investments in equity instruments and financial assets measured at fair value through other comprehensive income included in other comprehensive income.", "label": "Income Tax Relating To Investments In Equity Instruments And Financial Assets Measured At Fair Value Through Other Comprehensive Income Included In Other Comprehensive Income", "verboseLabel": "Tax on changes in fair value of equity and debt instruments" } } }, "localname": "IncomeTaxRelatingToInvestmentsInEquityInstrumentsAndFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIncludedInOtherComprehensiveIncome", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquityParenthetical" ], "xbrltype": "monetaryItemType" }, "rdy_IncreaseDecreaseInNumberOfTreasurySharesHeld": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The increase (decrease) in the number of treasury shares held.", "label": "Increase Decrease In Number Of Treasury Shares Held", "negatedLabel": "Effect of treasury shares held" } } }, "localname": "IncreaseDecreaseInNumberOfTreasurySharesHeld", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "rdy_IncreaseDecreaseThroughExerciseOfOption": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase decrease through exercise of option.", "label": "Increase Decrease Through Exercise Of Option", "terseLabel": "Increase (decrease) through exercise of options, equity" } } }, "localname": "IncreaseDecreaseThroughExerciseOfOption", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ShareCapitalDetails" ], "xbrltype": "monetaryItemType" }, "rdy_IncreaseDecreaseThroughNetExchangeDifferencesInvestmentInJointVentures": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of increase (decrease) through net exchange differences investment in joint ventures.", "label": "Increase Decrease Through Net Exchange Differences Investment in Joint Ventures", "verboseLabel": "Translation adjustment arising out of translation of foreign currency balances" } } }, "localname": "IncreaseDecreaseThroughNetExchangeDifferencesInvestmentInJointVentures", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails1" ], "xbrltype": "monetaryItemType" }, "rdy_IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) in right-of-use assets resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity.", "label": "Increase Decrease Through Net Exchange Differences Rightofuse Assets", "terseLabel": "Effect of changes in foreign exchange rates" } } }, "localname": "IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails1" ], "xbrltype": "monetaryItemType" }, "rdy_IncreaseDecreaseThroughTransferToSpecialEconomicZoneReserveNetOfReversal": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease through transfer to special economic zone reserve net of reversal.", "label": "Increase Decrease Through Transfer To Special Economic Zone Reserve Net Of Reversal", "terseLabel": "Transfer to special economic zone re-investment reserve, net of reversal of Rs.127" } } }, "localname": "IncreaseDecreaseThroughTransferToSpecialEconomicZoneReserveNetOfReversal", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "rdy_IncreaseInHedgingReserveSensitivityAnalysis": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount represent the increase in the hedging reserve sensitivity analysis.", "label": "Increase In Hedging Reserve Sensitivity Analysis" } } }, "localname": "IncreaseInHedgingReserveSensitivityAnalysis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_IncreaseInLiabilitiesOnAcquisitionOfEmployeesRelatingToBusinessAcquisition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase in liabilities on acquisition of employees relating to business acquisition.", "label": "Increase In Liabilities On Acquisition Of Employees Relating To Business Acquisition", "verboseLabel": "Increase in liabilities on acquisition of employees relating to business acquisition" } } }, "localname": "IncreaseInLiabilitiesOnAcquisitionOfEmployeesRelatingToBusinessAcquisition", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_IncreaseInProfitFromContractsSensitivityAnalysis": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount represent the increase in profit from contracts sensitivity analysis.", "label": "Increase In Profit From Contracts Sensitivity analysis" } } }, "localname": "IncreaseInProfitFromContractsSensitivityAnalysis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_IncrementalDeductionAllowedForResearchAndDevelopmentCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of incremental deduction allowed for research and development costs.", "label": "Incremental deduction allowed for research and development costs", "terseLabel": "Incremental deduction allowed for research and development costs" } } }, "localname": "IncrementalDeductionAllowedForResearchAndDevelopmentCosts", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails2" ], "xbrltype": "monetaryItemType" }, "rdy_IndiaCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "India Country [Member]", "terseLabel": "India [Member]", "verboseLabel": "India" } } }, "localname": "IndiaCountryMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails4", "http://www.drreddys.com/role/SegmentReportingDetails4", "http://www.drreddys.com/role/SegmentReportingDetails5", "http://www.drreddys.com/role/SegmentReportingDetails6" ], "xbrltype": "domainItemType" }, "rdy_IndustriasQuimicaFalconDeMexicoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Industrias Quimica Falcon de Mexico [Member]" } } }, "localname": "IndustriasQuimicaFalconDeMexicoMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails17" ], "xbrltype": "domainItemType" }, "rdy_IndustriasQuimicasFalconDeMexicoPensionPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Industrias Quimicas Falcon de Mexico Pension plan [Member]" } } }, "localname": "IndustriasQuimicasFalconDeMexicoPensionPlanMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails10", "http://www.drreddys.com/role/EmployeeBenefitsDetails11", "http://www.drreddys.com/role/EmployeeBenefitsDetails12", "http://www.drreddys.com/role/EmployeeBenefitsDetails13", "http://www.drreddys.com/role/EmployeeBenefitsDetails14", "http://www.drreddys.com/role/EmployeeBenefitsDetails16", "http://www.drreddys.com/role/EmployeeBenefitsDetails9", "http://www.drreddys.com/role/EmployeeBenefitsTables" ], "xbrltype": "domainItemType" }, "rdy_IndustriasQuimicasFalconDeMexicoSaDeCvMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Industrias Quimicas Falcon de Mexico, S.A. de CV [Member]", "terseLabel": "Industrias Quimicas Falcon de Mexico, S.A. de CV [member]" } } }, "localname": "IndustriasQuimicasFalconDeMexicoSaDeCvMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_InitialLiabilityAssumed": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "It represents the amount of Initial liability assumed.", "label": "Initial liability assumed", "verboseLabel": "Initial liability assumed" } } }, "localname": "InitialLiabilityAssumed", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ProvisionsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_IntangibleAssetsdeferredTaxLiabilityAssetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Intangible assetsDeferred Tax Liability Asset [Member]", "terseLabel": "Other intangible assets [Member]" } } }, "localname": "IntangibleAssetsdeferredTaxLiabilityAssetMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails5" ], "xbrltype": "domainItemType" }, "rdy_IntangiblesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Intangibles [Member]" } } }, "localname": "IntangiblesMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/GoodwillDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_InterestAndDividendReceived": { "auth_ref": [], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 26.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from interest and dividends received, classified as investing activities.", "label": "Interest and dividend received", "verboseLabel": "Interest and dividend received" } } }, "localname": "InterestAndDividendReceived", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "rdy_InterestCapitalizationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Interest capitalization [Axis]" } } }, "localname": "InterestCapitalizationAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_InterestCapitalizationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Interest capitalization [Domain]" } } }, "localname": "InterestCapitalizationDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_InterestExpenseIncomeDefinedBenefitObligation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "It represents the amount of interest expense income defined benefit obligation.", "label": "Interest expense income defined benefit obligation", "terseLabel": "Interest on defined obligations" } } }, "localname": "InterestExpenseIncomeDefinedBenefitObligation", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails11", "http://www.drreddys.com/role/EmployeeBenefitsDetails2" ], "xbrltype": "monetaryItemType" }, "rdy_InterestExpenseIncomePlanAssets": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "definitionGuidance": "Interest on plan assets", "disclosureGuidance": "Interest on plan assets", "documentation": "It represents the amount of interest expense income plan assets.", "label": "Interest Expense Income plan assets" } } }, "localname": "InterestExpenseIncomePlanAssets", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails12", "http://www.drreddys.com/role/EmployeeBenefitsDetails3" ], "xbrltype": "monetaryItemType" }, "rdy_InterestsInOtherEntitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Interests in other entities [Abstract]" } } }, "localname": "InterestsInOtherEntitiesAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_IntersegmentRevenuesFromPsaiToGlobalGeneric": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Inter-segment revenues from PSAI to Global Generic", "label": "Inter-segment revenues from PSAI to Global Generic" } } }, "localname": "IntersegmentRevenuesFromPsaiToGlobalGeneric", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SegmentReportingDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_IntrinsicValueOfOptionsExercisable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Intrinsic Value of Options Exercisable.", "label": "Intrinsic Value of Options Exercisable" } } }, "localname": "IntrinsicValueOfOptionsExercisable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_IntrinsicValueOfOptionsExercised": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Intrinsic Value of Options exercised.", "label": "Intrinsic Value of Options exercised" } } }, "localname": "IntrinsicValueOfOptionsExercised", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_IntrinsicValueOfOptionsOutstanding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Intrinsic Value of Options outstanding.", "label": "Intrinsic Value of Options outstanding" } } }, "localname": "IntrinsicValueOfOptionsOutstanding", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_InventoryTemporaryDifferenceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory temporary difference [Member]", "verboseLabel": "Inventory [Member]" } } }, "localname": "InventoryTemporaryDifferenceMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails4" ], "xbrltype": "domainItemType" }, "rdy_InventorydeferredTaxLiabilityAssetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "InventoryDeferred Tax Liability Asset [Member]", "verboseLabel": "Inventory [Member]" } } }, "localname": "InventorydeferredTaxLiabilityAssetMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails5" ], "xbrltype": "domainItemType" }, "rdy_InvestmentInCommercialPaperMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment in commercial paper [Member]" } } }, "localname": "InvestmentInCommercialPaperMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherInvestmentsDetails" ], "xbrltype": "domainItemType" }, "rdy_InvestmentInEquityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment in Equity [Member]" } } }, "localname": "InvestmentInEquityMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails1" ], "xbrltype": "domainItemType" }, "rdy_InvestmentInEquitySecuritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment In Equity Securities [Member]", "terseLabel": "Investment in equity securities [Member]" } } }, "localname": "InvestmentInEquitySecuritiesMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherInvestmentsDetails" ], "xbrltype": "domainItemType" }, "rdy_InvestmentInLimitedLiabilityPartnershipFirmMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment in Limited Liability Partnership Firm [Member]" } } }, "localname": "InvestmentInLimitedLiabilityPartnershipFirmMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails1" ], "xbrltype": "domainItemType" }, "rdy_InvestmentInLimitedLiabilityPartnershipMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment in limited liability partnership.", "label": "Investment In Limited Liability Partnership [Member]", "terseLabel": "Investment in limited liability partnership [Member]" } } }, "localname": "InvestmentInLimitedLiabilityPartnershipMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherInvestmentsDetails" ], "xbrltype": "domainItemType" }, "rdy_InvestmentInMfMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment in MF [Member]" } } }, "localname": "InvestmentInMfMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails1" ], "xbrltype": "domainItemType" }, "rdy_InvestmentsAccountedForUsingEquityMethodLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments accounted for using equity method [Line Items]" } } }, "localname": "InvestmentsAccountedForUsingEquityMethodLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails1", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails2", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetailsTextual", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesTables" ], "xbrltype": "stringItemType" }, "rdy_InvestmentsAccountedForUsingEquityMethodTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments accounted for using equity method [Table]" } } }, "localname": "InvestmentsAccountedForUsingEquityMethodTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails1", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails2", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetailsTextual", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesTables" ], "xbrltype": "stringItemType" }, "rdy_IssuedNoticeDemandingPaymentByNppa": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount demanded to pay by issuing notice.", "label": "Issued Notice Demanding Payment By NPPA" } } }, "localname": "IssuedNoticeDemandingPaymentByNppa", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_KeyManagementPersonnelMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Key Management Personnel [Member]" } } }, "localname": "KeyManagementPersonnelMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RelatedPartiesDetails2" ], "xbrltype": "domainItemType" }, "rdy_KunshanRotamReddyPharmaceuticalComanyLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Kunshan Rotam Reddy Pharmaceutical Comany Limited [Member]", "terseLabel": "Kunshan Rotam Reddy Pharmaceutical Comany Limited [member]" } } }, "localname": "KunshanRotamReddyPharmaceuticalComanyLimitedMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_KunshanRotamReddyPharmaceuticalsCoLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Kunshan Rotam Reddy Pharmaceuticals Co. Limited [Member]" } } }, "localname": "KunshanRotamReddyPharmaceuticalsCoLimitedMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetails1", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesDetailsTextual", "http://www.drreddys.com/role/InvestmentInEquityAccountedInvesteesTables", "http://www.drreddys.com/role/OrganizationalStructureDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_LacockHoldingsLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lacock Holdings Limited [Member]", "terseLabel": "Lacock Holdings Limited [member]" } } }, "localname": "LacockHoldingsLimitedMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_LandPollutionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Land pollution [Member]" } } }, "localname": "LandPollutionMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_LaterThanFourYearsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Later than four years [Member]" } } }, "localname": "LaterThanFourYearsMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetails2" ], "xbrltype": "domainItemType" }, "rdy_LaterThanOneYearButNotLaterThanTwoYearsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Later Than One Year But Not Later Than Two Years [Member]" } } }, "localname": "LaterThanOneYearButNotLaterThanTwoYearsMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetails2" ], "xbrltype": "domainItemType" }, "rdy_LeaseRentalsPaid": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represent the lease rentals paid.", "label": "Lease Rentals Paid", "verboseLabel": "Lease rentals paid" } } }, "localname": "LeaseRentalsPaid", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "rdy_LeaseRentalsReceived": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represent the lease rentals received.", "label": "Lease Rentals Received", "verboseLabel": "Lease rentals received" } } }, "localname": "LeaseRentalsReceived", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "rdy_LegalProceedingsContingentLiabilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Legal proceedings contingent liability [Axis]" } } }, "localname": "LegalProceedingsContingentLiabilityAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetails", "http://www.drreddys.com/role/ContingenciesDetailsTextual", "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_LegalProceedingsContingentLiabilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Legal proceedings contingent liability [Domain]" } } }, "localname": "LegalProceedingsContingentLiabilityDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetails", "http://www.drreddys.com/role/ContingenciesDetailsTextual", "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_LiabilitiesDefinedContributionPlan": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount represent the defined contribution plan.", "label": "Liabilities Defined Contribution Plan" } } }, "localname": "LiabilitiesDefinedContributionPlan", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_LicenseFee": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "License Fee.", "label": "License Fee", "terseLabel": "License fee" } } }, "localname": "LicenseFee", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "rdy_LoanAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Loan [Axis]" } } }, "localname": "LoanAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_LoanDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Loan [Domain]" } } }, "localname": "LoanDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_LoanEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loan eight.", "label": "Loan Eight [Member]" } } }, "localname": "LoanEightMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_LoanFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loan Five.", "label": "Loan Five [Member]" } } }, "localname": "LoanFiveMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_LoanFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loan Four", "label": "Loan Four [Member]" } } }, "localname": "LoanFourMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_LoanOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Loan one [Member]" } } }, "localname": "LoanOneMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_LoanSevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loan Seven.", "label": "Loan Seven [Member]" } } }, "localname": "LoanSevenMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_LoanSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loan Six.", "label": "Loan Six [Member]" } } }, "localname": "LoanSixMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_LoanThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Loan three [Member]" } } }, "localname": "LoanThreeMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_LoanTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Loan two [Member]" } } }, "localname": "LoanTwoMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_LocationOnIncomeStatementAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Location on income statement [Axis].", "label": "Location On Income Statement [Axis]", "terseLabel": "Location On Income Statement [Axis]" } } }, "localname": "LocationOnIncomeStatementAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_LocationOnIncomeStatementDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Location on income statement [Domain].", "label": "Location On Income Statement [Domain]", "terseLabel": "Location On Income Statement [Domain]" } } }, "localname": "LocationOnIncomeStatementDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_LossContingencyAmountRecordedAsExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognised as expense.", "label": "Loss Contingency Amount Recorded As Expense", "terseLabel": "Amount recognised as expense" } } }, "localname": "LossContingencyAmountRecordedAsExpense", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_LossContingencyAmountRecordedAsImpairmentOfNoncurrentAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognised to impairment of noncurrent assets.", "label": "Loss Contingency Amount Recorded As Impairment Of Noncurrent Assets", "terseLabel": "Amount recognised to impairment of noncurrent assets" } } }, "localname": "LossContingencyAmountRecordedAsImpairmentOfNoncurrentAssets", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_MajorCustomer1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Major Customer 1 [Member]" } } }, "localname": "MajorCustomer1Member", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SegmentReportingDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_MajorCustomer2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Major Customer 2 [Member]" } } }, "localname": "MajorCustomer2Member", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SegmentReportingDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_MajorCustomerOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Major Customer One [Member]", "verboseLabel": "Major Customer 1 [Member]" } } }, "localname": "MajorCustomerOneMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_MajorCustomerTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Major Customer Two [Member]", "verboseLabel": "Major Customer 2 [Member]" } } }, "localname": "MajorCustomerTwoMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_MankindPharmaLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mankind pharma limited.", "label": "Mankind Pharma Limited [Member]", "terseLabel": "Mankind pharma limited [member]" } } }, "localname": "MankindPharmaLimitedMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_MaturityAnalysisForFinancialLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity analysis for financial liabilities.", "label": "Maturity Analysis For Financial Liabilities [Table Text Block]" } } }, "localname": "MaturityAnalysisForFinancialLiabilitiesTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementTables" ], "xbrltype": "textBlockItemType" }, "rdy_MaturityProfileOfBenefitPaymentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Maturity Profile Of Benefit Payments [Line Items]" } } }, "localname": "MaturityProfileOfBenefitPaymentsLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails17" ], "xbrltype": "stringItemType" }, "rdy_MedicaidMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Medicaid [Member]" } } }, "localname": "MedicaidMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails6" ], "xbrltype": "domainItemType" }, "rdy_MilestoneAndOtherPaymentsToBeReceived": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of milestone and other payments to be received under collaboration agreement", "label": "Milestone and other payments to be received" } } }, "localname": "MilestoneAndOtherPaymentsToBeReceived", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_MilestoneAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Milestone [Axis]" } } }, "localname": "MilestoneAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual", "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_MilestoneDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Milestone [Domain]" } } }, "localname": "MilestoneDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual", "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_MilestonePayment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Milestone payment.", "label": "Milestone Payment", "terseLabel": "Milestone payment" } } }, "localname": "MilestonePayment", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_MilestonePaymentDuringTheYear": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Miliestone payments received", "label": "Milestone Payment During The Year", "verboseLabel": "Milestone payment received during the year" } } }, "localname": "MilestonePaymentDuringTheYear", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails5" ], "xbrltype": "monetaryItemType" }, "rdy_MinimumAlternateTaxTemporaryDifferenceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Minimum alternate tax temporary difference [Member]", "verboseLabel": "Minimum Alternate Tax [Member]" } } }, "localname": "MinimumAlternateTaxTemporaryDifferenceMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails4" ], "xbrltype": "domainItemType" }, "rdy_MinimumAlternateTaxdeferredTaxLiabilityAssetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Minimum Alternate TaxDeferred Tax Liability Asset [Member]", "verboseLabel": "Minimum Alternate Tax [Member]" } } }, "localname": "MinimumAlternateTaxdeferredTaxLiabilityAssetMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails5" ], "xbrltype": "domainItemType" }, "rdy_MiscellaneousOthersOperatingIncome": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Miscellaneous Others Operating Income.", "label": "Miscellaneous Others Operating Income", "terseLabel": "Miscellaneous income, net" } } }, "localname": "MiscellaneousOthersOperatingIncome", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "rdy_NamePartyInvolvedInTransactionAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Name Party involved in Transaction [Axis]" } } }, "localname": "NamePartyInvolvedInTransactionAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisInc", "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetails", "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetails1", "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetailsTextual", "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncTables" ], "xbrltype": "stringItemType" }, "rdy_NamePartyInvolvedInTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Name Party involved in Transaction [Domain]" } } }, "localname": "NamePartyInvolvedInTransactionDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisInc", "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetails", "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetails1", "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetailsTextual", "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncTables" ], "xbrltype": "domainItemType" }, "rdy_NamendaLitigationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Namenda Litigation [Member]" } } }, "localname": "NamendaLitigationMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_NatureOfExpenseTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nature of Expense [Table]" } } }, "localname": "NatureOfExpenseTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/NatureOfExpenseDetails" ], "xbrltype": "stringItemType" }, "rdy_NdaApprovedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NDA Approved [Member]", "terseLabel": "NDA Approved [Member]" } } }, "localname": "NdaApprovedMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_NeitherPastDueNorImpairedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Neither Past Due Nor Impaired [Member]" } } }, "localname": "NeitherPastDueNorImpairedMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetails1" ], "xbrltype": "domainItemType" }, "rdy_NervousSystemMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nervous System.", "label": "Nervous System [Member]", "verboseLabel": "Nervous System" } } }, "localname": "NervousSystemMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails2" ], "xbrltype": "domainItemType" }, "rdy_NetChangeInFairValueOfEquityAndDebtInstrumentsNetOfTax": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net change in fair value of equity and debt instruments net of tax.", "label": "Net Change In Fair Value Of Equity And Debt Instruments Net Of Tax", "verboseLabel": "Net change in fair value of equity and debt instruments, net of tax (expense)/benefit" } } }, "localname": "NetChangeInFairValueOfEquityAndDebtInstrumentsNetOfTax", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "rdy_NetGainsLossesOnForeignExchangeDerivativeAndInterestRateSwapsContracts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net gains (losses) on Foreign exchange derivative and interest rate swaps contracts.", "label": "Net Gains Losses On Foreign Exchange Derivative And Interest Rate Swaps Contracts", "terseLabel": "Net gain/(loss) recognized in finance costs in respect of foreign exchange derivative contracts and cross currency interest rate swaps contracts" } } }, "localname": "NetGainsLossesOnForeignExchangeDerivativeAndInterestRateSwapsContracts", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails2" ], "xbrltype": "monetaryItemType" }, "rdy_NetGainsLossesReclassifiedFromEquityAndRecordedInRevenueCashFlowHedges": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net gains (losses) reclassified from equity and recorded in revenue cash flow hedges.", "label": "Net Gains Losses Reclassified From Equity And Recorded In Revenue Cash Flow Hedges", "verboseLabel": "Net gain/(loss) reclassified from equity and recognized as component of revenue occurrence of forecasted transaction" } } }, "localname": "NetGainsLossesReclassifiedFromEquityAndRecordedInRevenueCashFlowHedges", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails2" ], "xbrltype": "monetaryItemType" }, "rdy_NetIdentifiableAssetsAcquiredIncludingGoodwill": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net identifiable assets acquired including goodwill.", "label": "Net Identifiable Assets Acquired Including Goodwill", "totalLabel": "Total net assets" } } }, "localname": "NetIdentifiableAssetsAcquiredIncludingGoodwill", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "rdy_NimbusHealthGmbhFromFebruary242022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nimbus Health, GmbH (from February 24, 2022) member.", "label": "Nimbus Health, GmbH (from February 24, 2022) [Member]" } } }, "localname": "NimbusHealthGmbhFromFebruary242022Member", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_NimbusHealthGmbhMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nimbus health gmbh.", "label": "Nimbus Health Gmbh [Member]", "terseLabel": "Nimbus Health, GmbH [member]" } } }, "localname": "NimbusHealthGmbhMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetails", "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual", "http://www.drreddys.com/role/BusinessCombinationsTables", "http://www.drreddys.com/role/FinancialInstrumentsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_NonConvertibleDebenturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non Convertible Debentures [Member]", "terseLabel": "Non Convertible Debentures" } } }, "localname": "NonConvertibleDebenturesMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails3", "http://www.drreddys.com/role/LoansAndBorrowingsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_NonCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non current.", "label": "Non Current [Abstract]", "verboseLabel": "Non-current" } } }, "localname": "NonCurrentAbstract", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/TradeAndOtherReceivablesDetails" ], "xbrltype": "stringItemType" }, "rdy_NonCurrentPortionOfNonCurrentDebenturesUndiscounted": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Non current portion of non current debentures undiscounted.", "label": "Non Current Portion Of Non Current Debentures Undiscounted", "terseLabel": "Non-convertible debentures" } } }, "localname": "NonCurrentPortionOfNonCurrentDebenturesUndiscounted", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails4" ], "xbrltype": "monetaryItemType" }, "rdy_NonCurrentTradeAndOtherReceivableGross": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Non current trade and other receivable gross.", "label": "Non Current Trade And Other Receivable Gross", "terseLabel": "Non-current trade and other receivables, gross" } } }, "localname": "NonCurrentTradeAndOtherReceivableGross", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/TradeAndOtherReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "rdy_NonadjustingEventsAfterReportingPeriodMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonadjusting Events After Reporting Period [Member]", "terseLabel": "Non-adjusting events after reporting period [Member]" } } }, "localname": "NonadjustingEventsAfterReportingPeriodMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_NonadjustongEventsAfterReportingPeriodMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonadjustong Events after reporting period [Member]", "terseLabel": "Nonadjusting Events after reporting period [Member]" } } }, "localname": "NonadjustongEventsAfterReportingPeriodMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_NoncurrentAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-current Assets [Member]", "terseLabel": "Non-current" } } }, "localname": "NoncurrentAssetsMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherAssetsDetails" ], "xbrltype": "domainItemType" }, "rdy_NonderivativeFinancialInstrumentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-derivative financial instruments [Member]" } } }, "localname": "NonderivativeFinancialInstrumentsMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetails" ], "xbrltype": "domainItemType" }, "rdy_NorfloxacinIndiaLitigationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Norfloxacin, India litigation [Member]" } } }, "localname": "NorfloxacinIndiaLitigationMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_NoticeReceivedFromCommissionerOfGoodsAndServicesTaxIndiaAllegingThatTheCompanyIrregularlyAvailedInputTaxCredit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Notice received from commissioner of goods and services tax india alleging that the company irregularly availed input tax credit.", "label": "Notice Received From Commissioner Of Goods And Services Tax India Alleging That The Company Irregularly Availed Input Tax Credit", "verboseLabel": "Notice Received From Commissioner Of Goods And Services Tax India Alleging That the Company Irregularly Availed Input tax Credit" } } }, "localname": "NoticeReceivedFromCommissionerOfGoodsAndServicesTaxIndiaAllegingThatTheCompanyIrregularlyAvailedInputTaxCredit", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_NovartisAGMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Novartis AG [Member]", "terseLabel": "Novartis AG [Member]" } } }, "localname": "NovartisAGMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_NovartisConsumerHealthIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Novartis Consumer Health Inc [Member]" } } }, "localname": "NovartisConsumerHealthIncMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetails2" ], "xbrltype": "domainItemType" }, "rdy_NumberOfAdditionalSharesToBeIssuedUnderAmendmentOfCollaborationAgreement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of additional shares issued under amendment of collaboration agreement", "label": "Number of additional shares to be issued under amendment of collaboration agreement" } } }, "localname": "NumberOfAdditionalSharesToBeIssuedUnderAmendmentOfCollaborationAgreement", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetails" ], "xbrltype": "sharesItemType" }, "rdy_NumberOfBrandsHeldUnderPortfolio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of brands held under portfolio by the entity at a date.", "label": "Number Of Brands Held Under Portfolio", "verboseLabel": "Number of brands" } } }, "localname": "NumberOfBrandsHeldUnderPortfolio", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual" ], "xbrltype": "decimalItemType" }, "rdy_NumberOfEquitySharesAllottedToShareholdersAsPerSchemeOfAmalgamationAndArrangement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of equity shares allotted to shareholders as per scheme of amalgamation and arrangement.", "label": "Number Of Equity Shares Allotted To Shareholders As Per Scheme Of Amalgamation And Arrangement", "terseLabel": "Number Of Equity Shares Allotted To Shareholders As Per Scheme Of Amalgamation And Arrangement" } } }, "localname": "NumberOfEquitySharesAllottedToShareholdersAsPerSchemeOfAmalgamationAndArrangement", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/MergerOfDrReddySHoldingsLimitedIntoDrReddySLaboratoriesLimitedDetailsTextual" ], "xbrltype": "sharesItemType" }, "rdy_NumberOfEquitySharesHeldCancelledAsPerSchemeOfAmalgamationAndArrangement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Equity shares held cancelled as per scheme of amalgamation and arrangement.", "label": "Number Of Equity Shares Held Cancelled As Per Scheme Of Amalgamation And Arrangement", "terseLabel": "Number Of Equity Shares Held Cancelled As Per Scheme Of Amalgamation And Arrangement" } } }, "localname": "NumberOfEquitySharesHeldCancelledAsPerSchemeOfAmalgamationAndArrangement", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/MergerOfDrReddySHoldingsLimitedIntoDrReddySLaboratoriesLimitedDetailsTextual" ], "xbrltype": "sharesItemType" }, "rdy_NumberOfInstrumentsInSharebasedPaymentArrangementAvailableForGrant": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of instruments share-based payment arrangement available for grants.", "label": "Number of instruments in sharebased payment arrangement available for grant", "verboseLabel": "Number of instruments in share based payment arrangement available for grant" } } }, "localname": "NumberOfInstrumentsInSharebasedPaymentArrangementAvailableForGrant", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetailsTextual" ], "xbrltype": "sharesItemType" }, "rdy_NumberOfSharesOptionsExpiredForfeitedInSharebasedPaymentArrangement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of share options expired/forfeited in a share-based payment arrangement.", "label": "Number Of Shares Options Expired Forfeited In Sharebased Payment Arrangement", "negatedTerseLabel": "Shares arising out of options, Expired/forfeited during the year", "verboseLabel": "Shares arising out of options, Expired/forfeited during the year" } } }, "localname": "NumberOfSharesOptionsExpiredForfeitedInSharebasedPaymentArrangement", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails1", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails2", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails4" ], "xbrltype": "decimalItemType" }, "rdy_NumberOfTreasurySharesIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of treasury shares issued by the entity.", "label": "Number Of Treasury Shares Issued", "terseLabel": "Number of Treasury shares" } } }, "localname": "NumberOfTreasurySharesIssued", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ShareCapitalDetails" ], "xbrltype": "sharesItemType" }, "rdy_NumberOfTreasurySharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of treasury shares outstanding.", "label": "Number of Treasury shares outstanding" } } }, "localname": "NumberOfTreasurySharesOutstanding", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ShareCapitalDetailsTextual" ], "xbrltype": "sharesItemType" }, "rdy_NutraceuticalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nutraceutical.", "label": "Nutraceutical [Member]", "terseLabel": "Nutraceuticals [Member]", "verboseLabel": "Nutraceutical [Member]" } } }, "localname": "NutraceuticalMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails2", "http://www.drreddys.com/role/SegmentReportingDetails2" ], "xbrltype": "domainItemType" }, "rdy_ObligationsUnderLeasesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Obligations Under Leases [Member]" } } }, "localname": "ObligationsUnderLeasesMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails2" ], "xbrltype": "domainItemType" }, "rdy_OncologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "definitionGuidance": "United States", "label": "Oncology [Member]", "terseLabel": "Oncology [member]", "verboseLabel": "United States Country [Member]" } } }, "localname": "OncologyMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails2", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails3", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails4", "http://www.drreddys.com/role/SegmentReportingDetails2", "http://www.drreddys.com/role/SegmentReportingDetails3", "http://www.drreddys.com/role/SegmentReportingDetails4", "http://www.drreddys.com/role/SegmentReportingDetails6" ], "xbrltype": "domainItemType" }, "rdy_OneYearFromClosingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "One year from closing.", "label": "One Year From Closing [Member]", "terseLabel": "One year from closing [member]" } } }, "localname": "OneYearFromClosingMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_OperatingAndOtherTaxLossCarryforwardMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating And Other tax Loss CarryForward [Member]", "verboseLabel": "Operating and other tax loss carry-forward [Member]" } } }, "localname": "OperatingAndOtherTaxLossCarryforwardMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails4", "http://www.drreddys.com/role/IncomeTaxesDetails5" ], "xbrltype": "domainItemType" }, "rdy_OptionContractUsInrSellMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Option contract US - INR Sell [Member]", "verboseLabel": "Option contract| US$ - INR| Sell [Member]" } } }, "localname": "OptionContractUsInrSellMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_OptionContractUsInrSellRiskReversalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Option contract US INR Sell Risk Reversal [Member]", "terseLabel": "Option contract| US$ - INR| Sell Risk Reversal [Member]" } } }, "localname": "OptionContractUsInrSellRiskReversalMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "rdy_OptionOneOnNineteenMayTwoThousandTwentyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Option one on nineteen may two thousand twenty.", "label": "Option One On Nineteen May Two Thousand Twenty [Member]", "verboseLabel": "Option One on May 19, 2020 [Member]" } } }, "localname": "OptionOneOnNineteenMayTwoThousandTwentyMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails5" ], "xbrltype": "domainItemType" }, "rdy_OptionOneOnThirteenMayTwoThousandTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Option One On Thirteen May Two Thousand Twenty One.", "label": "Option One On Thirteen May Two Thousand Twenty One [Member]", "terseLabel": "Option One on May 13, 2021 [Member]" } } }, "localname": "OptionOneOnThirteenMayTwoThousandTwentyOneMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails5" ], "xbrltype": "domainItemType" }, "rdy_OptionOneOnTwentyEightOctoberTwoThousandTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Option One On Twenty Eight October Two Thousand Twenty One.", "label": "Option One On Twenty Eight October Two Thousand Twenty One [Member]", "terseLabel": "Option One on October 28, 2021 [Member]" } } }, "localname": "OptionOneOnTwentyEightOctoberTwoThousandTwentyOneMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails5" ], "xbrltype": "domainItemType" }, "rdy_OptionTwoOnNineteenMayTwoThousandTwentyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Option two on nineteen may two thousand twenty.", "label": "Option Two On Nineteen May Two Thousand Twenty [Member]", "verboseLabel": "Option Two on May 19, 2020 [Member]" } } }, "localname": "OptionTwoOnNineteenMayTwoThousandTwentyMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails5" ], "xbrltype": "domainItemType" }, "rdy_OptionTwoOnThirteenMayTwoThousandTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Option Two On Thirteen May Two Thousand Twenty One.", "label": "Option Two On Thirteen May Two Thousand Twenty One [Member]", "terseLabel": "Option Two on May 13, 2021 [Member]" } } }, "localname": "OptionTwoOnThirteenMayTwoThousandTwentyOneMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails5" ], "xbrltype": "domainItemType" }, "rdy_OptionTwoOnTwentyEightOctoberTwoThousandTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Option Two On Twenty Eight October Two Thousand Twenty One.", "label": "Option Two On Twenty Eight October Two Thousand Twenty One [Member]", "terseLabel": "Option Two on October 28, 2021 [Member]" } } }, "localname": "OptionTwoOnTwentyEightOctoberTwoThousandTwentyOneMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails5" ], "xbrltype": "domainItemType" }, "rdy_OptionsArisingFromStockDividend": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares options arising from stock dividend.", "label": "Options arising from stock dividend", "verboseLabel": "Options arising from stock dividend (C)" } } }, "localname": "OptionsArisingFromStockDividend", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails" ], "xbrltype": "sharesItemType" }, "rdy_OptionsExercisedPriorToStockDividendDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares exercised prior to stock dividend date.", "label": "Options exercised prior to stock dividend date", "terseLabel": "Options exercised prior to stock dividend date (A)" } } }, "localname": "OptionsExercisedPriorToStockDividendDate", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails" ], "xbrltype": "sharesItemType" }, "rdy_OptionsReservedAfterStockDividend": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The total number of shares option reserved after stock dividend.", "label": "Options reserved after stock dividend", "verboseLabel": "Options reserved after stock dividend (A+B+C)" } } }, "localname": "OptionsReservedAfterStockDividend", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails" ], "xbrltype": "sharesItemType" }, "rdy_OptionsReservedAgainstADRS": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issue under options.", "label": "Options Reserved Against ADRS", "terseLabel": "Options reserved against ADRs" } } }, "localname": "OptionsReservedAgainstADRS", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails3" ], "xbrltype": "sharesItemType" }, "rdy_OptionsReservedAgainstEquityShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issue under options.", "label": "Options Reserved Against Equity Shares", "verboseLabel": "Options reserved against equity shares" } } }, "localname": "OptionsReservedAgainstEquityShares", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails3" ], "xbrltype": "sharesItemType" }, "rdy_OptionsReservedUnderStockPlan": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issue under options.", "label": "Options Reserved Under Stock Plan", "totalLabel": "Total", "verboseLabel": "Options reserved under original Plan" } } }, "localname": "OptionsReservedUnderStockPlan", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails3" ], "xbrltype": "sharesItemType" }, "rdy_OptionsReservedUnderStockPlanLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Options reserved under stock plan [Line Items]" } } }, "localname": "OptionsReservedUnderStockPlanLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails" ], "xbrltype": "stringItemType" }, "rdy_OrganizationalStructuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organizational structures [Abstract]" } } }, "localname": "OrganizationalStructuresAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_OrganizationalStructuresLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organizational structures [Line Items]" } } }, "localname": "OrganizationalStructuresLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_OrganizationalStructuresTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organizational structures [Table]" } } }, "localname": "OrganizationalStructuresTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_OtherAssetRecognizedAsOfAcquisitionDate": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other asset recognized as of acquisition date.", "label": "Other Asset Recognized As Of Acquisition Date", "terseLabel": "Other assets" } } }, "localname": "OtherAssetRecognizedAsOfAcquisitionDate", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "rdy_OtherAssetsRecognizedAsOfAcquistionDate": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other assets recognized as of acquistion date.", "label": "Other Assets Recognized As Of Acquistion Date", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsRecognizedAsOfAcquistionDate", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "rdy_OtherCashgeneratingUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Cash-generating units [Member]" } } }, "localname": "OtherCashgeneratingUnitsMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/GoodwillDetails1" ], "xbrltype": "domainItemType" }, "rdy_OtherCountriesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Countries [Member]", "terseLabel": "Others [Member]" } } }, "localname": "OtherCountriesMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SegmentReportingDetails5", "http://www.drreddys.com/role/SegmentReportingDetails6" ], "xbrltype": "domainItemType" }, "rdy_OtherCurrencyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Currency [Member]" } } }, "localname": "OtherCurrencyMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetails" ], "xbrltype": "domainItemType" }, "rdy_OtherCurrentAssetsAndOtherCurrentLiabilitiesNetTemporaryDifferenceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other current assets and other current liabilities, net temporary difference [Member]", "verboseLabel": "Other current assets and other current liabilities, net [Member]" } } }, "localname": "OtherCurrentAssetsAndOtherCurrentLiabilitiesNetTemporaryDifferenceMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails4" ], "xbrltype": "domainItemType" }, "rdy_OtherCurrentAssetsAndOtherCurrentLiabilitiesNetdeferredTaxLiabilityAssetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other current assets and other current liabilities, netDeferred Tax Liability Asset [Member]", "verboseLabel": "Other current assets and other current liabilities, net [Member]" } } }, "localname": "OtherCurrentAssetsAndOtherCurrentLiabilitiesNetdeferredTaxLiabilityAssetMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails5" ], "xbrltype": "domainItemType" }, "rdy_OtherCurrentAssetsOther": { "auth_ref": [], "calculation": { "http://www.drreddys.com/role/OtherAssetsDetails": { "order": 4.0, "parentTag": "ifrs-full_OtherCurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other miscellaneous assets expected to be realized or consumed within one year or operating cycle, if longer.", "label": "Other Current Assets Other", "terseLabel": "Others" } } }, "localname": "OtherCurrentAssetsOther", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "rdy_OtherGlobalGenericsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Global Generics [Member]", "terseLabel": "Others" } } }, "localname": "OtherGlobalGenericsMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails2", "http://www.drreddys.com/role/SegmentReportingDetails2" ], "xbrltype": "domainItemType" }, "rdy_OtherIPRDandotherintangibleassetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other IPR&D and other intangible assets.", "label": "Other IPRD and other intangible assets [Member]", "terseLabel": "Other IPR&D and other intangible assets" } } }, "localname": "OtherIPRDandotherintangibleassetsMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_OtherIntangibleAssetsTemporaryDifferenceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other intangible assets temporary difference [Member]", "verboseLabel": "Other intangible assets [Member]" } } }, "localname": "OtherIntangibleAssetsTemporaryDifferenceMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails4" ], "xbrltype": "domainItemType" }, "rdy_OtherInvestmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Investments [Line Items]", "verboseLabel": "Other Investments [Line Items]" } } }, "localname": "OtherInvestmentsLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherInvestmentsDetails" ], "xbrltype": "stringItemType" }, "rdy_OtherInvestmentsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other investments [Table]" } } }, "localname": "OtherInvestmentsTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherInvestmentsDetails" ], "xbrltype": "stringItemType" }, "rdy_OtherLiabilitiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Liabilities [Line Items]" } } }, "localname": "OtherLiabilitiesLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "rdy_OtherLiabilitiesRecognizedAsOfAcquistionDate": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other liabilities recognized as of acquistion date.", "label": "Other Liabilities Recognized As Of Acquistion Date", "negatedLabel": "Other liabilities" } } }, "localname": "OtherLiabilitiesRecognizedAsOfAcquistionDate", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "rdy_OtherLiabilitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Liabilities [Table]" } } }, "localname": "OtherLiabilitiesTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "rdy_OtherNoncurrentAssetsOther": { "auth_ref": [], "calculation": { "http://www.drreddys.com/role/OtherAssetsDetails": { "order": 6.0, "parentTag": "ifrs-full_OtherNoncurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.", "label": "Other Noncurrent Assets Other", "terseLabel": "Others" } } }, "localname": "OtherNoncurrentAssetsOther", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "rdy_OtherOperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other operating income expense [Abstract]", "terseLabel": "Other (income)/expense, net", "verboseLabel": "Other income, net" } } }, "localname": "OtherOperatingIncomeExpenseAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_OtherOperatingIncomeExpenseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule disclosing other income or expense, net.", "label": "Other operating income expense [Table Text Block]", "terseLabel": "Other income, net" } } }, "localname": "OtherOperatingIncomeExpenseTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherIncomeNetTables" ], "xbrltype": "textBlockItemType" }, "rdy_OtherPsaiMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other PSAI [Member]", "terseLabel": "Others [Member]" } } }, "localname": "OtherPsaiMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SegmentReportingDetails3" ], "xbrltype": "domainItemType" }, "rdy_OtherPsaiSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other PSAI segment.", "label": "Other PSAI Segment [Member]", "terseLabel": "Others [member]" } } }, "localname": "OtherPsaiSegmentMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails3" ], "xbrltype": "domainItemType" }, "rdy_OtherPurchasessalesRelatedPartyTransactions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of other purchases(sales) by the entity in related party transactions.", "label": "Other Purchasessales, related party transactions", "verboseLabel": "Others" } } }, "localname": "OtherPurchasessalesRelatedPartyTransactions", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "rdy_OtherSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other segment [Member]" } } }, "localname": "OtherSegmentMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SegmentReportingDetails" ], "xbrltype": "domainItemType" }, "rdy_OtherWorkingCapitalBorrowingsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Working Capital Borrowings [Member].", "label": "Other Working Capital Borrowings [Member]", "terseLabel": "Other working capital borrowings [Member]" } } }, "localname": "OtherWorkingCapitalBorrowingsMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails" ], "xbrltype": "domainItemType" }, "rdy_OtherWorkingCapitalBorrowingsUsdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Working Capital Borrowings USD.", "label": "Other Working Capital Borrowings USD [Member]", "terseLabel": "Other Working Capital Borrowings USD [Member]" } } }, "localname": "OtherWorkingCapitalBorrowingsUsdMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails1" ], "xbrltype": "domainItemType" }, "rdy_OtherWorkingsCapitalBorrowingsBrlMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other foreign currency borrowings brl.", "label": "Other Workings Capital Borrowings Brl [Member]", "terseLabel": "Other Working Capital Borrowings BRL [Member]" } } }, "localname": "OtherWorkingsCapitalBorrowingsBrlMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails1" ], "xbrltype": "domainItemType" }, "rdy_OtherWorkingsCapitalBorrowingsMxnMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Working Capital Borrowings MXN [Member]" } } }, "localname": "OtherWorkingsCapitalBorrowingsMxnMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails1" ], "xbrltype": "domainItemType" }, "rdy_OtherWorkingsCapitalBorrowingsRubMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Workings Capital Borrowings rub [Member]", "verboseLabel": "Other Working Capital Borrowings RUB [Member]" } } }, "localname": "OtherWorkingsCapitalBorrowingsRubMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails1" ], "xbrltype": "domainItemType" }, "rdy_OtherWorkingsCapitalBorrowingsUahMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Working Capital Borrowings UAH [Member]" } } }, "localname": "OtherWorkingsCapitalBorrowingsUahMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails1" ], "xbrltype": "domainItemType" }, "rdy_OtherWorkingsCapitalBorrowingssInrMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other workings capital borrowings Inr.", "label": "Other Workings Capital Borrowingss Inr [Member]", "terseLabel": "Other Working Capital Borrowings INR [Member]" } } }, "localname": "OtherWorkingsCapitalBorrowingssInrMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails1" ], "xbrltype": "domainItemType" }, "rdy_OthersClassifiedAsCurrent": { "auth_ref": [], "calculation": { "http://www.drreddys.com/role/OtherLiabilitiesDetails": { "order": 6.0, "parentTag": "ifrs-full_OtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Others classified as current.", "label": "Others Classified As Current", "verboseLabel": "Others" } } }, "localname": "OthersClassifiedAsCurrent", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "rdy_OthersClassifiedAsNoncurrent": { "auth_ref": [], "calculation": { "http://www.drreddys.com/role/OtherLiabilitiesDetails": { "order": 7.0, "parentTag": "ifrs-full_OtherNoncurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Others classified as noncurrent.", "label": "Others Classified As Noncurrent", "verboseLabel": "Others" } } }, "localname": "OthersClassifiedAsNoncurrent", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "rdy_OthersCountriesCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Others Countries Country [Member]", "terseLabel": "Others [Member]", "verboseLabel": "Others" } } }, "localname": "OthersCountriesCountryMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails4", "http://www.drreddys.com/role/SegmentReportingDetails4" ], "xbrltype": "domainItemType" }, "rdy_OthersInvestmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment in others [Member]" } } }, "localname": "OthersInvestmentMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherInvestmentsDetails" ], "xbrltype": "domainItemType" }, "rdy_OthersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Others [Member]" } } }, "localname": "OthersMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails16", "http://www.drreddys.com/role/EmployeeBenefitsDetails7" ], "xbrltype": "domainItemType" }, "rdy_OthersSegmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "definitionGuidance": "Others [Member]", "label": "Others segments [Member]", "terseLabel": "Others" } } }, "localname": "OthersSegmentsMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails1", "http://www.drreddys.com/role/SegmentReportingDetails7" ], "xbrltype": "domainItemType" }, "rdy_OthersdeferredTaxLiabilityAssetMemberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OthersDeferred Tax Liability Asset Member [Member]", "verboseLabel": "Others [Member]" } } }, "localname": "OthersdeferredTaxLiabilityAssetMemberMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails5" ], "xbrltype": "domainItemType" }, "rdy_OutstandingBalancesForRelatedPartyTransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Outstanding balances for related party transactions [Line Items]", "verboseLabel": "Due from/to related parties [Line Items]" } } }, "localname": "OutstandingBalancesForRelatedPartyTransactionsLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RelatedPartiesDetails1" ], "xbrltype": "stringItemType" }, "rdy_OutstandingBalancesForRelatedPartyTransactionsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Outstanding balances for related party transactions [Table]", "verboseLabel": "Due from/to related parties [Table]" } } }, "localname": "OutstandingBalancesForRelatedPartyTransactionsTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RelatedPartiesDetails1" ], "xbrltype": "stringItemType" }, "rdy_OvicidalLabelApprovedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ovicidal Label Approved [Member]" } } }, "localname": "OvicidalLabelApprovedMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_PPC06TepilamideFumarateExtendedReleaseTabletsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PPC-06 (Tepilamide Fumarate Extended Release Tablets).", "label": "PPC06 Tepilamide Fumarate Extended Release Tablets [Member]", "terseLabel": "PPC-06 (Tepilamide Fumarate Extended Release Tablets)" } } }, "localname": "PPC06TepilamideFumarateExtendedReleaseTabletsMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_PackingCreditBorrowingsInrMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Packing credit borrowings inr [Member]", "verboseLabel": "Pre-Shipment Credit borrowings INR [Member]" } } }, "localname": "PackingCreditBorrowingsInrMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails1" ], "xbrltype": "domainItemType" }, "rdy_PackingCreditBorrowingsInrOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Packing credit borrowings inr one [Member]", "verboseLabel": "Pre-Shipment Credit borrowings INR [Member]" } } }, "localname": "PackingCreditBorrowingsInrOneMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails1" ], "xbrltype": "domainItemType" }, "rdy_PainManagementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Pain Management [Member]", "terseLabel": "Pain Management [member]" } } }, "localname": "PainManagementMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails2", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails3", "http://www.drreddys.com/role/SegmentReportingDetails2", "http://www.drreddys.com/role/SegmentReportingDetails3" ], "xbrltype": "domainItemType" }, "rdy_ParValueOfUnderlyingEquityShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Par value of underlying equity shares per option.", "label": "Par value of underlying equity shares" } } }, "localname": "ParValueOfUnderlyingEquityShares", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetailsTextual" ], "xbrltype": "perShareItemType" }, "rdy_ParentCompanyGratuityPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Parent Company Gratuity plan [Member]" } } }, "localname": "ParentCompanyGratuityPlanMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails", "http://www.drreddys.com/role/EmployeeBenefitsDetails1", "http://www.drreddys.com/role/EmployeeBenefitsDetails2", "http://www.drreddys.com/role/EmployeeBenefitsDetails4", "http://www.drreddys.com/role/EmployeeBenefitsDetails5", "http://www.drreddys.com/role/EmployeeBenefitsDetails7", "http://www.drreddys.com/role/EmployeeBenefitsDetails8", "http://www.drreddys.com/role/EmployeeBenefitsTables" ], "xbrltype": "domainItemType" }, "rdy_PayableTowardsSettlement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payable towards settlement.", "label": "Payable Towards Settlement", "terseLabel": "Payable towards settlement" } } }, "localname": "PayableTowardsSettlement", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_PaymentOfCostsAndDamages": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Disclosure of payment costs and damages.", "label": "Payment Of Costs and Damages" } } }, "localname": "PaymentOfCostsAndDamages", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_PaymentThroughEscrowAccount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payment through escrow account.", "label": "Payment Through Escrow Account", "terseLabel": "Payment through Escrow account" } } }, "localname": "PaymentThroughEscrowAccount", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "rdy_PaymentTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payment Type [Axis]" } } }, "localname": "PaymentTypeAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_PaymentTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payment Type [Domain]" } } }, "localname": "PaymentTypeDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_PaymentsOfLeaseLiabilities": { "auth_ref": [], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows": { "order": 38.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments of lease liabilities.", "label": "Payments of Lease Liabilities", "negatedLabel": "Payment of principal portion of lease liabilities (Refer to Note 17)" } } }, "localname": "PaymentsOfLeaseLiabilities", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "rdy_PaymentsOfPrincipalPortionOfLeaseLiabilitiesClassifiedAsFinancingActivitiees": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for payment of principal portion of lease liabilities, classified as financing activities.", "label": "Payments Of Principal Portion Of Lease Liabilities Classified As Financing Activitiees", "terseLabel": "Payment of principal portion of lease liabilities" } } }, "localname": "PaymentsOfPrincipalPortionOfLeaseLiabilitiesClassifiedAsFinancingActivitiees", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails5" ], "xbrltype": "monetaryItemType" }, "rdy_PaymentsReceivablePursuantToLitigation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Payments receivable pursuant to litigation.", "label": "Payments Receivable Pursuant to Litigation" } } }, "localname": "PaymentsReceivablePursuantToLitigation", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_PaymentsUnderProtest": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of payments under protest demanded by the power distribution companies as part of monthly electricity bills.", "label": "Payments under protest" } } }, "localname": "PaymentsUnderProtest", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_PercentageDecreaseIncreaseExchangeRatesOfEachOfCurrenciesUnderlyingDerivativeContractsUsedForSensitivityAnalysis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage decrease increase exchange rates of each of currencies underlying derivative contracts used for sensitivity analysis.", "label": "Percentage Decrease Increase Exchange Rates Of Each Of Currencies Underlying Derivative Contracts Used For Sensitivity Analysis", "verboseLabel": "Percentage decrease increase in exchange rates of each of the currencies underlying derivative contracts used for sensitivity analysis" } } }, "localname": "PercentageDecreaseIncreaseExchangeRatesOfEachOfCurrenciesUnderlyingDerivativeContractsUsedForSensitivityAnalysis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "percentItemType" }, "rdy_PercentageOfAmountDischargedAgainstPenalty": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It refers the percentage of amount discharged against penalty.", "label": "Percentage of amount discharged against penalty" } } }, "localname": "PercentageOfAmountDischargedAgainstPenalty", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "percentItemType" }, "rdy_PercentageOfDepreciationOrAppreciationInExchangeRateUsedForSensitivityAnalysis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage shows depreciation or appreciation in the exchange rate used for sensitivity analysis.", "label": "Percentage Of Depreciation Or Appreciation In Exchange Rate Used For Sensitivity Analysis" } } }, "localname": "PercentageOfDepreciationOrAppreciationInExchangeRateUsedForSensitivityAnalysis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "percentItemType" }, "rdy_PercentageOfIncreaseOrDecreaseInFloatingInterestRateUsedForSensitivityAnalysis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The Percentage show of increase or decrease in the floating interest rate used for sensitivity analysis.", "label": "Percentage Of Increase Or Decrease In Floating Interest Rate Used For Sensitivity Analysis" } } }, "localname": "PercentageOfIncreaseOrDecreaseInFloatingInterestRateUsedForSensitivityAnalysis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "percentItemType" }, "rdy_PercentageOfPenaltyChargedByCommercialTaxesDepartmentToCompany": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of penalty charged by Commercial Taxes Department to the company.", "label": "Percentage of penalty charged by Commercial Taxes Department to the company", "terseLabel": "Percentage demanded" } } }, "localname": "PercentageOfPenaltyChargedByCommercialTaxesDepartmentToCompany", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetails" ], "xbrltype": "percentItemType" }, "rdy_PercentageOfWeightedAverageAssetAllocation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of Weighted average asset allocation", "label": "Percentage of Weighted average asset allocation" } } }, "localname": "PercentageOfWeightedAverageAssetAllocation", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails16", "http://www.drreddys.com/role/EmployeeBenefitsDetails7" ], "xbrltype": "percentItemType" }, "rdy_PeriodsWhenCashFlowsExpectedToOccur": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The periods when cash flows are expected to affect profit or loss for cash flow hedges.", "label": "Periods When Cash Flows Expected To Occur", "verboseLabel": "Forecast cash flows classified as cash flow hedges" } } }, "localname": "PeriodsWhenCashFlowsExpectedToOccur", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails4" ], "xbrltype": "monetaryItemType" }, "rdy_PharmaceuticalServicesAndActiveIngredientMember": { "auth_ref": [], "lang": { "en-us": { "role": { "definitionGuidance": "PSAI [Member]", "label": "Pharmaceutical Services and Active Ingredient [Member]", "terseLabel": "Pharmaceutical Services and Active Ingredient [member]" } } }, "localname": "PharmaceuticalServicesAndActiveIngredientMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails1", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails3", "http://www.drreddys.com/role/SegmentReportingDetails3", "http://www.drreddys.com/role/SegmentReportingDetails7" ], "xbrltype": "domainItemType" }, "rdy_PharmaceuticalServicesAndActiveIngredientsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Pharmaceutical Services and Active Ingredients [Member]" } } }, "localname": "PharmaceuticalServicesAndActiveIngredientsMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SegmentReportingDetails" ], "xbrltype": "domainItemType" }, "rdy_PlanAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Plan [Axis]" } } }, "localname": "PlanAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails3", "http://www.drreddys.com/role/ShareCapitalDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_PlanDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Plan [Domain]" } } }, "localname": "PlanDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails3", "http://www.drreddys.com/role/ShareCapitalDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_PlanNameAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_PlanProvidesForStockOptionGrantsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Plan provides for stock option grants [Table]" } } }, "localname": "PlanProvidesForStockOptionGrantsTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails" ], "xbrltype": "stringItemType" }, "rdy_PlantAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Plant and equipment [member]" } } }, "localname": "PlantAndEquipmentMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails", "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetails1", "http://www.drreddys.com/role/SignificantAccountingPoliciesDetails1" ], "xbrltype": "domainItemType" }, "rdy_PollutionCompensationPerAcreFixedForDryLand": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of pollution compensation per acre fixed for dry land.", "label": "Pollution compensation per acre fixed for dry land" } } }, "localname": "PollutionCompensationPerAcreFixedForDryLand", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "perUnitItemType" }, "rdy_PollutionCompensationPerAcreFixedForWetLand": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of pollution compensation per acre fixed for wet land.", "label": "Pollution compensation per acre fixed for wet land" } } }, "localname": "PollutionCompensationPerAcreFixedForWetLand", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "perUnitItemType" }, "rdy_PreshipmentCreditBorrowingsUsdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pre-Shipment Credit Borrowings USD.", "label": "PreShipment Credit Borrowings USD [Member]", "verboseLabel": "Pre-Shipment Credit Borrowings USD [Member]" } } }, "localname": "PreshipmentCreditBorrowingsUsdMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails1" ], "xbrltype": "domainItemType" }, "rdy_PreshipmentCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Preshipment Credit [Member]", "terseLabel": "Pre-shipment credit [Member]" } } }, "localname": "PreshipmentCreditMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails" ], "xbrltype": "domainItemType" }, "rdy_ProductOfTheNumberOfTimesAndTheExcessOfTheMinimumThresholdRevenueOfTheAcquiree": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Product of the number of times and the excess of the minimum threshold revenue of the acquiree.", "label": "Product Of The Number Of Times And The Excess Of The Minimum Threshold Revenue Of The Acquiree", "terseLabel": "Number of times and the product of excess of minimum threshold revenue of the acquiree" } } }, "localname": "ProductOfTheNumberOfTimesAndTheExcessOfTheMinimumThresholdRevenueOfTheAcquiree", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual" ], "xbrltype": "pureItemType" }, "rdy_ProductOrServicesAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Product or service.", "label": "Product Or Services [Axis]" } } }, "localname": "ProductOrServicesAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_ProductOrServicesDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Product or service.", "label": "Product Or Services [Domain]" } } }, "localname": "ProductOrServicesDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_ProfessionalConsultancyServicesPaidRelatedPartyTransactions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Professional consultancy services paid.", "label": "Professional Consultancy Services Paid Related Party Transactions", "terseLabel": "Professional consultancy services paid" } } }, "localname": "ProfessionalConsultancyServicesPaidRelatedPartyTransactions", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "rdy_ProfitTaxImpactMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Profit tax impact.", "label": "Profit Tax Impact [Member]", "terseLabel": "Profit Tax Impact [Member]" } } }, "localname": "ProfitTaxImpactMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_PromiusPharmaLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Promius Pharma LLC [Member]", "terseLabel": "Promius Pharma LLC [member]" } } }, "localname": "PromiusPharmaLlcMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_PropertyPlantAndEquipmentTemporaryDifferenceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, plant and equipment temporary difference [Member]", "verboseLabel": "Property, plant and equipment [Member]" } } }, "localname": "PropertyPlantAndEquipmentTemporaryDifferenceMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails4" ], "xbrltype": "domainItemType" }, "rdy_PropertyPlantAndEquipmentdeferredTaxLiabilityAssetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, plant and equipmentDeferred Tax Liability Asset [Member]", "verboseLabel": "Property, plant and equipment [Member]" } } }, "localname": "PropertyPlantAndEquipmentdeferredTaxLiabilityAssetMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails5" ], "xbrltype": "domainItemType" }, "rdy_PropertyPlantAndEquipmentsIncludingCapitalWorkInProgressAndIntangibleAssetsAcquiredOtherThanGoodwillArisingOnBusinessCombination": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of property, plant and equipment including capital work in progress and intangible assets acquired, other than goodwill arising on business combination", "label": "Property, plant and equipments including capital work in progress and intangible assets acquired, other than goodwill arising on business combination" } } }, "localname": "PropertyPlantAndEquipmentsIncludingCapitalWorkInProgressAndIntangibleAssetsAcquiredOtherThanGoodwillArisingOnBusinessCombination", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SegmentReportingDetails6" ], "xbrltype": "monetaryItemType" }, "rdy_ProprietaryProductMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Proprietary Product [Member]" } } }, "localname": "ProprietaryProductMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SegmentReportingDetails" ], "xbrltype": "domainItemType" }, "rdy_ProprietaryProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Proprietary Products [Member]", "terseLabel": "Proprietary products" } } }, "localname": "ProprietaryProductsMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherIncomeNetDetailsTextual", "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails1", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetailsTextual", "http://www.drreddys.com/role/SegmentReportingDetails7" ], "xbrltype": "domainItemType" }, "rdy_ProvidentFundBenefitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Provident Fund Benefits [Member]" } } }, "localname": "ProvidentFundBenefitsMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_ProvisionAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Provision [Axis]" } } }, "localname": "ProvisionAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails6", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails7" ], "xbrltype": "stringItemType" }, "rdy_ProvisionForCostOfExpansion": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount represents provision for cost of expansion.", "label": "Provision For Cost Of Expansion" } } }, "localname": "ProvisionForCostOfExpansion", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_ProvisionForTaxDemandFromGstAuthorities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Provision for tax demand from GST authorities.", "label": "Provision For Tax Demand From GST Authorities", "verboseLabel": "Provision For Tax Demand From GST Authorities" } } }, "localname": "ProvisionForTaxDemandFromGstAuthorities", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_ProvisionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Provision [Member]" } } }, "localname": "ProvisionMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails6", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails7" ], "xbrltype": "domainItemType" }, "rdy_PsaiActivePharmaceuticalOperationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PSAI- Active Pharmaceutical Operations [Member]" } } }, "localname": "PsaiActivePharmaceuticalOperationsMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/GoodwillDetails1" ], "xbrltype": "domainItemType" }, "rdy_PurchaseOfSolarPower": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represent the purchase of solar power.", "label": "Purchase of Solar Power", "verboseLabel": "Purchase of Solar power" } } }, "localname": "PurchaseOfSolarPower", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "rdy_RangeOfExercisePriceOfShareOptionsExercisedInShareBasedPaymentArrangement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Range of exercise price of share options exercised in share based payment arrangement", "label": "Range Of Exercise Price Of Share Options Exercised In Share Based Payment Arrangement", "terseLabel": "Range of exercise prices, Exercised during the year" } } }, "localname": "RangeOfExercisePriceOfShareOptionsExercisedInShareBasedPaymentArrangement", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails2" ], "xbrltype": "perShareItemType" }, "rdy_RangeOfExercisePriceOfShareOptionsExpiredForfeitedInShareBasedPaymentArrangement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The range of exercise price of share options expired and forfeited in a share-based payment arrangement.", "label": "Range Of Exercise Price Of Share Options Expired Forfeited In Share based Payment Arrangement", "verboseLabel": "Range of exercise prices, Expired/forfeited during the year" } } }, "localname": "RangeOfExercisePriceOfShareOptionsExpiredForfeitedInShareBasedPaymentArrangement", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails4" ], "xbrltype": "perShareItemType" }, "rdy_RangeOfExercisePriceOfShareOptionsExpiredOrForfeitedShareBasedPaymentArrangement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents exercise price, expired/forfeited during the year.", "label": "Range Of Exercise Price Of Share Options expired Or Forfeited Share Based Payment Arrangement", "terseLabel": "Range of exercise prices,exercised/forfeited during the year" } } }, "localname": "RangeOfExercisePriceOfShareOptionsExpiredOrForfeitedShareBasedPaymentArrangement", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails2" ], "xbrltype": "perShareItemType" }, "rdy_RangesOfExercisePricesForOptionsExpiredForfeitedInSharebasedPaymentArrangement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "commentaryGuidance": "Ranges of exercise prices, Expired/forfeited during the year", "documentation": "Ranges of exercise prices for Options Expired Forfeited In Sharebased Payment Arrangement.", "label": "Ranges of exercise prices for Options Expired Forfeited In Sharebased Payment Arrangement" } } }, "localname": "RangesOfExercisePricesForOptionsExpiredForfeitedInSharebasedPaymentArrangement", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails1" ], "xbrltype": "monetaryItemType" }, "rdy_RangesOfExercisePricesForOutstandingShareOptionsInSharebasedPaymentArrangement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Ranges of exercise prices for outstanding share options in sharebased payment arrangement", "label": "Ranges of exercise prices for outstanding share options in sharebased payment arrangement", "periodEndLabel": "Ranges of exercise prices, Outstanding at the end of the year", "periodStartLabel": "Ranges of exercise prices, Outstanding at the beginning of the year" } } }, "localname": "RangesOfExercisePricesForOutstandingShareOptionsInSharebasedPaymentArrangement", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails1" ], "xbrltype": "monetaryItemType" }, "rdy_RangesOfExercisePricesForShareOptionsExercisableInSharebasedPaymentArrangement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Ranges of exercise prices for share options exercisable in sharebased payment arrangement.", "label": "Ranges Of Exercise Prices For Share Options Exercisable In Sharebased Payment Arrangement", "verboseLabel": "Ranges of exercise prices, Exercisable at the end of the year" } } }, "localname": "RangesOfExercisePricesForShareOptionsExercisableInSharebasedPaymentArrangement", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails1" ], "xbrltype": "monetaryItemType" }, "rdy_RangesOfExercisePricesForShareOptionsExercisedInSharebasedPaymentArrangement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Ranges of exercise prices for share options exercised in sharebased payment arrangement", "label": "Ranges of exercise prices for share options exercised in sharebased payment arrangement", "verboseLabel": "Ranges of exercise prices, Exercised during the year" } } }, "localname": "RangesOfExercisePricesForShareOptionsExercisedInSharebasedPaymentArrangement", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails1" ], "xbrltype": "monetaryItemType" }, "rdy_RangesOfExercisePricesForShareOptionsGrantedInSharebasedPaymentArrangement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Ranges of exercise prices for share options granted in sharebased payment arrangement.", "label": "Ranges of exercise prices for share options granted in sharebased payment arrangement", "verboseLabel": "Ranges of exercise prices, Granted during the year" } } }, "localname": "RangesOfExercisePricesForShareOptionsGrantedInSharebasedPaymentArrangement", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails1" ], "xbrltype": "monetaryItemType" }, "rdy_RebatesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Rebates [Member]" } } }, "localname": "RebatesMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails6" ], "xbrltype": "domainItemType" }, "rdy_RecognisedDirectlyInEquityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Recognised directly in Equity [Member]", "terseLabel": "Unrealised gain/(loss) [member]" } } }, "localname": "RecognisedDirectlyInEquityMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherInvestmentsDetails" ], "xbrltype": "domainItemType" }, "rdy_RecognitionOfPreviouslyUnrecognisedDeferredTaxAssetsOrUnrecognisedDeferredTaxAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "It represents the amount of recognition of previously unrecognized deferred tax assets or unrecognised deferred tax assets.", "label": "Recognition of previously unrecognised deferred tax assets or unrecognised deferred tax assets", "negatedLabel": "Unrecognized deferred tax assets/(recognition of previously unrecognized deferred tax assets, net)" } } }, "localname": "RecognitionOfPreviouslyUnrecognisedDeferredTaxAssetsOrUnrecognisedDeferredTaxAssets", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails2" ], "xbrltype": "monetaryItemType" }, "rdy_ReconciliationBetweenEnactedAndEffectiveTaxRatesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of reconciliation between enacted and effective tax rates.", "label": "Reconciliation Between Enacted and Effective Tax Rates [Table Text Block]" } } }, "localname": "ReconciliationBetweenEnactedAndEffectiveTaxRatesTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "rdy_ReconciliationOfEffectiveTaxRateAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Reconciliation of effective tax rate [Abstract]", "verboseLabel": "Effect of:" } } }, "localname": "ReconciliationOfEffectiveTaxRateAbstract", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails2" ], "xbrltype": "stringItemType" }, "rdy_ReddyHoldingGmbhMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Reddy Holding GmbH [Member]", "terseLabel": "Reddy Holding GmbH [member]" } } }, "localname": "ReddyHoldingGmbhMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_ReddyNetherlandsBvMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Reddy Netherlands B.V. [Member]", "terseLabel": "Reddy Netherlands B.V. [member]" } } }, "localname": "ReddyNetherlandsBvMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_ReddyPharmaIberiaSauMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Reddy Pharma Iberia SAU [Member]", "terseLabel": "Reddy Pharma Iberia S.A.U [member]" } } }, "localname": "ReddyPharmaIberiaSauMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_ReddyPharmaItaliaSrlMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Reddy Pharma Italia S.R.L. [Member]", "terseLabel": "Reddy Pharma Italia S.R.L. [member]" } } }, "localname": "ReddyPharmaItaliaSrlMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_ReddyPharmasSasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Reddy Pharmas SAS [Member]", "terseLabel": "Reddy Pharma SAS [member]" } } }, "localname": "ReddyPharmasSasMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_RefundLiabilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Refund Liability [Member]" } } }, "localname": "RefundLiabilityMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails6", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails7" ], "xbrltype": "domainItemType" }, "rdy_RegulatoryInspectionOfFacilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Regulatory inspection of facilities abstract.", "label": "Regulatory Inspection Of Facilities [Abstract]" } } }, "localname": "RegulatoryInspectionOfFacilitiesAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_RemeasurementsDueToAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Re-measurements due to [Abstract]", "terseLabel": "Re-measurements due to:" } } }, "localname": "RemeasurementsDueToAbstract", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails12" ], "xbrltype": "stringItemType" }, "rdy_RequisitePeriodForRecognitionOfExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Requisite period for recognition of expense from share-based payment transactions in which goods or services received did not qualify for recognition as assets.", "label": "Requisite period for recognition of expense from share-based payment transactions in which goods or services received did not qualify for recognition as assets" } } }, "localname": "RequisitePeriodForRecognitionOfExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_ResearchAndDevelopmentExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Research and development expenses [Member]", "terseLabel": "Research and development expenses [Member]" } } }, "localname": "ResearchAndDevelopmentExpensesMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/NatureOfExpenseDetails" ], "xbrltype": "domainItemType" }, "rdy_RespiratoryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Respiratory.", "label": "Respiratory [Member]", "terseLabel": "Respiratory", "verboseLabel": "Respiratory [Member]" } } }, "localname": "RespiratoryMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails2", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails3", "http://www.drreddys.com/role/SegmentReportingDetails2", "http://www.drreddys.com/role/SegmentReportingDetails3" ], "xbrltype": "domainItemType" }, "rdy_ReturnOtherThanInterestOnPlanAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount represent the return other than interest on plan assets.", "label": "Return Other Than Interest On Plan Assets", "terseLabel": "Return on plan assets excluding interest on plan assets", "verboseLabel": "Return on plan assets excluding interest on plan assets" } } }, "localname": "ReturnOtherThanInterestOnPlanAssets", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails12", "http://www.drreddys.com/role/EmployeeBenefitsDetails3" ], "xbrltype": "monetaryItemType" }, "rdy_RevenueRecognised": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "It represents of revenue recognised .", "label": "Revenue Recognised", "negatedLabel": "Revenue recognized during the year" } } }, "localname": "RevenueRecognised", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails5" ], "xbrltype": "monetaryItemType" }, "rdy_Revenues": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Revenues.", "label": "Revenues" } } }, "localname": "Revenues", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SegmentReportingDetails4" ], "xbrltype": "monetaryItemType" }, "rdy_ReversalFromSpecialEconomicZoneReinvestmentReserve": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reversal from special economic zone reinvestment reserve.", "label": "Reversal From Special Economic Zone Reinvestment Reserve", "verboseLabel": "Reversal from special economic zone reinvestment reserve" } } }, "localname": "ReversalFromSpecialEconomicZoneReinvestmentReserve", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquityParenthetical" ], "xbrltype": "monetaryItemType" }, "rdy_ReverseStockSplit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of the reverse stock split arrangement.", "label": "Reverse Stock Split" } } }, "localname": "ReverseStockSplit", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_RoundingOfAmountsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rounding of amounts", "label": "Rounding of amounts [Policy Text Block]", "verboseLabel": "Rounding of amounts" } } }, "localname": "RoundingOfAmountsPolicyTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "rdy_RussiaCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Russia Country [Member]", "terseLabel": "Russia [Member]", "verboseLabel": "Russia" } } }, "localname": "RussiaCountryMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails4", "http://www.drreddys.com/role/SegmentReportingDetails4" ], "xbrltype": "domainItemType" }, "rdy_RussianRoublesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Russian Roubles [Member]", "verboseLabel": "Russian roubles [Member]" } } }, "localname": "RussianRoublesMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails4", "http://www.drreddys.com/role/FinancialRiskManagementDetails" ], "xbrltype": "domainItemType" }, "rdy_SalaryGrowthMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Salary growth [Member]", "verboseLabel": "Salary growth" } } }, "localname": "SalaryGrowthMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails13", "http://www.drreddys.com/role/EmployeeBenefitsDetails4" ], "xbrltype": "domainItemType" }, "rdy_SaleOfSpentChemical": { "auth_ref": [], "calculation": { "http://www.drreddys.com/role/OtherIncomeNetDetails": { "order": 2.0, "parentTag": "ifrs-full_OtherOperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gains (losses) on sale of spent chemical.", "label": "Sale of Spent Chemical", "negatedLabel": "Sale of spent chemicals" } } }, "localname": "SaleOfSpentChemical", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "rdy_SalesReturnLiabilityRecognizedAsOfAcquisitionDate": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sales return liability recognized as of acquisition date.", "label": "Sales Return Liability Recognized As Of Acquisition Date", "terseLabel": "Refund liability" } } }, "localname": "SalesReturnLiabilityRecognizedAsOfAcquisitionDate", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "rdy_SaxagliptinMetforminPhentermineAndTopiramateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Saxagliptin Metformin Phentermine And Topiramate [Member]", "terseLabel": "Saxagliptin/metformin and phentermine and topiramate [Member]" } } }, "localname": "SaxagliptinMetforminPhentermineAndTopiramateMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_ScenarioForecastOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Scenario Forecast One [Member].", "label": "Scenario Forecast One [Member]" } } }, "localname": "ScenarioForecastOneMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_ScheduleOfDividendsPayableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Dividends Payable [Abstract]" } } }, "localname": "ScheduleOfDividendsPayableAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_ScheduleOfFinanceExpenseIncomeTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The schedule of finance expense income.", "label": "Schedule of finance expense income [Table Text Block]", "terseLabel": "Finance income, net" } } }, "localname": "ScheduleOfFinanceExpenseIncomeTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinanceIncomeNetTables" ], "xbrltype": "textBlockItemType" }, "rdy_ScheduleOfIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Intangible Assets Acquired as Part of Business Combination [Table]" } } }, "localname": "ScheduleOfIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisInc", "http://www.drreddys.com/role/CollaborationLicenseAndOptionAgreementWithCurisIncTables" ], "xbrltype": "stringItemType" }, "rdy_ScheduleOfMovementOfRefundLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of refund liabilities.", "label": "Schedule Of Movement Of Refund Liabilities Table Text Block", "terseLabel": "Details of refund liabilities [Table Text Block]" } } }, "localname": "ScheduleOfMovementOfRefundLiabilitiesTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesTables" ], "xbrltype": "textBlockItemType" }, "rdy_ScheduleOfOtherLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The schedule of other liabilities.", "label": "Schedule Of Other Liabilities [Table Text Block]", "verboseLabel": "Schedule Of Other Liabilities" } } }, "localname": "ScheduleOfOtherLiabilitiesTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "rdy_ScheduleOfOutstandingBalancesForRelatedPartyTransactionsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The schedule of outstanding balances for related party transactions.", "label": "Schedule of outstanding balances for related party transactions [Table Text Block]" } } }, "localname": "ScheduleOfOutstandingBalancesForRelatedPartyTransactionsTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RelatedPartiesTables" ], "xbrltype": "textBlockItemType" }, "rdy_ScheduleOfRevenueTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of revenue.", "label": "Schedule Of Revenue [Table Text Block]", "terseLabel": "Schedule of Revenue from contracts with customers [Table Text Block]" } } }, "localname": "ScheduleOfRevenueTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesTables" ], "xbrltype": "textBlockItemType" }, "rdy_ScheduleOfWeightedAverageInputsOfFairValueOfOptionsGrantedTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The schedule of weighted average inputs of fair value of options granted.", "label": "Schedule of weighted average inputs of fair value of options granted [Table Text Block]", "terseLabel": "Schedule of weighted average inputs of fair value of options granted" } } }, "localname": "ScheduleOfWeightedAverageInputsOfFairValueOfOptionsGrantedTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansTables" ], "xbrltype": "textBlockItemType" }, "rdy_SecuritiesAcquiredFromSecondaryMarketMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Securities Acquired From Secondary Market [Member]", "terseLabel": "Number of securities to be acquired from secondary market" } } }, "localname": "SecuritiesAcquiredFromSecondaryMarketMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails3" ], "xbrltype": "domainItemType" }, "rdy_SecuritiesAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Securities [Axis]" } } }, "localname": "SecuritiesAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails3" ], "xbrltype": "stringItemType" }, "rdy_SecuritiesClassActionLitigationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Securities Class Action Litigation", "label": "Securities Class Action Litigation [Member]", "verboseLabel": "Securities Class Action Litigation [Member]" } } }, "localname": "SecuritiesClassActionLitigationMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_SecuritiesDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Securities [Domain]" } } }, "localname": "SecuritiesDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails3" ], "xbrltype": "domainItemType" }, "rdy_SecuritiesIssuedByTheCompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Securities Issued By the Company [Member]", "terseLabel": "Number of securities to be issued by the Company" } } }, "localname": "SecuritiesIssuedByTheCompanyMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails3" ], "xbrltype": "domainItemType" }, "rdy_SecurityDepositForExpansionOnTurnover": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents security deposit for expansion on annual turnover.", "label": "Security Deposit For Expansion On Turnover" } } }, "localname": "SecurityDepositForExpansionOnTurnover", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "percentItemType" }, "rdy_SellingGeneralAndAdministrativeExpensesOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Selling, general and administrative expenses one [Member]", "verboseLabel": "Selling, general and administrative expenses [Member]" } } }, "localname": "SellingGeneralAndAdministrativeExpensesOneMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/NatureOfExpenseDetails" ], "xbrltype": "domainItemType" }, "rdy_ServicesReceived": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of services received in related party transactions.", "label": "Services Received", "verboseLabel": "Research and development services received" } } }, "localname": "ServicesReceived", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "rdy_SettlementAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Settlement agreement.", "label": "Settlement Agreement [Member]" } } }, "localname": "SettlementAgreementMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_SettlementAndTransferAgreementDated2February2022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Settlement and Transfer Agreement dated 2 February 2022 .", "label": "Settlement and Transfer Agreement dated 2 February 2022 [Member]" } } }, "localname": "SettlementAndTransferAgreementDated2February2022Member", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_SettlementCompensationHeldInEscrow": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents the\u00a0settlement compensation held in escrow.", "label": "Settlement Compensation Held In Escrow", "terseLabel": "Settlement Compensation held in Escrow" } } }, "localname": "SettlementCompensationHeldInEscrow", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_SettlementCompensationPaid": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents the settlement compensation paid.", "label": "Settlement Compensation Paid" } } }, "localname": "SettlementCompensationPaid", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_SettlementCompensationTowardsMilestonePaymentsNetOfInterestAndFees": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Settlement compensation towards milestone payments net of interest and fees.", "label": "Settlement Compensation Towards Milestone Payments Net Of Interest And Fees", "terseLabel": "Arbitration amount recorded towards milestone payments" } } }, "localname": "SettlementCompensationTowardsMilestonePaymentsNetOfInterestAndFees", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_SharesArisingOutOfOptionsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shares arising out of Options [Axis]" } } }, "localname": "SharesArisingOutOfOptionsAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails1" ], "xbrltype": "stringItemType" }, "rdy_SharesArisingOutOfOptionsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shares arising out of Options [Domain]" } } }, "localname": "SharesArisingOutOfOptionsDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails1" ], "xbrltype": "domainItemType" }, "rdy_SignificantAccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Significant accounting policies [Abstract]" } } }, "localname": "SignificantAccountingPoliciesAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_SignificantOfAccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Significant Of accounting policies [Abstract]" } } }, "localname": "SignificantOfAccountingPoliciesAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_SouthAfricanRandsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "South African Rands [Member]" } } }, "localname": "SouthAfricanRandsMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails4" ], "xbrltype": "domainItemType" }, "rdy_SpecialEconomicZoneReinvestmentReserve": { "auth_ref": [], "calculation": { "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 23.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Special economic zone reinvestment reserve.", "label": "Special Economic Zone Reinvestment Reserve", "verboseLabel": "Special economic zone re-investment reserve" } } }, "localname": "SpecialEconomicZoneReinvestmentReserve", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "rdy_SpecialEconomicZoneReinvestmentReserveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Special economic zone re-investment reserve.", "label": "Special Economic Zone Reinvestment Reserve [Member]" } } }, "localname": "SpecialEconomicZoneReinvestmentReserveMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "domainItemType" }, "rdy_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails2", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails3", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails4", "http://www.drreddys.com/role/OtherIncomeNetDetailsTextual", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails1", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails2", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails3", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails4", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails6", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails7", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails8", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_StatementTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails2", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails3", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails4", "http://www.drreddys.com/role/OtherIncomeNetDetailsTextual", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails1", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails2", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails3", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails4", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails5", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails6", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails7", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetails8", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_StockOptionsActivityUnderThisCategoryLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock options activity under this category [Line Items]" } } }, "localname": "StockOptionsActivityUnderThisCategoryLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails1" ], "xbrltype": "stringItemType" }, "rdy_SubclassificationsOfAssetsLiabilitiesAndEquitiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subclassifications Of Assets Liabilities And Equities [Line Items]", "terseLabel": "Subclassifications Of Assets Liabilities And Equities [Line Items]" } } }, "localname": "SubclassificationsOfAssetsLiabilitiesAndEquitiesLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails", "http://www.drreddys.com/role/OtherAssetsDetails" ], "xbrltype": "stringItemType" }, "rdy_SubclassificationsOfAssetsLiabilitiesAndEquitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subclassifications Of Assets Liabilities And Equities [Table]", "terseLabel": "Subclassifications Of Assets Liabilities And Equities [Table]" } } }, "localname": "SubclassificationsOfAssetsLiabilitiesAndEquitiesTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails", "http://www.drreddys.com/role/FinancialInstrumentsDetailsTextual", "http://www.drreddys.com/role/OtherAssetsDetails" ], "xbrltype": "stringItemType" }, "rdy_SummaryOfDetailedInformationAboutAmountsRecognizedInIncomeStatementForRightofuseAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summary of detailed information about amounts recognized in Income statement for Right-of-Use Assets.", "label": "Summary Of Detailed Information About Amounts Recognized In Income Statement For RightofUse Assets [Table Text Block]", "terseLabel": "Summary of detailed information about amounts recognized in Income statement for Right-of-Use Assets" } } }, "localname": "SummaryOfDetailedInformationAboutAmountsRecognizedInIncomeStatementForRightofuseAssetsTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "rdy_SummaryOfDetailedInformationAboutRightofuseAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summary of detailed information about Right-of-Use Assets.", "label": "Summary Of Detailed Information About RightofUse Assets [Table Text Block]", "terseLabel": "Summary of detailed information about Right-of-Use Assets" } } }, "localname": "SummaryOfDetailedInformationAboutRightofuseAssetsTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "rdy_SuperannuationBenefitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Superannuation Benefits [Member]" } } }, "localname": "SuperannuationBenefitsMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_SupplementalInformationAboutExpenseByNatureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The detailed information about the amount of expenses aggregated according to their nature.", "label": "Supplemental Information About Expense By Nature [Text Block]" } } }, "localname": "SupplementalInformationAboutExpenseByNatureTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/NatureOfExpenseTables" ], "xbrltype": "textBlockItemType" }, "rdy_SupplierAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Supplier", "label": "Supplier [Axis]" } } }, "localname": "SupplierAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_SupplierDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Supplier", "label": "Supplier [Domain]" } } }, "localname": "SupplierDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SubsequentEventsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_SurplusDeficitInPlanTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Surplus Deficit In Plan [Table]" } } }, "localname": "SurplusDeficitInPlanTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails1" ], "xbrltype": "stringItemType" }, "rdy_SvaasWellnessLimitedFormerlyRegkineticsServicesLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Svaas Wellness Limited (formerly Regkinetics Services Limited).", "label": "Svaas Wellness Limited (formerly Regkinetics Services Limited) [Member]", "terseLabel": "Svaas Wellness Limited" } } }, "localname": "SvaasWellnessLimitedFormerlyRegkineticsServicesLimitedMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OrganizationalStructureDetails" ], "xbrltype": "domainItemType" }, "rdy_SwitzerlandCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Switzerland Country [Member]", "verboseLabel": "Switzerland Country [Member]" } } }, "localname": "SwitzerlandCountryMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/SegmentReportingDetails5", "http://www.drreddys.com/role/SegmentReportingDetails6" ], "xbrltype": "domainItemType" }, "rdy_TaxDemandReceivedFromGstAuthorities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Tax demand received from GST authorities.", "label": "Tax Demand Received From GST Authorities", "verboseLabel": "Tax demand received from GST authorities" } } }, "localname": "TaxDemandReceivedFromGstAuthorities", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_TaxExpenseOnDistrubutionOfProfitsBySubsidiary": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "It represents the amount of tax expense on distribution of profits by subsidiary.", "label": "Tax expense on distrubution of profits by subsidiary", "negatedLabel": "Tax expense on distributed/undistributed earnings of subsidiary outside India" } } }, "localname": "TaxExpenseOnDistrubutionOfProfitsBySubsidiary", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails2" ], "xbrltype": "monetaryItemType" }, "rdy_TaxImpactsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Tax Impacts [Axis]" } } }, "localname": "TaxImpactsAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_TaxImpactsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Tax Impacts [Domain]" } } }, "localname": "TaxImpactsDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_TaxableRateLowerThanEnactedTaxRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Taxable rate lower than enacted tax rate.", "label": "Taxable Rate Lower Than Enacted Tax Rate", "terseLabel": "Enacted tax rate" } } }, "localname": "TaxableRateLowerThanEnactedTaxRate", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetailsTextual" ], "xbrltype": "percentItemType" }, "rdy_TermDepositsWithBanksAndBondsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term Deposits with Banks and Bonds [Member].", "label": "Term Deposits with Banks and Bonds [Member]" } } }, "localname": "TermDepositsWithBanksAndBondsMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_TermDepositsWithBanksMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Term deposits with banks [Member]" } } }, "localname": "TermDepositsWithBanksMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherInvestmentsDetails" ], "xbrltype": "domainItemType" }, "rdy_TevaAndAnAffiliateOfAllerganMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Teva and an affiliate of Allergan [Member]" } } }, "localname": "TevaAndAnAffiliateOfAllerganMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetails2" ], "xbrltype": "domainItemType" }, "rdy_TexasAgAndTexasHealthAndHumanServicesCommissionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Texas AG And Texas Health And Human Services Commission [Member]" } } }, "localname": "TexasAgAndTexasHealthAndHumanServicesCommissionMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_TimeBandAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Time Band [Axis]" } } }, "localname": "TimeBandAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails8" ], "xbrltype": "stringItemType" }, "rdy_TimeTakenAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Time Taken [Axis]" } } }, "localname": "TimeTakenAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails5" ], "xbrltype": "stringItemType" }, "rdy_TimeTakenDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Time Taken [Domain]" } } }, "localname": "TimeTakenDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails5" ], "xbrltype": "domainItemType" }, "rdy_TimeTakensAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Time Takens [Axis]" } } }, "localname": "TimeTakensAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails17" ], "xbrltype": "stringItemType" }, "rdy_TimeTakensDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Time Takens [Domain]" } } }, "localname": "TimeTakensDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails17" ], "xbrltype": "domainItemType" }, "rdy_TimesBandDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Times Band [Domain]" } } }, "localname": "TimesBandDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails8" ], "xbrltype": "domainItemType" }, "rdy_TobramycinInhalationSolutionRamelteonAndImiquimodCreamProductMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Tobramycin Inhalation Solution Ramelteon And Imiquimod Cream Product [Member]" } } }, "localname": "TobramycinInhalationSolutionRamelteonAndImiquimodCreamProductMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_TotalAmountApprovedByApercForCollectionRegardingFsaCharges": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total amount approved by APERC for collection regarding FSA charges.", "label": "Total amount approved by APERC for collection regarding FSA charges" } } }, "localname": "TotalAmountApprovedByApercForCollectionRegardingFsaCharges", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_TotalCarryingValueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Total Carrying Value [Member]", "verboseLabel": "Total carrying value [Member]" } } }, "localname": "TotalCarryingValueMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "rdy_TotalFairValueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Total fair Value [Member]", "verboseLabel": "Total fair value [Member]" } } }, "localname": "TotalFairValueMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "rdy_TotalTransferThroughTofromSpecialEconomicZoneReinvestmentReserveOnUtilization": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total transfer through to (from) special economic zone reinvestment reserve on utilization.", "label": "Total Transfer through To From special economic zone reinvestment reserve on utilization", "verboseLabel": "Total (D)" } } }, "localname": "TotalTransferThroughTofromSpecialEconomicZoneReinvestmentReserveOnUtilization", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "rdy_TradeAndOtherPayablesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of trade and other payables.", "label": "Trade And Other Payables [Table Text Block]", "terseLabel": "Trade And Other Payables" } } }, "localname": "TradeAndOtherPayablesTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/TradeAndOtherPayablesTables" ], "xbrltype": "textBlockItemType" }, "rdy_TradeAndOtherReceivablesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Trade And Other Receivables [Line Items]" } } }, "localname": "TradeAndOtherReceivablesLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/TradeAndOtherReceivablesDetails" ], "xbrltype": "stringItemType" }, "rdy_TradeAndOtherReceivablesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Trade And Other Receivables [Table]" } } }, "localname": "TradeAndOtherReceivablesTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/TradeAndOtherReceivablesDetails" ], "xbrltype": "stringItemType" }, "rdy_TradeAndOtherReceivablesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule depicting amounts due from customers for goods and services sold.", "label": "Trade And Other Receivables [Table Text Block]" } } }, "localname": "TradeAndOtherReceivablesTableTextBlock", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/TradeAndOtherReceivablesTables" ], "xbrltype": "textBlockItemType" }, "rdy_TradeAndOtherReceivablesTemporaryDifferenceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Trade and other receivables temporary difference [Member]", "verboseLabel": "Trade and other receivables [Member]" } } }, "localname": "TradeAndOtherReceivablesTemporaryDifferenceMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails4" ], "xbrltype": "domainItemType" }, "rdy_TradeAndOtherReceivablesdeferredTaxLiabilityAssetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Trade and other receivablesDeferred Tax Liability Asset [Member]", "terseLabel": "Trade and other receivables [Member]" } } }, "localname": "TradeAndOtherReceivablesdeferredTaxLiabilityAssetMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails5" ], "xbrltype": "domainItemType" }, "rdy_TradeReceivablesDerecognisedPursuantToSaleToTheBank": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Trade Receivables Derecognised pursuant to sale to the bank.", "label": "Trade Receivables Derecognised Pursuant To Sale To The Bank" } } }, "localname": "TradeReceivablesDerecognisedPursuantToSaleToTheBank", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/TradeAndOtherReceivablesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_TradeReceivablesRecognizedAsOfAcquistionDate": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Trade receivables recognized as of acquistion date.", "label": "Trade Receivables Recognized As Of Acquistion Date", "terseLabel": "Trade receivables" } } }, "localname": "TradeReceivablesRecognizedAsOfAcquistionDate", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "rdy_TransactionTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Transaction Type [Domain]" } } }, "localname": "TransactionTypeDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails1", "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_TransactionTypesAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Transaction Types [Axis]" } } }, "localname": "TransactionTypesAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails1", "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_TransferFromGeneralReserveToDebentureRedemptionReserve": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Transfer from general reserve to debenture redemption reserve.", "label": "Transfer From General Reserve To Debenture Redemption Reserve", "terseLabel": "Transfer to debenture redemption reserve" } } }, "localname": "TransferFromGeneralReserveToDebentureRedemptionReserve", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "rdy_TransferFromSpecialEconomicZoneReserveOnUtilization": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Transfer from special economic zone reserve on utilization.", "label": "Transfer From Special Economic Zone Reserve On Utilization", "verboseLabel": "Transfer from special economic zone re-investment reserve on utilization" } } }, "localname": "TransferFromSpecialEconomicZoneReserveOnUtilization", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "rdy_TransferOfLiabilitiesOnRestructuringOfServices": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Transfer of liabilities on restructuring of services.", "label": "Transfer Of Liabilities On Restructuring Of Services", "verboseLabel": "Transfer of liabilities on restructuring of services" } } }, "localname": "TransferOfLiabilitiesOnRestructuringOfServices", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_TransferOfPlanAssetsOnAccountOfTransferForEmployees": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Transfer of plan assets on account of transfer for employees.", "label": "Transfer Of Plan Assets On Account Of Transfer For Employees", "terseLabel": "Transfer of plan assets on account of transfer for employees" } } }, "localname": "TransferOfPlanAssetsOnAccountOfTransferForEmployees", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_TriggeringEventAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Triggering Event.", "label": "Triggering Event [Axis]" } } }, "localname": "TriggeringEventAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_TriggeringEventDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Triggering Event.", "label": "Triggering Event [Domain]" } } }, "localname": "TriggeringEventDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_TypeOfCashgeneratingUnitsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Type of Cash-generating units [Axis]" } } }, "localname": "TypeOfCashgeneratingUnitsAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/GoodwillDetails1", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetailsTextual" ], "xbrltype": "stringItemType" }, "rdy_TypeOfCashgeneratingUnitsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Type of Cash-generating units [Domain]" } } }, "localname": "TypeOfCashgeneratingUnitsDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/GoodwillDetails1", "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_TypeOfCurrencyAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Type of Currency [Axis]" } } }, "localname": "TypeOfCurrencyAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails4", "http://www.drreddys.com/role/FinancialRiskManagementDetails" ], "xbrltype": "stringItemType" }, "rdy_TypeOfCurrencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Type of Currency [Domain]" } } }, "localname": "TypeOfCurrencyDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails4", "http://www.drreddys.com/role/FinancialRiskManagementDetails" ], "xbrltype": "domainItemType" }, "rdy_TypeOfExpensesByNatureAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Type of Expenses by Nature [Axis]" } } }, "localname": "TypeOfExpensesByNatureAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/NatureOfExpenseDetails", "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual", "http://www.drreddys.com/role/SegmentReportingDetails7" ], "xbrltype": "stringItemType" }, "rdy_UcbIndiaPrivateLimitedAndAffiliatesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UCB India Private Limited and affiliates [Member]" } } }, "localname": "UcbIndiaPrivateLimitedAndAffiliatesMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetails2" ], "xbrltype": "domainItemType" }, "rdy_UkSocialSecuriyPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UK social securiy plan [Member]" } } }, "localname": "UkSocialSecuriyPlanMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_UnrecognizedDeferredTaxAssetsAndLiabilities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of unrecognized deferred tax (liabilities) or assets.", "label": "Unrecognized Deferred Tax Assets And Liabilities", "verboseLabel": "Unrecognized Deferred Tax Assets And Liabilities" } } }, "localname": "UnrecognizedDeferredTaxAssetsAndLiabilities", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetails3" ], "xbrltype": "monetaryItemType" }, "rdy_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Unrecognized tax benefits that would impact effective tax rate.", "label": "Unrecognized Tax Benefits That Would Impact Effective Tax Rate", "terseLabel": "Unrecognized tax benefits that would impact effective tax rate" } } }, "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/IncomeTaxesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_UnutilizedCreditLimitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Unutilized credit limits [Member]" } } }, "localname": "UnutilizedCreditLimitsMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_UpFrontPaymentReceived": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Up front payment received.", "label": "Up Front Payment Received", "terseLabel": "Upfront payment received" } } }, "localname": "UpFrontPaymentReceived", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherIncomeNetDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_UpfrontPaymentReceived": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Upfront payment received.", "label": "Upfront Payment Received", "terseLabel": "Upfront payment received" } } }, "localname": "UpfrontPaymentReceived", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_UpsherSmithLaboratoriesLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UpsherSmith Laboratories LLC [Member]", "terseLabel": "UpsherSmith Laboratories LLC [member]" } } }, "localname": "UpsherSmithLaboratoriesLLCMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_Us401kretirementSavingsPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "US 401kretirement savings Plan [Member]" } } }, "localname": "Us401kretirementSavingsPlanMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_UsDollarsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "US Dollars [Member]" } } }, "localname": "UsDollarsMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails4", "http://www.drreddys.com/role/FinancialRiskManagementDetails" ], "xbrltype": "domainItemType" }, "rdy_ValueOfStockPurchased": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount represents value of shares purchased.", "label": "Value Of Stock Purchased" } } }, "localname": "ValueOfStockPurchased", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_ValueTypeOfFinancialInstrumentAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Value Type Of Financial Instrument [Axis]", "terseLabel": "Value Type Of Financial Instrument [Axis]" } } }, "localname": "ValueTypeOfFinancialInstrumentAxis", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "rdy_ValueTypeOfFinancialInstrumentDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Value Type Of Financial Instrument [Domain]", "terseLabel": "Value Type Of Financial Instrument [Domain]" } } }, "localname": "ValueTypeOfFinancialInstrumentDomain", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "rdy_VatProvisionRecorded": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents the provision for recorded of VAT.", "label": "VAT Provision Recorded" } } }, "localname": "VatProvisionRecorded", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_WarehousingAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warehousing Agreement.", "label": "Warehousing Agreement [Member]" } } }, "localname": "WarehousingAgreementMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_WeightedAverageExercisePriceOfShareOptionsExpiredForfeitedInShareBasedPaymentArrangements": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Exercise Price Of Share Options Expired Forfeited In Share Based Payment Arrangements.", "label": "Weighted Average Exercise Price Of Share Options Expired Forfeited In Share Based Payment Arrangements", "verboseLabel": "Weighted average exercise price, Expired/forfeited during the year" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsExpiredForfeitedInShareBasedPaymentArrangements", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails4" ], "xbrltype": "perShareItemType" }, "rdy_WeightedAverageExercisePriceOfShareOptionsExpiredForfeitedInSharebasedPaymentArrangement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average exercise price of share options expired and forfeited in a share-based payment arrangement.", "label": "Weighted Average Exercise Price Of Share Options Expired Forfeited In Sharebased Payment Arrangement", "verboseLabel": "Weighted average exercise price, Expired/forfeited during the year" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsExpiredForfeitedInSharebasedPaymentArrangement", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails1" ], "xbrltype": "perShareItemType" }, "rdy_WeightedAverageInputsUsedInFairValueOfOptionsGrantedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average inputs used in fair value of options granted [Abstract]" } } }, "localname": "WeightedAverageInputsUsedInFairValueOfOptionsGrantedAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_WeightedAverageInputsUsedInFairValueOfOptionsGrantedLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average inputs used in the fair value of options granted [Line Items]" } } }, "localname": "WeightedAverageInputsUsedInFairValueOfOptionsGrantedLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails5" ], "xbrltype": "stringItemType" }, "rdy_WeightedAverageInputsUsedInFairValueOfOptionsGrantedTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average inputs used in fair value of options granted [Table]" } } }, "localname": "WeightedAverageInputsUsedInFairValueOfOptionsGrantedTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails6" ], "xbrltype": "stringItemType" }, "rdy_WeightedAverageRemainingContractualLifeOfExercisableSharesOptionsAtEnd": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Remaining Contractual Life Of Exercisable Shares Options at the periods end.", "label": "Weighted Average Remaining Contractual Life Of Exercisable Shares Options at the end", "terseLabel": "Weighted average remaining useful life, Exercisable at the end of the year" } } }, "localname": "WeightedAverageRemainingContractualLifeOfExercisableSharesOptionsAtEnd", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails1", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails2", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails4" ], "xbrltype": "decimalItemType" }, "rdy_WeightedAverageRemainingContractualLifeOfGrantedShareOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average remaining contractual life of granted share options.", "label": "Weighted Average Remaining Contractual Life Of Granted Share Options", "terseLabel": "Weighted average remaining useful life, Granted during the year" } } }, "localname": "WeightedAverageRemainingContractualLifeOfGrantedShareOptions", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails1", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails2", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails4" ], "xbrltype": "decimalItemType" }, "rdy_WeightedAverageRemainingContractualLifeOutstandingShareOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual life outstanding share options.", "label": "Weighted Average Remaining Contractual Life Outstanding Share Options", "periodEndLabel": "Weighted average remaining useful life, Outstanding at the end of the year", "periodStartLabel": "Weighted average remaining useful life, Outstanding at the beginning of the year" } } }, "localname": "WeightedAverageRemainingContractualLifeOutstandingShareOptions", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails1", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails2", "http://www.drreddys.com/role/EmployeeStockIncentivePlansDetails4" ], "xbrltype": "decimalItemType" }, "rdy_WeightedaverageAssetAllocationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted-average asset allocation [Abstract]" } } }, "localname": "WeightedaverageAssetAllocationAbstract", "nsuri": "http://www.drreddys.com/20220331", "xbrltype": "stringItemType" }, "rdy_WeightedaverageAssetAllocationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted-average asset allocation [Line Items]" } } }, "localname": "WeightedaverageAssetAllocationLineItems", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails16" ], "xbrltype": "stringItemType" }, "rdy_WeightedaverageAssetAllocationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted-average asset allocation [Table]" } } }, "localname": "WeightedaverageAssetAllocationTable", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails16" ], "xbrltype": "stringItemType" }, "rdy_WockhardtLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Wockhardt Limited.", "label": "Wockhardt Limited [Member]", "terseLabel": "Wockhardt limited [member]" } } }, "localname": "WockhardtLimitedMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetails", "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual", "http://www.drreddys.com/role/EmployeeBenefitsDetailsTextual", "http://www.drreddys.com/role/FinancialInstrumentsDetailsTextual", "http://www.drreddys.com/role/OtherIntangibleAssetsDetails2" ], "xbrltype": "domainItemType" }, "rdy_WorkingCapital": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of working capital.", "label": "Working capital" } } }, "localname": "WorkingCapital", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/FinancialRiskManagementDetailsTextual" ], "xbrltype": "monetaryItemType" }, "rdy_XeglyzeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Xeglyze [Member]", "terseLabel": "Xeglyze [Member]" } } }, "localname": "XeglyzeMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/OtherIntangibleAssetsDetailsTextual" ], "xbrltype": "domainItemType" }, "rdy_Year1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Year 1 [Member]", "verboseLabel": "March 31, 2022" } } }, "localname": "Year1Member", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails8" ], "xbrltype": "domainItemType" }, "rdy_Year2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Year 2 [Member]", "verboseLabel": "March 31, 2023" } } }, "localname": "Year2Member", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails8" ], "xbrltype": "domainItemType" }, "rdy_Year3Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Year 3 [Member]", "verboseLabel": "March 31, 2024" } } }, "localname": "Year3Member", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails8" ], "xbrltype": "domainItemType" }, "rdy_Year4Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Year 4 [Member]", "verboseLabel": "March 31, 2025" } } }, "localname": "Year4Member", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails8" ], "xbrltype": "domainItemType" }, "rdy_Year5Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Year 5 [Member]", "verboseLabel": "March 31, 2026" } } }, "localname": "Year5Member", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails8" ], "xbrltype": "domainItemType" }, "rdy_YearFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Year Five [Member]", "verboseLabel": "March 31, 2027" } } }, "localname": "YearFiveMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails17" ], "xbrltype": "domainItemType" }, "rdy_YearFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Year Four [Member]", "verboseLabel": "March 31, 2026" } } }, "localname": "YearFourMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails17" ], "xbrltype": "domainItemType" }, "rdy_YearOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Year One [Member]", "verboseLabel": "March 31, 2023" } } }, "localname": "YearOneMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails17" ], "xbrltype": "domainItemType" }, "rdy_YearThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Year Three [Member]", "verboseLabel": "March 31, 2025" } } }, "localname": "YearThreeMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails17" ], "xbrltype": "domainItemType" }, "rdy_YearTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Year Two [Member]", "verboseLabel": "March 31, 2024" } } }, "localname": "YearTwoMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails17" ], "xbrltype": "domainItemType" }, "rdy_YearZeroMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Year Zero [Member]", "terseLabel": "During the year ended March 31, 2023 (estimated)" } } }, "localname": "YearZeroMember", "nsuri": "http://www.drreddys.com/20220331", "presentation": [ "http://www.drreddys.com/role/EmployeeBenefitsDetails17" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "stringItemType" }, "srt_CurrencyAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Currency [Axis]" } } }, "localname": "CurrencyAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetails3" ], "xbrltype": "stringItemType" }, "srt_LitigationCaseAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Litigation Case [Axis]" } } }, "localname": "LitigationCaseAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.drreddys.com/role/OtherIncomeNetDetailsTextual" ], "xbrltype": "stringItemType" }, "srt_LitigationCaseTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Litigation Case [Domain]" } } }, "localname": "LitigationCaseTypeDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.drreddys.com/role/OtherIncomeNetDetailsTextual" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.drreddys.com/role/RevenueFromContractsWithCustomersAndTradeReceivablesDetailsTextual", "http://www.drreddys.com/role/SegmentReportingDetailsTextual" ], "xbrltype": "stringItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.drreddys.com/role/ContingenciesDetailsTextual" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetailsTextual", "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetailsTextual" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.drreddys.com/role/LoansAndBorrowingsDetailsTextual", "http://www.drreddys.com/role/PropertyPlantAndEquipmentDetailsTextual" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.drreddys.com/role/BusinessCombinationsDetailsTextual" ], "xbrltype": "stringItemType" } }, "unitCount": 22 } }, "std_ref": { "r0": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "10", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_10_e&doctype=Standard", "URIDate": "2021-03-24" }, "r1": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "102", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_102&doctype=Standard", "URIDate": "2021-03-24" }, "r10": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "106", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106&doctype=Standard", "URIDate": "2021-03-24" }, "r100": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "75", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_75_b&doctype=Standard", "URIDate": "2021-03-24" }, "r101": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Section": "Disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS16_g73-79_TI", "URIDate": "2021-03-24" }, "r102": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "135", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_135_b&doctype=Standard", "URIDate": "2021-03-24" }, "r103": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "138", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_138_a&doctype=Standard", "URIDate": "2021-03-24" }, "r104": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "138", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_138_d&doctype=Standard", "URIDate": "2021-03-24" }, "r105": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "138", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_138&doctype=Standard", "URIDate": "2021-03-24" }, "r106": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "140", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_140_a&doctype=Standard", "URIDate": "2021-03-24" }, "r107": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "141", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_a&doctype=Standard", "URIDate": "2021-03-24" }, "r108": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "141", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_b&doctype=Standard", "URIDate": "2021-03-24" }, "r109": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "141", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_c_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r11": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "107", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_107&doctype=Standard", "URIDate": "2021-03-24" }, "r110": { "Clause": "iii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "141", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_c_iii&doctype=Standard", "URIDate": "2021-03-24" }, "r111": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "141", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_c&doctype=Standard", "URIDate": "2021-03-24" }, "r112": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "141", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_e&doctype=Standard", "URIDate": "2021-03-24" }, "r113": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "141", "Subparagraph": "f", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_f&doctype=Standard", "URIDate": "2021-03-24" }, "r114": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "141", "Subparagraph": "g", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_g&doctype=Standard", "URIDate": "2021-03-24" }, "r115": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "142", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_142&doctype=Standard", "URIDate": "2021-03-24" }, "r116": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "144", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_144&doctype=Standard", "URIDate": "2021-03-24" }, "r117": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "145", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_145&doctype=Standard", "URIDate": "2021-03-24" }, "r118": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "147", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_147_c&doctype=Standard", "URIDate": "2021-03-24" }, "r119": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "5", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_5&doctype=Standard", "URIDate": "2021-03-24" }, "r12": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "108", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_108&doctype=Standard", "URIDate": "2021-03-24" }, "r120": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "53", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_53&doctype=Standard", "URIDate": "2021-03-24" }, "r121": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "57", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_57_a&doctype=Standard", "URIDate": "2021-03-24" }, "r122": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "9", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_9&doctype=Standard", "URIDate": "2021-03-24" }, "r123": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Section": "Scope", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS19_g2-7_TI", "URIDate": "2021-03-24" }, "r124": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "2", "Paragraph": "36", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&anchor=para_36_a&doctype=Standard", "URIDate": "2021-03-24" }, "r125": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "2", "Paragraph": "36", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&anchor=para_36_b&doctype=Standard", "URIDate": "2021-03-24" }, "r126": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "2", "Paragraph": "36", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&anchor=para_36_d&doctype=Standard", "URIDate": "2021-03-24" }, "r127": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "2", "Paragraph": "36", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&anchor=para_36_e&doctype=Standard", "URIDate": "2021-03-24" }, "r128": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "2", "Paragraph": "37", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&anchor=para_37&doctype=Standard", "URIDate": "2021-03-24" }, "r129": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "2", "Section": "Disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS02_g36-39__IAS02_g36-39_TI", "URIDate": "2021-03-24" }, "r13": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "112", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_112_c&doctype=Standard", "URIDate": "2021-03-24" }, "r130": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "20", "Paragraph": "39", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=20&code=ifrs-tx-2021-en-r&anchor=para_39_a&doctype=Standard", "URIDate": "2021-03-24" }, "r131": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "21", "Paragraph": "52", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=21&code=ifrs-tx-2021-en-r&anchor=para_52_a&doctype=Standard", "URIDate": "2021-03-24" }, "r132": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "23", "Paragraph": "26", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=23&code=ifrs-tx-2021-en-r&anchor=para_26_b&doctype=Standard", "URIDate": "2021-03-24" }, "r133": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Paragraph": "17", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_17_a&doctype=Standard", "URIDate": "2021-03-24" }, "r134": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Paragraph": "17", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2021-03-24" }, "r135": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Paragraph": "17", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2021-03-24" }, "r136": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Paragraph": "17", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_17&doctype=Standard", "URIDate": "2021-03-24" }, "r137": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Paragraph": "18", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_18_b&doctype=Standard", "URIDate": "2021-03-24" }, "r138": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Paragraph": "18", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_18&doctype=Standard", "URIDate": "2021-03-24" }, "r139": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Paragraph": "19", "Subparagraph": "f", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_19_f&doctype=Standard", "URIDate": "2021-03-24" }, "r14": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "117", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_117_a&doctype=Standard", "URIDate": "2021-03-24" }, "r140": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Paragraph": "19", "Subparagraph": "g", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_19_g&doctype=Standard", "URIDate": "2021-03-24" }, "r141": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Paragraph": "19", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_19&doctype=Standard", "URIDate": "2021-03-24" }, "r142": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Paragraph": "20", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_20&doctype=Standard", "URIDate": "2021-03-24" }, "r143": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Paragraph": "21", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_21_a&doctype=Standard", "URIDate": "2021-03-24" }, "r144": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Paragraph": "21", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_21_c&doctype=Standard", "URIDate": "2021-03-24" }, "r145": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Section": "Disclosures", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI", "URIDate": "2021-03-24" }, "r146": { "Clause": "iii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "26", "Paragraph": "35", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=26&code=ifrs-tx-2021-en-r&anchor=para_35_b_iii&doctype=Standard", "URIDate": "2021-03-24" }, "r147": { "Clause": "vii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "26", "Paragraph": "35", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=26&code=ifrs-tx-2021-en-r&anchor=para_35_b_vii&doctype=Standard", "URIDate": "2021-03-24" }, "r148": { "Clause": "viii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "26", "Paragraph": "35", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=26&code=ifrs-tx-2021-en-r&anchor=para_35_b_viii&doctype=Standard", "URIDate": "2021-03-24" }, "r149": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "27", "Paragraph": "16", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_16_b_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r15": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "117", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_117_b&doctype=Standard", "URIDate": "2021-03-24" }, "r150": { "Clause": "iii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "27", "Paragraph": "16", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_16_b_iii&doctype=Standard", "URIDate": "2021-03-24" }, "r151": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "27", "Paragraph": "16", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_16_b&doctype=Standard", "URIDate": "2021-03-24" }, "r152": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "27", "Paragraph": "17", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_17_b_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r153": { "Clause": "iii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "27", "Paragraph": "17", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_17_b_iii&doctype=Standard", "URIDate": "2021-03-24" }, "r154": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "27", "Paragraph": "17", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2021-03-24" }, "r155": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "32", "Paragraph": "34", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=32&code=ifrs-tx-2021-en-r&anchor=para_34&doctype=Standard", "URIDate": "2021-03-24" }, "r156": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "32", "Paragraph": "IE33", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=32&code=ifrs-tx-2021-en-r&anchor=para_IE33&doctype=Illustrative%20Examples", "URIDate": "2021-03-24" }, "r157": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "33", "Paragraph": "66", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_66&doctype=Standard", "URIDate": "2021-03-24" }, "r158": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "33", "Paragraph": "67", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_67&doctype=Standard", "URIDate": "2021-03-24" }, "r159": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "33", "Paragraph": "70", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_70_a&doctype=Standard", "URIDate": "2021-03-24" }, "r16": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "117", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_117&doctype=Standard", "URIDate": "2021-03-24" }, "r160": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "33", "Paragraph": "70", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_70_b&doctype=Standard", "URIDate": "2021-03-24" }, "r161": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "33", "Section": "Disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS33_g70-73A_TI", "URIDate": "2021-03-24" }, "r162": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "36", "Paragraph": "126", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_126&doctype=Standard", "URIDate": "2021-03-24" }, "r163": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "36", "Paragraph": "127", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_127&doctype=Standard", "URIDate": "2021-03-24" }, "r164": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "36", "Paragraph": "130", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_130_b&doctype=Standard", "URIDate": "2021-03-24" }, "r165": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "36", "Paragraph": "130", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_130_d_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r166": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "36", "Paragraph": "130", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_130_e&doctype=Standard", "URIDate": "2021-03-24" }, "r167": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "36", "Paragraph": "134", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_134_a&doctype=Standard", "URIDate": "2021-03-24" }, "r168": { "Clause": "iv", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "36", "Paragraph": "134", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_134_d_iv&doctype=Standard", "URIDate": "2021-03-24" }, "r169": { "Clause": "v", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "36", "Paragraph": "134", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_134_d_v&doctype=Standard", "URIDate": "2021-03-24" }, "r17": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "137", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_137_a&doctype=Standard", "URIDate": "2021-03-24" }, "r170": { "Clause": "iv", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "36", "Paragraph": "134", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_134_e_iv&doctype=Standard", "URIDate": "2021-03-24" }, "r171": { "Clause": "v", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "36", "Paragraph": "134", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_134_e_v&doctype=Standard", "URIDate": "2021-03-24" }, "r172": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "36", "Paragraph": "134", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_134&doctype=Standard", "URIDate": "2021-03-24" }, "r173": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "36", "Paragraph": "135", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_135_a&doctype=Standard", "URIDate": "2021-03-24" }, "r174": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "36", "Paragraph": "135", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_135&doctype=Standard", "URIDate": "2021-03-24" }, "r175": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "37", "Paragraph": "84", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&anchor=para_84_a&doctype=Standard", "URIDate": "2021-03-24" }, "r176": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "37", "Paragraph": "84", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&anchor=para_84_b&doctype=Standard", "URIDate": "2021-03-24" }, "r177": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "37", "Paragraph": "84", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&anchor=para_84_c&doctype=Standard", "URIDate": "2021-03-24" }, "r178": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "37", "Paragraph": "84", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&anchor=para_84&doctype=Standard", "URIDate": "2021-03-24" }, "r179": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "37", "Paragraph": "86", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&anchor=para_86&doctype=Standard", "URIDate": "2021-03-24" }, "r18": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "16", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_16&doctype=Standard", "URIDate": "2021-03-24" }, "r180": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "37", "Paragraph": "87", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&anchor=para_87&doctype=Standard", "URIDate": "2021-03-24" }, "r181": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "37", "Section": "Example 10 A court case", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&doctype=Illustrative%20Examples&dita_xref=IAS37_IE_C_ex10__IAS37_IE_C_ex10_TI", "URIDate": "2021-03-24" }, "r182": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "37", "Section": "Example 4 Refunds policy", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&doctype=Illustrative%20Examples&dita_xref=IAS37_IE_C_ex4__IAS37_IE_C_ex4_TI", "URIDate": "2021-03-24" }, "r183": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_a&doctype=Standard", "URIDate": "2021-03-24" }, "r184": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_c&doctype=Standard", "URIDate": "2021-03-24" }, "r185": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e_i&doctype=Standard", "URIDate": "2021-03-24" }, "r186": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r187": { "Clause": "iv", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e_iv&doctype=Standard", "URIDate": "2021-03-24" }, "r188": { "Clause": "vi", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e_vi&doctype=Standard", "URIDate": "2021-03-24" }, "r189": { "Clause": "vii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e_vii&doctype=Standard", "URIDate": "2021-03-24" }, "r19": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "20", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_20_d&doctype=Standard", "URIDate": "2021-03-24" }, "r190": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e&doctype=Standard", "URIDate": "2021-03-24" }, "r191": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "118", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118&doctype=Standard", "URIDate": "2021-03-24" }, "r192": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "119", "Subparagraph": "f", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_119_f&doctype=Standard", "URIDate": "2021-03-24" }, "r193": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "119", "Subparagraph": "g", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_119_g&doctype=Standard", "URIDate": "2021-03-24" }, "r194": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "119", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_119&doctype=Standard", "URIDate": "2021-03-24" }, "r195": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "122", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_122_b&doctype=Standard", "URIDate": "2021-03-24" }, "r196": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "126", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_126&doctype=Standard", "URIDate": "2021-03-24" }, "r197": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Section": "Disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS38_g118-128_TI", "URIDate": "2021-03-24" }, "r198": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "39", "Paragraph": "86", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=39&code=ifrs-tx-2021-en-r&anchor=para_86_b&doctype=Standard", "URIDate": "2021-03-24" }, "r199": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "40", "Paragraph": "32A", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2021-en-r&anchor=para_32A&doctype=Standard", "URIDate": "2021-03-24" }, "r2": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "103", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_103&doctype=Standard", "URIDate": "2021-03-24" }, "r20": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "35", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_35&doctype=Standard", "URIDate": "2021-03-24" }, "r200": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "40", "Paragraph": "76", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2021-en-r&anchor=para_76&doctype=Standard", "URIDate": "2021-03-24" }, "r201": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "40", "Paragraph": "79", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2021-en-r&anchor=para_79_c&doctype=Standard", "URIDate": "2021-03-24" }, "r202": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "40", "Paragraph": "79", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2021-en-r&anchor=para_79_d&doctype=Standard", "URIDate": "2021-03-24" }, "r203": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "41", "Paragraph": "50", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=41&code=ifrs-tx-2021-en-r&anchor=para_50&doctype=Standard", "URIDate": "2021-03-24" }, "r204": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "41", "Paragraph": "54", "Subparagraph": "f", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=41&code=ifrs-tx-2021-en-r&anchor=para_54_f&doctype=Standard", "URIDate": "2021-03-24" }, "r205": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "41", "Paragraph": "55", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=41&code=ifrs-tx-2021-en-r&anchor=para_55&doctype=Standard", "URIDate": "2021-03-24" }, "r206": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "10", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_10&doctype=Standard", "URIDate": "2021-03-24" }, "r207": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "14", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_14&doctype=Standard", "URIDate": "2021-03-24" }, "r208": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "16", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_16_a&doctype=Standard", "URIDate": "2021-03-24" }, "r209": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "16", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_16_b&doctype=Standard", "URIDate": "2021-03-24" }, "r21": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_a&doctype=Standard", "URIDate": "2021-03-24" }, "r210": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "16", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_16&doctype=Standard", "URIDate": "2021-03-24" }, "r211": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "17", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2021-03-24" }, "r212": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "17", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17_c&doctype=Standard", "URIDate": "2021-03-24" }, "r213": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "17", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17_d&doctype=Standard", "URIDate": "2021-03-24" }, "r214": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "17", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17&doctype=Standard", "URIDate": "2021-03-24" }, "r215": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "18", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_18_b&doctype=Standard", "URIDate": "2021-03-24" }, "r216": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "20", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20_a&doctype=Standard", "URIDate": "2021-03-24" }, "r217": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "20", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20_b&doctype=Standard", "URIDate": "2021-03-24" }, "r218": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "20", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20&doctype=Standard", "URIDate": "2021-03-24" }, "r219": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "25", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_25&doctype=Standard", "URIDate": "2021-03-24" }, "r22": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_c&doctype=Standard", "URIDate": "2021-03-24" }, "r220": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "28", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_28&doctype=Standard", "URIDate": "2021-03-24" }, "r221": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "31", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_31&doctype=Standard", "URIDate": "2021-03-24" }, "r222": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "35", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35&doctype=Standard", "URIDate": "2021-03-24" }, "r223": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "39", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_39&doctype=Standard", "URIDate": "2021-03-24" }, "r224": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "40", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_40_a&doctype=Standard", "URIDate": "2021-03-24" }, "r225": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "44B", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_44B_c&doctype=Standard", "URIDate": "2021-03-24" }, "r226": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "44B", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_44B&doctype=Standard", "URIDate": "2021-03-24" }, "r227": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "44C", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_44C&doctype=Standard", "URIDate": "2021-03-24" }, "r228": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "44D", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_44D&doctype=Standard", "URIDate": "2021-03-24" }, "r229": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "45", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_45&doctype=Standard", "URIDate": "2021-03-24" }, "r23": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_d&doctype=Standard", "URIDate": "2021-03-24" }, "r230": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "50", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_50_a&doctype=Standard", "URIDate": "2021-03-24" }, "r231": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "50", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_50_d&doctype=Standard", "URIDate": "2021-03-24" }, "r232": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Section": "A Statement of cash flows for an entity other than a financial institution", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_A__IAS07_IE_A_TI", "URIDate": "2021-03-24" }, "r233": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Section": "C Reconciliation of liabilities arising from financing activities", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_C__IAS07_IE_C_TI", "URIDate": "2021-03-24" }, "r234": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "8", "Paragraph": "28", "Subparagraph": "f", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_f_i&doctype=Standard", "URIDate": "2021-03-24" }, "r235": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "8", "Paragraph": "29", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=8&code=ifrs-tx-2021-en-r&anchor=para_29_c_i&doctype=Standard", "URIDate": "2021-03-24" }, "r236": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "8", "Paragraph": "49", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=8&code=ifrs-tx-2021-en-r&anchor=para_49_b_i&doctype=Standard", "URIDate": "2021-03-24" }, "r237": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "1", "Paragraph": "24", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_24_a&doctype=Standard", "URIDate": "2021-03-24" }, "r238": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "1", "Paragraph": "24", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_24_b&doctype=Standard", "URIDate": "2021-03-24" }, "r239": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "1", "Paragraph": "24", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_24&doctype=Standard", "URIDate": "2021-03-24" }, "r24": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_e&doctype=Standard", "URIDate": "2021-03-24" }, "r240": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "1", "Paragraph": "32", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_32_a_i&doctype=Standard", "URIDate": "2021-03-24" }, "r241": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "1", "Paragraph": "32", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_32_a_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r242": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "1", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_1&doctype=Standard", "URIDate": "2021-03-24" }, "r243": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "12", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_12_b&doctype=Standard", "URIDate": "2021-03-24" }, "r244": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "12", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_12_c&doctype=Standard", "URIDate": "2021-03-24" }, "r245": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "19B", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_19B_b&doctype=Standard", "URIDate": "2021-03-24" }, "r246": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "19B", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_19B_c&doctype=Standard", "URIDate": "2021-03-24" }, "r247": { "Clause": "iv", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "21", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_21_a_iv&doctype=Standard", "URIDate": "2021-03-24" }, "r248": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B10", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r249": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r25": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "g", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_g&doctype=Standard", "URIDate": "2021-03-24" }, "r250": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r251": { "Clause": "iii", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r252": { "Clause": "iv", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r253": { "Clause": "ix", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r254": { "Clause": "v", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r255": { "Clause": "viii", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r256": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B13", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r257": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B13", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_d&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r258": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B13", "Subparagraph": "f", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_f&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r259": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B13", "Subparagraph": "g", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r26": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "h", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_h&doctype=Standard", "URIDate": "2021-03-24" }, "r260": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B16", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B16&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r261": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B23", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B23_c&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r262": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B4", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r263": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B4", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B4_b&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r264": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B4", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B4_e&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r265": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "13", "Paragraph": "93", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_a&doctype=Standard", "URIDate": "2021-03-24" }, "r266": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "13", "Paragraph": "93", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_b&doctype=Standard", "URIDate": "2021-03-24" }, "r267": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "13", "Paragraph": "93", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_e&doctype=Standard", "URIDate": "2021-03-24" }, "r268": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "13", "Paragraph": "93", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93&doctype=Standard", "URIDate": "2021-03-24" }, "r269": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "13", "Paragraph": "94", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_94&doctype=Standard", "URIDate": "2021-03-24" }, "r27": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "i", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_i&doctype=Standard", "URIDate": "2021-03-24" }, "r270": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "13", "Paragraph": "B6", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_B6&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r271": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "13", "Paragraph": "IE60", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_IE60&doctype=Illustrative%20Examples", "URIDate": "2021-03-24" }, "r272": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "13", "Paragraph": "IE63", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_IE63&doctype=Illustrative%20Examples", "URIDate": "2021-03-24" }, "r273": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "13", "Section": "Disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS13_g91-99_TI", "URIDate": "2021-03-24" }, "r274": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "14", "Paragraph": "33", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2021-en-r&anchor=para_33_b&doctype=Standard", "URIDate": "2021-03-24" }, "r275": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "15", "Paragraph": "105", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_105&doctype=Standard", "URIDate": "2021-03-24" }, "r276": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "15", "Paragraph": "115", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_115&doctype=Standard", "URIDate": "2021-03-24" }, "r277": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "15", "Paragraph": "116", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_116_a&doctype=Standard", "URIDate": "2021-03-24" }, "r278": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "15", "Paragraph": "120", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_120_b_i&doctype=Standard", "URIDate": "2021-03-24" }, "r279": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "15", "Paragraph": "B89", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_B89_a&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r28": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "j", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_j&doctype=Standard", "URIDate": "2021-03-24" }, "r280": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "15", "Paragraph": "B89", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_B89_b&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r281": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "47", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2021-03-24" }, "r282": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "53", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_a&doctype=Standard", "URIDate": "2021-03-24" }, "r283": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "53", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_b&doctype=Standard", "URIDate": "2021-03-24" }, "r284": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "53", "Subparagraph": "g", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_g&doctype=Standard", "URIDate": "2021-03-24" }, "r285": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "53", "Subparagraph": "h", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_h&doctype=Standard", "URIDate": "2021-03-24" }, "r286": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "53", "Subparagraph": "j", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_j&doctype=Standard", "URIDate": "2021-03-24" }, "r287": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "53", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53&doctype=Standard", "URIDate": "2021-03-24" }, "r288": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "58", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_58&doctype=Standard", "URIDate": "2021-03-24" }, "r289": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "94", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_94&doctype=Standard", "URIDate": "2021-03-24" }, "r29": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "k", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_k&doctype=Standard", "URIDate": "2021-03-24" }, "r290": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "97", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_97&doctype=Standard", "URIDate": "2021-03-24" }, "r291": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "44", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_44&doctype=Standard", "URIDate": "2021-03-24" }, "r292": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_i&doctype=Standard", "URIDate": "2021-03-24" }, "r293": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r294": { "Clause": "iv", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_iv&doctype=Standard", "URIDate": "2021-03-24" }, "r295": { "Clause": "v", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_v&doctype=Standard", "URIDate": "2021-03-24" }, "r296": { "Clause": "vi", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_vi&doctype=Standard", "URIDate": "2021-03-24" }, "r297": { "Clause": "vii", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_vii&doctype=Standard", "URIDate": "2021-03-24" }, "r298": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_c&doctype=Standard", "URIDate": "2021-03-24" }, "r299": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_d&doctype=Standard", "URIDate": "2021-03-24" }, "r3": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "104", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_104&doctype=Standard", "URIDate": "2021-03-24" }, "r30": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "m", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_m&doctype=Standard", "URIDate": "2021-03-24" }, "r300": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45&doctype=Standard", "URIDate": "2021-03-24" }, "r301": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "47", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_47_a_i&doctype=Standard", "URIDate": "2021-03-24" }, "r302": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "47", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_47_a&doctype=Standard", "URIDate": "2021-03-24" }, "r303": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_c&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r304": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "Subparagraph": "f", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_f_i&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r305": { "Clause": "iii", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "Subparagraph": "f", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_f_iii&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r306": { "Clause": "iv", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "Subparagraph": "f", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_f_iv&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r307": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "Subparagraph": "f", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_f&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r308": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "Subparagraph": "g", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_g_i&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r309": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "Subparagraph": "i", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_i&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r31": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "n", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_n&doctype=Standard", "URIDate": "2021-03-24" }, "r310": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "Subparagraph": "m", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_m&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r311": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "Subparagraph": "q", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_q_i&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r312": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r313": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B67", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B67_c&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r314": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B67", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B67_d_ii&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r315": { "Clause": "v", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B67", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B67_d_v&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r316": { "Clause": "vi", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B67", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B67_d_vi&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r317": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B67", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r318": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B67", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B67&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r319": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "IE72", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_IE72&doctype=Illustrative%20Examples", "URIDate": "2021-03-24" }, "r32": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "o", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_o&doctype=Standard", "URIDate": "2021-03-24" }, "r320": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Section": "Disclosures", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS03_g59-63__IFRS03_g59-63_TI", "URIDate": "2021-03-24" }, "r321": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Section": "Disclosures application of paragraphs 59 and 61", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&doctype=Appendix&subtype=B&dita_xref=IFRS03_gB64-B67_TI", "URIDate": "2021-03-24" }, "r322": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "5", "Paragraph": "33", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2021-en-r&anchor=para_33_b_i&doctype=Standard", "URIDate": "2021-03-24" }, "r323": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "11A", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_11A_c&doctype=Standard", "URIDate": "2021-03-24" }, "r324": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "21C", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_21C&doctype=Standard", "URIDate": "2021-03-24" }, "r325": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "23A", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_23A&doctype=Standard", "URIDate": "2021-03-24" }, "r326": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "23B", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_23B_a&doctype=Standard", "URIDate": "2021-03-24" }, "r327": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "24A", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_24A_d&doctype=Standard", "URIDate": "2021-03-24" }, "r328": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "24A", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_24A&doctype=Standard", "URIDate": "2021-03-24" }, "r329": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "24B", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_24B&doctype=Standard", "URIDate": "2021-03-24" }, "r33": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "55", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_55&doctype=Standard", "URIDate": "2021-03-24" }, "r330": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "24C", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_24C_b_i&doctype=Standard", "URIDate": "2021-03-24" }, "r331": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "24C", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_24C&doctype=Standard", "URIDate": "2021-03-24" }, "r332": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "24E", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_24E_a&doctype=Standard", "URIDate": "2021-03-24" }, "r333": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "25", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_25&doctype=Standard", "URIDate": "2021-03-24" }, "r334": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "31", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_31&doctype=Standard", "URIDate": "2021-03-24" }, "r335": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "33", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_33&doctype=Standard", "URIDate": "2021-03-24" }, "r336": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "34", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_34&doctype=Standard", "URIDate": "2021-03-24" }, "r337": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "35H", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35H&doctype=Standard", "URIDate": "2021-03-24" }, "r338": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "35I", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35I&doctype=Standard", "URIDate": "2021-03-24" }, "r339": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "35K", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35K&doctype=Standard", "URIDate": "2021-03-24" }, "r34": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "56", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_56&doctype=Standard", "URIDate": "2021-03-24" }, "r340": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "35M", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35M&doctype=Standard", "URIDate": "2021-03-24" }, "r341": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "35N", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35N&doctype=Standard", "URIDate": "2021-03-24" }, "r342": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "36", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_36&doctype=Standard", "URIDate": "2021-03-24" }, "r343": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "39", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_39&doctype=Standard", "URIDate": "2021-03-24" }, "r344": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "42E", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_42E_e&doctype=Standard", "URIDate": "2021-03-24" }, "r345": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "42I", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_42I&doctype=Standard", "URIDate": "2021-03-24" }, "r346": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "6", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_6&doctype=Standard", "URIDate": "2021-03-24" }, "r347": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "7", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_7&doctype=Standard", "URIDate": "2021-03-24" }, "r348": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "8", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_8_a&doctype=Standard", "URIDate": "2021-03-24" }, "r349": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "8", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_8_e&doctype=Standard", "URIDate": "2021-03-24" }, "r35": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "61", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_61_a&doctype=Standard", "URIDate": "2021-03-24" }, "r350": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "8", "Subparagraph": "h", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_8_h&doctype=Standard", "URIDate": "2021-03-24" }, "r351": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "8", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_8&doctype=Standard", "URIDate": "2021-03-24" }, "r352": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "B11", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B11_a&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r353": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "B11", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B11_b&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r354": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "B11", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B11&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r355": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "B11D", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B11D_a&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r356": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "B33", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B33&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r357": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "B35", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35_a&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r358": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "B35", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35_b&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r359": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "B35", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35_c&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r36": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "61", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_61_b&doctype=Standard", "URIDate": "2021-03-24" }, "r360": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "B35", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35_d&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r361": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "B35", "Subparagraph": "g", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35_g&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r362": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "B35", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r363": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "B52", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B52&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r364": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "IG31A", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance", "URIDate": "2021-03-24" }, "r365": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "IG40B", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_IG40B&doctype=Implementation%20Guidance", "URIDate": "2021-03-24" }, "r366": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Section": "Scope", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS07_g3-5A_TI", "URIDate": "2021-03-24" }, "r367": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "23", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_a&doctype=Standard", "URIDate": "2021-03-24" }, "r368": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "23", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_d&doctype=Standard", "URIDate": "2021-03-24" }, "r369": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "23", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_e&doctype=Standard", "URIDate": "2021-03-24" }, "r37": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "61", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_61&doctype=Standard", "URIDate": "2021-03-24" }, "r370": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "23", "Subparagraph": "h", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_h&doctype=Standard", "URIDate": "2021-03-24" }, "r371": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "23", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23&doctype=Standard", "URIDate": "2021-03-24" }, "r372": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "24", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_24_a&doctype=Standard", "URIDate": "2021-03-24" }, "r373": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_a&doctype=Standard", "URIDate": "2021-03-24" }, "r374": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2021-03-24" }, "r375": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_c&doctype=Standard", "URIDate": "2021-03-24" }, "r376": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_d&doctype=Standard", "URIDate": "2021-03-24" }, "r377": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_e&doctype=Standard", "URIDate": "2021-03-24" }, "r378": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "28", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28&doctype=Standard", "URIDate": "2021-03-24" }, "r379": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "32", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_32&doctype=Standard", "URIDate": "2021-03-24" }, "r38": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "66", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_66&doctype=Standard", "URIDate": "2021-03-24" }, "r380": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "33", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_33_a&doctype=Standard", "URIDate": "2021-03-24" }, "r381": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "33", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_33_b&doctype=Standard", "URIDate": "2021-03-24" }, "r382": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "33", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_33&doctype=Standard", "URIDate": "2021-03-24" }, "r383": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "34", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_34&doctype=Standard", "URIDate": "2021-03-24" }, "r384": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Section": "Disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS08_g20-24_TI", "URIDate": "2021-03-24" }, "r385": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "9", "Paragraph": "6.5.11", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2021-en-r&anchor=para_6.5.11&doctype=Standard", "URIDate": "2021-03-24" }, "r386": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "9", "Paragraph": "6.5.16", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2021-en-r&anchor=para_6.5.16&doctype=Standard", "URIDate": "2021-03-24" }, "r387": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "9", "Paragraph": "7.2.34", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2021-en-r&anchor=para_7.2.34&doctype=Standard", "URIDate": "2021-03-24" }, "r388": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "109", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_109&doctype=Standard", "URIDate": "2021-03-24" }, "r389": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "109A", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_109A&doctype=Standard", "URIDate": "2021-03-24" }, "r39": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "68", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_68&doctype=Standard", "URIDate": "2021-03-24" }, "r390": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "113", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_113_b&doctype=Standard", "URIDate": "2021-03-24" }, "r391": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "120", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_120&doctype=Standard", "URIDate": "2021-03-24" }, "r392": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "124", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_124&doctype=Standard", "URIDate": "2021-03-24" }, "r393": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "125", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_125&doctype=Standard", "URIDate": "2021-03-24" }, "r394": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "127", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_127&doctype=Standard", "URIDate": "2021-03-24" }, "r395": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "128", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_128_a&doctype=Standard", "URIDate": "2021-03-24" }, "r396": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "132", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_132_b&doctype=Standard", "URIDate": "2021-03-24" }, "r397": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "96", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_96_b&doctype=Standard", "URIDate": "2021-03-24" }, "r398": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "96", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_96_c&doctype=Standard", "URIDate": "2021-03-24" }, "r399": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "C32", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_C32&doctype=Appendix&subtype=C", "URIDate": "2021-03-24" }, "r4": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_a&doctype=Standard", "URIDate": "2021-03-24" }, "r40": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "69", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_69&doctype=Standard", "URIDate": "2021-03-24" }, "r400": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "9", "Paragraph": "7.2.42", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2021-en-r&anchor=para_7.2.42&doctype=Standard", "URIDate": "2021-03-24" }, "r401": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective on first application of IFRS 9", "Number": "4", "Paragraph": "39L", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2021-en-b&anchor=para_39L_b&doctype=Standard", "URIDate": "2021-03-24" }, "r402": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective on first application of IFRS 9", "Number": "4", "Paragraph": "39L", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2021-en-b&anchor=para_39L_e&doctype=Standard", "URIDate": "2021-03-24" }, "r403": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective on first application of IFRS 9", "Number": "4", "Paragraph": "39M", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2021-en-b&anchor=para_39M&doctype=Standard", "URIDate": "2021-03-24" }, "r404": { "IssueDate": "2021-01-01", "Name": "IAS", "Note": "Expiry date 2023-01-01", "Number": "1", "Paragraph": "90", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2017-en-b&anchor=para_90&doctype=Standard&forcepdf=true", "URIDate": "2021-03-24" }, "r405": { "IssueDate": "2021-01-01", "Name": "IAS", "Note": "Expiry date 2023-01-01", "Number": "12", "Paragraph": "81", "Subparagraph": "ab", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2017-en-b&anchor=para_81_ab&doctype=Standard&forcepdf=true", "URIDate": "2021-03-24" }, "r406": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "4", "Paragraph": "39J", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2021-en-b&anchor=para_39J&doctype=Standard&book=b", "URIDate": "2021-03-24" }, "r407": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "16", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_16&doctype=Standard&book=b", "URIDate": "2021-03-24" }, "r408": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "22", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_22&doctype=Standard&book=b", "URIDate": "2021-03-24" }, "r409": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "23", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_23_c&doctype=Standard&book=b", "URIDate": "2021-03-24" }, "r41": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "7", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_7&doctype=Standard", "URIDate": "2021-03-24" }, "r410": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "37", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37_a&doctype=Standard&book=b", "URIDate": "2021-03-24" }, "r411": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "37", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37_b&doctype=Standard&book=b", "URIDate": "2021-03-24" }, "r412": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "37", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37&doctype=Standard&book=b", "URIDate": "2021-03-24" }, "r413": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "8", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_8_d&doctype=Standard&book=b", "URIDate": "2021-03-24" }, "r414": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "IG28", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG28_b&doctype=Implementation%20Guidance&book=b", "URIDate": "2021-03-24" }, "r415": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "IG28", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG28_c&doctype=Implementation%20Guidance&book=b", "URIDate": "2021-03-24" }, "r416": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "IG28", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG28_d&doctype=Implementation%20Guidance&book=b", "URIDate": "2021-03-24" }, "r417": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "IG29", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG29_a&doctype=Implementation%20Guidance&book=b", "URIDate": "2021-03-24" }, "r418": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "IG29", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG29&doctype=Implementation%20Guidance&book=b", "URIDate": "2021-03-24" }, "r419": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r42": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "70", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_70&doctype=Standard", "URIDate": "2021-03-24" }, "r420": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r421": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r422": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r423": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d-3" }, "r424": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r425": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r426": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r427": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r428": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r429": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r43": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2021-03-24" }, "r44": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_c&doctype=Standard", "URIDate": "2021-03-24" }, "r45": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_d&doctype=Standard", "URIDate": "2021-03-24" }, "r46": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2021-03-24" }, "r47": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "78", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78&doctype=Standard", "URIDate": "2021-03-24" }, "r48": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "79", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a_i&doctype=Standard", "URIDate": "2021-03-24" }, "r49": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "79", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r5": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_b&doctype=Standard", "URIDate": "2021-03-24" }, "r50": { "Clause": "iii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "79", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a_iii&doctype=Standard", "URIDate": "2021-03-24" }, "r51": { "Clause": "iv", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "79", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a_iv&doctype=Standard", "URIDate": "2021-03-24" }, "r52": { "Clause": "v", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "79", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a_v&doctype=Standard", "URIDate": "2021-03-24" }, "r53": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "79", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a&doctype=Standard", "URIDate": "2021-03-24" }, "r54": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "81A", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81A_a&doctype=Standard", "URIDate": "2021-03-24" }, "r55": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "81A", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81A_b&doctype=Standard", "URIDate": "2021-03-24" }, "r56": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "81A", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81A_c&doctype=Standard", "URIDate": "2021-03-24" }, "r57": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "82", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_a&doctype=Standard", "URIDate": "2021-03-24" }, "r58": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "82", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_b&doctype=Standard", "URIDate": "2021-03-24" }, "r59": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "82", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_d&doctype=Standard", "URIDate": "2021-03-24" }, "r6": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d_i&doctype=Standard", "URIDate": "2021-03-24" }, "r60": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "82A", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82A&doctype=Standard", "URIDate": "2021-03-24" }, "r61": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "85", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_85&doctype=Standard", "URIDate": "2021-03-24" }, "r62": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "90", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_90&doctype=Standard", "URIDate": "2021-03-24" }, "r63": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "91", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_91_a&doctype=Standard", "URIDate": "2021-03-24" }, "r64": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "91", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_91_b&doctype=Standard", "URIDate": "2021-03-24" }, "r65": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "91", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_91&doctype=Standard", "URIDate": "2021-03-24" }, "r66": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "98", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_98_a&doctype=Standard", "URIDate": "2021-03-24" }, "r67": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "99", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_99&doctype=Standard", "URIDate": "2021-03-24" }, "r68": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "IG6", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_IG6&doctype=Implementation%20Guidance", "URIDate": "2021-03-24" }, "r69": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "10", "Paragraph": "13", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=10&code=ifrs-tx-2021-en-r&anchor=para_13&doctype=Standard", "URIDate": "2021-03-24" }, "r7": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r70": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "10", "Paragraph": "21", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=10&code=ifrs-tx-2021-en-r&anchor=para_21&doctype=Standard", "URIDate": "2021-03-24" }, "r71": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "10", "Paragraph": "22", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=10&code=ifrs-tx-2021-en-r&anchor=para_22_a&doctype=Standard", "URIDate": "2021-03-24" }, "r72": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "10", "Section": "Disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=10&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS10_g17-22_TI", "URIDate": "2021-03-24" }, "r73": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Paragraph": "79", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_79&doctype=Standard", "URIDate": "2021-03-24" }, "r74": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Paragraph": "80", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_80_a&doctype=Standard", "URIDate": "2021-03-24" }, "r75": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_a&doctype=Standard", "URIDate": "2021-03-24" }, "r76": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "ab", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_ab&doctype=Standard", "URIDate": "2021-03-24" }, "r77": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_c_i&doctype=Standard", "URIDate": "2021-03-24" }, "r78": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_c_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r79": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_e&doctype=Standard", "URIDate": "2021-03-24" }, "r8": { "Clause": "iii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d_iii&doctype=Standard", "URIDate": "2021-03-24" }, "r80": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "g", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_g_i&doctype=Standard", "URIDate": "2021-03-24" }, "r81": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "g", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_g_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r82": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "g", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_g&doctype=Standard", "URIDate": "2021-03-24" }, "r83": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Section": "Disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI", "URIDate": "2021-03-24" }, "r84": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "37", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_37_a&doctype=Standard", "URIDate": "2021-03-24" }, "r85": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "37", "Subparagraph": "g", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_37_g&doctype=Standard", "URIDate": "2021-03-24" }, "r86": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "37", "Subparagraph": "h", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_37_h&doctype=Standard", "URIDate": "2021-03-24" }, "r87": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "37", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_37&doctype=Standard", "URIDate": "2021-03-24" }, "r88": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_c&doctype=Standard", "URIDate": "2021-03-24" }, "r89": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_d&doctype=Standard", "URIDate": "2021-03-24" }, "r9": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d&doctype=Standard", "URIDate": "2021-03-24" }, "r90": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_i&doctype=Standard", "URIDate": "2021-03-24" }, "r91": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r92": { "Clause": "iii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_iii&doctype=Standard", "URIDate": "2021-03-24" }, "r93": { "Clause": "v", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_v&doctype=Standard", "URIDate": "2021-03-24" }, "r94": { "Clause": "vii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_vii&doctype=Standard", "URIDate": "2021-03-24" }, "r95": { "Clause": "viii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_viii&doctype=Standard", "URIDate": "2021-03-24" }, "r96": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e&doctype=Standard", "URIDate": "2021-03-24" }, "r97": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73&doctype=Standard", "URIDate": "2021-03-24" }, "r98": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "74", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_74_c&doctype=Standard", "URIDate": "2021-03-24" }, "r99": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "75", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_75_a&doctype=Standard", "URIDate": "2021-03-24" } }, "version": "2.1" }